BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= 043620
(573 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|D Chain D, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|G Chain G, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|H Chain H, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
Length = 349
Score = 124 bits (312), Expect = 1e-28, Method: Compositional matrix adjust.
Identities = 85/257 (33%), Positives = 127/257 (49%), Gaps = 45/257 (17%)
Query: 356 NLRCFSYKALEEATDNF--KEEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGERE 413
L+ FS + L+ A+DNF K +GRG FG VYKG + L+ ++ Q GE +
Sbjct: 24 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADG--TLVAVKRLKEERXQGGELQ 81
Query: 414 FKNEVFVISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPS----WNLR 469
F+ EV +IS H+NL+RL GFC RLLVY ++ NG++AS L + W R
Sbjct: 82 FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKR 141
Query: 470 TNIAFQIARGLLYLHEDCSSQII--------------------------LYSYKR----- 498
IA ARGL YLH+ C +II L YK
Sbjct: 142 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXX 201
Query: 499 ----TEGYVAPEWFRNSTITAKVDVYSFGFLLLEIISCRKSFDIE--MGEEYAILTDWAF 552
T G++APE+ + K DV+ +G +LLE+I+ +++FD+ ++ +L DW
Sbjct: 202 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 261
Query: 553 DCYRNGKLDDLVEGDME 569
+ KL+ LV+ D++
Sbjct: 262 GLLKEKKLEALVDVDLQ 278
>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On
Plant Receptor- Like Kinase Bak1 Activation
pdb|3ULZ|A Chain A, Crystal Structure Of Apo Bak1
Length = 326
Score = 122 bits (307), Expect = 4e-28, Method: Compositional matrix adjust.
Identities = 84/257 (32%), Positives = 125/257 (48%), Gaps = 45/257 (17%)
Query: 356 NLRCFSYKALEEATDNF--KEEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGERE 413
L+ FS + L+ A+DNF K +GRG FG VYKG + V ++ Q GE +
Sbjct: 16 QLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERT--QGGELQ 73
Query: 414 FKNEVFVISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPS----WNLR 469
F+ EV +IS H+NL+RL GFC RLLVY ++ NG++AS L + W R
Sbjct: 74 FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKR 133
Query: 470 TNIAFQIARGLLYLHEDCSSQII--------------------------LYSYKRTE--- 500
IA ARGL YLH+ C +II L YK
Sbjct: 134 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXX 193
Query: 501 ------GYVAPEWFRNSTITAKVDVYSFGFLLLEIISCRKSFDIE--MGEEYAILTDWAF 552
G++APE+ + K DV+ +G +LLE+I+ +++FD+ ++ +L DW
Sbjct: 194 AVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253
Query: 553 DCYRNGKLDDLVEGDME 569
+ KL+ LV+ D++
Sbjct: 254 GLLKEKKLEALVDVDLQ 270
>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By
Bacterial Effector Protein Avrpto
Length = 321
Score = 115 bits (288), Expect = 6e-26, Method: Compositional matrix adjust.
Identities = 91/267 (34%), Positives = 129/267 (48%), Gaps = 47/267 (17%)
Query: 346 NSPGDGTVETNLRCF-SYKA----LEEATDNFKEE--VGRGSFGIVYKGVIQTTRQVLLQ 398
NS D + L F SY+ LEEAT+NF + +G G FG VYKGV++ +V L+
Sbjct: 10 NSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALK 69
Query: 399 LQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFL 458
R G EF+ E+ +S H +LV L+GFCDE +L+Y+++ NG L L
Sbjct: 70 ---RRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHL 126
Query: 459 FGNLKP----SWNLRTNIAFQIARGLLYL------HEDCSSQIILY-------------S 495
+G+ P SW R I ARGL YL H D S IL S
Sbjct: 127 YGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGIS 186
Query: 496 YKRTE--------------GYVAPEWFRNSTITAKVDVYSFGFLLLEIISCRKSFDIEMG 541
K TE GY+ PE+F +T K DVYSFG +L E++ R + +
Sbjct: 187 KKGTELDQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP 246
Query: 542 EEYAILTDWAFDCYRNGKLDDLVEGDM 568
E L +WA + + NG+L+ +V+ ++
Sbjct: 247 REMVNLAEWAVESHNNGQLEQIVDPNL 273
>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|B Chain B, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|C Chain C, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|D Chain D, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
Length = 327
Score = 115 bits (288), Expect = 7e-26, Method: Compositional matrix adjust.
Identities = 91/267 (34%), Positives = 129/267 (48%), Gaps = 47/267 (17%)
Query: 346 NSPGDGTVETNLRCF-SYKA----LEEATDNFKEE--VGRGSFGIVYKGVIQTTRQVLLQ 398
NS D + L F SY+ LEEAT+NF + +G G FG VYKGV++ +V L+
Sbjct: 10 NSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALK 69
Query: 399 LQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFL 458
R G EF+ E+ +S H +LV L+GFCDE +L+Y+++ NG L L
Sbjct: 70 ---RRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHL 126
Query: 459 FGNLKP----SWNLRTNIAFQIARGLLYL------HEDCSSQIILY-------------S 495
+G+ P SW R I ARGL YL H D S IL S
Sbjct: 127 YGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGIS 186
Query: 496 YKRTE--------------GYVAPEWFRNSTITAKVDVYSFGFLLLEIISCRKSFDIEMG 541
K TE GY+ PE+F +T K DVYSFG +L E++ R + +
Sbjct: 187 KKGTELGQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP 246
Query: 542 EEYAILTDWAFDCYRNGKLDDLVEGDM 568
E L +WA + + NG+L+ +V+ ++
Sbjct: 247 REMVNLAEWAVESHNNGQLEQIVDPNL 273
>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|B Chain B, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|C Chain C, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|D Chain D, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIC|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OID|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
Length = 301
Score = 103 bits (257), Expect = 3e-22, Method: Compositional matrix adjust.
Identities = 74/228 (32%), Positives = 113/228 (49%), Gaps = 45/228 (19%)
Query: 354 ETNLRCFSYKALEEATDNFKE--------EVGRGSFGIVYKGVIQTTRQVLLQLQSRNWI 405
+T FS+ L+ T+NF E ++G G FG+VYKG + T + +L + I
Sbjct: 3 DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDI 62
Query: 406 VFQDGEREFKNEVFVISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTL---ASFLFGNL 462
++ +++F E+ V+++ H+NLV LLGF +G + LVY ++ NG+L S L G
Sbjct: 63 TTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTP 122
Query: 463 KPSWNLRTNIAFQIARGLLYLHEDC-------SSQIIL----------YSYKR------- 498
SW++R IA A G+ +LHE+ S+ I+L + R
Sbjct: 123 PLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 182
Query: 499 ---------TEGYVAPEWFRNSTITAKVDVYSFGFLLLEIISCRKSFD 537
T Y+APE R IT K D+YSFG +LLEII+ + D
Sbjct: 183 XVMXXRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVD 229
>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4
pdb|2NRY|B Chain B, Crystal Structure Of Irak-4
pdb|2NRY|C Chain C, Crystal Structure Of Irak-4
pdb|2NRY|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 103 bits (256), Expect = 3e-22, Method: Compositional matrix adjust.
Identities = 74/228 (32%), Positives = 113/228 (49%), Gaps = 45/228 (19%)
Query: 354 ETNLRCFSYKALEEATDNFKE--------EVGRGSFGIVYKGVIQTTRQVLLQLQSRNWI 405
+T FS+ L+ T+NF E ++G G FG+VYKG + T + +L + I
Sbjct: 9 DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDI 68
Query: 406 VFQDGEREFKNEVFVISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTL---ASFLFGNL 462
++ +++F E+ V+++ H+NLV LLGF +G + LVY ++ NG+L S L G
Sbjct: 69 TTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTP 128
Query: 463 KPSWNLRTNIAFQIARGLLYLHEDC-------SSQIIL----------YSYKR------- 498
SW++R IA A G+ +LHE+ S+ I+L + R
Sbjct: 129 PLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 499 ---------TEGYVAPEWFRNSTITAKVDVYSFGFLLLEIISCRKSFD 537
T Y+APE R IT K D+YSFG +LLEII+ + D
Sbjct: 189 TVMXSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVD 235
>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4
pdb|2NRU|B Chain B, Crystal Structure Of Irak-4
pdb|2NRU|C Chain C, Crystal Structure Of Irak-4
pdb|2NRU|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 103 bits (256), Expect = 3e-22, Method: Compositional matrix adjust.
Identities = 74/228 (32%), Positives = 113/228 (49%), Gaps = 45/228 (19%)
Query: 354 ETNLRCFSYKALEEATDNFKE--------EVGRGSFGIVYKGVIQTTRQVLLQLQSRNWI 405
+T FS+ L+ T+NF E ++G G FG+VYKG + T + +L + I
Sbjct: 9 DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDI 68
Query: 406 VFQDGEREFKNEVFVISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTL---ASFLFGNL 462
++ +++F E+ V+++ H+NLV LLGF +G + LVY ++ NG+L S L G
Sbjct: 69 TTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTP 128
Query: 463 KPSWNLRTNIAFQIARGLLYLHEDC-------SSQIIL----------YSYKR------- 498
SW++R IA A G+ +LHE+ S+ I+L + R
Sbjct: 129 PLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 499 ---------TEGYVAPEWFRNSTITAKVDVYSFGFLLLEIISCRKSFD 537
T Y+APE R IT K D+YSFG +LLEII+ + D
Sbjct: 189 TVMXXRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVD 235
>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain
pdb|2O8Y|B Chain B, Apo Irak4 Kinase Domain
Length = 298
Score = 97.4 bits (241), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 74/227 (32%), Positives = 107/227 (47%), Gaps = 45/227 (19%)
Query: 355 TNLRCFSYKALEEATDNFKE--------EVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIV 406
T FS+ L+ T+NF E + G G FG+VYKG + T + +L + I
Sbjct: 1 TRFHSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNNTTVAVKKLAAMVDIT 60
Query: 407 FQDGEREFKNEVFVISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTL---ASFLFGNLK 463
++ +++F E+ V ++ H+NLV LLGF +G + LVY + NG+L S L G
Sbjct: 61 TEELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPP 120
Query: 464 PSWNLRTNIAFQIARGLLYLHEDC-------SSQIIL----------YSYKR-------- 498
SW+ R IA A G+ +LHE+ S+ I+L + R
Sbjct: 121 LSWHXRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQX 180
Query: 499 --------TEGYVAPEWFRNSTITAKVDVYSFGFLLLEIISCRKSFD 537
T Y APE R IT K D+YSFG +LLEII+ + D
Sbjct: 181 VXXSRIVGTTAYXAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVD 226
>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol
Length = 315
Score = 72.4 bits (176), Expect = 7e-13, Method: Compositional matrix adjust.
Identities = 67/253 (26%), Positives = 112/253 (44%), Gaps = 55/253 (21%)
Query: 356 NLRCFSYKALEEATDNFKEEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFK 415
+L YK +E +E VGRG+FG+V K + + Q++S + + F
Sbjct: 2 SLHMIDYKEIE-----VEEVVGRGAFGVVCKAKWRAKDVAIKQIES------ESERKAFI 50
Query: 416 NEVFVISQTHHKNLVRLLGFCDEGLNRL-LVYEFLNNGTLASFLFGNLK-PSWNLRTNIA 473
E+ +S+ +H N+V+L G C LN + LV E+ G+L + L G P + ++
Sbjct: 51 VELRQLSRVNHPNIVKLYGAC---LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMS 107
Query: 474 F--QIARGLLYLHE--------------------------------DCSSQIILYSYKRT 499
+ Q ++G+ YLH C Q + + K +
Sbjct: 108 WCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGS 167
Query: 500 EGYVAPEWFRNSTITAKVDVYSFGFLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 559
++APE F S + K DV+S+G +L E+I+ RK FD G + I+ WA NG
Sbjct: 168 AAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM--WAV---HNGT 222
Query: 560 LDDLVEGDMEAID 572
L++ + I+
Sbjct: 223 RPPLIKNLPKPIE 235
>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With
Its Activating Protein Tab1
pdb|2YIY|A Chain A, Crystal Structure Of Compound 8 Bound To Tak1-Tab
Length = 307
Score = 72.0 bits (175), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 67/253 (26%), Positives = 112/253 (44%), Gaps = 55/253 (21%)
Query: 356 NLRCFSYKALEEATDNFKEEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFK 415
+L YK +E +E VGRG+FG+V K + + Q++S + + F
Sbjct: 1 SLHMIDYKEIE-----VEEVVGRGAFGVVCKAKWRAKDVAIKQIES------ESERKAFI 49
Query: 416 NEVFVISQTHHKNLVRLLGFCDEGLNRL-LVYEFLNNGTLASFLFGNLK-PSWNLRTNIA 473
E+ +S+ +H N+V+L G C LN + LV E+ G+L + L G P + ++
Sbjct: 50 VELRQLSRVNHPNIVKLYGAC---LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMS 106
Query: 474 F--QIARGLLYLHE--------------------------------DCSSQIILYSYKRT 499
+ Q ++G+ YLH C Q + + K +
Sbjct: 107 WCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGS 166
Query: 500 EGYVAPEWFRNSTITAKVDVYSFGFLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 559
++APE F S + K DV+S+G +L E+I+ RK FD G + I+ WA NG
Sbjct: 167 AAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM--WAV---HNGT 221
Query: 560 LDDLVEGDMEAID 572
L++ + I+
Sbjct: 222 RPPLIKNLPKPIE 234
>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With
Staurosporine
pdb|3PPZ|B Chain B, Crystal Structure Of Ctr1 Kinase Domain In Complex With
Staurosporine
Length = 309
Score = 64.3 bits (155), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 52/204 (25%), Positives = 88/204 (43%), Gaps = 42/204 (20%)
Query: 371 NFKEEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGER--EFKNEVFVISQTHHKN 428
N KE++G GSFG V++ + + L +++ ER EF EV ++ + H N
Sbjct: 40 NIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDF----HAERVNEFLREVAIMKRLRHPN 95
Query: 429 LVRLLGFCDEGLNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYLH- 484
+V +G + N +V E+L+ G+L L + R ++A+ +A+G+ YLH
Sbjct: 96 IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN 155
Query: 485 -------EDCSSQIILYSYKRT-------------------------EGYVAPEWFRNST 512
D S +L K T ++APE R+
Sbjct: 156 RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWMAPEVLRDEP 215
Query: 513 ITAKVDVYSFGFLLLEIISCRKSF 536
K DVYSFG +L E+ + ++ +
Sbjct: 216 SNEKSDVYSFGVILWELATLQQPW 239
>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a
Resolution.
pdb|1P4O|B Chain B, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a
Resolution
Length = 322
Score = 64.3 bits (155), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 55/205 (26%), Positives = 90/205 (43%), Gaps = 47/205 (22%)
Query: 375 EVGRGSFGIVY----KGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLV 430
E+G+GSFG+VY KGV++ + + +++ N EF NE V+ + + ++V
Sbjct: 32 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 431 RLLGFCDEGLNRLLVYEFLNNGTLASFL------FGN----LKPSWNLRTNIAFQIARGL 480
RLLG +G L++ E + G L S+L N PS + +A +IA G+
Sbjct: 92 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151
Query: 481 LYL------HEDCSSQ--------------------IILYSYKRTEG-------YVAPEW 507
YL H D +++ I Y R G +++PE
Sbjct: 152 AYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPES 211
Query: 508 FRNSTITAKVDVYSFGFLLLEIISC 532
++ T DV+SFG +L EI +
Sbjct: 212 LKDGVFTTYSDVWSFGVVLWEIATL 236
>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|B Chain B, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|C Chain C, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|D Chain D, Igf-1rk In Complex With Ligand Msc1609119a-1
Length = 304
Score = 63.9 bits (154), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 55/204 (26%), Positives = 90/204 (44%), Gaps = 47/204 (23%)
Query: 375 EVGRGSFGIVY----KGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLV 430
E+G+GSFG+VY KGV++ + + +++ N EF NE V+ + + ++V
Sbjct: 22 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 81
Query: 431 RLLGFCDEGLNRLLVYEFLNNGTLASFL------FGN----LKPSWNLRTNIAFQIARGL 480
RLLG +G L++ E + G L S+L N PS + +A +IA G+
Sbjct: 82 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 141
Query: 481 LYL------HEDCSSQ--------------------IILYSYKRTEG-------YVAPEW 507
YL H D +++ I Y R G +++PE
Sbjct: 142 AYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPES 201
Query: 508 FRNSTITAKVDVYSFGFLLLEIIS 531
++ T DV+SFG +L EI +
Sbjct: 202 LKDGVFTTYSDVWSFGVVLWEIAT 225
>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth
Factor-1 Receptor Kinase Domain
pdb|1M7N|B Chain B, Crystal Structure Of Unactivated Apo Insulin-Like Growth
Factor-1 Receptor Kinase Domain
Length = 322
Score = 63.5 bits (153), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 49/206 (23%)
Query: 375 EVGRGSFGIVY----KGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLV 430
E+G+GSFG+VY KGV++ + + +++ N EF NE V+ + + ++V
Sbjct: 32 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 431 RLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLK-----------PSWNLRTNIAFQIARG 479
RLLG +G L++ E + G L S+L +L+ PS + +A +IA G
Sbjct: 92 RLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKMIQMAGEIADG 150
Query: 480 LLYL------HEDCSSQ--------------------IILYSYKRTEG-------YVAPE 506
+ YL H D +++ I Y R G +++PE
Sbjct: 151 MAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 210
Query: 507 WFRNSTITAKVDVYSFGFLLLEIISC 532
++ T DV+SFG +L EI +
Sbjct: 211 SLKDGVFTTYSDVWSFGVVLWEIATL 236
>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain
pdb|1JQH|B Chain B, Igf-1 Receptor Kinase Domain
pdb|1JQH|C Chain C, Igf-1 Receptor Kinase Domain
Length = 308
Score = 63.2 bits (152), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 55/205 (26%), Positives = 92/205 (44%), Gaps = 49/205 (23%)
Query: 375 EVGRGSFGIVY----KGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLV 430
E+G+GSFG+VY KGV++ + + +++ N EF NE V+ + + ++V
Sbjct: 26 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 85
Query: 431 RLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLK-----------PSWNLRTNIAFQIARG 479
RLLG +G L++ E + G L S+L +L+ PS + +A +IA G
Sbjct: 86 RLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKMIQMAGEIADG 144
Query: 480 LLYL------HEDCSSQ--------------------IILYSYKRTEG-------YVAPE 506
+ YL H D +++ I Y R G +++PE
Sbjct: 145 MAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 204
Query: 507 WFRNSTITAKVDVYSFGFLLLEIIS 531
++ T DV+SFG +L EI +
Sbjct: 205 SLKDGVFTTYSDVWSFGVVLWEIAT 229
>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex
With An Hydantoin Inhibitor
Length = 305
Score = 63.2 bits (152), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 55/205 (26%), Positives = 92/205 (44%), Gaps = 49/205 (23%)
Query: 375 EVGRGSFGIVY----KGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLV 430
E+G+GSFG+VY KGV++ + + +++ N EF NE V+ + + ++V
Sbjct: 23 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 82
Query: 431 RLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLK-----------PSWNLRTNIAFQIARG 479
RLLG +G L++ E + G L S+L +L+ PS + +A +IA G
Sbjct: 83 RLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKMIQMAGEIADG 141
Query: 480 LLYL------HEDCSSQ--------------------IILYSYKRTEG-------YVAPE 506
+ YL H D +++ I Y R G +++PE
Sbjct: 142 MAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 201
Query: 507 WFRNSTITAKVDVYSFGFLLLEIIS 531
++ T DV+SFG +L EI +
Sbjct: 202 SLKDGVFTTYSDVWSFGVVLWEIAT 226
>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With Bms-754807
[1-(4-((5-Cyclopropyl-
1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2,
4]triazin-2-Yl)-N-
(6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide]
Length = 315
Score = 63.2 bits (152), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 55/205 (26%), Positives = 92/205 (44%), Gaps = 49/205 (23%)
Query: 375 EVGRGSFGIVY----KGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLV 430
E+G+GSFG+VY KGV++ + + +++ N EF NE V+ + + ++V
Sbjct: 25 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 84
Query: 431 RLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLK-----------PSWNLRTNIAFQIARG 479
RLLG +G L++ E + G L S+L +L+ PS + +A +IA G
Sbjct: 85 RLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKMIQMAGEIADG 143
Query: 480 LLYL------HEDCSSQ--------------------IILYSYKRTEG-------YVAPE 506
+ YL H D +++ I Y R G +++PE
Sbjct: 144 MAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 203
Query: 507 WFRNSTITAKVDVYSFGFLLLEIIS 531
++ T DV+SFG +L EI +
Sbjct: 204 SLKDGVFTTYSDVWSFGVVLWEIAT 228
>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|B Chain B, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|C Chain C, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|D Chain D, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
Length = 301
Score = 63.2 bits (152), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 55/205 (26%), Positives = 92/205 (44%), Gaps = 49/205 (23%)
Query: 375 EVGRGSFGIVY----KGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLV 430
E+G+GSFG+VY KGV++ + + +++ N EF NE V+ + + ++V
Sbjct: 19 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 78
Query: 431 RLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLK-----------PSWNLRTNIAFQIARG 479
RLLG +G L++ E + G L S+L +L+ PS + +A +IA G
Sbjct: 79 RLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKMIQMAGEIADG 137
Query: 480 LLYL------HEDCSSQ--------------------IILYSYKRTEG-------YVAPE 506
+ YL H D +++ I Y R G +++PE
Sbjct: 138 MAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 197
Query: 507 WFRNSTITAKVDVYSFGFLLLEIIS 531
++ T DV+SFG +L EI +
Sbjct: 198 SLKDGVFTTYSDVWSFGVVLWEIAT 222
>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A
Benzimidazole Inhibitor
pdb|3NW5|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (11b)
pdb|3NW6|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (11a)
pdb|3NW7|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (34)
Length = 307
Score = 63.2 bits (152), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 55/205 (26%), Positives = 92/205 (44%), Gaps = 49/205 (23%)
Query: 375 EVGRGSFGIVY----KGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLV 430
E+G+GSFG+VY KGV++ + + +++ N EF NE V+ + + ++V
Sbjct: 25 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 84
Query: 431 RLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLK-----------PSWNLRTNIAFQIARG 479
RLLG +G L++ E + G L S+L +L+ PS + +A +IA G
Sbjct: 85 RLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKMIQMAGEIADG 143
Query: 480 LLYL------HEDCSSQ--------------------IILYSYKRTEG-------YVAPE 506
+ YL H D +++ I Y R G +++PE
Sbjct: 144 MAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 203
Query: 507 WFRNSTITAKVDVYSFGFLLLEIIS 531
++ T DV+SFG +L EI +
Sbjct: 204 SLKDGVFTTYSDVWSFGVVLWEIAT 228
>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1
Receptor Kinase In Complex With Pqip
Length = 301
Score = 62.8 bits (151), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 55/205 (26%), Positives = 92/205 (44%), Gaps = 49/205 (23%)
Query: 375 EVGRGSFGIVY----KGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLV 430
E+G+GSFG+VY KGV++ + + +++ N EF NE V+ + + ++V
Sbjct: 19 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 78
Query: 431 RLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKP-----------SWNLRTNIAFQIARG 479
RLLG +G L++ E + G L S+L +L+P S + +A +IA G
Sbjct: 79 RLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKMIQMAGEIADG 137
Query: 480 LLYL------HEDCSSQ--------------------IILYSYKRTEG-------YVAPE 506
+ YL H D +++ I Y R G +++PE
Sbjct: 138 MAYLNANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 197
Query: 507 WFRNSTITAKVDVYSFGFLLLEIIS 531
++ T DV+SFG +L EI +
Sbjct: 198 SLKDGVFTTYSDVWSFGVVLWEIAT 222
>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of
The Insulin Receptor Tyrosine Kinase
Length = 306
Score = 62.8 bits (151), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 55/204 (26%), Positives = 89/204 (43%), Gaps = 47/204 (23%)
Query: 375 EVGRGSFGIVYKG----VIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLV 430
E+G+GSFG+VY+G +I+ + + +++ N EF NE V+ ++V
Sbjct: 24 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 431 RLLGFCDEGLNRLLVYEFLNNGTLASFLF----------GNLKPSWNLRTNIAFQIARGL 480
RLLG +G L+V E + +G L S+L G P+ +A +IA G+
Sbjct: 84 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 481 LYL------HEDCSSQ--------------------IILYSYKRTEG-------YVAPEW 507
YL H D +++ I +Y R G ++APE
Sbjct: 144 AYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMAPES 203
Query: 508 FRNSTITAKVDVYSFGFLLLEIIS 531
++ T D++SFG +L EI S
Sbjct: 204 LKDGVFTTSSDMWSFGVVLWEITS 227
>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|B Chain B, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|C Chain C, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|D Chain D, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
Length = 336
Score = 62.4 bits (150), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 49/206 (23%)
Query: 375 EVGRGSFGIVY----KGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLV 430
E+G+GSFG+VY KGV++ + + +++ N EF NE V+ + + ++V
Sbjct: 54 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 113
Query: 431 RLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLK-----------PSWNLRTNIAFQIARG 479
RLLG +G L++ E + G L S+L +L+ PS + +A +IA G
Sbjct: 114 RLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKMIQMAGEIADG 172
Query: 480 LLYL------HEDCSSQ--------------------IILYSYKRTEG-------YVAPE 506
+ YL H D +++ I Y R G +++PE
Sbjct: 173 MAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 232
Query: 507 WFRNSTITAKVDVYSFGFLLLEIISC 532
++ T DV+SFG +L EI +
Sbjct: 233 SLKDGVFTTYSDVWSFGVVLWEIATL 258
>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo
Pyridine Inhibitor
pdb|3ETA|B Chain B, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo
Pyridine Inhibitor
Length = 317
Score = 62.4 bits (150), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 55/204 (26%), Positives = 88/204 (43%), Gaps = 47/204 (23%)
Query: 375 EVGRGSFGIVYKG----VIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLV 430
E+G+GSFG+VY+G +I+ + + +++ N EF NE V+ ++V
Sbjct: 23 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 82
Query: 431 RLLGFCDEGLNRLLVYEFLNNGTLASFLF----------GNLKPSWNLRTNIAFQIARGL 480
RLLG +G L+V E + +G L S+L G P+ +A +IA G+
Sbjct: 83 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 142
Query: 481 LYL------HEDCSSQ--------------------IILYSYKRTEG-------YVAPEW 507
YL H D +++ I Y R G ++APE
Sbjct: 143 AYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPES 202
Query: 508 FRNSTITAKVDVYSFGFLLLEIIS 531
++ T D++SFG +L EI S
Sbjct: 203 LKDGVFTTSSDMWSFGVVLWEITS 226
>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In
Complex With Staurosporine
pdb|3P86|B Chain B, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In
Complex With Staurosporine
Length = 309
Score = 62.4 bits (150), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 51/204 (25%), Positives = 88/204 (43%), Gaps = 42/204 (20%)
Query: 371 NFKEEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGER--EFKNEVFVISQTHHKN 428
N KE++G GSFG V++ + + L +++ ER EF EV ++ + H N
Sbjct: 40 NIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDF----HAERVNEFLREVAIMKRLRHPN 95
Query: 429 LVRLLGFCDEGLNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYL-- 483
+V +G + N +V E+L+ G+L L + R ++A+ +A+G+ YL
Sbjct: 96 IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN 155
Query: 484 ------HEDCSSQIILYSYKR-------------------------TEGYVAPEWFRNST 512
H + S +L K T ++APE R+
Sbjct: 156 RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEP 215
Query: 513 ITAKVDVYSFGFLLLEIISCRKSF 536
K DVYSFG +L E+ + ++ +
Sbjct: 216 SNEKSDVYSFGVILWELATLQQPW 239
>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Human Insulin Receptor
Length = 306
Score = 62.0 bits (149), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 55/204 (26%), Positives = 88/204 (43%), Gaps = 47/204 (23%)
Query: 375 EVGRGSFGIVYKG----VIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLV 430
E+G+GSFG+VY+G +I+ + + +++ N EF NE V+ ++V
Sbjct: 24 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 431 RLLGFCDEGLNRLLVYEFLNNGTLASFLF----------GNLKPSWNLRTNIAFQIARGL 480
RLLG +G L+V E + +G L S+L G P+ +A +IA G+
Sbjct: 84 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 481 LYL------HEDCSSQ--------------------IILYSYKRTEG-------YVAPEW 507
YL H D +++ I Y R G ++APE
Sbjct: 144 AYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPES 203
Query: 508 FRNSTITAKVDVYSFGFLLLEIIS 531
++ T D++SFG +L EI S
Sbjct: 204 LKDGVFTTSSDMWSFGVVLWEITS 227
>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|B Chain B, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|C Chain C, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|D Chain D, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|3F5P|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|B Chain B, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|C Chain C, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|D Chain D, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|E Chain E, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|F Chain F, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|G Chain G, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|H Chain H, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|I Chain I, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|J Chain J, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|K Chain K, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|M Chain M, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|L Chain L, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|R Chain R, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|S Chain S, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|T Chain T, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
Length = 308
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 49/205 (23%)
Query: 375 EVGRGSFGIVY----KGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLV 430
E+G+GSFG+VY KGV++ + + +++ N EF NE V+ + + ++V
Sbjct: 26 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 85
Query: 431 RLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLK-----------PSWNLRTNIAFQIARG 479
RLLG +G L++ E + G L S+L +L+ PS + +A +IA G
Sbjct: 86 RLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKMIQMAGEIADG 144
Query: 480 LLYL------HEDCSSQ--------------------IILYSYKRTEG-------YVAPE 506
+ YL H D +++ I R G +++PE
Sbjct: 145 MAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSPE 204
Query: 507 WFRNSTITAKVDVYSFGFLLLEIIS 531
++ T DV+SFG +L EI +
Sbjct: 205 SLKDGVFTTYSDVWSFGVVLWEIAT 229
>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor
Kinase
Length = 299
Score = 61.2 bits (147), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 49/205 (23%)
Query: 375 EVGRGSFGIVY----KGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLV 430
E+G+GSFG+VY KGV++ + + +++ N EF NE V+ + + ++V
Sbjct: 17 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 76
Query: 431 RLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLK-----------PSWNLRTNIAFQIARG 479
RLLG +G L++ E + G L S+L +L+ PS + +A +IA G
Sbjct: 77 RLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKMIQMAGEIADG 135
Query: 480 LLYL------HEDCSSQ--------------------IILYSYKRTEG-------YVAPE 506
+ YL H D +++ I R G +++PE
Sbjct: 136 MAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSPE 195
Query: 507 WFRNSTITAKVDVYSFGFLLLEIIS 531
++ T DV+SFG +L EI +
Sbjct: 196 SLKDGVFTTYSDVWSFGVVLWEIAT 220
>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex
With Peptide Substrate And Atp Analog
pdb|1GAG|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With A Bisubstrate Inhibitor
Length = 306
Score = 61.2 bits (147), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 53/204 (25%), Positives = 89/204 (43%), Gaps = 47/204 (23%)
Query: 375 EVGRGSFGIVYKG----VIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLV 430
E+G+GSFG+VY+G +I+ + + +++ N EF NE V+ ++V
Sbjct: 24 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 431 RLLGFCDEGLNRLLVYEFLNNGTLASFLF----------GNLKPSWNLRTNIAFQIARGL 480
RLLG +G L+V E + +G L S+L G P+ +A +IA G+
Sbjct: 84 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 481 LYL------HEDCSSQIILYSY--------------------KRTEG-------YVAPEW 507
YL H D +++ + ++ R G ++APE
Sbjct: 144 AYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPES 203
Query: 508 FRNSTITAKVDVYSFGFLLLEIIS 531
++ T D++SFG +L EI S
Sbjct: 204 LKDGVFTTSSDMWSFGVVLWEITS 227
>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With The Sh2 Domain Of Aps
pdb|1RQQ|B Chain B, Crystal Structure Of The Insulin Receptor Kinase In
Complex With The Sh2 Domain Of Aps
pdb|2AUH|A Chain A, Crystal Structure Of The Grb14 Bps Region In Complex With
The Insulin Receptor Tyrosine Kinase
pdb|2B4S|B Chain B, Crystal Structure Of A Complex Between Ptp1b And The
Insulin Receptor Tyrosine Kinase
pdb|2B4S|D Chain D, Crystal Structure Of A Complex Between Ptp1b And The
Insulin Receptor Tyrosine Kinase
pdb|3BU3|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Peptide
pdb|3BU5|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Peptide And Atp
pdb|3BU6|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Phosphopeptide
Length = 306
Score = 60.8 bits (146), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 53/204 (25%), Positives = 89/204 (43%), Gaps = 47/204 (23%)
Query: 375 EVGRGSFGIVYKG----VIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLV 430
E+G+GSFG+VY+G +I+ + + +++ N EF NE V+ ++V
Sbjct: 24 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 431 RLLGFCDEGLNRLLVYEFLNNGTLASFLF----------GNLKPSWNLRTNIAFQIARGL 480
RLLG +G L+V E + +G L S+L G P+ +A +IA G+
Sbjct: 84 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 481 LYL------HEDCSSQIILYSY--------------------KRTEG-------YVAPEW 507
YL H D +++ + ++ R G ++APE
Sbjct: 144 AYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPES 203
Query: 508 FRNSTITAKVDVYSFGFLLLEIIS 531
++ T D++SFG +L EI S
Sbjct: 204 LKDGVFTTSSDMWSFGVVLWEITS 227
>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex
With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2-
Yl]amino}phenyl)acetic Acid
Length = 303
Score = 60.8 bits (146), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 53/204 (25%), Positives = 89/204 (43%), Gaps = 47/204 (23%)
Query: 375 EVGRGSFGIVYKG----VIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLV 430
E+G+GSFG+VY+G +I+ + + +++ N EF NE V+ ++V
Sbjct: 21 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 80
Query: 431 RLLGFCDEGLNRLLVYEFLNNGTLASFLF----------GNLKPSWNLRTNIAFQIARGL 480
RLLG +G L+V E + +G L S+L G P+ +A +IA G+
Sbjct: 81 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 140
Query: 481 LYL------HEDCSSQIILYSY--------------------KRTEG-------YVAPEW 507
YL H D +++ + ++ R G ++APE
Sbjct: 141 AYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPES 200
Query: 508 FRNSTITAKVDVYSFGFLLLEIIS 531
++ T D++SFG +L EI S
Sbjct: 201 LKDGVFTTSSDMWSFGVVLWEITS 224
>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 60.5 bits (145), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 50/204 (24%), Positives = 88/204 (43%), Gaps = 49/204 (24%)
Query: 376 VGRGSFGIVYKGVIQ----TTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVR 431
+G G+FG VY+G + + + +++ + + E +F E +IS+ +H+N+VR
Sbjct: 53 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 432 LLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARGLL------ 481
+G + L R ++ E + G L SFL +P + +++A +AR +
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQYL 171
Query: 482 ----YLHEDCSSQ-----------------------IILYSYKRTEG-------YVAPEW 507
++H D +++ I SY R G ++ PE
Sbjct: 172 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEA 231
Query: 508 FRNSTITAKVDVYSFGFLLLEIIS 531
F T+K D +SFG LL EI S
Sbjct: 232 FMEGIFTSKTDTWSFGVLLWEIFS 255
>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma
Kinase Catalytic Domain
Length = 327
Score = 60.5 bits (145), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 50/204 (24%), Positives = 88/204 (43%), Gaps = 49/204 (24%)
Query: 376 VGRGSFGIVYKGVIQ----TTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVR 431
+G G+FG VY+G + + + +++ + + E +F E +IS+ +H+N+VR
Sbjct: 39 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 432 LLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARGLL------ 481
+G + L R ++ E + G L SFL +P + +++A +AR +
Sbjct: 99 CIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQYL 157
Query: 482 ----YLHEDCSSQ-----------------------IILYSYKRTEG-------YVAPEW 507
++H D +++ I SY R G ++ PE
Sbjct: 158 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEA 217
Query: 508 FRNSTITAKVDVYSFGFLLLEIIS 531
F T+K D +SFG LL EI S
Sbjct: 218 FMEGIFTSKTDTWSFGVLLWEIFS 241
>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain
From D. Discoideum Bound To Appcp
Length = 287
Score = 60.1 bits (144), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 57/228 (25%), Positives = 90/228 (39%), Gaps = 56/228 (24%)
Query: 360 FSYKALEEATDN---FKEEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGE----- 411
F L DN +++++G+G FG+V+KG + + V+ + ++ D E
Sbjct: 8 FPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVV----AIKSLILGDSEGETEM 63
Query: 412 ----REFKNEVFVISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKP-SW 466
+EF+ EVF++S +H N+V+L G +V EF+ G L L P W
Sbjct: 64 IEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKW 121
Query: 467 NLRTNIAFQIARGLLYL--------HEDC-SSQIILYSYKRTEGYVAP------------ 505
+++ + IA G+ Y+ H D S I L S A
Sbjct: 122 SVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVH 181
Query: 506 ---------EWFRNSTI-------TAKVDVYSFGFLLLEIISCRKSFD 537
+W TI T K D YSF +L I++ FD
Sbjct: 182 SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229
>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To
Appcp From D. Discoideum
pdb|4F0G|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum
pdb|4F1T|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum Bound To The Rock Inhibitor H1152
Length = 287
Score = 60.1 bits (144), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 57/228 (25%), Positives = 90/228 (39%), Gaps = 56/228 (24%)
Query: 360 FSYKALEEATDN---FKEEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGE----- 411
F L DN +++++G+G FG+V+KG + + V+ + ++ D E
Sbjct: 8 FPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVV----AIKSLILGDSEGETEM 63
Query: 412 ----REFKNEVFVISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKP-SW 466
+EF+ EVF++S +H N+V+L G +V EF+ G L L P W
Sbjct: 64 IEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKW 121
Query: 467 NLRTNIAFQIARGLLYL--------HEDC-SSQIILYSYKRTEGYVAP------------ 505
+++ + IA G+ Y+ H D S I L S A
Sbjct: 122 SVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH 181
Query: 506 ---------EWFRNSTI-------TAKVDVYSFGFLLLEIISCRKSFD 537
+W TI T K D YSF +L I++ FD
Sbjct: 182 SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229
>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor
pdb|3EKN|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor
Length = 307
Score = 60.1 bits (144), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 54/204 (26%), Positives = 88/204 (43%), Gaps = 47/204 (23%)
Query: 375 EVGRGSFGIVYKG----VIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLV 430
E+G+GSFG+VY+G +I+ + + +++ N EF NE V+ ++V
Sbjct: 25 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 84
Query: 431 RLLGFCDEGLNRLLVYEFLNNGTLASFLF----------GNLKPSWNLRTNIAFQIARGL 480
RLLG +G L+V E + +G L S+L G P+ +A +IA G+
Sbjct: 85 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 144
Query: 481 LYL------HEDCSSQ--------------------IILYSYKRTEG-------YVAPEW 507
YL H + +++ I Y R G ++APE
Sbjct: 145 AYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPES 204
Query: 508 FRNSTITAKVDVYSFGFLLLEIIS 531
++ T D++SFG +L EI S
Sbjct: 205 LKDGVFTTSSDMWSFGVVLWEITS 228
>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound
To Appcp From D. Discoideum
Length = 287
Score = 60.1 bits (144), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 57/228 (25%), Positives = 90/228 (39%), Gaps = 56/228 (24%)
Query: 360 FSYKALEEATDN---FKEEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGE----- 411
F L DN +++++G+G FG+V+KG + + V+ + ++ D E
Sbjct: 8 FPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVV----AIKSLILGDSEGETEM 63
Query: 412 ----REFKNEVFVISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKP-SW 466
+EF+ EVF++S +H N+V+L G +V EF+ G L L P W
Sbjct: 64 IEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKW 121
Query: 467 NLRTNIAFQIARGLLYL--------HEDC-SSQIILYSYKRTEGYVAP------------ 505
+++ + IA G+ Y+ H D S I L S A
Sbjct: 122 SVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVH 181
Query: 506 ---------EWFRNSTI-------TAKVDVYSFGFLLLEIISCRKSFD 537
+W TI T K D YSF +L I++ FD
Sbjct: 182 SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229
>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The
Insulin Receptor Tyrosine Kinase
Length = 306
Score = 60.1 bits (144), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 54/204 (26%), Positives = 88/204 (43%), Gaps = 47/204 (23%)
Query: 375 EVGRGSFGIVYKG----VIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLV 430
E+G+GSFG+VY+G +I+ + + +++ N EF NE V+ ++V
Sbjct: 24 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 431 RLLGFCDEGLNRLLVYEFLNNGTLASFLF----------GNLKPSWNLRTNIAFQIARGL 480
RLLG +G L+V E + +G L S+L G P+ +A +IA G+
Sbjct: 84 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 481 LYL------HEDCSSQ--------------------IILYSYKRTEG-------YVAPEW 507
YL H + +++ I Y R G ++APE
Sbjct: 144 AYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPES 203
Query: 508 FRNSTITAKVDVYSFGFLLLEIIS 531
++ T D++SFG +L EI S
Sbjct: 204 LKDGVFTTSSDMWSFGVVLWEITS 227
>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 60.1 bits (144), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 50/204 (24%), Positives = 88/204 (43%), Gaps = 49/204 (24%)
Query: 376 VGRGSFGIVYKGVIQ----TTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVR 431
+G G+FG VY+G + + + +++ + + E +F E +IS+ +H+N+VR
Sbjct: 53 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 432 LLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARGLL------ 481
+G + L R ++ E + G L SFL +P + +++A +AR +
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQYL 171
Query: 482 ----YLHEDCSSQ-----------------------IILYSYKRTEG-------YVAPEW 507
++H D +++ I SY R G ++ PE
Sbjct: 172 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEA 231
Query: 508 FRNSTITAKVDVYSFGFLLLEIIS 531
F T+K D +SFG LL EI S
Sbjct: 232 FMEGIFTSKTDTWSFGVLLWEIFS 255
>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma
Kinase Catalytic Domain
pdb|4FNY|A Chain A, Crystal Structure Of The R1275q Anaplastic Lymphoma Kinase
Catalytic Domain In Complex With A Benzoxazole Inhibitor
Length = 327
Score = 59.7 bits (143), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 50/204 (24%), Positives = 88/204 (43%), Gaps = 49/204 (24%)
Query: 376 VGRGSFGIVYKGVIQ----TTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVR 431
+G G+FG VY+G + + + +++ + + E +F E +IS+ +H+N+VR
Sbjct: 39 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 432 LLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARGLL------ 481
+G + L R ++ E + G L SFL +P + +++A +AR +
Sbjct: 99 CIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQYL 157
Query: 482 ----YLHEDCSSQ-----------------------IILYSYKRTEG-------YVAPEW 507
++H D +++ I SY R G ++ PE
Sbjct: 158 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMPPEA 217
Query: 508 FRNSTITAKVDVYSFGFLLLEIIS 531
F T+K D +SFG LL EI S
Sbjct: 218 FMEGIFTSKTDTWSFGVLLWEIFS 241
>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In
Complex With Crizotinib
Length = 327
Score = 59.7 bits (143), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 50/204 (24%), Positives = 88/204 (43%), Gaps = 49/204 (24%)
Query: 376 VGRGSFGIVYKGVIQ----TTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVR 431
+G G+FG VY+G + + + +++ + + E +F E +IS+ +H+N+VR
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 432 LLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARGLL------ 481
+G + L R ++ E + G L SFL +P + +++A +AR +
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 482 ----YLHEDCSSQ-----------------------IILYSYKRTEG-------YVAPEW 507
++H D +++ I SY R G ++ PE
Sbjct: 157 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEA 216
Query: 508 FRNSTITAKVDVYSFGFLLLEIIS 531
F T+K D +SFG LL EI S
Sbjct: 217 FMEGIFTSKTDTWSFGVLLWEIFS 240
>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In
Complex With Crizotinib (Pf-02341066)
Length = 327
Score = 59.7 bits (143), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 50/204 (24%), Positives = 88/204 (43%), Gaps = 49/204 (24%)
Query: 376 VGRGSFGIVYKGVIQ----TTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVR 431
+G G+FG VY+G + + + +++ + + E +F E +IS+ +H+N+VR
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 432 LLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARGLL------ 481
+G + L R ++ E + G L SFL +P + +++A +AR +
Sbjct: 98 CIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 482 ----YLHEDCSSQ-----------------------IILYSYKRTEG-------YVAPEW 507
++H D +++ I SY R G ++ PE
Sbjct: 157 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEA 216
Query: 508 FRNSTITAKVDVYSFGFLLLEIIS 531
F T+K D +SFG LL EI S
Sbjct: 217 FMEGIFTSKTDTWSFGVLLWEIFS 240
>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Piperidine-Carboxamide Inhibitor 2
Length = 327
Score = 59.7 bits (143), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 50/204 (24%), Positives = 88/204 (43%), Gaps = 49/204 (24%)
Query: 376 VGRGSFGIVYKGVIQ----TTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVR 431
+G G+FG VY+G + + + +++ + + E +F E +IS+ +H+N+VR
Sbjct: 39 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 432 LLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARGLL------ 481
+G + L R ++ E + G L SFL +P + +++A +AR +
Sbjct: 99 CIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQYL 157
Query: 482 ----YLHEDCSSQ-----------------------IILYSYKRTEG-------YVAPEW 507
++H D +++ I SY R G ++ PE
Sbjct: 158 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEA 217
Query: 508 FRNSTITAKVDVYSFGFLLLEIIS 531
F T+K D +SFG LL EI S
Sbjct: 218 FMEGIFTSKTDTWSFGVLLWEIFS 241
>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex
With Nvp- Tae684
pdb|2XBA|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex
With Pha-E429
Length = 315
Score = 59.7 bits (143), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 50/204 (24%), Positives = 88/204 (43%), Gaps = 49/204 (24%)
Query: 376 VGRGSFGIVYKGVIQ----TTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVR 431
+G G+FG VY+G + + + +++ + + E +F E +IS+ +H+N+VR
Sbjct: 30 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 432 LLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARGLL------ 481
+G + L R ++ E + G L SFL +P + +++A +AR +
Sbjct: 90 CIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQYL 148
Query: 482 ----YLHEDCSSQ-----------------------IILYSYKRTEG-------YVAPEW 507
++H D +++ I SY R G ++ PE
Sbjct: 149 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEA 208
Query: 508 FRNSTITAKVDVYSFGFLLLEIIS 531
F T+K D +SFG LL EI S
Sbjct: 209 FMEGIFTSKTDTWSFGVLLWEIFS 232
>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With A Piperidine-Carboxamide Inhibitor
pdb|4DCE|B Chain B, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With A Piperidine-Carboxamide Inhibitor
pdb|4FOD|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 36
Length = 333
Score = 59.7 bits (143), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 50/204 (24%), Positives = 88/204 (43%), Gaps = 49/204 (24%)
Query: 376 VGRGSFGIVYKGVIQ----TTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVR 431
+G G+FG VY+G + + + +++ + + E +F E +IS+ +H+N+VR
Sbjct: 45 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 432 LLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARGLL------ 481
+G + L R ++ E + G L SFL +P + +++A +AR +
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQYL 163
Query: 482 ----YLHEDCSSQ-----------------------IILYSYKRTEG-------YVAPEW 507
++H D +++ I SY R G ++ PE
Sbjct: 164 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEA 223
Query: 508 FRNSTITAKVDVYSFGFLLLEIIS 531
F T+K D +SFG LL EI S
Sbjct: 224 FMEGIFTSKTDTWSFGVLLWEIFS 247
>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma
Kinase In Complex With Ch5424802
Length = 344
Score = 59.7 bits (143), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 50/204 (24%), Positives = 88/204 (43%), Gaps = 49/204 (24%)
Query: 376 VGRGSFGIVYKGVIQ----TTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVR 431
+G G+FG VY+G + + + +++ + + E +F E +IS+ +H+N+VR
Sbjct: 55 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 432 LLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARGLL------ 481
+G + L R ++ E + G L SFL +P + +++A +AR +
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQYL 173
Query: 482 ----YLHEDCSSQ-----------------------IILYSYKRTEG-------YVAPEW 507
++H D +++ I SY R G ++ PE
Sbjct: 174 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEA 233
Query: 508 FRNSTITAKVDVYSFGFLLLEIIS 531
F T+K D +SFG LL EI S
Sbjct: 234 FMEGIFTSKTDTWSFGVLLWEIFS 257
>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 59.3 bits (142), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 50/204 (24%), Positives = 88/204 (43%), Gaps = 49/204 (24%)
Query: 376 VGRGSFGIVYKGVIQ----TTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVR 431
+G G+FG VY+G + + + +++ + + E +F E +IS+ +H+N+VR
Sbjct: 53 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 432 LLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARGLL------ 481
+G + L R ++ E + G L SFL +P + +++A +AR +
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQYL 171
Query: 482 ----YLHEDCSSQ-----------------------IILYSYKRTEG-------YVAPEW 507
++H D +++ I SY R G ++ PE
Sbjct: 172 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEA 231
Query: 508 FRNSTITAKVDVYSFGFLLLEIIS 531
F T+K D +SFG LL EI S
Sbjct: 232 FMEGIFTSKTDTWSFGVLLWEIFS 255
>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 1
pdb|4FOC|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 2
Length = 353
Score = 59.3 bits (142), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 50/204 (24%), Positives = 88/204 (43%), Gaps = 49/204 (24%)
Query: 376 VGRGSFGIVYKGVIQ----TTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVR 431
+G G+FG VY+G + + + +++ + + E +F E +IS+ +H+N+VR
Sbjct: 65 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 432 LLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARGLL------ 481
+G + L R ++ E + G L SFL +P + +++A +AR +
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQYL 183
Query: 482 ----YLHEDCSSQ-----------------------IILYSYKRTEG-------YVAPEW 507
++H D +++ I SY R G ++ PE
Sbjct: 184 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEA 243
Query: 508 FRNSTITAKVDVYSFGFLLLEIIS 531
F T+K D +SFG LL EI S
Sbjct: 244 FMEGIFTSKTDTWSFGVLLWEIFS 267
>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
pdb|3LCS|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
Length = 344
Score = 58.9 bits (141), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 49/204 (24%), Positives = 88/204 (43%), Gaps = 49/204 (24%)
Query: 376 VGRGSFGIVYKGVIQ----TTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVR 431
+G G+FG VY+G + + + +++ + + E +F E +IS+ +H+N+VR
Sbjct: 56 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 432 LLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARGLL------ 481
+G + L R ++ E + G L SFL +P + +++A +AR +
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQYL 174
Query: 482 ----YLHEDCSSQIILYS-----------------------YKRTEG-------YVAPEW 507
++H D +++ L + Y R G ++ PE
Sbjct: 175 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEA 234
Query: 508 FRNSTITAKVDVYSFGFLLLEIIS 531
F T+K D +SFG LL EI S
Sbjct: 235 FMEGIFTSKTDTWSFGVLLWEIFS 258
>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
Length = 367
Score = 58.5 bits (140), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 49/204 (24%), Positives = 88/204 (43%), Gaps = 49/204 (24%)
Query: 376 VGRGSFGIVYKGVIQ----TTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVR 431
+G G+FG VY+G + + + +++ + + E +F E +IS+ +H+N+VR
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 432 LLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARGLL------ 481
+G + L R ++ E + G L SFL +P + +++A +AR +
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197
Query: 482 ----YLHEDCSSQIILYS-----------------------YKRTEG-------YVAPEW 507
++H D +++ L + Y R G ++ PE
Sbjct: 198 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEA 257
Query: 508 FRNSTITAKVDVYSFGFLLLEIIS 531
F T+K D +SFG LL EI S
Sbjct: 258 FMEGIFTSKTDTWSFGVLLWEIFS 281
>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52
pdb|4HCU|A Chain A, Crystal Structure Of Itk In Complext With Compound 40
pdb|4HCV|A Chain A, Crystal Structure Of Itk In Complex With Compound 53
Length = 269
Score = 58.2 bits (139), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 52/195 (26%), Positives = 83/195 (42%), Gaps = 39/195 (20%)
Query: 371 NFKEEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLV 430
F +E+G G FG+V+ G +V ++ + E +F E V+ + H LV
Sbjct: 13 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLV 68
Query: 431 RLLGFCDEGLNRLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDC- 487
+L G C E LV+EF+ +G L+ +L L + L + + G+ YL E C
Sbjct: 69 QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETL-LGMCLDVCEGMAYLEEACV 127
Query: 488 -------------SSQIILYS------------YKRTEG------YVAPEWFRNSTITAK 516
+Q+I S Y + G + +PE F S ++K
Sbjct: 128 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 187
Query: 517 VDVYSFGFLLLEIIS 531
DV+SFG L+ E+ S
Sbjct: 188 SDVWSFGVLMWEVFS 202
>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5J|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5L|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|C Chain C, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|D Chain D, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V8T|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8T|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8W|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
pdb|3V8W|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
Length = 266
Score = 58.2 bits (139), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 52/195 (26%), Positives = 83/195 (42%), Gaps = 39/195 (20%)
Query: 371 NFKEEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLV 430
F +E+G G FG+V+ G +V ++ + E +F E V+ + H LV
Sbjct: 10 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLV 65
Query: 431 RLLGFCDEGLNRLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDC- 487
+L G C E LV+EF+ +G L+ +L L + L + + G+ YL E C
Sbjct: 66 QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETL-LGMCLDVCEGMAYLEEACV 124
Query: 488 -------------SSQIILYS------------YKRTEG------YVAPEWFRNSTITAK 516
+Q+I S Y + G + +PE F S ++K
Sbjct: 125 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 184
Query: 517 VDVYSFGFLLLEIIS 531
DV+SFG L+ E+ S
Sbjct: 185 SDVWSFGVLMWEVFS 199
>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SM2|B Chain B, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|A Chain A, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|B Chain B, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNX|A Chain A, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
pdb|1SNX|B Chain B, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
Length = 264
Score = 58.2 bits (139), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 52/195 (26%), Positives = 83/195 (42%), Gaps = 39/195 (20%)
Query: 371 NFKEEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLV 430
F +E+G G FG+V+ G +V ++ + E +F E V+ + H LV
Sbjct: 8 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLV 63
Query: 431 RLLGFCDEGLNRLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDC- 487
+L G C E LV+EF+ +G L+ +L L + L + + G+ YL E C
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETL-LGMCLDVCEGMAYLEEACV 122
Query: 488 -------------SSQIILYS------------YKRTEG------YVAPEWFRNSTITAK 516
+Q+I S Y + G + +PE F S ++K
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 182
Query: 517 VDVYSFGFLLLEIIS 531
DV+SFG L+ E+ S
Sbjct: 183 SDVWSFGVLMWEVFS 197
>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGW|B Chain B, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGY|A Chain A, Crystal Structure Of Itk Inhibitor Complex
pdb|3QGY|B Chain B, Crystal Structure Of Itk Inhibitor Complex
Length = 286
Score = 57.4 bits (137), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 52/204 (25%), Positives = 87/204 (42%), Gaps = 39/204 (19%)
Query: 362 YKALEEATDNFKEEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVI 421
+ ++ + F +E+G G FG+V+ G +V ++ + E +F E V+
Sbjct: 21 HMVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGSM----SEDDFIEEAEVM 76
Query: 422 SQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARG 479
+ H LV+L G C E LV+EF+ +G L+ +L L + L + + G
Sbjct: 77 MKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETL-LGMCLDVCEG 135
Query: 480 LLYLHEDC--------------SSQIILYS------------YKRTEG------YVAPEW 507
+ YL E C +Q+I S Y + G + +PE
Sbjct: 136 MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEV 195
Query: 508 FRNSTITAKVDVYSFGFLLLEIIS 531
F S ++K DV+SFG L+ E+ S
Sbjct: 196 FSFSRYSSKSDVWSFGVLMWEVFS 219
>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed
With Compound 16
Length = 271
Score = 56.6 bits (135), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 56/210 (26%), Positives = 83/210 (39%), Gaps = 43/210 (20%)
Query: 368 ATDNFKEEVGRGSFGIVYKGV-IQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHH 426
A +E +G G FG VY+ I V + + Q E + E + + H
Sbjct: 7 AELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIE-NVRQEAKLFAMLKH 65
Query: 427 KNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHED 486
N++ L G C + N LV EF G L L G P ++ N A QIARG+ YLH++
Sbjct: 66 PNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPP-DILVNWAVQIARGMNYLHDE 124
Query: 487 C----------SSQIILYS----------------------YKRTE--------GYVAPE 506
SS I++ + RT ++APE
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPE 184
Query: 507 WFRNSTITAKVDVYSFGFLLLEIISCRKSF 536
R S + DV+S+G LL E+++ F
Sbjct: 185 VIRASMFSKGSDVWSYGVLLWELLTGEVPF 214
>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed
With Imidazo[1,5-A]quinoxaline
Length = 267
Score = 56.2 bits (134), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 52/195 (26%), Positives = 82/195 (42%), Gaps = 39/195 (20%)
Query: 371 NFKEEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLV 430
F +E+G G FG+V+ G +V ++ + E +F E V+ + H LV
Sbjct: 11 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLV 66
Query: 431 RLLGFCDEGLNRLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDC- 487
+L G C E LV EF+ +G L+ +L L + L + + G+ YL E C
Sbjct: 67 QLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETL-LGMCLDVCEGMAYLEEACV 125
Query: 488 -------------SSQIILYS------------YKRTEG------YVAPEWFRNSTITAK 516
+Q+I S Y + G + +PE F S ++K
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 185
Query: 517 VDVYSFGFLLLEIIS 531
DV+SFG L+ E+ S
Sbjct: 186 SDVWSFGVLMWEVFS 200
>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)
pdb|3CBL|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (v- Fes) In Complex With Staurosporine And A
Consensus Peptide
pdb|4E93|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)in Complex With Tae684
Length = 377
Score = 55.8 bits (133), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 66/285 (23%), Positives = 109/285 (38%), Gaps = 79/285 (27%)
Query: 284 YKNKGDDPPSVPRPPDHEDKKKRKMMNATGSVLLGSSVFVNFAMVCAVVLGFFFIYKKKW 343
Y+ +G+ PS+P DH ++ + +G VL + + K KW
Sbjct: 68 YRLEGEGFPSIPLLIDHLLSTQQPLTKKSGVVLHRA------------------VPKDKW 109
Query: 344 IRNSPGDGTVETNLRCFSYKALEEATDNFKEEVGRGSFGIVYKGVIQTTRQVLLQLQSRN 403
+ N E+ E++GRG+FG V+ G ++ L+ ++S
Sbjct: 110 VLNH------------------EDLV--LGEQIGRGNFGEVFSGRLRAD-NTLVAVKSCR 148
Query: 404 WIVFQDGEREFKNEVFVISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLK 463
+ D + +F E ++ Q H N+VRL+G C + +V E + G +FL
Sbjct: 149 ETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTE-- 206
Query: 464 PSWNLRTNIAFQI----ARGLLYL------HEDCSSQIILYSYK-----------RTEG- 501
LR Q+ A G+ YL H D +++ L + K R E
Sbjct: 207 -GARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265
Query: 502 ---------------YVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
+ APE +++ DV+SFG LL E S
Sbjct: 266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFS 310
>pdb|2PL0|A Chain A, Lck Bound To Imatinib
Length = 289
Score = 55.8 bits (133), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 54/197 (27%), Positives = 81/197 (41%), Gaps = 39/197 (19%)
Query: 369 TDNFKEEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKN 428
T E +G G FG V+ G +V ++ + + F E ++ Q H+
Sbjct: 24 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQR 79
Query: 429 LVRLLGFCDEGLNRLLVYEFLNNGTLASFLF--GNLKPSWNLRTNIAFQIARGLL----- 481
LVRL + ++ E++ NG+L FL +K + N ++A QIA G+
Sbjct: 80 LVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 138
Query: 482 -YLHEDCSSQIILYS--------------------YKRTEG------YVAPEWFRNSTIT 514
Y+H D + IL S Y EG + APE T T
Sbjct: 139 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 198
Query: 515 AKVDVYSFGFLLLEIIS 531
K DV+SFG LL EI++
Sbjct: 199 IKSDVWSFGILLTEIVT 215
>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma
Viral Oncogene Homologue (V-Fes) In Complex With
Staurosporine And A Consensus Peptide
Length = 377
Score = 55.8 bits (133), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 66/285 (23%), Positives = 109/285 (38%), Gaps = 79/285 (27%)
Query: 284 YKNKGDDPPSVPRPPDHEDKKKRKMMNATGSVLLGSSVFVNFAMVCAVVLGFFFIYKKKW 343
Y+ +G+ PS+P DH ++ + +G VL + + K KW
Sbjct: 68 YRLEGEGFPSIPLLIDHLLSTQQPLTKKSGVVLHRA------------------VPKDKW 109
Query: 344 IRNSPGDGTVETNLRCFSYKALEEATDNFKEEVGRGSFGIVYKGVIQTTRQVLLQLQSRN 403
+ N E+ E++GRG+FG V+ G ++ L+ ++S
Sbjct: 110 VLNH------------------EDLV--LGEQIGRGNFGEVFSGRLRAD-NTLVAVKSCR 148
Query: 404 WIVFQDGEREFKNEVFVISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLK 463
+ D + +F E ++ Q H N+VRL+G C + +V E + G +FL
Sbjct: 149 ETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTE-- 206
Query: 464 PSWNLRTNIAFQI----ARGLLYL------HEDCSSQIILYSYK-----------RTEG- 501
LR Q+ A G+ YL H D +++ L + K R E
Sbjct: 207 -GARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265
Query: 502 ---------------YVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
+ APE +++ DV+SFG LL E S
Sbjct: 266 GVXAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFS 310
>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b
pdb|3BYU|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Reverse
Amide 23
Length = 277
Score = 55.5 bits (132), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 54/197 (27%), Positives = 81/197 (41%), Gaps = 39/197 (19%)
Query: 369 TDNFKEEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKN 428
T E +G G FG V+ G +V ++ + + F E ++ Q H+
Sbjct: 20 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQR 75
Query: 429 LVRLLGFCDEGLNRLLVYEFLNNGTLASFLF--GNLKPSWNLRTNIAFQIARGLL----- 481
LVRL + ++ E++ NG+L FL +K + N ++A QIA G+
Sbjct: 76 LVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 134
Query: 482 -YLHEDCSSQIILYS--------------------YKRTEG------YVAPEWFRNSTIT 514
Y+H D + IL S Y EG + APE T T
Sbjct: 135 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 194
Query: 515 AKVDVYSFGFLLLEIIS 531
K DV+SFG LL EI++
Sbjct: 195 IKSDVWSFGILLTEIVT 211
>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|2OFV|B Chain B, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|3B2W|A Chain A, Crystal Structure Of Pyrimidine Amide 11 Bound To Lck
Length = 277
Score = 55.5 bits (132), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 54/197 (27%), Positives = 81/197 (41%), Gaps = 39/197 (19%)
Query: 369 TDNFKEEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKN 428
T E +G G FG V+ G +V ++ + + F E ++ Q H+
Sbjct: 19 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQR 74
Query: 429 LVRLLGFCDEGLNRLLVYEFLNNGTLASFLF--GNLKPSWNLRTNIAFQIARGLL----- 481
LVRL + ++ E++ NG+L FL +K + N ++A QIA G+
Sbjct: 75 LVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 133
Query: 482 -YLHEDCSSQIILYS--------------------YKRTEG------YVAPEWFRNSTIT 514
Y+H D + IL S Y EG + APE T T
Sbjct: 134 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 193
Query: 515 AKVDVYSFGFLLLEIIS 531
K DV+SFG LL EI++
Sbjct: 194 IKSDVWSFGILLTEIVT 210
>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck
pdb|2OF4|A Chain A, Crystal Structure Of Furanopyrimidine 1 Bound To Lck
Length = 271
Score = 55.5 bits (132), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 54/197 (27%), Positives = 81/197 (41%), Gaps = 39/197 (19%)
Query: 369 TDNFKEEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKN 428
T E +G G FG V+ G +V ++ + + F E ++ Q H+
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQR 69
Query: 429 LVRLLGFCDEGLNRLLVYEFLNNGTLASFLF--GNLKPSWNLRTNIAFQIARGLL----- 481
LVRL + ++ E++ NG+L FL +K + N ++A QIA G+
Sbjct: 70 LVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 482 -YLHEDCSSQIILYS--------------------YKRTEG------YVAPEWFRNSTIT 514
Y+H D + IL S Y EG + APE T T
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 188
Query: 515 AKVDVYSFGFLLLEIIS 531
K DV+SFG LL EI++
Sbjct: 189 IKSDVWSFGILLTEIVT 205
>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
pdb|2OG8|B Chain B, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
Length = 265
Score = 55.5 bits (132), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 54/197 (27%), Positives = 81/197 (41%), Gaps = 39/197 (19%)
Query: 369 TDNFKEEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKN 428
T E +G G FG V+ G +V ++ + + F E ++ Q H+
Sbjct: 9 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQR 64
Query: 429 LVRLLGFCDEGLNRLLVYEFLNNGTLASFLF--GNLKPSWNLRTNIAFQIARGLL----- 481
LVRL + ++ E++ NG+L FL +K + N ++A QIA G+
Sbjct: 65 LVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 123
Query: 482 -YLHEDCSSQIILYS--------------------YKRTEG------YVAPEWFRNSTIT 514
Y+H D + IL S Y EG + APE T T
Sbjct: 124 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 183
Query: 515 AKVDVYSFGFLLLEIIS 531
K DV+SFG LL EI++
Sbjct: 184 IKSDVWSFGILLTEIVT 200
>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein
Kinase
pdb|1MQB|B Chain B, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein
Kinase
Length = 333
Score = 55.5 bits (132), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 49/199 (24%), Positives = 87/199 (43%), Gaps = 48/199 (24%)
Query: 376 VGRGSFGIVYKGVIQTT---RQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRL 432
+G G FG VYKG+++T+ ++V + +++ + +F E ++ Q H N++RL
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 433 LGFCDEGLNRLLVYEFLNNGTLASFL------FGNLKPSWNLRTNIAFQIARGLLYL--- 483
G + +++ E++ NG L FL F L+ LR IA G+ YL
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRG-----IAAGMKYLANM 166
Query: 484 ---HEDCSSQIILY-----------------------SYKRTEG-----YVAPEWFRNST 512
H D +++ IL +Y + G + APE
Sbjct: 167 NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK 226
Query: 513 ITAKVDVYSFGFLLLEIIS 531
T+ DV+SFG ++ E+++
Sbjct: 227 FTSASDVWSFGIVMWEVMT 245
>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase
pdb|3RHK|A Chain A, Crystal Structure Of The Catalytic Domain Of C-Met Kinase
In Complex With Arq 197
pdb|3RHK|B Chain B, Crystal Structure Of The Catalytic Domain Of C-Met Kinase
In Complex With Arq 197
Length = 318
Score = 55.5 bits (132), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 51/201 (25%), Positives = 86/201 (42%), Gaps = 41/201 (20%)
Query: 371 NFKEEVGRGSFGIVYKGVIQTT--RQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKN 428
+F E +GRG FG VY G + +++ ++S N I +F E ++ H N
Sbjct: 51 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 110
Query: 429 LVRLLGFC--DEGLNRLLVYEFLNNGTLASFLFGNLK-PSWNLRTNIAFQIARGLLYL-- 483
++ LLG C EG + L+V ++ +G L +F+ P+ Q+A+G+ YL
Sbjct: 111 VLSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 169
Query: 484 ----HEDCSSQIIL-----------------------YSYKRTEG------YVAPEWFRN 510
H D +++ + YS G ++A E +
Sbjct: 170 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 229
Query: 511 STITAKVDVYSFGFLLLEIIS 531
T K DV+SFG LL E+++
Sbjct: 230 QKFTTKSDVWSFGVLLWELMT 250
>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MIY|B Chain B, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MJ1|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Ro5191614
pdb|3MJ2|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Bms-509744
Length = 266
Score = 55.1 bits (131), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 52/195 (26%), Positives = 84/195 (43%), Gaps = 39/195 (20%)
Query: 371 NFKEEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLV 430
F +E+G G FG+V+ G +V ++ + E +F E V+ + H LV
Sbjct: 10 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLV 65
Query: 431 RLLGFCDEGLNRLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYL----- 483
+L G C E LV+EF+ +G L+ +L L + L + + G+ YL
Sbjct: 66 QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETL-LGMCLDVCEGMAYLEEASV 124
Query: 484 -HEDCSS--------QIILYS------------YKRTEG------YVAPEWFRNSTITAK 516
H D ++ Q+I S Y + G + +PE F S ++K
Sbjct: 125 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 184
Query: 517 VDVYSFGFLLLEIIS 531
DV+SFG L+ E+ S
Sbjct: 185 SDVWSFGVLMWEVFS 199
>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880
(Gsk1
Length = 302
Score = 55.1 bits (131), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 51/201 (25%), Positives = 86/201 (42%), Gaps = 41/201 (20%)
Query: 371 NFKEEVGRGSFGIVYKGVIQTT--RQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKN 428
+F E +GRG FG VY G + +++ ++S N I +F E ++ H N
Sbjct: 31 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 90
Query: 429 LVRLLGFC--DEGLNRLLVYEFLNNGTLASFLFGNLK-PSWNLRTNIAFQIARGLLYL-- 483
++ LLG C EG + L+V ++ +G L +F+ P+ Q+A+G+ YL
Sbjct: 91 VLSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 149
Query: 484 ----HEDCSSQIIL-----------------------YSYKRTEG------YVAPEWFRN 510
H D +++ + YS G ++A E +
Sbjct: 150 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 209
Query: 511 STITAKVDVYSFGFLLLEIIS 531
T K DV+SFG LL E+++
Sbjct: 210 QKFTTKSDVWSFGVLLWELMT 230
>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor
pdb|3F66|B Chain B, Human C-Met Kinase In Complex With Quinoxaline Inhibitor
Length = 298
Score = 55.1 bits (131), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 51/201 (25%), Positives = 86/201 (42%), Gaps = 41/201 (20%)
Query: 371 NFKEEVGRGSFGIVYKGVIQTT--RQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKN 428
+F E +GRG FG VY G + +++ ++S N I +F E ++ H N
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 429 LVRLLGFC--DEGLNRLLVYEFLNNGTLASFLFGNLK-PSWNLRTNIAFQIARGLLYL-- 483
++ LLG C EG + L+V ++ +G L +F+ P+ Q+A+G+ YL
Sbjct: 88 VLSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 146
Query: 484 ----HEDCSSQIIL-----------------------YSYKRTEG------YVAPEWFRN 510
H D +++ + YS G ++A E +
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 206
Query: 511 STITAKVDVYSFGFLLLEIIS 531
T K DV+SFG LL E+++
Sbjct: 207 QKFTTKSDVWSFGVLLWELMT 227
>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor
Length = 292
Score = 54.7 bits (130), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 51/201 (25%), Positives = 86/201 (42%), Gaps = 41/201 (20%)
Query: 371 NFKEEVGRGSFGIVYKGVIQTT--RQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKN 428
+F E +GRG FG VY G + +++ ++S N I +F E ++ H N
Sbjct: 25 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 84
Query: 429 LVRLLGFC--DEGLNRLLVYEFLNNGTLASFLFGNLK-PSWNLRTNIAFQIARGLLYL-- 483
++ LLG C EG + L+V ++ +G L +F+ P+ Q+A+G+ YL
Sbjct: 85 VLSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 143
Query: 484 ----HEDCSSQIIL-----------------------YSYKRTEG------YVAPEWFRN 510
H D +++ + YS G ++A E +
Sbjct: 144 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 203
Query: 511 STITAKVDVYSFGFLLLEIIS 531
T K DV+SFG LL E+++
Sbjct: 204 QKFTTKSDVWSFGVLLWELMT 224
>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The
Dually-Phosphorylated, Activated State
Length = 308
Score = 54.7 bits (130), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 51/201 (25%), Positives = 86/201 (42%), Gaps = 41/201 (20%)
Query: 371 NFKEEVGRGSFGIVYKGVIQTT--RQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKN 428
+F E +GRG FG VY G + +++ ++S N I +F E ++ H N
Sbjct: 33 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 429 LVRLLGFC--DEGLNRLLVYEFLNNGTLASFLFGNLK-PSWNLRTNIAFQIARGLLYL-- 483
++ LLG C EG + L+V ++ +G L +F+ P+ Q+A+G+ YL
Sbjct: 93 VLSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 151
Query: 484 ----HEDCSSQIIL-----------------------YSYKRTEG------YVAPEWFRN 510
H D +++ + YS G ++A E +
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 211
Query: 511 STITAKVDVYSFGFLLLEIIS 531
T K DV+SFG LL E+++
Sbjct: 212 QKFTTKSDVWSFGVLLWELMT 232
>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine
Inhibitor 13
pdb|3U6H|A Chain A, Crystal Structure Of C-Met In Complex With Pyrazolone
Inhibitor 26
pdb|3U6I|A Chain A, Crystal Structure Of C-Met In Complex With Pyrazolone
Inhibitor 58a
pdb|4DEG|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridazine Inhibitor 2
pdb|4DEH|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridinone Inhibitor 3
pdb|4DEI|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridinone Inhibitor 24
Length = 309
Score = 54.7 bits (130), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 51/201 (25%), Positives = 86/201 (42%), Gaps = 41/201 (20%)
Query: 371 NFKEEVGRGSFGIVYKGVIQTT--RQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKN 428
+F E +GRG FG VY G + +++ ++S N I +F E ++ H N
Sbjct: 32 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 91
Query: 429 LVRLLGFC--DEGLNRLLVYEFLNNGTLASFLFGNLK-PSWNLRTNIAFQIARGLLYL-- 483
++ LLG C EG + L+V ++ +G L +F+ P+ Q+A+G+ YL
Sbjct: 92 VLSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 150
Query: 484 ----HEDCSSQIIL-----------------------YSYKRTEG------YVAPEWFRN 510
H D +++ + YS G ++A E +
Sbjct: 151 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 210
Query: 511 STITAKVDVYSFGFLLLEIIS 531
T K DV+SFG LL E+++
Sbjct: 211 QKFTTKSDVWSFGVLLWELMT 231
>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain
Of C-Met
pdb|2WKM|A Chain A, X-Ray Structure Of Pha-00665752 Bound To The Kinase Domain
Of C-Met
pdb|3ZXZ|A Chain A, X-Ray Structure Of Pf-04217903 Bound To The Kinase Domain
Of C-Met
pdb|3ZZE|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
N'-
((3z)-4-Chloro-7-Methyl-2-Oxo-1,2-Dihydro-3h-Indol-3-
Ylidene)-2-(4-Hydroxyphenyl)propanohydrazide
pdb|4AOI|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
4-( 3-((1h-
Pyrrolo(2,3-B)pyridin-3-Yl)methyl)-(1,2,4)triazolo(
4,3-B)(1,2,4) Triazin-6-Yl)benzonitrile
pdb|4AP7|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
4-( (6-(4-
Fluorophenyl)-(1,2,4)triazolo(4,3-B)(1,2,
4)triazin-3-Yl)methyl) Phenol
Length = 306
Score = 54.7 bits (130), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 51/201 (25%), Positives = 86/201 (42%), Gaps = 41/201 (20%)
Query: 371 NFKEEVGRGSFGIVYKGVIQTT--RQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKN 428
+F E +GRG FG VY G + +++ ++S N I +F E ++ H N
Sbjct: 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89
Query: 429 LVRLLGFC--DEGLNRLLVYEFLNNGTLASFLFGNLK-PSWNLRTNIAFQIARGLLYL-- 483
++ LLG C EG + L+V ++ +G L +F+ P+ Q+A+G+ YL
Sbjct: 90 VLSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 148
Query: 484 ----HEDCSSQIIL-----------------------YSYKRTEG------YVAPEWFRN 510
H D +++ + YS G ++A E +
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 208
Query: 511 STITAKVDVYSFGFLLLEIIS 531
T K DV+SFG LL E+++
Sbjct: 209 QKFTTKSDVWSFGVLLWELMT 229
>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor.
pdb|2RFN|B Chain B, X-ray Structure Of C-met With Inhibitor.
pdb|2RFS|A Chain A, X-Ray Structure Of Su11274 Bound To C-Met
pdb|3CCN|A Chain A, X-Ray Structure Of C-Met With Triazolopyridazine
Inhibitor.
pdb|3CD8|A Chain A, X-Ray Structure Of C-Met With Triazolopyridazine
Inhibitor.
pdb|3EFJ|A Chain A, Structure Of C-Met With Pyrimidone Inhibitor 7
pdb|3EFJ|B Chain B, Structure Of C-Met With Pyrimidone Inhibitor 7
pdb|3EFK|A Chain A, Structure Of C-Met With Pyrimidone Inhibitor 50
pdb|3EFK|B Chain B, Structure Of C-Met With Pyrimidone Inhibitor 50
Length = 310
Score = 54.7 bits (130), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 51/201 (25%), Positives = 86/201 (42%), Gaps = 41/201 (20%)
Query: 371 NFKEEVGRGSFGIVYKGVIQTT--RQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKN 428
+F E +GRG FG VY G + +++ ++S N I +F E ++ H N
Sbjct: 33 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 429 LVRLLGFC--DEGLNRLLVYEFLNNGTLASFLFGNLK-PSWNLRTNIAFQIARGLLYL-- 483
++ LLG C EG + L+V ++ +G L +F+ P+ Q+A+G+ YL
Sbjct: 93 VLSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 151
Query: 484 ----HEDCSSQIIL-----------------------YSYKRTEG------YVAPEWFRN 510
H D +++ + YS G ++A E +
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 211
Query: 511 STITAKVDVYSFGFLLLEIIS 531
T K DV+SFG LL E+++
Sbjct: 212 QKFTTKSDVWSFGVLLWELMT 232
>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor
pdb|4GG7|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor
Length = 319
Score = 54.7 bits (130), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 51/201 (25%), Positives = 86/201 (42%), Gaps = 41/201 (20%)
Query: 371 NFKEEVGRGSFGIVYKGVIQTT--RQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKN 428
+F E +GRG FG VY G + +++ ++S N I +F E ++ H N
Sbjct: 52 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 111
Query: 429 LVRLLGFC--DEGLNRLLVYEFLNNGTLASFLFGNLK-PSWNLRTNIAFQIARGLLYL-- 483
++ LLG C EG + L+V ++ +G L +F+ P+ Q+A+G+ YL
Sbjct: 112 VLSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 170
Query: 484 ----HEDCSSQIIL-----------------------YSYKRTEG------YVAPEWFRN 510
H D +++ + YS G ++A E +
Sbjct: 171 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 230
Query: 511 STITAKVDVYSFGFLLLEIIS 531
T K DV+SFG LL E+++
Sbjct: 231 QKFTTKSDVWSFGVLLWELMT 251
>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23
pdb|4AOJ|B Chain B, Human Trka In Complex With The Inhibitor Az-23
pdb|4AOJ|C Chain C, Human Trka In Complex With The Inhibitor Az-23
Length = 329
Score = 54.7 bits (130), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 57/241 (23%), Positives = 99/241 (41%), Gaps = 61/241 (25%)
Query: 372 FKEEVGRGSFGIVY----KGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHK 427
K E+G G+FG V+ ++ ++L+ +++ + ++F+ E +++ H+
Sbjct: 45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE-ASESARQDFQREAELLTMLQHQ 103
Query: 428 NLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN---------------- 471
++VR G C EG L+V+E++ +G L FL + P L
Sbjct: 104 HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSH-GPDAKLLAGGEDVAPGPLGLGQLLA 162
Query: 472 IAFQIARGLLYL------HEDCSSQIIL------------------YS--YKRTEG---- 501
+A Q+A G++YL H D +++ L YS Y R G
Sbjct: 163 VASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222
Query: 502 ---YVAPEWFRNSTITAKVDVYSFGFLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 558
++ PE T + DV+SFG +L EI + K Y + A DC G
Sbjct: 223 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQ------PWYQLSNTEAIDCITQG 276
Query: 559 K 559
+
Sbjct: 277 R 277
>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972
pdb|3QTI|B Chain B, C-Met Kinase In Complex With Nvp-Bvu972
Length = 314
Score = 54.3 bits (129), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 54/233 (23%), Positives = 95/233 (40%), Gaps = 51/233 (21%)
Query: 349 GDGTVETNLRCFSYKALEEATD----------NFKEEVGRGSFGIVYKGVIQTT--RQVL 396
G GTV +L + + ++ +F E +GRG FG VY G + +++
Sbjct: 1 GPGTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIH 60
Query: 397 LQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLGFC--DEGLNRLLVYEFLNNGTL 454
++S N I +F E ++ H N++ LLG C EG + L+V ++ +G L
Sbjct: 61 CAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG-SPLVVLPYMKHGDL 119
Query: 455 ASFLFGNLK-PSWNLRTNIAFQIARGLLYL------HEDCSSQIILYSYKRT-------- 499
+F+ P+ Q+A+G+ +L H D +++ + K T
Sbjct: 120 RNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGL 179
Query: 500 ---------------------EGYVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
++A E + T K DV+SFG LL E+++
Sbjct: 180 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 232
>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In
Complex With An Mk-2461 Analog With Specificity For The
Activated Receptor
pdb|3R7O|A Chain A, Structure Of Dually Phosphorylated C-Met Receptor Kinase
In Complex With An Mk-2461 Analog
Length = 307
Score = 53.9 bits (128), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 50/201 (24%), Positives = 85/201 (42%), Gaps = 41/201 (20%)
Query: 371 NFKEEVGRGSFGIVYKGVIQTT--RQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKN 428
+F E +GRG FG VY G + +++ ++S N I +F E ++ H N
Sbjct: 32 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 91
Query: 429 LVRLLGFC--DEGLNRLLVYEFLNNGTLASFLFGNLK-PSWNLRTNIAFQIARGLLYL-- 483
++ LLG C EG + L+V ++ +G L +F+ P+ Q+A+G+ YL
Sbjct: 92 VLSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 150
Query: 484 ----HEDCSSQIILYSYKRT-----------------------------EGYVAPEWFRN 510
H D +++ + K T ++A E +
Sbjct: 151 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQT 210
Query: 511 STITAKVDVYSFGFLLLEIIS 531
T K DV+SFG LL E+++
Sbjct: 211 QKFTTKSDVWSFGVLLWELMT 231
>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka
pdb|4F0I|B Chain B, Crystal Structure Of Apo Trka
Length = 300
Score = 53.9 bits (128), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 57/241 (23%), Positives = 99/241 (41%), Gaps = 61/241 (25%)
Query: 372 FKEEVGRGSFGIVY----KGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHK 427
K E+G G+FG V+ ++ ++L+ +++ + ++F+ E +++ H+
Sbjct: 16 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE-ASESARQDFQREAELLTMLQHQ 74
Query: 428 NLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN---------------- 471
++VR G C EG L+V+E++ +G L FL + P L
Sbjct: 75 HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSH-GPDAKLLAGGEDVAPGPLGLGQLLA 133
Query: 472 IAFQIARGLLYL------HEDCSSQIIL------------------YS--YKRTEG---- 501
+A Q+A G++YL H D +++ L YS Y R G
Sbjct: 134 VASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 193
Query: 502 ---YVAPEWFRNSTITAKVDVYSFGFLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 558
++ PE T + DV+SFG +L EI + K Y + A DC G
Sbjct: 194 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQ------PWYQLSNTEAIDCITQG 247
Query: 559 K 559
+
Sbjct: 248 R 248
>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase
pdb|3COK|B Chain B, Crystal Structure Of Plk4 Kinase
Length = 278
Score = 53.9 bits (128), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 53/237 (22%), Positives = 99/237 (41%), Gaps = 38/237 (16%)
Query: 367 EATDNFK--EEVGRGSFGIVYKG-VIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQ 423
E ++FK +G+GSF VY+ I T +V +++ + + + +NEV + Q
Sbjct: 8 EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQ 67
Query: 424 THHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNIAFQIARGLLY 482
H +++ L + ++ LV E +NG + +L +KP S N + QI G+LY
Sbjct: 68 LKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLY 127
Query: 483 LHED--------------------------CSSQIIL-----YSYKRTEGYVAPEWFRNS 511
LH ++Q+ + Y+ T Y++PE S
Sbjct: 128 LHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRS 187
Query: 512 TITAKVDVYSFGFLLLEIISCRKSFDIEMGEEY---AILTDWAFDCYRNGKLDDLVE 565
+ DV+S G + ++ R FD + + +L D+ + + + DL+
Sbjct: 188 AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIH 244
>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain
Length = 306
Score = 53.9 bits (128), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 57/241 (23%), Positives = 99/241 (41%), Gaps = 61/241 (25%)
Query: 372 FKEEVGRGSFGIVY----KGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHK 427
K E+G G+FG V+ ++ ++L+ +++ + ++F+ E +++ H+
Sbjct: 22 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE-ASESARQDFQREAELLTMLQHQ 80
Query: 428 NLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN---------------- 471
++VR G C EG L+V+E++ +G L FL + P L
Sbjct: 81 HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSH-GPDAKLLAGGEDVAPGPLGLGQLLA 139
Query: 472 IAFQIARGLLYL------HEDCSSQIIL------------------YS--YKRTEG---- 501
+A Q+A G++YL H D +++ L YS Y R G
Sbjct: 140 VASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 199
Query: 502 ---YVAPEWFRNSTITAKVDVYSFGFLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 558
++ PE T + DV+SFG +L EI + K Y + A DC G
Sbjct: 200 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQ------PWYQLSNTEAIDCITQG 253
Query: 559 K 559
+
Sbjct: 254 R 254
>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7)
pdb|3DKO|A Chain A, Complex Between The Kinase Domain Of Human Ephrin Type-A
Receptor 7 (Epha7) And Inhibitor Alw-Ii-49-7
Length = 318
Score = 53.5 bits (127), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 53/211 (25%), Positives = 88/211 (41%), Gaps = 47/211 (22%)
Query: 363 KALEEATDNFKEEVGRGSFGIVYKGVIQT--TRQVLLQLQSRNWIVFQDGEREFKNEVFV 420
K L+ + + +G G FG V G ++ R V + +++ + R+F E +
Sbjct: 38 KELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASI 97
Query: 421 ISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFL------FGNLKPSWNLRTNIAF 474
+ Q H N+V L G G ++V EF+ NG L +FL F ++ LR
Sbjct: 98 MGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRG---- 153
Query: 475 QIARGLLYL------HEDCSSQIILYS-----------------------YKRTEG---- 501
IA G+ YL H D +++ IL + Y T G
Sbjct: 154 -IAAGMRYLADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPV 212
Query: 502 -YVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
+ APE + T+ DV+S+G ++ E++S
Sbjct: 213 RWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 243
>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of
Triazine Derivatives As Potent, Selective Tie-2
Inhibitors
pdb|2OSC|A Chain A, Synthesis, Structural Analysis, And Sar Studies Of
Triazine Derivatives As Potent, Selective Tie-2
Inhibitors
pdb|2P4I|A Chain A, Evolution Of A Highly Selective And Potent
2-(Pyridin-2-Yl)- 1,3,5-Triazine Tie-2 Kinase Inhibitor
pdb|2P4I|B Chain B, Evolution Of A Highly Selective And Potent
2-(Pyridin-2-Yl)- 1,3,5-Triazine Tie-2 Kinase Inhibitor
pdb|3L8P|A Chain A, Crystal Structure Of Cytoplasmic Kinase Domain Of Tie2
Complexed With Inhibitor Cep11207
Length = 317
Score = 53.5 bits (127), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 58/222 (26%), Positives = 89/222 (40%), Gaps = 56/222 (25%)
Query: 362 YKALEEATDNFKEEVGRGSFGIVYKGVIQTT-RQVLLQLQSRNWIVFQDGEREFKNEVFV 420
Y L+ F++ +G G+FG V K I+ ++ ++ +D R+F E+ V
Sbjct: 9 YPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV 68
Query: 421 ISQT-HHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIA-- 477
+ + HH N++ LLG C+ L E+ +G L FL + S L T+ AF IA
Sbjct: 69 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL----RKSRVLETDPAFAIANS 124
Query: 478 ------------------RGLLYL------HEDCSSQIILYS------------------ 495
RG+ YL H D +++ IL
Sbjct: 125 TASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV 184
Query: 496 -YKRTEGYVAPEW-----FRNSTITAKVDVYSFGFLLLEIIS 531
K+T G + W S T DV+S+G LL EI+S
Sbjct: 185 YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226
>pdb|1FVR|A Chain A, Tie2 Kinase Domain
pdb|1FVR|B Chain B, Tie2 Kinase Domain
Length = 327
Score = 53.5 bits (127), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 58/222 (26%), Positives = 89/222 (40%), Gaps = 56/222 (25%)
Query: 362 YKALEEATDNFKEEVGRGSFGIVYKGVIQTT-RQVLLQLQSRNWIVFQDGEREFKNEVFV 420
Y L+ F++ +G G+FG V K I+ ++ ++ +D R+F E+ V
Sbjct: 19 YPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV 78
Query: 421 ISQT-HHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIA-- 477
+ + HH N++ LLG C+ L E+ +G L FL + S L T+ AF IA
Sbjct: 79 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL----RKSRVLETDPAFAIANS 134
Query: 478 ------------------RGLLYL------HEDCSSQIILYS------------------ 495
RG+ YL H D +++ IL
Sbjct: 135 TASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV 194
Query: 496 -YKRTEGYVAPEW-----FRNSTITAKVDVYSFGFLLLEIIS 531
K+T G + W S T DV+S+G LL EI+S
Sbjct: 195 YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine
Length = 267
Score = 53.5 bits (127), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 53/197 (26%), Positives = 81/197 (41%), Gaps = 39/197 (19%)
Query: 369 TDNFKEEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKN 428
T E +G G FG V+ G +V ++ + + F E ++ Q H+
Sbjct: 10 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQR 65
Query: 429 LVRLLGFCDEGLNRLLVYEFLNNGTLASFLF--GNLKPSWNLRTNIAFQIARGLL----- 481
LVRL + ++ E++ NG+L FL +K + N ++A QIA G+
Sbjct: 66 LVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 124
Query: 482 -YLHEDCSSQIILYS--------------------YKRTEG------YVAPEWFRNSTIT 514
Y+H + + IL S Y EG + APE T T
Sbjct: 125 NYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 184
Query: 515 AKVDVYSFGFLLLEIIS 531
K DV+SFG LL EI++
Sbjct: 185 IKSDVWSFGILLTEIVT 201
>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Pyrrolotriazine Based Inhibitor
Length = 373
Score = 53.1 bits (126), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 49/201 (24%), Positives = 85/201 (42%), Gaps = 41/201 (20%)
Query: 371 NFKEEVGRGSFGIVYKGVIQTT--RQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKN 428
+F E +GRG FG VY G + +++ ++S N I +F E ++ H N
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 429 LVRLLGFC--DEGLNRLLVYEFLNNGTLASFLFGNLK-PSWNLRTNIAFQIARGLLYL-- 483
++ LLG C EG + L+V ++ +G L +F+ P+ Q+A+G+ +L
Sbjct: 152 VLSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 210
Query: 484 ----HEDCSSQIILYSYKRT-----------------------------EGYVAPEWFRN 510
H D +++ + K T ++A E +
Sbjct: 211 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 270
Query: 511 STITAKVDVYSFGFLLLEIIS 531
T K DV+SFG LL E+++
Sbjct: 271 QKFTTKSDVWSFGVLLWELMT 291
>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule
W259
Length = 287
Score = 52.8 bits (125), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 53/197 (26%), Positives = 80/197 (40%), Gaps = 39/197 (19%)
Query: 369 TDNFKEEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKN 428
T E +G G FG V+ G +V ++ + + F E ++ Q H+
Sbjct: 22 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQR 77
Query: 429 LVRLLGFCDEGLNRLLVYEFLNNGTLASFLF--GNLKPSWNLRTNIAFQIARGLL----- 481
LVRL + ++ E++ NG+L FL +K + N ++A QIA G+
Sbjct: 78 LVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 136
Query: 482 -YLHEDCSSQIILYS--------------------YKRTEG------YVAPEWFRNSTIT 514
Y+H D + IL S EG + APE T T
Sbjct: 137 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFT 196
Query: 515 AKVDVYSFGFLLLEIIS 531
K DV+SFG LL EI++
Sbjct: 197 IKSDVWSFGILLTEIVT 213
>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase
Domain Of Human Lck, (Auto-Phosphorylated On Tyr394)
pdb|2ZM4|A Chain A, Crystal Structure Of Imidazo Quinoxaline 1 Bound To The
Kinase Domain Of Human Lck, Activated Form (Auto-
Phosphorylated On Tyr394)
pdb|2ZYB|A Chain A, Crystal Structure Of Phenylimidazo Pyrazin 2 Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC1|A Chain A, Crystal Structure Of Pyrazin Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC2|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC3|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC4|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC5|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC8|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACJ|A Chain A, Crystal Structure Of Imidazo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACK|A Chain A, Crystal Structure Of Pyrrolo Pyrazine Derivative Bound To
The Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD4|A Chain A, Crystal Structure Of Methoxy Benzofuran Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AD5|A Chain A, Crystal Structure Of Triazolone Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD6|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
Length = 285
Score = 52.8 bits (125), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 53/197 (26%), Positives = 80/197 (40%), Gaps = 39/197 (19%)
Query: 369 TDNFKEEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKN 428
T E +G G FG V+ G +V ++ + + F E ++ Q H+
Sbjct: 20 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQR 75
Query: 429 LVRLLGFCDEGLNRLLVYEFLNNGTLASFLF--GNLKPSWNLRTNIAFQIARGLL----- 481
LVRL + ++ E++ NG+L FL +K + N ++A QIA G+
Sbjct: 76 LVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 134
Query: 482 -YLHEDCSSQIILYS--------------------YKRTEG------YVAPEWFRNSTIT 514
Y+H D + IL S EG + APE T T
Sbjct: 135 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFT 194
Query: 515 AKVDVYSFGFLLLEIIS 531
K DV+SFG LL EI++
Sbjct: 195 IKSDVWSFGILLTEIVT 211
>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule
Inhibitor
Length = 288
Score = 52.8 bits (125), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 53/197 (26%), Positives = 80/197 (40%), Gaps = 39/197 (19%)
Query: 369 TDNFKEEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKN 428
T E +G G FG V+ G +V ++ + + F E ++ Q H+
Sbjct: 23 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQR 78
Query: 429 LVRLLGFCDEGLNRLLVYEFLNNGTLASFLF--GNLKPSWNLRTNIAFQIARGLL----- 481
LVRL + ++ E++ NG+L FL +K + N ++A QIA G+
Sbjct: 79 LVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 137
Query: 482 -YLHEDCSSQIILYS--------------------YKRTEG------YVAPEWFRNSTIT 514
Y+H D + IL S EG + APE T T
Sbjct: 138 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFT 197
Query: 515 AKVDVYSFGFLLLEIIS 531
K DV+SFG LL EI++
Sbjct: 198 IKSDVWSFGILLTEIVT 214
>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Aminopyridine Based Inhibitor
pdb|3CTJ|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Aminopyridine Based Inhibitor
pdb|3CE3|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Pyrrolopyridinepyridone Based Inhibitor
pdb|3F82|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
N-
(4-(2-Amino-3-Chloropyridin-4-Yloxy)-3-Fluorophenyl)-4-
Ethoxy-1-(4-Fluorophenyl)-2-Oxo-1,2-Dihydropyridine-3-
Carboxamide
pdb|3L8V|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepat Growth Factor Receptor C-Met In Complex With A
Biarylamine Inhibitor
Length = 314
Score = 52.8 bits (125), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 49/201 (24%), Positives = 85/201 (42%), Gaps = 41/201 (20%)
Query: 371 NFKEEVGRGSFGIVYKGVIQTT--RQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKN 428
+F E +GRG FG VY G + +++ ++S N I +F E ++ H N
Sbjct: 33 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 429 LVRLLGFC--DEGLNRLLVYEFLNNGTLASFLFGNLK-PSWNLRTNIAFQIARGLLYL-- 483
++ LLG C EG + L+V ++ +G L +F+ P+ Q+A+G+ +L
Sbjct: 93 VLSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 151
Query: 484 ----HEDCSSQIILYSYKRT-----------------------------EGYVAPEWFRN 510
H D +++ + K T ++A E +
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 211
Query: 511 STITAKVDVYSFGFLLLEIIS 531
T K DV+SFG LL E+++
Sbjct: 212 QKFTTKSDVWSFGVLLWELMT 232
>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With
6-Benzyloxyquinoline Inhibitor
Length = 319
Score = 52.8 bits (125), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 49/201 (24%), Positives = 85/201 (42%), Gaps = 41/201 (20%)
Query: 371 NFKEEVGRGSFGIVYKGVIQTT--RQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKN 428
+F E +GRG FG VY G + +++ ++S N I +F E ++ H N
Sbjct: 38 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 97
Query: 429 LVRLLGFC--DEGLNRLLVYEFLNNGTLASFLFGNLK-PSWNLRTNIAFQIARGLLYL-- 483
++ LLG C EG + L+V ++ +G L +F+ P+ Q+A+G+ +L
Sbjct: 98 VLSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 156
Query: 484 ----HEDCSSQIILYSYKRT-----------------------------EGYVAPEWFRN 510
H D +++ + K T ++A E +
Sbjct: 157 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 216
Query: 511 STITAKVDVYSFGFLLLEIIS 531
T K DV+SFG LL E+++
Sbjct: 217 QKFTTKSDVWSFGVLLWELMT 237
>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1
pdb|3DKF|A Chain A, Sgx Clone 5698a65kfg1h1
Length = 317
Score = 52.8 bits (125), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 49/201 (24%), Positives = 85/201 (42%), Gaps = 41/201 (20%)
Query: 371 NFKEEVGRGSFGIVYKGVIQTT--RQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKN 428
+F E +GRG FG VY G + +++ ++S N I +F E ++ H N
Sbjct: 34 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 93
Query: 429 LVRLLGFC--DEGLNRLLVYEFLNNGTLASFLFGNLK-PSWNLRTNIAFQIARGLLYL-- 483
++ LLG C EG + L+V ++ +G L +F+ P+ Q+A+G+ +L
Sbjct: 94 VLSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 152
Query: 484 ----HEDCSSQIILYSYKRT-----------------------------EGYVAPEWFRN 510
H D +++ + K T ++A E +
Sbjct: 153 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 212
Query: 511 STITAKVDVYSFGFLLLEIIS 531
T K DV+SFG LL E+++
Sbjct: 213 QKFTTKSDVWSFGVLLWELMT 233
>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
pdb|1QPJ|A Chain A, Crystal Structure Of The Lymphocyte-Specific Kinase Lck In
Complex With Staurosporine.
pdb|1QPC|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 52.4 bits (124), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 53/197 (26%), Positives = 80/197 (40%), Gaps = 39/197 (19%)
Query: 369 TDNFKEEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKN 428
T E +G G FG V+ G +V ++ + + F E ++ Q H+
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQR 69
Query: 429 LVRLLGFCDEGLNRLLVYEFLNNGTLASFLF--GNLKPSWNLRTNIAFQIARGLL----- 481
LVRL + ++ E++ NG+L FL +K + N ++A QIA G+
Sbjct: 70 LVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 482 -YLHEDCSSQIILYS--------------------YKRTEG------YVAPEWFRNSTIT 514
Y+H D + IL S EG + APE T T
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFT 188
Query: 515 AKVDVYSFGFLLLEIIS 531
K DV+SFG LL EI++
Sbjct: 189 IKSDVWSFGILLTEIVT 205
>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43
Bound To Lck
Length = 273
Score = 52.4 bits (124), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 53/197 (26%), Positives = 80/197 (40%), Gaps = 39/197 (19%)
Query: 369 TDNFKEEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKN 428
T E +G G FG V+ G +V ++ + + F E ++ Q H+
Sbjct: 16 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQR 71
Query: 429 LVRLLGFCDEGLNRLLVYEFLNNGTLASFLF--GNLKPSWNLRTNIAFQIARGLL----- 481
LVRL + ++ E++ NG+L FL +K + N ++A QIA G+
Sbjct: 72 LVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 130
Query: 482 -YLHEDCSSQIILYS--------------------YKRTEG------YVAPEWFRNSTIT 514
Y+H D + IL S EG + APE T T
Sbjct: 131 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFT 190
Query: 515 AKVDVYSFGFLLLEIIS 531
K DV+SFG LL EI++
Sbjct: 191 IKSDVWSFGILLTEIVT 207
>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck),
Activated Form (Auto-Phosphorylated On Tyr394)
pdb|3BYO|A Chain A, X-Ray Co-Crystal Structure Of 2-Amino-6-Phenylpyrimido[5',
4':5,6]pyrimido[1,2-A]benzimidazol-5(6h)-One 25 Bound To
Lck
Length = 271
Score = 52.4 bits (124), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 53/197 (26%), Positives = 80/197 (40%), Gaps = 39/197 (19%)
Query: 369 TDNFKEEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKN 428
T E +G G FG V+ G +V ++ + + F E ++ Q H+
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQR 69
Query: 429 LVRLLGFCDEGLNRLLVYEFLNNGTLASFLF--GNLKPSWNLRTNIAFQIARGLL----- 481
LVRL + ++ E++ NG+L FL +K + N ++A QIA G+
Sbjct: 70 LVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 482 -YLHEDCSSQIILYS--------------------YKRTEG------YVAPEWFRNSTIT 514
Y+H D + IL S EG + APE T T
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFT 188
Query: 515 AKVDVYSFGFLLLEIIS 531
K DV+SFG LL EI++
Sbjct: 189 IKSDVWSFGILLTEIVT 205
>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
The Microbial Alkaloid K-252a
pdb|1R1W|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met
Length = 312
Score = 52.4 bits (124), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 49/201 (24%), Positives = 85/201 (42%), Gaps = 41/201 (20%)
Query: 371 NFKEEVGRGSFGIVYKGVIQTT--RQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKN 428
+F E +GRG FG VY G + +++ ++S N I +F E ++ H N
Sbjct: 31 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 90
Query: 429 LVRLLGFC--DEGLNRLLVYEFLNNGTLASFLFGNLK-PSWNLRTNIAFQIARGLLYL-- 483
++ LLG C EG + L+V ++ +G L +F+ P+ Q+A+G+ +L
Sbjct: 91 VLSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 149
Query: 484 ----HEDCSSQIILYSYKRT-----------------------------EGYVAPEWFRN 510
H D +++ + K T ++A E +
Sbjct: 150 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 209
Query: 511 STITAKVDVYSFGFLLLEIIS 531
T K DV+SFG LL E+++
Sbjct: 210 QKFTTKSDVWSFGVLLWELMT 230
>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1
Bound To Lck
Length = 272
Score = 52.4 bits (124), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 53/197 (26%), Positives = 80/197 (40%), Gaps = 39/197 (19%)
Query: 369 TDNFKEEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKN 428
T E +G G FG V+ G +V ++ + + F E ++ Q H+
Sbjct: 15 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQR 70
Query: 429 LVRLLGFCDEGLNRLLVYEFLNNGTLASFLF--GNLKPSWNLRTNIAFQIARGLL----- 481
LVRL + ++ E++ NG+L FL +K + N ++A QIA G+
Sbjct: 71 LVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 129
Query: 482 -YLHEDCSSQIILYS--------------------YKRTEG------YVAPEWFRNSTIT 514
Y+H D + IL S EG + APE T T
Sbjct: 130 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFT 189
Query: 515 AKVDVYSFGFLLLEIIS 531
K DV+SFG LL EI++
Sbjct: 190 IKSDVWSFGILLTEIVT 206
>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1
Length = 317
Score = 52.4 bits (124), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 49/201 (24%), Positives = 85/201 (42%), Gaps = 41/201 (20%)
Query: 371 NFKEEVGRGSFGIVYKGVIQTT--RQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKN 428
+F E +GRG FG VY G + +++ ++S N I +F E ++ H N
Sbjct: 34 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 93
Query: 429 LVRLLGFC--DEGLNRLLVYEFLNNGTLASFLFGNLK-PSWNLRTNIAFQIARGLLYL-- 483
++ LLG C EG + L+V ++ +G L +F+ P+ Q+A+G+ +L
Sbjct: 94 VLSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 152
Query: 484 ----HEDCSSQIILYSYKRT-----------------------------EGYVAPEWFRN 510
H D +++ + K T ++A E +
Sbjct: 153 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQT 212
Query: 511 STITAKVDVYSFGFLLLEIIS 531
T K DV+SFG LL E+++
Sbjct: 213 QKFTTKSDVWSFGVLLWELMT 233
>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8)
Length = 325
Score = 52.0 bits (123), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 48/211 (22%), Positives = 93/211 (44%), Gaps = 38/211 (18%)
Query: 358 RCFSYKALEEATDNFKEEVGRGSFGIVYKGVIQT--TRQVLLQLQSRNWIVFQDGEREFK 415
R F+ + +E + + ++ +G G G V G ++ R V + +++ + R+F
Sbjct: 40 RSFT-REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFL 98
Query: 416 NEVFVISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFL------FGNLKPSWNLR 469
+E ++ Q H N++RL G G ++V E++ NG+L +FL F ++ LR
Sbjct: 99 SEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLR 158
Query: 470 -TNIAFQIARGLLYLHEDCSSQIILY-----------------------SYKRTEG---- 501
+ L Y+H D +++ +L +Y T G
Sbjct: 159 GVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPI 218
Query: 502 -YVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
+ APE T ++ DV+SFG ++ E+++
Sbjct: 219 RWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249
>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor
Tyrosine Kinase And Juxtamembrane Region
pdb|1JPA|B Chain B, Crystal Structure Of Unphosphorylated Ephb2 Receptor
Tyrosine Kinase And Juxtamembrane Region
Length = 312
Score = 52.0 bits (123), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 50/222 (22%), Positives = 93/222 (41%), Gaps = 50/222 (22%)
Query: 360 FSYKALEEATDNFKEEV-----------GRGSFGIVYKGVIQTT--RQVLLQLQSRNWIV 406
F+++ EA F +E+ G G FG V G ++ R++ + +++
Sbjct: 14 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 73
Query: 407 FQDGEREFKNEVFVISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSW 466
+ R+F +E ++ Q H N++ L G + +++ EF+ NG+L SFL N
Sbjct: 74 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 133
Query: 467 NLR-TNIAFQIARGLLYL------HEDCSSQIILY------------------------S 495
++ + IA G+ YL H D +++ IL +
Sbjct: 134 VIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT 193
Query: 496 YKRTEG------YVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
Y G + APE + T+ DV+S+G ++ E++S
Sbjct: 194 YTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 235
>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
pdb|2R4B|B Chain B, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
Length = 321
Score = 51.6 bits (122), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 36/127 (28%), Positives = 62/127 (48%), Gaps = 5/127 (3%)
Query: 363 KALEEATDNFKEEVGRGSFGIVYKGVIQT---TRQVLLQLQSRNWIVFQDGEREFKNEVF 419
+ L+E + +G G+FG VYKG+ T ++ + ++ N EF +E
Sbjct: 33 RILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEAL 92
Query: 420 VISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNL-KPSWNLRTNIAFQIAR 478
+++ H +LVRLLG C + LV + + +G L ++ + L N QIA+
Sbjct: 93 IMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAK 151
Query: 479 GLLYLHE 485
G++YL E
Sbjct: 152 GMMYLEE 158
>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor
Awl-Ii- 38.3
pdb|4G2F|A Chain A, Human Epha3 Kinase Domain In Complex With Compound 7
pdb|4GK2|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 66
pdb|4GK3|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 87
pdb|4GK4|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 90
Length = 361
Score = 51.6 bits (122), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 50/211 (23%), Positives = 89/211 (42%), Gaps = 47/211 (22%)
Query: 363 KALEEATDNFKEEVGRGSFGIVYKGVIQ--TTRQVLLQLQSRNWIVFQDGEREFKNEVFV 420
K L+ + + VG G FG V G ++ + +++ + +++ + R+F E +
Sbjct: 28 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 87
Query: 421 ISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFL------FGNLKPSWNLRTNIAF 474
+ Q H N++RL G + ++V E++ NG+L SFL F ++ LR
Sbjct: 88 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRG---- 143
Query: 475 QIARGLLYL------HEDCSSQIILY-----------------------SYKRTEGYVAP 505
IA G+ YL H D +++ IL +Y G +
Sbjct: 144 -IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 202
Query: 506 EWFRNSTI-----TAKVDVYSFGFLLLEIIS 531
W I T+ DV+S+G +L E++S
Sbjct: 203 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 233
>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596:y602:s768g Triple Mutant
Length = 373
Score = 51.6 bits (122), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 50/211 (23%), Positives = 89/211 (42%), Gaps = 47/211 (22%)
Query: 363 KALEEATDNFKEEVGRGSFGIVYKGVIQ--TTRQVLLQLQSRNWIVFQDGEREFKNEVFV 420
K L+ + + VG G FG V G ++ + +++ + +++ + R+F E +
Sbjct: 40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 421 ISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFL------FGNLKPSWNLRTNIAF 474
+ Q H N++RL G + ++V E++ NG+L SFL F ++ LR
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRG---- 155
Query: 475 QIARGLLYL------HEDCSSQIILY-----------------------SYKRTEGYVAP 505
IA G+ YL H D +++ IL +Y G +
Sbjct: 156 -IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPI 214
Query: 506 EWFRNSTI-----TAKVDVYSFGFLLLEIIS 531
W I T+ DV+S+G +L E++S
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245
>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane
Region
pdb|2QO2|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Dephosphorylated, Apo Structure
pdb|2QO9|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Phosphorylated, Amp-pnp Bound
Length = 373
Score = 51.6 bits (122), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 50/211 (23%), Positives = 89/211 (42%), Gaps = 47/211 (22%)
Query: 363 KALEEATDNFKEEVGRGSFGIVYKGVIQ--TTRQVLLQLQSRNWIVFQDGEREFKNEVFV 420
K L+ + + VG G FG V G ++ + +++ + +++ + R+F E +
Sbjct: 40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 421 ISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFL------FGNLKPSWNLRTNIAF 474
+ Q H N++RL G + ++V E++ NG+L SFL F ++ LR
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRG---- 155
Query: 475 QIARGLLYL------HEDCSSQIILY-----------------------SYKRTEGYVAP 505
IA G+ YL H D +++ IL +Y G +
Sbjct: 156 -IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 214
Query: 506 EWFRNSTI-----TAKVDVYSFGFLLLEIIS 531
W I T+ DV+S+G +L E++S
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245
>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole
Inhibitor
Length = 291
Score = 51.6 bits (122), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 49/213 (23%), Positives = 90/213 (42%), Gaps = 49/213 (23%)
Query: 363 KALEEATDNFKEEVGRGSFGIVYKGVIQTT--RQVLLQLQSRNWIVFQDGEREFKNEVFV 420
K ++ + +E +G G FG V +G ++ ++ + +++ + REF +E +
Sbjct: 9 KEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASI 68
Query: 421 ISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFL------FGNLKPSWNLRTNIAF 474
+ Q H N++RL G + +++ EF+ NG L SFL F ++ LR
Sbjct: 69 MGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRG---- 124
Query: 475 QIARGLLYL------HEDCSSQIILY------------------------SYKRTEG--- 501
IA G+ YL H D +++ IL +Y + G
Sbjct: 125 -IASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKI 183
Query: 502 ---YVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
+ APE T+ D +S+G ++ E++S
Sbjct: 184 PIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMS 216
>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A
Thiazolopyrimidine Inhibitor
Length = 324
Score = 51.6 bits (122), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 61/240 (25%), Positives = 97/240 (40%), Gaps = 65/240 (27%)
Query: 344 IRNSPGDGTVETNLRCFSYKALEEATDNFKEEVGRGSFGIVYKGVIQTT-RQVLLQLQSR 402
++N+P D T+ Y L+ F++ +G G+FG V K I+ ++ ++
Sbjct: 7 VKNNP-DPTI--------YPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM 57
Query: 403 NWIVFQDGEREFKNEVFVISQT-HHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGN 461
+D R+F E+ V+ + HH N++ LLG C+ L E+ +G L FL
Sbjct: 58 KEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL--- 114
Query: 462 LKPSWNLRTNIAFQIA--------------------RGLLYL------HEDCSSQIILYS 495
+ S L T+ AF IA RG+ YL H + +++ IL
Sbjct: 115 -RKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRNLAARNILVG 173
Query: 496 -------------------YKRTEGYVAPEW-----FRNSTITAKVDVYSFGFLLLEIIS 531
K+T G + W S T DV+S+G LL EI+S
Sbjct: 174 ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233
>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f
Double Mutant
Length = 373
Score = 51.6 bits (122), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 50/211 (23%), Positives = 89/211 (42%), Gaps = 47/211 (22%)
Query: 363 KALEEATDNFKEEVGRGSFGIVYKGVIQ--TTRQVLLQLQSRNWIVFQDGEREFKNEVFV 420
K L+ + + VG G FG V G ++ + +++ + +++ + R+F E +
Sbjct: 40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 421 ISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFL------FGNLKPSWNLRTNIAF 474
+ Q H N++RL G + ++V E++ NG+L SFL F ++ LR
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRG---- 155
Query: 475 QIARGLLYL------HEDCSSQIILY-----------------------SYKRTEGYVAP 505
IA G+ YL H D +++ IL +Y G +
Sbjct: 156 -IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 214
Query: 506 EWFRNSTI-----TAKVDVYSFGFLLLEIIS 531
W I T+ DV+S+G +L E++S
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245
>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:s768a Triple Mutant
Length = 373
Score = 51.6 bits (122), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 50/211 (23%), Positives = 89/211 (42%), Gaps = 47/211 (22%)
Query: 363 KALEEATDNFKEEVGRGSFGIVYKGVIQ--TTRQVLLQLQSRNWIVFQDGEREFKNEVFV 420
K L+ + + VG G FG V G ++ + +++ + +++ + R+F E +
Sbjct: 40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 421 ISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFL------FGNLKPSWNLRTNIAF 474
+ Q H N++RL G + ++V E++ NG+L SFL F ++ LR
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRG---- 155
Query: 475 QIARGLLYL------HEDCSSQIILY-----------------------SYKRTEGYVAP 505
IA G+ YL H D +++ IL +Y G +
Sbjct: 156 -IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPI 214
Query: 506 EWFRNSTI-----TAKVDVYSFGFLLLEIIS 531
W I T+ DV+S+G +L E++S
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245
>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant
Length = 373
Score = 51.6 bits (122), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 50/211 (23%), Positives = 89/211 (42%), Gaps = 47/211 (22%)
Query: 363 KALEEATDNFKEEVGRGSFGIVYKGVIQ--TTRQVLLQLQSRNWIVFQDGEREFKNEVFV 420
K L+ + + VG G FG V G ++ + +++ + +++ + R+F E +
Sbjct: 40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 421 ISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFL------FGNLKPSWNLRTNIAF 474
+ Q H N++RL G + ++V E++ NG+L SFL F ++ LR
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRG---- 155
Query: 475 QIARGLLYL------HEDCSSQIILY-----------------------SYKRTEGYVAP 505
IA G+ YL H D +++ IL +Y G +
Sbjct: 156 -IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 214
Query: 506 EWFRNSTI-----TAKVDVYSFGFLLLEIIS 531
W I T+ DV+S+G +L E++S
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245
>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant
Length = 373
Score = 51.6 bits (122), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 50/211 (23%), Positives = 89/211 (42%), Gaps = 47/211 (22%)
Query: 363 KALEEATDNFKEEVGRGSFGIVYKGVIQ--TTRQVLLQLQSRNWIVFQDGEREFKNEVFV 420
K L+ + + VG G FG V G ++ + +++ + +++ + R+F E +
Sbjct: 40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 421 ISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFL------FGNLKPSWNLRTNIAF 474
+ Q H N++RL G + ++V E++ NG+L SFL F ++ LR
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRG---- 155
Query: 475 QIARGLLYL------HEDCSSQIILY-----------------------SYKRTEGYVAP 505
IA G+ YL H D +++ IL +Y G +
Sbjct: 156 -IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 214
Query: 506 EWFRNSTI-----TAKVDVYSFGFLLLEIIS 531
W I T+ DV+S+G +L E++S
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245
>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound
Structure
Length = 344
Score = 51.6 bits (122), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 50/211 (23%), Positives = 89/211 (42%), Gaps = 47/211 (22%)
Query: 363 KALEEATDNFKEEVGRGSFGIVYKGVIQ--TTRQVLLQLQSRNWIVFQDGEREFKNEVFV 420
K L+ + + VG G FG V G ++ + +++ + +++ + R+F E +
Sbjct: 11 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 70
Query: 421 ISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFL------FGNLKPSWNLRTNIAF 474
+ Q H N++RL G + ++V E++ NG+L SFL F ++ LR
Sbjct: 71 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRG---- 126
Query: 475 QIARGLLYL------HEDCSSQIILY-----------------------SYKRTEGYVAP 505
IA G+ YL H D +++ IL +Y G +
Sbjct: 127 -IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 185
Query: 506 EWFRNSTI-----TAKVDVYSFGFLLLEIIS 531
W I T+ DV+S+G +L E++S
Sbjct: 186 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 216
>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To
Substrate Kqwdnye[ptyr]iw
pdb|3FY2|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To
Substrate Kqwdnyefiw
Length = 371
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 50/211 (23%), Positives = 89/211 (42%), Gaps = 47/211 (22%)
Query: 363 KALEEATDNFKEEVGRGSFGIVYKGVIQ--TTRQVLLQLQSRNWIVFQDGEREFKNEVFV 420
K L+ + + VG G FG V G ++ + +++ + +++ + R+F E +
Sbjct: 38 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 97
Query: 421 ISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFL------FGNLKPSWNLRTNIAF 474
+ Q H N++RL G + ++V E++ NG+L SFL F ++ LR
Sbjct: 98 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRG---- 153
Query: 475 QIARGLLYL------HEDCSSQIILY-----------------------SYKRTEGYVAP 505
IA G+ YL H D +++ IL +Y G +
Sbjct: 154 -IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 212
Query: 506 EWFRNSTI-----TAKVDVYSFGFLLLEIIS 531
W I T+ DV+S+G +L E++S
Sbjct: 213 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 243
>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:y742f Triple Mutant
Length = 373
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 50/211 (23%), Positives = 89/211 (42%), Gaps = 47/211 (22%)
Query: 363 KALEEATDNFKEEVGRGSFGIVYKGVIQ--TTRQVLLQLQSRNWIVFQDGEREFKNEVFV 420
K L+ + + VG G FG V G ++ + +++ + +++ + R+F E +
Sbjct: 40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 421 ISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFL------FGNLKPSWNLRTNIAF 474
+ Q H N++RL G + ++V E++ NG+L SFL F ++ LR
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRG---- 155
Query: 475 QIARGLLYL------HEDCSSQIILY-----------------------SYKRTEGYVAP 505
IA G+ YL H D +++ IL +Y G +
Sbjct: 156 -IASGMKYLSDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 214
Query: 506 EWFRNSTI-----TAKVDVYSFGFLLLEIIS 531
W I T+ DV+S+G +L E++S
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245
>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBT|D Chain D, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBW|B Chain B, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BBW|A Chain A, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BCE|A Chain A, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|B Chain B, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|C Chain C, Crystal Structure Of The Erbb4 Kinase
Length = 328
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 36/127 (28%), Positives = 62/127 (48%), Gaps = 5/127 (3%)
Query: 363 KALEEATDNFKEEVGRGSFGIVYKGVIQT---TRQVLLQLQSRNWIVFQDGEREFKNEVF 419
+ L+E + +G G+FG VYKG+ T ++ + ++ N EF +E
Sbjct: 10 RILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEAL 69
Query: 420 VISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNL-KPSWNLRTNIAFQIAR 478
+++ H +LVRLLG C + LV + + +G L ++ + L N QIA+
Sbjct: 70 IMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAK 128
Query: 479 GLLYLHE 485
G++YL E
Sbjct: 129 GMMYLEE 135
>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In
Complex With Staurosporine
pdb|3S95|B Chain B, Crystal Structure Of The Human Limk1 Kinase Domain In
Complex With Staurosporine
Length = 310
Score = 50.8 bits (120), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 51/206 (24%), Positives = 89/206 (43%), Gaps = 54/206 (26%)
Query: 374 EEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVF-QDGEREFKNEVFVISQTHHKNLVRL 432
E +G+G FG K + T +V++ + I F ++ +R F EV V+ H N+++
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVM---KELIRFDEETQRTFLKEVKVMRCLEHPNVLKF 72
Query: 433 LG--FCDEGLNRLLVYEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLH----- 484
+G + D+ LN + E++ GTL + + + W+ R + A IA G+ YLH
Sbjct: 73 IGVLYKDKRLN--FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNII 130
Query: 485 ------EDC--------------SSQIILYSYKRTEG--------------------YVA 504
+C +++++ + EG ++A
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 505 PEWFRNSTITAKVDVYSFGFLLLEII 530
PE + KVDV+SFG +L EII
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEII 216
>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 269
Score = 50.8 bits (120), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 49/189 (25%), Positives = 80/189 (42%), Gaps = 37/189 (19%)
Query: 374 EEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLL 433
+ +G+G FG V G + + + +++ + F E V++Q H NLV+LL
Sbjct: 18 QTIGKGEFGDVMLGDYRGNKVAVKCIKN------DATAQAFLAEASVMTQLRHSNLVQLL 71
Query: 434 GFCDEGLNRL-LVYEFLNNGTLA--------SFLFGNLKPSWNLRTNIAFQIARGLLYLH 484
G E L +V E++ G+L S L G+ ++L A + G ++H
Sbjct: 72 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVH 131
Query: 485 EDCSSQIILYSY----------------------KRTEGYVAPEWFRNSTITAKVDVYSF 522
D +++ +L S K + APE R + + K DV+SF
Sbjct: 132 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREAAFSTKSDVWSF 191
Query: 523 GFLLLEIIS 531
G LL EI S
Sbjct: 192 GILLWEIYS 200
>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dorsomorphin
pdb|3Q4T|B Chain B, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dorsomorphin
pdb|3SOC|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With A Quinazolin
pdb|3SOC|B Chain B, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With A Quinazolin
pdb|4ASX|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dihydro-Bauerine C
pdb|4ASX|B Chain B, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dihydro-Bauerine C
Length = 322
Score = 50.4 bits (119), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 38/116 (32%), Positives = 61/116 (52%), Gaps = 14/116 (12%)
Query: 377 GRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNE--VFVISQTHHKNLVRLLG 434
RG FG V+K Q+L + + QD ++ ++NE V+ + H+N+++ +G
Sbjct: 33 ARGRFGCVWKA------QLLNEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIG 85
Query: 435 FCDEG----LNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHED 486
G ++ L+ F G+L+ FL N+ SWN +IA +ARGL YLHED
Sbjct: 86 AEKRGTSVDVDLWLITAFHEKGSLSDFLKANV-VSWNELCHIAETMARGLAYLHED 140
>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWV|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWW|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWX|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWY|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWZ|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VX0|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VX1|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2X9F|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2XVD|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|4BB4|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
Length = 302
Score = 50.4 bits (119), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 50/213 (23%), Positives = 89/213 (41%), Gaps = 49/213 (23%)
Query: 363 KALEEATDNFKEEVGRGSFGIVYKGVIQTT--RQVLLQLQSRNWIVFQDGEREFKNEVFV 420
K ++ + +E +G G FG V +G ++ ++ + +++ + REF +E +
Sbjct: 11 KEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASI 70
Query: 421 ISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFL------FGNLKPSWNLRTNIAF 474
+ Q H N++RL G + +++ EF+ NG L SFL F ++ LR
Sbjct: 71 MGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRG---- 126
Query: 475 QIARGLLYL------HEDCSSQIILY--------------------SYKRTEG------- 501
IA G+ YL H D +++ IL S TE
Sbjct: 127 -IASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKI 185
Query: 502 ---YVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
+ APE T+ D +S+G ++ E++S
Sbjct: 186 PIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMS 218
>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck
In Complex With Non-selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 50.4 bits (119), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 44/152 (28%), Positives = 64/152 (42%), Gaps = 35/152 (23%)
Query: 414 FKNEVFVISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLF--GNLKPSWNLRTN 471
F E ++ Q H+ LVRL + ++ E++ NG+L FL +K + N +
Sbjct: 55 FLAEANLMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 113
Query: 472 IAFQIARGLL------YLHEDCSSQIILYS--------------------YKRTEG---- 501
+A QIA G+ Y+H D + IL S EG
Sbjct: 114 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFP 173
Query: 502 --YVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
+ APE T T K DV+SFG LL EI++
Sbjct: 174 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205
>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXR|B Chain B, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXS|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complexed With Pp2
Length = 268
Score = 50.1 bits (118), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 53/227 (23%), Positives = 92/227 (40%), Gaps = 42/227 (18%)
Query: 374 EEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLL 433
+E+G G FG+V G + V +++ + E EF E + + H LV+
Sbjct: 14 KELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM----SEDEFFQEAQTMMKLSHPKLVKFY 69
Query: 434 GFCDEGLNRLLVYEFLNNGTLASFLFGN---LKPSWNLRTNIAFQIARGLLYL------H 484
G C + +V E+++NG L ++L + L+PS L + + + G+ +L H
Sbjct: 70 GVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLL--EMCYDVCEGMAFLESHQFIH 127
Query: 485 EDCSSQIILYS--------------YKRTEGYV------------APEWFRNSTITAKVD 518
D +++ L Y + YV APE F ++K D
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSD 187
Query: 519 VYSFGFLLLEIISCRK-SFDIEMGEEYAILTDWAFDCYRNGKLDDLV 564
V++FG L+ E+ S K +D+ E + YR D +
Sbjct: 188 VWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTI 234
>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
pdb|3V5Q|B Chain B, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
Length = 297
Score = 50.1 bits (118), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 53/215 (24%), Positives = 92/215 (42%), Gaps = 58/215 (26%)
Query: 372 FKEEVGRGSFGIVYKG----VIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHK 427
K E+G G+FG V+ + T ++L+ +++ ++F+ E +++ H+
Sbjct: 19 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLA-ARKDFQREAELLTNLQHE 77
Query: 428 NLVRLLGFCDEGLNRLLVYEFLNNGTLASFLF------------------GNLKPSWNLR 469
++V+ G C +G ++V+E++ +G L FL G L S L
Sbjct: 78 HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQML- 136
Query: 470 TNIAFQIARGLLYL------HEDCSSQIIL------------------YS--YKRTEGY- 502
+IA QIA G++YL H D +++ L YS Y R G+
Sbjct: 137 -HIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 195
Query: 503 ------VAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
+ PE T + DV+SFG +L EI +
Sbjct: 196 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|B Chain B, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|C Chain C, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|D Chain D, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|E Chain E, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|F Chain F, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
Length = 450
Score = 50.1 bits (118), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 49/189 (25%), Positives = 79/189 (41%), Gaps = 37/189 (19%)
Query: 374 EEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLL 433
+ +G+G FG V G + + + +++ + F E V++Q H NLV+LL
Sbjct: 199 QTIGKGEFGDVMLGDYRGNKVAVKCIKN------DATAQAFLAEASVMTQLRHSNLVQLL 252
Query: 434 GFCDEGLNRL-LVYEFLNNGTLA--------SFLFGNLKPSWNLRTNIAFQIARGLLYLH 484
G E L +V E++ G+L S L G+ ++L A + G ++H
Sbjct: 253 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVH 312
Query: 485 EDCSSQIILYSY----------------------KRTEGYVAPEWFRNSTITAKVDVYSF 522
D +++ +L S K + APE R + K DV+SF
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSF 372
Query: 523 GFLLLEIIS 531
G LL EI S
Sbjct: 373 GILLWEIYS 381
>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure
Length = 344
Score = 50.1 bits (118), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 50/211 (23%), Positives = 88/211 (41%), Gaps = 47/211 (22%)
Query: 363 KALEEATDNFKEEVGRGSFGIVYKGVIQ--TTRQVLLQLQSRNWIVFQDGEREFKNEVFV 420
K L+ + + VG G FG V G ++ + +++ + +++ + R+F E +
Sbjct: 11 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 70
Query: 421 ISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFL------FGNLKPSWNLRTNIAF 474
+ Q H N++RL G + ++V E + NG+L SFL F ++ LR
Sbjct: 71 MGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRG---- 126
Query: 475 QIARGLLYL------HEDCSSQIILY-----------------------SYKRTEGYVAP 505
IA G+ YL H D +++ IL +Y G +
Sbjct: 127 -IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 185
Query: 506 EWFRNSTI-----TAKVDVYSFGFLLLEIIS 531
W I T+ DV+S+G +L E++S
Sbjct: 186 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 216
>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Dephosphorylated, Amp-Pnp Bound
pdb|2QOQ|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Base, Amp-Pnp
Bound Structure
Length = 373
Score = 49.7 bits (117), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 50/211 (23%), Positives = 88/211 (41%), Gaps = 47/211 (22%)
Query: 363 KALEEATDNFKEEVGRGSFGIVYKGVIQ--TTRQVLLQLQSRNWIVFQDGEREFKNEVFV 420
K L+ + + VG G FG V G ++ + +++ + +++ + R+F E +
Sbjct: 40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 421 ISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFL------FGNLKPSWNLRTNIAF 474
+ Q H N++RL G + ++V E + NG+L SFL F ++ LR
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRG---- 155
Query: 475 QIARGLLYL------HEDCSSQIILY-----------------------SYKRTEGYVAP 505
IA G+ YL H D +++ IL +Y G +
Sbjct: 156 -IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 214
Query: 506 EWFRNSTI-----TAKVDVYSFGFLLLEIIS 531
W I T+ DV+S+G +L E++S
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245
>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:y742a Triple Mutant
Length = 373
Score = 49.7 bits (117), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 50/211 (23%), Positives = 88/211 (41%), Gaps = 47/211 (22%)
Query: 363 KALEEATDNFKEEVGRGSFGIVYKGVIQ--TTRQVLLQLQSRNWIVFQDGEREFKNEVFV 420
K L+ + + VG G FG V G ++ + +++ + +++ + R+F E +
Sbjct: 40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 421 ISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFL------FGNLKPSWNLRTNIAF 474
+ Q H N++RL G + ++V E + NG+L SFL F ++ LR
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRG---- 155
Query: 475 QIARGLLYL------HEDCSSQIILY-----------------------SYKRTEGYVAP 505
IA G+ YL H D +++ IL +Y G +
Sbjct: 156 -IASGMKYLSDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 214
Query: 506 EWFRNSTI-----TAKVDVYSFGFLLLEIIS 531
W I T+ DV+S+G +L E++S
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245
>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8)
Length = 325
Score = 49.7 bits (117), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 47/211 (22%), Positives = 92/211 (43%), Gaps = 38/211 (18%)
Query: 358 RCFSYKALEEATDNFKEEVGRGSFGIVYKGVIQT--TRQVLLQLQSRNWIVFQDGEREFK 415
R F+ + +E + + ++ +G G G V G ++ R V + +++ + R+F
Sbjct: 40 RSFT-REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFL 98
Query: 416 NEVFVISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFL------FGNLKPSWNLR 469
+E ++ Q H N++RL G G ++V E++ NG+L +FL F ++ LR
Sbjct: 99 SEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLR 158
Query: 470 -TNIAFQIARGLLYLHEDCSSQIILY----------------------SYKRTEG----- 501
+ L Y+H D +++ +L + T G
Sbjct: 159 GVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPI 218
Query: 502 -YVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
+ APE T ++ DV+SFG ++ E+++
Sbjct: 219 RWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249
>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In
Complex With Inhibitor Staurosporine
Length = 278
Score = 49.7 bits (117), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 49/189 (25%), Positives = 79/189 (41%), Gaps = 37/189 (19%)
Query: 374 EEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLL 433
+ +G+G FG V G + + + +++ + F E V++Q H NLV+LL
Sbjct: 27 QTIGKGEFGDVMLGDYRGNKVAVKCIKN------DATAQAFLAEASVMTQLRHSNLVQLL 80
Query: 434 GFCDEGLNRL-LVYEFLNNGTLA--------SFLFGNLKPSWNLRTNIAFQIARGLLYLH 484
G E L +V E++ G+L S L G+ ++L A + G ++H
Sbjct: 81 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVH 140
Query: 485 EDCSSQIILYSY----------------------KRTEGYVAPEWFRNSTITAKVDVYSF 522
D +++ +L S K + APE R + K DV+SF
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSF 200
Query: 523 GFLLLEIIS 531
G LL EI S
Sbjct: 201 GILLWEIYS 209
>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3D7U|C Chain C, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 263
Score = 49.3 bits (116), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 49/189 (25%), Positives = 79/189 (41%), Gaps = 37/189 (19%)
Query: 374 EEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLL 433
+ +G+G FG V G + + + +++ + F E V++Q H NLV+LL
Sbjct: 12 QTIGKGEFGDVMLGDYRGNKVAVKCIKN------DATAQAFLAEASVMTQLRHSNLVQLL 65
Query: 434 GFCDEGLNRL-LVYEFLNNGTLA--------SFLFGNLKPSWNLRTNIAFQIARGLLYLH 484
G E L +V E++ G+L S L G+ ++L A + G ++H
Sbjct: 66 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVH 125
Query: 485 EDCSSQIILYSY----------------------KRTEGYVAPEWFRNSTITAKVDVYSF 522
D +++ +L S K + APE R + K DV+SF
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSF 185
Query: 523 GFLLLEIIS 531
G LL EI S
Sbjct: 186 GILLWEIYS 194
>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2F|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
Length = 287
Score = 49.3 bits (116), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 50/210 (23%), Positives = 85/210 (40%), Gaps = 55/210 (26%)
Query: 365 LEEATDNFKEEVGRGSFGIVYKGV---------IQTTRQVLLQLQSRNWIVFQDGEREFK 415
+E K ++G G +G VY+GV ++T ++ ++++ EF
Sbjct: 12 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE------------EFL 59
Query: 416 NEVFVISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWN--LRTNIA 473
E V+ + H NLV+LLG C ++ EF+ G L +L + N + +A
Sbjct: 60 KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMA 119
Query: 474 FQIARGLLYL------HEDCSSQIILY--------------------SYKRTEG------ 501
QI+ + YL H D +++ L +Y G
Sbjct: 120 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIK 179
Query: 502 YVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
+ APE + + K DV++FG LL EI +
Sbjct: 180 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209
>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
pdb|3QRJ|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
Length = 277
Score = 49.3 bits (116), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 50/210 (23%), Positives = 85/210 (40%), Gaps = 55/210 (26%)
Query: 365 LEEATDNFKEEVGRGSFGIVYKGV---------IQTTRQVLLQLQSRNWIVFQDGEREFK 415
+E K ++G G +G VY+GV ++T ++ ++++ EF
Sbjct: 15 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE------------EFL 62
Query: 416 NEVFVISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWN--LRTNIA 473
E V+ + H NLV+LLG C ++ EF+ G L +L + N + +A
Sbjct: 63 KEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMA 122
Query: 474 FQIARGLLYL------HEDCSSQIILY--------------------SYKRTEG------ 501
QI+ + YL H D +++ L +Y G
Sbjct: 123 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 182
Query: 502 YVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
+ APE + + K DV++FG LL EI +
Sbjct: 183 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212
>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
pdb|2E2B|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
Length = 293
Score = 49.3 bits (116), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 50/210 (23%), Positives = 85/210 (40%), Gaps = 55/210 (26%)
Query: 365 LEEATDNFKEEVGRGSFGIVYKGV---------IQTTRQVLLQLQSRNWIVFQDGEREFK 415
+E K ++G G +G VY+GV ++T ++ ++++ EF
Sbjct: 15 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE------------EFL 62
Query: 416 NEVFVISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWN--LRTNIA 473
E V+ + H NLV+LLG C ++ EF+ G L +L + N + +A
Sbjct: 63 KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMA 122
Query: 474 FQIARGLLYL------HEDCSSQIILY--------------------SYKRTEG------ 501
QI+ + YL H D +++ L +Y G
Sbjct: 123 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 182
Query: 502 YVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
+ APE + + K DV++FG LL EI +
Sbjct: 183 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212
>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1FPU|B Chain B, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1IEP|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1IEP|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1M52|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1M52|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1OPJ|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPJ|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|2HZN|A Chain A, Abl Kinase Domain In Complex With Nvp-Afg210
pdb|3K5V|A Chain A, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3K5V|B Chain B, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3MS9|A Chain A, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MS9|B Chain B, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MSS|A Chain A, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|B Chain B, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|C Chain C, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|D Chain D, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
Length = 293
Score = 49.3 bits (116), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 50/210 (23%), Positives = 85/210 (40%), Gaps = 55/210 (26%)
Query: 365 LEEATDNFKEEVGRGSFGIVYKGV---------IQTTRQVLLQLQSRNWIVFQDGEREFK 415
+E K ++G G +G VY+GV ++T ++ ++++ EF
Sbjct: 15 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE------------EFL 62
Query: 416 NEVFVISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLF--GNLKPSWNLRTNIA 473
E V+ + H NLV+LLG C ++ EF+ G L +L + S + +A
Sbjct: 63 KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 122
Query: 474 FQIARGLLYL------HEDCSSQIILY--------------------SYKRTEG------ 501
QI+ + YL H D +++ L +Y G
Sbjct: 123 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 182
Query: 502 YVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
+ APE + + K DV++FG LL EI +
Sbjct: 183 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212
>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant
Abl Mutant In Complex With The Aurora Kinase Inhibitor
Vx-680
Length = 287
Score = 49.3 bits (116), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 50/210 (23%), Positives = 85/210 (40%), Gaps = 55/210 (26%)
Query: 365 LEEATDNFKEEVGRGSFGIVYKGV---------IQTTRQVLLQLQSRNWIVFQDGEREFK 415
+E K ++G G +G VY+GV ++T ++ ++++ EF
Sbjct: 11 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE------------EFL 58
Query: 416 NEVFVISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWN--LRTNIA 473
E V+ + H NLV+LLG C ++ EF+ G L +L + N + +A
Sbjct: 59 KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMA 118
Query: 474 FQIARGLLYL------HEDCSSQIILY--------------------SYKRTEG------ 501
QI+ + YL H D +++ L +Y G
Sbjct: 119 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIK 178
Query: 502 YVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
+ APE + + K DV++FG LL EI +
Sbjct: 179 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 208
>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970
pdb|2HZI|B Chain B, Abl Kinase Domain In Complex With Pd180970
pdb|3CS9|A Chain A, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|B Chain B, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|C Chain C, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|D Chain D, Human Abl Kinase In Complex With Nilotinib
Length = 277
Score = 49.3 bits (116), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 50/210 (23%), Positives = 85/210 (40%), Gaps = 55/210 (26%)
Query: 365 LEEATDNFKEEVGRGSFGIVYKGV---------IQTTRQVLLQLQSRNWIVFQDGEREFK 415
+E K ++G G +G VY+GV ++T ++ ++++ EF
Sbjct: 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE------------EFL 61
Query: 416 NEVFVISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWN--LRTNIA 473
E V+ + H NLV+LLG C ++ EF+ G L +L + N + +A
Sbjct: 62 KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMA 121
Query: 474 FQIARGLLYL------HEDCSSQIILY--------------------SYKRTEG------ 501
QI+ + YL H D +++ L +Y G
Sbjct: 122 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 181
Query: 502 YVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
+ APE + + K DV++FG LL EI +
Sbjct: 182 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 211
>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRI|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRK|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dp- 987
Length = 277
Score = 49.3 bits (116), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 50/210 (23%), Positives = 85/210 (40%), Gaps = 55/210 (26%)
Query: 365 LEEATDNFKEEVGRGSFGIVYKGV---------IQTTRQVLLQLQSRNWIVFQDGEREFK 415
+E K ++G G +G VY+GV ++T ++ ++++ EF
Sbjct: 15 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE------------EFL 62
Query: 416 NEVFVISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWN--LRTNIA 473
E V+ + H NLV+LLG C ++ EF+ G L +L + N + +A
Sbjct: 63 KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMA 122
Query: 474 FQIARGLLYL------HEDCSSQIILY--------------------SYKRTEG------ 501
QI+ + YL H D +++ L +Y G
Sbjct: 123 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 182
Query: 502 YVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
+ APE + + K DV++FG LL EI +
Sbjct: 183 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212
>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound
With Ppy-A
pdb|3IK3|A Chain A, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
pdb|3IK3|B Chain B, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
Length = 288
Score = 49.3 bits (116), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 50/210 (23%), Positives = 85/210 (40%), Gaps = 55/210 (26%)
Query: 365 LEEATDNFKEEVGRGSFGIVYKGV---------IQTTRQVLLQLQSRNWIVFQDGEREFK 415
+E K ++G G +G VY+GV ++T ++ ++++ EF
Sbjct: 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE------------EFL 57
Query: 416 NEVFVISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLF--GNLKPSWNLRTNIA 473
E V+ + H NLV+LLG C ++ EF+ G L +L + S + +A
Sbjct: 58 KEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMA 117
Query: 474 FQIARGLLYL------HEDCSSQIILY--------------------SYKRTEG------ 501
QI+ + YL H D +++ L +Y G
Sbjct: 118 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 177
Query: 502 YVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
+ APE + + K DV++FG LL EI +
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207
>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
pdb|2HIW|B Chain B, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
Length = 287
Score = 48.9 bits (115), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 50/210 (23%), Positives = 85/210 (40%), Gaps = 55/210 (26%)
Query: 365 LEEATDNFKEEVGRGSFGIVYKGV---------IQTTRQVLLQLQSRNWIVFQDGEREFK 415
+E K ++G G +G VY+GV ++T ++ ++++ EF
Sbjct: 12 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE------------EFL 59
Query: 416 NEVFVISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWN--LRTNIA 473
E V+ + H NLV+LLG C ++ EF+ G L +L + N + +A
Sbjct: 60 KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMA 119
Query: 474 FQIARGLLYL------HEDCSSQIILY--------------------SYKRTEG------ 501
QI+ + YL H D +++ L +Y G
Sbjct: 120 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 179
Query: 502 YVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
+ APE + + K DV++FG LL EI +
Sbjct: 180 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209
>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
pdb|3OY3|B Chain B, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
Length = 284
Score = 48.9 bits (115), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 50/210 (23%), Positives = 85/210 (40%), Gaps = 55/210 (26%)
Query: 365 LEEATDNFKEEVGRGSFGIVYKGV---------IQTTRQVLLQLQSRNWIVFQDGEREFK 415
+E K ++G G +G VY+GV ++T ++ ++++ EF
Sbjct: 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE------------EFL 57
Query: 416 NEVFVISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLF--GNLKPSWNLRTNIA 473
E V+ + H NLV+LLG C ++ EF+ G L +L + S + +A
Sbjct: 58 KEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMA 117
Query: 474 FQIARGLLYL------HEDCSSQIILY--------------------SYKRTEG------ 501
QI+ + YL H D +++ L +Y G
Sbjct: 118 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 177
Query: 502 YVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
+ APE + + K DV++FG LL EI +
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207
>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|2QOH|B Chain B, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|3KF4|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KF4|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
Length = 288
Score = 48.9 bits (115), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 50/210 (23%), Positives = 85/210 (40%), Gaps = 55/210 (26%)
Query: 365 LEEATDNFKEEVGRGSFGIVYKGV---------IQTTRQVLLQLQSRNWIVFQDGEREFK 415
+E K ++G G +G VY+GV ++T ++ ++++ EF
Sbjct: 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE------------EFL 57
Query: 416 NEVFVISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLF--GNLKPSWNLRTNIA 473
E V+ + H NLV+LLG C ++ EF+ G L +L + S + +A
Sbjct: 58 KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 117
Query: 474 FQIARGLLYL------HEDCSSQIILY--------------------SYKRTEG------ 501
QI+ + YL H D +++ L +Y G
Sbjct: 118 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 177
Query: 502 YVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
+ APE + + K DV++FG LL EI +
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207
>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|C Chain C, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|D Chain D, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|3UE4|A Chain A, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
pdb|3UE4|B Chain B, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
Length = 287
Score = 48.9 bits (115), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 50/210 (23%), Positives = 85/210 (40%), Gaps = 55/210 (26%)
Query: 365 LEEATDNFKEEVGRGSFGIVYKGV---------IQTTRQVLLQLQSRNWIVFQDGEREFK 415
+E K ++G G +G VY+GV ++T ++ ++++ EF
Sbjct: 12 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE------------EFL 59
Query: 416 NEVFVISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWN--LRTNIA 473
E V+ + H NLV+LLG C ++ EF+ G L +L + N + +A
Sbjct: 60 KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMA 119
Query: 474 FQIARGLLYL------HEDCSSQIILY--------------------SYKRTEG------ 501
QI+ + YL H D +++ L +Y G
Sbjct: 120 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 179
Query: 502 YVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
+ APE + + K DV++FG LL EI +
Sbjct: 180 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209
>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
3,4,5-Trimethoxy Aniline Containing Pyrimidine
Length = 309
Score = 48.9 bits (115), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 55/212 (25%), Positives = 89/212 (41%), Gaps = 51/212 (24%)
Query: 371 NFKEEVGRGSFGIVYK----GVIQTTRQVLLQLQSRNWIVFQDGEREFKNEV-FVISQTH 425
N + +GRG+FG V + G+ +T + ++ R +E+ +I H
Sbjct: 30 NLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89
Query: 426 HKNLVRLLGFCDE-GLNRLLVYEFLNNGTLASFLFGN---LKPSWNLRTNI--------- 472
H N+V LLG C + G +++ EF G L+++L P +L +
Sbjct: 90 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICY 149
Query: 473 AFQIARGLLYL------HEDCSSQIILYSYK---------------RTEGYV-------- 503
+FQ+A+G+ +L H D +++ IL S K + YV
Sbjct: 150 SFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 209
Query: 504 ----APEWFRNSTITAKVDVYSFGFLLLEIIS 531
APE + T + DV+SFG LL EI S
Sbjct: 210 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241
>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|B Chain B, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|C Chain C, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|D Chain D, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HZ4|A Chain A, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|B Chain B, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|C Chain C, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
Length = 273
Score = 48.9 bits (115), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 50/210 (23%), Positives = 85/210 (40%), Gaps = 55/210 (26%)
Query: 365 LEEATDNFKEEVGRGSFGIVYKGV---------IQTTRQVLLQLQSRNWIVFQDGEREFK 415
+E K ++G G +G VY+GV ++T ++ ++++ EF
Sbjct: 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE------------EFL 57
Query: 416 NEVFVISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWN--LRTNIA 473
E V+ + H NLV+LLG C ++ EF+ G L +L + N + +A
Sbjct: 58 KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMA 117
Query: 474 FQIARGLLYL------HEDCSSQIILY--------------------SYKRTEG------ 501
QI+ + YL H D +++ L +Y G
Sbjct: 118 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 177
Query: 502 YVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
+ APE + + K DV++FG LL EI +
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207
>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A
Dfg-Out Inhibitor Ap24534
Length = 284
Score = 48.9 bits (115), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 50/210 (23%), Positives = 85/210 (40%), Gaps = 55/210 (26%)
Query: 365 LEEATDNFKEEVGRGSFGIVYKGV---------IQTTRQVLLQLQSRNWIVFQDGEREFK 415
+E K ++G G +G VY+GV ++T ++ ++++ EF
Sbjct: 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE------------EFL 57
Query: 416 NEVFVISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLF--GNLKPSWNLRTNIA 473
E V+ + H NLV+LLG C ++ EF+ G L +L + S + +A
Sbjct: 58 KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 117
Query: 474 FQIARGLLYL------HEDCSSQIILY--------------------SYKRTEG------ 501
QI+ + YL H D +++ L +Y G
Sbjct: 118 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 177
Query: 502 YVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
+ APE + + K DV++FG LL EI +
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207
>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
pdb|3PYY|B Chain B, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
Length = 298
Score = 48.9 bits (115), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 50/210 (23%), Positives = 85/210 (40%), Gaps = 55/210 (26%)
Query: 365 LEEATDNFKEEVGRGSFGIVYKGV---------IQTTRQVLLQLQSRNWIVFQDGEREFK 415
+E K ++G G +G VY+GV ++T ++ ++++ EF
Sbjct: 23 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE------------EFL 70
Query: 416 NEVFVISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWN--LRTNIA 473
E V+ + H NLV+LLG C ++ EF+ G L +L + N + +A
Sbjct: 71 KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMA 130
Query: 474 FQIARGLLYL------HEDCSSQIILY--------------------SYKRTEG------ 501
QI+ + YL H D +++ L +Y G
Sbjct: 131 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 190
Query: 502 YVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
+ APE + + K DV++FG LL EI +
Sbjct: 191 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 220
>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082
pdb|2HZ0|B Chain B, Abl Kinase Domain In Complex With Nvp-Aeg082
Length = 270
Score = 48.9 bits (115), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 50/210 (23%), Positives = 85/210 (40%), Gaps = 55/210 (26%)
Query: 365 LEEATDNFKEEVGRGSFGIVYKGV---------IQTTRQVLLQLQSRNWIVFQDGEREFK 415
+E K ++G G +G VY+GV ++T ++ ++++ EF
Sbjct: 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE------------EFL 57
Query: 416 NEVFVISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWN--LRTNIA 473
E V+ + H NLV+LLG C ++ EF+ G L +L + N + +A
Sbjct: 58 KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMA 117
Query: 474 FQIARGLLYL------HEDCSSQIILY--------------------SYKRTEG------ 501
QI+ + YL H D +++ L +Y G
Sbjct: 118 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 177
Query: 502 YVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
+ APE + + K DV++FG LL EI +
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207
>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase
Length = 453
Score = 48.5 bits (114), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 52/192 (27%), Positives = 78/192 (40%), Gaps = 41/192 (21%)
Query: 375 EVGRGSFGIVYKGVIQ-TTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLL 433
++G+G FG V+ G TTR + L+ N F E V+ + H+ LV+L
Sbjct: 192 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGNM-----SPEAFLQEAQVMKKLRHEKLVQLY 246
Query: 434 GFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLR--TNIAFQIARGLLYL------HE 485
E +V E+++ G+L FL G + L ++A QIA G+ Y+ H
Sbjct: 247 AVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 305
Query: 486 DCSSQIILY--------------------SYKRTEG------YVAPEWFRNSTITAKVDV 519
D + IL Y +G + APE T K DV
Sbjct: 306 DLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 365
Query: 520 YSFGFLLLEIIS 531
+SFG LL E+ +
Sbjct: 366 WSFGILLTELTT 377
>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5)
Length = 295
Score = 48.5 bits (114), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 44/206 (21%), Positives = 87/206 (42%), Gaps = 37/206 (17%)
Query: 363 KALEEATDNFKEEVGRGSFGIVYKGVIQTT--RQVLLQLQSRNWIVFQDGEREFKNEVFV 420
K +E + + +G G FG V G ++ R++ + +++ + R+F E +
Sbjct: 17 KEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASI 76
Query: 421 ISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFL------FGNLKPSWNLR-TNIA 473
+ Q H N++ L G + ++V E++ NG+L +FL F ++ LR +
Sbjct: 77 MGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAG 136
Query: 474 FQIARGLLYLHEDCSSQIILY-----------------------SYKRTEG-----YVAP 505
+ + Y+H D +++ IL +Y G + AP
Sbjct: 137 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAP 196
Query: 506 EWFRNSTITAKVDVYSFGFLLLEIIS 531
E T+ DV+S+G ++ E++S
Sbjct: 197 EAIAFRKFTSASDVWSYGIVMWEVVS 222
>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain
pdb|4AT3|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Cpd5n
pdb|4AT4|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Ex429
pdb|4AT5|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Gw2580
Length = 299
Score = 48.5 bits (114), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 51/210 (24%), Positives = 90/210 (42%), Gaps = 51/210 (24%)
Query: 372 FKEEVGRGSFGIVYKG----VIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHK 427
K E+G G+FG V+ + ++L+ +++ + ++F E +++ H+
Sbjct: 17 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLK-DASDNARKDFHREAELLTNLQHE 75
Query: 428 NLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGN-----LKPSWNLRT--------NIAF 474
++V+ G C EG ++V+E++ +G L FL + L N T +IA
Sbjct: 76 HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQ 135
Query: 475 QIARGLLYL------HEDCSSQIIL------------------YS--YKRTEGY------ 502
QIA G++YL H D +++ L YS Y R G+
Sbjct: 136 QIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 195
Query: 503 -VAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
+ PE T + DV+S G +L EI +
Sbjct: 196 WMPPESIMYRKFTTESDVWSLGVVLWEIFT 225
>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|B Chain B, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|C Chain C, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|D Chain D, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
Length = 286
Score = 48.5 bits (114), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 45/208 (21%), Positives = 89/208 (42%), Gaps = 39/208 (18%)
Query: 363 KALEEATDNFKEEVGRGSFGIVYKGVIQT--TRQVLLQLQSRNWIVFQDGEREFKNEVFV 420
K ++ + ++ +G G FG V G ++ R++ + +++ + R+F +E +
Sbjct: 2 KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASI 61
Query: 421 ISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLR-TNIAFQIARG 479
+ Q H N++ L G + +++ EF+ NG+L SFL N ++ + IA G
Sbjct: 62 MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAG 121
Query: 480 LLYL------HEDCSSQIILY------------------------SYKRTEG------YV 503
+ YL H +++ IL +Y G +
Sbjct: 122 MKYLADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWT 181
Query: 504 APEWFRNSTITAKVDVYSFGFLLLEIIS 531
APE + T+ DV+S+G ++ E++S
Sbjct: 182 APEAIQYRKFTSASDVWSYGIVMWEVMS 209
>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
3,4,5-Trimethoxy Aniline Containing Pyrimidine
Length = 309
Score = 48.5 bits (114), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 56/216 (25%), Positives = 90/216 (41%), Gaps = 51/216 (23%)
Query: 371 NFKEEVGRGSFGIVYK----GVIQTTRQVLLQLQSRNWIVFQDGEREFKNEV-FVISQTH 425
N + +GRG+FG V + G+ +T + ++ R +E+ +I H
Sbjct: 30 NLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89
Query: 426 HKNLVRLLGFCDE-GLNRLLVYEFLNNGTLASFLFGN---LKPSWNLRTNI--------- 472
H N+V LLG C + G +++ EF G L+++L P +L +
Sbjct: 90 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXY 149
Query: 473 AFQIARGLLYL------HEDCSSQIILYSYK---------------RTEGYV-------- 503
+FQ+A+G+ +L H D +++ IL S K + YV
Sbjct: 150 SFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLP 209
Query: 504 ----APEWFRNSTITAKVDVYSFGFLLLEIISCRKS 535
APE + T + DV+SFG LL EI S S
Sbjct: 210 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 245
>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase
Domain From Human
Length = 314
Score = 48.5 bits (114), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 41/153 (26%), Positives = 71/153 (46%), Gaps = 22/153 (14%)
Query: 377 GRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGER-EFKNEVFVISQTHHKNLVRLLGF 435
RG FG V+K Q++ + QD + + + E+F H+NL++ +
Sbjct: 24 ARGRFGCVWKA------QLMNDFVAVKIFPLQDKQSWQSEREIFSTPGMKHENLLQFIAA 77
Query: 436 CDEGLNR----LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQI 491
G N L+ F + G+L +L GN+ +WN ++A ++RGL YLHED
Sbjct: 78 EKRGSNLEVELWLITAFHDKGSLTDYLKGNII-TWNELCHVAETMSRGLSYLHEDV---- 132
Query: 492 ILYSYKRTEGY---VAPEWFRNSTITAKVDVYS 521
+ R EG+ +A F++ + K D+ +
Sbjct: 133 ---PWCRGEGHKPSIAHRDFKSKNVLLKSDLTA 162
>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK6|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 48.1 bits (113), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 50/210 (23%), Positives = 83/210 (39%), Gaps = 55/210 (26%)
Query: 365 LEEATDNFKEEVGRGSFGIVYKGV---------IQTTRQVLLQLQSRNWIVFQDGEREFK 415
+E K ++G G FG VY+GV ++T ++ ++++ EF
Sbjct: 8 MERTDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVE------------EFL 55
Query: 416 NEVFVISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLF--GNLKPSWNLRTNIA 473
E V+ + H NLV+LLG C ++ EF+ G L +L + S + +A
Sbjct: 56 KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 115
Query: 474 FQIARGLLYL------HEDCSSQIILY--------------------------SYKRTEG 501
QI+ + YL H D +++ L K
Sbjct: 116 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK 175
Query: 502 YVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
+ APE + + K DV++FG LL EI +
Sbjct: 176 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 205
>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase
Activity
pdb|3GEQ|B Chain B, Structural Basis For The Chemical Rescue Of Src Kinase
Activity
Length = 286
Score = 48.1 bits (113), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 49/191 (25%), Positives = 78/191 (40%), Gaps = 39/191 (20%)
Query: 375 EVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
++G+G FG V+ G T +V ++ + F E V+ + H+ LV+L
Sbjct: 25 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLR--TNIAFQIARGLLYL------HED 486
E +V E+++ G+L FL G + L ++A QIA G+ Y+ H D
Sbjct: 81 VVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 487 CSSQIILY--------------------SYKRTEG------YVAPEWFRNSTITAKVDVY 520
++ IL Y +G + APE T K DV+
Sbjct: 140 LAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 521 SFGFLLLEIIS 531
SFG LL E+ +
Sbjct: 200 SFGILLTELTT 210
>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea
Inhibitor
Length = 316
Score = 48.1 bits (113), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 54/215 (25%), Positives = 89/215 (41%), Gaps = 54/215 (25%)
Query: 371 NFKEEVGRGSFGIVYK----GVIQTTRQVLLQLQSRNWIVFQDGEREFKNEV-FVISQTH 425
N + +GRG+FG V + G+ +T + ++ R +E+ +I H
Sbjct: 31 NLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 90
Query: 426 HKNLVRLLGFCDE-GLNRLLVYEFLNNGTLASFL------FGNLKPSWNLRTNI------ 472
H N+V LLG C + G +++ EF G L+++L F K +L +
Sbjct: 91 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHL 150
Query: 473 ---AFQIARGLLYL------HEDCSSQIILYSYKRTE----------------------- 500
+FQ+A+G+ +L H D +++ IL S K
Sbjct: 151 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 210
Query: 501 ----GYVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
++APE + T + DV+SFG LL EI S
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120
Length = 316
Score = 48.1 bits (113), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 53/209 (25%), Positives = 86/209 (41%), Gaps = 53/209 (25%)
Query: 376 VGRGSFGIVYK----GVIQTTRQVLLQLQSRNWIVFQDGEREFKNEV-FVISQTHHKNLV 430
+GRG+FG V + G+ +T + ++ R +E+ +I HH N+V
Sbjct: 37 LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 431 RLLGFCDE-GLNRLLVYEFLNNGTLASFL------FGNLKP--------SWNLRTNIAFQ 475
LLG C + G +++ EF G L+++L F KP + +FQ
Sbjct: 97 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQ 156
Query: 476 IARGLLYL------HEDCSSQIILYSYKRTE---------------------------GY 502
+A+G+ +L H D +++ IL S K +
Sbjct: 157 VAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKW 216
Query: 503 VAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
+APE + T + DV+SFG LL EI S
Sbjct: 217 MAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 495
Score = 47.8 bits (112), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 49/210 (23%), Positives = 85/210 (40%), Gaps = 55/210 (26%)
Query: 365 LEEATDNFKEEVGRGSFGIVYKGV---------IQTTRQVLLQLQSRNWIVFQDGEREFK 415
+E K ++G G +G VY+GV ++T ++ ++++ EF
Sbjct: 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE------------EFL 264
Query: 416 NEVFVISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLF--GNLKPSWNLRTNIA 473
E V+ + H NLV+LLG C ++ EF+ G L +L + S + +A
Sbjct: 265 KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 324
Query: 474 FQIARGLLYL------HEDCSSQIILY--------------------SYKRTEG------ 501
QI+ + YL H + +++ L +Y G
Sbjct: 325 TQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 384
Query: 502 YVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
+ APE + + K DV++FG LL EI +
Sbjct: 385 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 414
>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain Complexed With Imatinib
pdb|3OEZ|B Chain B, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain Complexed With Imatinib
pdb|3OF0|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain
pdb|3OF0|B Chain B, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain
pdb|3QLF|A Chain A, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Pyrazolopyrimidine
5
pdb|3QLF|B Chain B, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Pyrazolopyrimidine
5
pdb|3QLG|A Chain A, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Dasatinib
pdb|3QLG|B Chain B, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Dasatinib
Length = 286
Score = 47.8 bits (112), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 49/191 (25%), Positives = 77/191 (40%), Gaps = 39/191 (20%)
Query: 375 EVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
++G+G FG V+ G T +V ++ + F E V+ + H+ LV+L
Sbjct: 25 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKIRHEKLVQLYA 80
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLR--TNIAFQIARGLLYL------HED 486
E +V E+++ G+L FL G + L ++A QIA G+ Y+ H D
Sbjct: 81 VVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 487 CSSQIILY--------------------SYKRTEG------YVAPEWFRNSTITAKVDVY 520
+ IL Y +G + APE T K DV+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 521 SFGFLLLEIIS 531
SFG LL E+ +
Sbjct: 200 SFGILLTELTT 210
>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
Mst4 In Complex With An Quinazolin
pdb|3GGF|B Chain B, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
Mst4 In Complex With An Quinazolin
Length = 301
Score = 47.8 bits (112), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 42/187 (22%), Positives = 80/187 (42%), Gaps = 33/187 (17%)
Query: 374 EEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLL 433
E +G+GSFG V+KG+ T+QV+ ++ + +D + + E+ V+SQ + +
Sbjct: 29 ERIGKGSFGEVFKGIDNRTQQVV-AIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYY 87
Query: 434 GFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHED------- 486
G +G ++ E+L G+ L + + T + +I +GL YLH +
Sbjct: 88 GSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK-EILKGLDYLHSEKKIHRDI 146
Query: 487 ------------------------CSSQIILYSYKRTEGYVAPEWFRNSTITAKVDVYSF 522
+QI ++ T ++APE + S +K D++S
Sbjct: 147 KAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSL 206
Query: 523 GFLLLEI 529
G +E+
Sbjct: 207 GITAIEL 213
>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
pdb|2V7A|B Chain B, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
Length = 286
Score = 47.4 bits (111), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 49/210 (23%), Positives = 83/210 (39%), Gaps = 55/210 (26%)
Query: 365 LEEATDNFKEEVGRGSFGIVYKGV---------IQTTRQVLLQLQSRNWIVFQDGEREFK 415
+E K ++G G +G VY+GV ++T ++ ++++ EF
Sbjct: 11 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE------------EFL 58
Query: 416 NEVFVISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWN--LRTNIA 473
E V+ + H NLV+LLG C ++ EF+ G L +L + N + +A
Sbjct: 59 KEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMA 118
Query: 474 FQIARGLLYL------HEDCSSQIILY--------------------------SYKRTEG 501
QI+ + YL H D +++ L K
Sbjct: 119 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK 178
Query: 502 YVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
+ APE + + K DV++FG LL EI +
Sbjct: 179 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 208
>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPL|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 537
Score = 47.4 bits (111), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 49/210 (23%), Positives = 85/210 (40%), Gaps = 55/210 (26%)
Query: 365 LEEATDNFKEEVGRGSFGIVYKGV---------IQTTRQVLLQLQSRNWIVFQDGEREFK 415
+E K ++G G +G VY+GV ++T ++ ++++ EF
Sbjct: 256 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE------------EFL 303
Query: 416 NEVFVISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWN--LRTNIA 473
E V+ + H NLV+LLG C ++ EF+ G L +L + N + +A
Sbjct: 304 KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMA 363
Query: 474 FQIARGLLYL------HEDCSSQIILY--------------------SYKRTEG------ 501
QI+ + YL H + +++ L +Y G
Sbjct: 364 TQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 423
Query: 502 YVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
+ APE + + K DV++FG LL EI +
Sbjct: 424 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 453
>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation
pdb|3G6H|B Chain B, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation
Length = 286
Score = 47.4 bits (111), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 49/191 (25%), Positives = 77/191 (40%), Gaps = 39/191 (20%)
Query: 375 EVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
++G+G FG V+ G T +V ++ + F E V+ + H+ LV+L
Sbjct: 25 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLR--TNIAFQIARGLLYL------HED 486
E +V E+++ G+L FL G + L ++A QIA G+ Y+ H D
Sbjct: 81 VVSEE-PIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 487 CSSQIILY--------------------SYKRTEG------YVAPEWFRNSTITAKVDVY 520
+ IL Y +G + APE T K DV+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 521 SFGFLLLEIIS 531
SFG LL E+ +
Sbjct: 200 SFGILLTELTT 210
>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
pdb|2GQG|B Chain B, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
Length = 278
Score = 47.4 bits (111), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 49/210 (23%), Positives = 83/210 (39%), Gaps = 55/210 (26%)
Query: 365 LEEATDNFKEEVGRGSFGIVYKGV---------IQTTRQVLLQLQSRNWIVFQDGEREFK 415
+E K ++G G +G VY+GV ++T ++ ++++ EF
Sbjct: 15 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE------------EFL 62
Query: 416 NEVFVISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWN--LRTNIA 473
E V+ + H NLV+LLG C ++ EF+ G L +L + N + +A
Sbjct: 63 KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMA 122
Query: 474 FQIARGLLYL------HEDCSSQIILY--------------------------SYKRTEG 501
QI+ + YL H D +++ L K
Sbjct: 123 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK 182
Query: 502 YVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
+ APE + + K DV++FG LL EI +
Sbjct: 183 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212
>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK7|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 277
Score = 47.4 bits (111), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 49/210 (23%), Positives = 83/210 (39%), Gaps = 55/210 (26%)
Query: 365 LEEATDNFKEEVGRGSFGIVYKGV---------IQTTRQVLLQLQSRNWIVFQDGEREFK 415
+E K ++G G +G VY+GV ++T ++ ++++ EF
Sbjct: 8 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE------------EFL 55
Query: 416 NEVFVISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLF--GNLKPSWNLRTNIA 473
E V+ + H NLV+LLG C ++ EF+ G L +L + S + +A
Sbjct: 56 KEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMA 115
Query: 474 FQIARGLLYL------HEDCSSQIILY--------------------------SYKRTEG 501
QI+ + YL H D +++ L K
Sbjct: 116 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK 175
Query: 502 YVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
+ APE + + K DV++FG LL EI +
Sbjct: 176 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 205
>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 1
pdb|4F63|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 1
pdb|4F64|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 6
pdb|4F64|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 6
pdb|4F65|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 8
pdb|4F65|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 8
Length = 309
Score = 47.4 bits (111), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 41/155 (26%), Positives = 65/155 (41%), Gaps = 49/155 (31%)
Query: 426 HKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKP----SWNLRTN---------- 471
HKN++ LLG C + ++ E+ + G L +L P S+N N
Sbjct: 85 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 144
Query: 472 --IAFQIARGLLYL------HEDCSSQIILYS---------------------YKRTEG- 501
A+Q+ARG+ YL H D +++ +L + YK+T
Sbjct: 145 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 204
Query: 502 -----YVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
++APE + T + DV+SFG LL EI +
Sbjct: 205 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239
>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex
pdb|1AD5|B Chain B, Src Family Kinase Hck-Amp-Pnp Complex
pdb|2HCK|A Chain A, Src Family Kinase Hck-Quercetin Complex
pdb|2HCK|B Chain B, Src Family Kinase Hck-Quercetin Complex
Length = 438
Score = 47.4 bits (111), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 47/185 (25%), Positives = 74/185 (40%), Gaps = 29/185 (15%)
Query: 371 NFKEEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLV 430
++++G G FG V+ +V ++ + + F E V+ H LV
Sbjct: 185 KLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE----AFLAEANVMKTLQHDKLV 240
Query: 431 RLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF--QIARGLL------Y 482
+L + ++ EF+ G+L FL + L I F QIA G+ Y
Sbjct: 241 KLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY 299
Query: 483 LHEDCSSQIILYSY----------------KRTEGYVAPEWFRNSTITAKVDVYSFGFLL 526
+H D + IL S K + APE + T K DV+SFG LL
Sbjct: 300 IHRDLRAANILVSASLVCKIADFGLARVGAKFPIKWTAPEAINFGSFTIKSDVWSFGILL 359
Query: 527 LEIIS 531
+EI++
Sbjct: 360 MEIVT 364
>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK3|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 47.4 bits (111), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 49/210 (23%), Positives = 85/210 (40%), Gaps = 55/210 (26%)
Query: 365 LEEATDNFKEEVGRGSFGIVYKGV---------IQTTRQVLLQLQSRNWIVFQDGEREFK 415
+E K ++G G +G VY+GV ++T ++ ++++ EF
Sbjct: 8 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE------------EFL 55
Query: 416 NEVFVISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLF--GNLKPSWNLRTNIA 473
E V+ + H NLV+LLG C ++ EF+ G L +L + S + +A
Sbjct: 56 KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 115
Query: 474 FQIARGLLYL------HEDCSSQIILY--------------------SYKRTEG------ 501
QI+ + YL H D +++ L ++ G
Sbjct: 116 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIK 175
Query: 502 YVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
+ APE + + K DV++FG LL EI +
Sbjct: 176 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 205
>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase
In Complex With Arq 069
pdb|3RHX|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase
In Complex With Arq 069
Length = 306
Score = 47.4 bits (111), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 41/155 (26%), Positives = 65/155 (41%), Gaps = 49/155 (31%)
Query: 426 HKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKP----SWNLRTN---------- 471
HKN++ LLG C + ++ E+ + G L +L P S+N N
Sbjct: 82 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 141
Query: 472 --IAFQIARGLLYL------HEDCSSQIILYS---------------------YKRTEG- 501
A+Q+ARG+ YL H D +++ +L + YK+T
Sbjct: 142 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 201
Query: 502 -----YVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
++APE + T + DV+SFG LL EI +
Sbjct: 202 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236
>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In
Complex With The Cancer Drug Imatinib.
pdb|2OIQ|B Chain B, Crystal Structure Of Chicken C-Src Kinase Domain In
Complex With The Cancer Drug Imatinib.
pdb|3D7T|B Chain B, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3DQX|A Chain A, Chicken C-Src Kinase Domain In Complex With Atpgs
pdb|3DQX|B Chain B, Chicken C-Src Kinase Domain In Complex With Atpgs
pdb|3EN4|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp121, A Multitargeted
Kinase Inhibitor
pdb|3EN4|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp121, A Multitargeted
Kinase Inhibitor
pdb|3EN5|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp494, A Multitargeted
Kinase Inhibitor
pdb|3EN5|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp494, A Multitargeted
Kinase Inhibitor
pdb|3EN6|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp102, A Multitargeted
Kinase Inhibitor
pdb|3EN6|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp102, A Multitargeted
Kinase Inhibitor
pdb|3EN7|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With S1, A Multitargeted Kinase
Inhibitor
pdb|3EN7|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With S1, A Multitargeted Kinase
Inhibitor
pdb|3EL7|A Chain A, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 3
pdb|3EL8|A Chain A, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 5
pdb|3EL8|B Chain B, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 5
pdb|3F6X|A Chain A, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|B Chain B, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|C Chain C, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|D Chain D, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3G6G|A Chain A, Equally Potent Inhibition Of C-Src And Abl By Compounds
That Recognize Inactive Kinase Conformations
pdb|3G6G|B Chain B, Equally Potent Inhibition Of C-Src And Abl By Compounds
That Recognize Inactive Kinase Conformations
pdb|4AGW|A Chain A, Discovery Of A Small Molecule Type Ii Inhibitor Of Wild-
Type And Gatekeeper Mutants Of Bcr-Abl, Pdgfralpha, Kit,
And Src Kinases
pdb|4AGW|B Chain B, Discovery Of A Small Molecule Type Ii Inhibitor Of Wild-
Type And Gatekeeper Mutants Of Bcr-Abl, Pdgfralpha, Kit,
And Src Kinases
pdb|3UQF|A Chain A, C-Src Kinase Domain In Complex With Bki Rm-1-89
pdb|3UQF|B Chain B, C-Src Kinase Domain In Complex With Bki Rm-1-89
pdb|3UQG|A Chain A, C-Src Kinase Domain In Complex With Bumpless Bki Analog
Uw1243
pdb|3UQG|B Chain B, C-Src Kinase Domain In Complex With Bumpless Bki Analog
Uw1243
pdb|4DGG|A Chain A, C-Src Kinase Domain In Complex With Rm-1-176
pdb|4DGG|B Chain B, C-Src Kinase Domain In Complex With Rm-1-176
Length = 286
Score = 47.4 bits (111), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 49/191 (25%), Positives = 77/191 (40%), Gaps = 39/191 (20%)
Query: 375 EVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
++G+G FG V+ G T +V ++ + F E V+ + H+ LV+L
Sbjct: 25 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLR--TNIAFQIARGLLYL------HED 486
E +V E+++ G+L FL G + L ++A QIA G+ Y+ H D
Sbjct: 81 VVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 487 CSSQIILY--------------------SYKRTEG------YVAPEWFRNSTITAKVDVY 520
+ IL Y +G + APE T K DV+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 521 SFGFLLLEIIS 531
SFG LL E+ +
Sbjct: 200 SFGILLTELTT 210
>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast
Growth Factor Receptor 1 In Complex With 5-(2-Thienyl)
Nicotinic Acid
pdb|3JS2|B Chain B, Crystal Structure Of Minimal Kinase Domain Of Fibroblast
Growth Factor Receptor 1 In Complex With 5-(2-Thienyl)
Nicotinic Acid
pdb|3KY2|A Chain A, Crystal Structure Of Fibroblast Growth Factor Receptor 1
Kinase Domain
pdb|3KY2|B Chain B, Crystal Structure Of Fibroblast Growth Factor Receptor 1
Kinase Domain
Length = 317
Score = 47.4 bits (111), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 41/155 (26%), Positives = 65/155 (41%), Gaps = 49/155 (31%)
Query: 426 HKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKP----SWNLRTN---------- 471
HKN++ LLG C + ++ E+ + G L +L P S+N N
Sbjct: 93 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 152
Query: 472 --IAFQIARGLLYL------HEDCSSQIILYS---------------------YKRTEG- 501
A+Q+ARG+ YL H D +++ +L + YK+T
Sbjct: 153 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 502 -----YVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
++APE + T + DV+SFG LL EI +
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247
>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor
Length = 535
Score = 47.4 bits (111), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 54/216 (25%), Positives = 85/216 (39%), Gaps = 41/216 (18%)
Query: 352 TVETNLRCFSYKALEEATDNFKEEV--GRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQD 409
T + + + A E ++ + EV G+G FG V+ G T +V ++ +
Sbjct: 249 TSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---- 304
Query: 410 GEREFKNEVFVISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLR 469
F E V+ + H+ LV+L E +V E+++ G+L FL G L
Sbjct: 305 SPEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLP 363
Query: 470 --TNIAFQIARGLLYL------HEDCSSQIILY--------------------SYKRTEG 501
++A QIA G+ Y+ H D + IL Y +G
Sbjct: 364 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 423
Query: 502 ------YVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
+ APE T K DV+SFG LL E+ +
Sbjct: 424 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 459
>pdb|2FO0|A Chain A, Organization Of The Sh3-Sh2 Unit In Active And Inactive
Forms Of The C-Abl Tyrosine Kinase
Length = 495
Score = 47.4 bits (111), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 49/210 (23%), Positives = 85/210 (40%), Gaps = 55/210 (26%)
Query: 365 LEEATDNFKEEVGRGSFGIVYKGV---------IQTTRQVLLQLQSRNWIVFQDGEREFK 415
+E K ++G G +G VY+GV ++T ++ ++++ EF
Sbjct: 214 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE------------EFL 261
Query: 416 NEVFVISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWN--LRTNIA 473
E V+ + H NLV+LLG C ++ EF+ G L +L + N + +A
Sbjct: 262 KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMA 321
Query: 474 FQIARGLLYL------HEDCSSQIILY--------------------SYKRTEG------ 501
QI+ + YL H + +++ L +Y G
Sbjct: 322 TQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 381
Query: 502 YVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
+ APE + + K DV++FG LL EI +
Sbjct: 382 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 411
>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With
Vuf 12058
Length = 285
Score = 47.4 bits (111), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 42/206 (20%), Positives = 87/206 (42%), Gaps = 37/206 (17%)
Query: 363 KALEEATDNFKEEVGRGSFGIVYKGVIQT--TRQVLLQLQSRNWIVFQDGEREFKNEVFV 420
K ++ + ++ +G G FG V G ++ R++ + +++ R+F +E +
Sbjct: 3 KEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASI 62
Query: 421 ISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFL------FGNLKPSWNLR-TNIA 473
+ Q H N++ L G + +++ E++ NG+L +FL F ++ LR
Sbjct: 63 MGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSG 122
Query: 474 FQIARGLLYLHEDCSSQIILY-----------------------SYKRTEG-----YVAP 505
+ + Y+H D +++ IL +Y G + AP
Sbjct: 123 MKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAP 182
Query: 506 EWFRNSTITAKVDVYSFGFLLLEIIS 531
E T+ DV+S+G ++ E++S
Sbjct: 183 EAIAYRKFTSASDVWSYGIVMWEVMS 208
>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3D7U|D Chain D, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 277
Score = 47.4 bits (111), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 49/191 (25%), Positives = 77/191 (40%), Gaps = 39/191 (20%)
Query: 375 EVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
++G+G FG V+ G T +V ++ + F E V+ + H+ LV+L
Sbjct: 16 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYA 71
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLR--TNIAFQIARGLLYL------HED 486
E +V E+++ G+L FL G + L ++A QIA G+ Y+ H D
Sbjct: 72 VVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 130
Query: 487 CSSQIILY--------------------SYKRTEG------YVAPEWFRNSTITAKVDVY 520
+ IL Y +G + APE T K DV+
Sbjct: 131 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 190
Query: 521 SFGFLLLEIIS 531
SFG LL E+ +
Sbjct: 191 SFGILLTELTT 201
>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1
pdb|1FGK|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1
pdb|1FGI|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su5402 Inhibitor
pdb|1FGI|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su5402 Inhibitor
pdb|1AGW|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su4984 Inhibitor
pdb|1AGW|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su4984 Inhibitor
pdb|2FGI|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fgf
Receptor 1 In Complex With Inhibitor Pd173074
pdb|2FGI|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of Fgf
Receptor 1 In Complex With Inhibitor Pd173074
Length = 310
Score = 47.0 bits (110), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 41/155 (26%), Positives = 65/155 (41%), Gaps = 49/155 (31%)
Query: 426 HKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKP----SWNLRTN---------- 471
HKN++ LLG C + ++ E+ + G L +L P S+N N
Sbjct: 86 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 145
Query: 472 --IAFQIARGLLYL------HEDCSSQIILYS---------------------YKRTEG- 501
A+Q+ARG+ YL H D +++ +L + YK+T
Sbjct: 146 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 205
Query: 502 -----YVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
++APE + T + DV+SFG LL EI +
Sbjct: 206 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240
>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form
pdb|2ZV8|A Chain A, Lyn Tyrosine Kinase Domain-Amp-Pnp Complex
pdb|2ZV9|A Chain A, Lyn Tyrosine Kinase Domain-Pp2 Complex
pdb|2ZVA|A Chain A, Lyn Tyrosine Kinase Domain-dasatinib Complex
Length = 279
Score = 47.0 bits (110), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 49/192 (25%), Positives = 75/192 (39%), Gaps = 38/192 (19%)
Query: 374 EEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLL 433
+++G G FG V+ G + +V ++ + Q F E ++ H LVRL
Sbjct: 18 KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQ----AFLEEANLMKTLQHDKLVRLY 73
Query: 434 GFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF--QIARGLLYL------HE 485
+ ++ EF+ G+L FL + L I F QIA G+ Y+ H
Sbjct: 74 AVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHR 133
Query: 486 DCSSQIILYS--------------------YKRTEG------YVAPEWFRNSTITAKVDV 519
D + +L S Y EG + APE T K +V
Sbjct: 134 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSNV 193
Query: 520 YSFGFLLLEIIS 531
+SFG LL EI++
Sbjct: 194 WSFGILLYEIVT 205
>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXQ|A Chain A, Cdk2 In Complex With 3 Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXR|A Chain A, Apo Cdk2 Crystallized From Jeffamine
pdb|3PXY|A Chain A, Cdk2 In Complex With Inhibitor Jws648
pdb|3PXZ|A Chain A, Cdk2 Ternary Complex With Jws648 And Ans
pdb|3PY0|A Chain A, Cdk2 In Complex With Inhibitor Su9516
pdb|3PY1|A Chain A, Cdk2 Ternary Complex With Su9516 And Ans
pdb|3QL8|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-260
pdb|3QQF|A Chain A, Cdk2 In Complex With Inhibitor L1
pdb|3QQG|A Chain A, Cdk2 In Complex With Inhibitor L2-5
pdb|3QQH|A Chain A, Cdk2 In Complex With Inhibitor L2-2
pdb|3QQJ|A Chain A, Cdk2 In Complex With Inhibitor L2
pdb|3QQL|A Chain A, Cdk2 In Complex With Inhibitor L3
pdb|3QRT|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc2-55
pdb|3QRU|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-12
pdb|3QWJ|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-142
pdb|3QWK|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-150
pdb|3QX2|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-190
pdb|3QX4|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-78
pdb|3QXO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-84
pdb|3QZF|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-52
pdb|3QZG|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-76
pdb|3QZH|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-124
pdb|3QZI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-126
pdb|3R1Q|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-102
pdb|3R1S|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-127
pdb|3R1Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-134
pdb|3R28|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-140
pdb|3R6X|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-158
pdb|3R71|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-162
pdb|3R73|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-164
pdb|3R7E|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-67
pdb|3R7I|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-74
pdb|3R7U|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-75
pdb|3R7V|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-9
pdb|3R7Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-88
pdb|3R83|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-92
pdb|3R8L|A Chain A, Cdk2 In Complex With Inhibitor L3-4
pdb|3R8M|A Chain A, Cdk2 In Complex With Inhibitor L3-3
pdb|3R8P|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-6
pdb|3RAI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-160
pdb|3RM6|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-80
pdb|3RM7|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-91
pdb|3ROY|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-154
pdb|3RPO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-156
pdb|4EZ3|A Chain A, Cdk2 In Complex With Nsc 134199
pdb|4EZ7|A Chain A, Cdk2 In Complex With Staurosporine And 2 Molecules Of
8-Anilino-1- Naphthalene Sulfonic Acid
pdb|3QQK|A Chain A, Cdk2 In Complex With Inhibitor L4
pdb|3QTQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-137
pdb|3QTR|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-148
pdb|3QTS|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-12
pdb|3QTU|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-132
pdb|3QTW|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-13
pdb|3QTX|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-35
pdb|3QTZ|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-36
pdb|3QU0|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-38
pdb|3QXP|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
pdb|3R8U|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-132
pdb|3R8V|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-135
pdb|3R8Z|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-136
pdb|3R9D|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-135
pdb|3R9H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-142
pdb|3R9N|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-21
pdb|3R9O|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-143
pdb|3RAH|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-22
pdb|3RAK|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-32
pdb|3RAL|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-34
pdb|3RJC|A Chain A, Cdk2 In Complex With Inhibitor L4-12
pdb|3RK5|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-72
pdb|3RK7|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-71
pdb|3RK9|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-74
pdb|3RKB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-73
pdb|3RMF|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-33
pdb|3RNI|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-86
pdb|3RPR|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-49
pdb|3RPV|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-88
pdb|3RPY|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-40
pdb|3RZB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-23
pdb|3S00|A Chain A, Cdk2 In Complex With Inhibitor L4-14
pdb|3S0O|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-138
pdb|3S1H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-39
pdb|3SQQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-96
pdb|4GCJ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
Length = 306
Score = 47.0 bits (110), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 55/220 (25%), Positives = 93/220 (42%), Gaps = 43/220 (19%)
Query: 367 EATDNFK--EEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQT 424
E +NF+ E++G G++G+VYK + T +V+ + R + E+ ++ +
Sbjct: 7 EFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 66
Query: 425 HHKNLVRLLGFCDEGLNRLLVYEFLNNGTL----ASFLFGNLKPSWNLRTNIAFQIARGL 480
+H N+V+LL LV+EFL+ AS L G P L + FQ+ +GL
Sbjct: 67 NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGL 123
Query: 481 LY------LHEDCSSQIIL-----------YSYKRTEGY--------VAPEWFRNSTI-- 513
+ LH D Q +L + R G V W+R I
Sbjct: 124 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 183
Query: 514 -----TAKVDVYSFGFLLLEIISCRKSF--DIEMGEEYAI 546
+ VD++S G + E+++ R F D E+ + + I
Sbjct: 184 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 223
>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone
Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A
Resolution
pdb|3G2F|B Chain B, Crystal Structure Of The Kinase Domain Of Bone
Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A
Resolution
Length = 336
Score = 47.0 bits (110), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 42/128 (32%), Positives = 61/128 (47%), Gaps = 21/128 (16%)
Query: 370 DNFK--EEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGERE-FKNE--VFVISQT 424
DN K E +GRG +G VYKG + R V ++ VF R+ F NE ++ +
Sbjct: 13 DNLKLLELIGRGRYGAVYKGSLD-ERPVAVK-------VFSFANRQNFINEKNIYRVPLM 64
Query: 425 HHKNLVRLL-----GFCDEGLNRLLVYEFLNNGTLASFLFGNLKPS-WNLRTNIAFQIAR 478
H N+ R + D + LLV E+ NG+L +L +L S W +A + R
Sbjct: 65 EHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL--SLHTSDWVSSCRLAHSVTR 122
Query: 479 GLLYLHED 486
GL YLH +
Sbjct: 123 GLAYLHTE 130
>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc4b
pdb|3U51|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc1
pdb|3U51|B Chain B, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc1
Length = 275
Score = 47.0 bits (110), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 49/191 (25%), Positives = 77/191 (40%), Gaps = 39/191 (20%)
Query: 375 EVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
++G+G FG V+ G T +V ++ + F E V+ + H+ LV+L
Sbjct: 14 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYA 69
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLR--TNIAFQIARGLLYL------HED 486
E +V E+++ G+L FL G + L ++A QIA G+ Y+ H D
Sbjct: 70 VVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 128
Query: 487 CSSQIILY--------------------SYKRTEG------YVAPEWFRNSTITAKVDVY 520
+ IL Y +G + APE T K DV+
Sbjct: 129 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 188
Query: 521 SFGFLLLEIIS 531
SFG LL E+ +
Sbjct: 189 SFGILLTELTT 199
>pdb|3A4O|X Chain X, Lyn Kinase Domain
Length = 286
Score = 47.0 bits (110), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 49/192 (25%), Positives = 73/192 (38%), Gaps = 38/192 (19%)
Query: 374 EEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLL 433
+ +G G FG V+ G + +V ++ + Q F E ++ H LVRL
Sbjct: 19 KRLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQ----AFLEEANLMKTLQHDKLVRLY 74
Query: 434 GFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF--QIARGLLYL------HE 485
++ E++ G+L FL + L I F QIA G+ Y+ H
Sbjct: 75 AVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHR 134
Query: 486 DCSSQIILYS--------------------YKRTEG------YVAPEWFRNSTITAKVDV 519
D + +L S Y EG + APE T K DV
Sbjct: 135 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSDV 194
Query: 520 YSFGFLLLEIIS 531
+SFG LL EI++
Sbjct: 195 WSFGILLYEIVT 206
>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|B Chain B, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|C Chain C, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|D Chain D, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
Length = 317
Score = 47.0 bits (110), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 41/155 (26%), Positives = 65/155 (41%), Gaps = 49/155 (31%)
Query: 426 HKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKP----SWNLRTN---------- 471
HKN++ LLG C + ++ E+ + G L +L P S+N N
Sbjct: 93 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDL 152
Query: 472 --IAFQIARGLLYL------HEDCSSQIILYS---------------------YKRTEG- 501
A+Q+ARG+ YL H D +++ +L + YK+T
Sbjct: 153 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 502 -----YVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
++APE + T + DV+SFG LL EI +
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247
>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase
Domain With
3-(2,6-Dichloro-3,
5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1-
Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398)
pdb|3TT0|B Chain B, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase
Domain With
3-(2,6-Dichloro-3,
5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1-
Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398)
Length = 382
Score = 47.0 bits (110), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 41/155 (26%), Positives = 65/155 (41%), Gaps = 49/155 (31%)
Query: 426 HKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKP----SWNLRTN---------- 471
HKN++ LLG C + ++ E+ + G L +L P S+N N
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 472 --IAFQIARGLLYL------HEDCSSQIILYS---------------------YKRTEG- 501
A+Q+ARG+ YL H D +++ +L + YK+T
Sbjct: 194 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 502 -----YVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
++APE + T + DV+SFG LL EI +
Sbjct: 254 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain
pdb|2Y6O|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With
Dasatinib
Length = 291
Score = 47.0 bits (110), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 42/206 (20%), Positives = 87/206 (42%), Gaps = 37/206 (17%)
Query: 363 KALEEATDNFKEEVGRGSFGIVYKGVIQT--TRQVLLQLQSRNWIVFQDGEREFKNEVFV 420
K ++ + ++ +G G FG V G ++ R++ + +++ R+F +E +
Sbjct: 9 KEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASI 68
Query: 421 ISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFL------FGNLKPSWNLR-TNIA 473
+ Q H N++ L G + +++ E++ NG+L +FL F ++ LR
Sbjct: 69 MGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSG 128
Query: 474 FQIARGLLYLHEDCSSQIILY-----------------------SYKRTEG-----YVAP 505
+ + Y+H D +++ IL +Y G + AP
Sbjct: 129 MKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAP 188
Query: 506 EWFRNSTITAKVDVYSFGFLLLEIIS 531
E T+ DV+S+G ++ E++S
Sbjct: 189 EAIAYRKFTSASDVWSYGIVMWEVMS 214
>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To
Vinylsulfonamide- Pyrazolopyrimidine 9
pdb|3SVV|B Chain B, Crystal Structure Of T338c C-Src Covalently Bound To
Vinylsulfonamide- Pyrazolopyrimidine 9
Length = 286
Score = 47.0 bits (110), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 49/191 (25%), Positives = 77/191 (40%), Gaps = 39/191 (20%)
Query: 375 EVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
++G+G FG V+ G T +V ++ + F E V+ + H+ LV+L
Sbjct: 25 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLR--TNIAFQIARGLLYL------HED 486
E +V E+++ G+L FL G + L ++A QIA G+ Y+ H D
Sbjct: 81 VVSEE-PIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 487 CSSQIILY--------------------SYKRTEG------YVAPEWFRNSTITAKVDVY 520
+ IL Y +G + APE T K DV+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 521 SFGFLLLEIIS 531
SFG LL E+ +
Sbjct: 200 SFGILLTELTT 210
>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family-
Selective Tyrosine Kinase Inhibitor
pdb|2C0I|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-420983
pdb|2C0I|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-420983
pdb|2C0O|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-770041
pdb|2C0O|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-770041
pdb|2C0T|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-641359
pdb|2C0T|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-641359
Length = 454
Score = 47.0 bits (110), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 49/195 (25%), Positives = 76/195 (38%), Gaps = 39/195 (20%)
Query: 371 NFKEEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLV 430
++++G G FG V+ +V ++ + + F E V+ H LV
Sbjct: 191 KLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE----AFLAEANVMKTLQHDKLV 246
Query: 431 RLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF--QIARGLL------Y 482
+L + ++ EF+ G+L FL + L I F QIA G+ Y
Sbjct: 247 KLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY 305
Query: 483 LHEDCSSQIILYS--------------------YKRTEG------YVAPEWFRNSTITAK 516
+H D + IL S Y EG + APE + T K
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 365
Query: 517 VDVYSFGFLLLEIIS 531
DV+SFG LL+EI++
Sbjct: 366 SDVWSFGILLMEIVT 380
>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein
Kinase Domain
pdb|1KOB|B Chain B, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein
Kinase Domain
Length = 387
Score = 47.0 bits (110), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 33/115 (28%), Positives = 58/115 (50%), Gaps = 7/115 (6%)
Query: 374 EEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWI--VFQDGEREFKNEVFVISQTHHKNLVR 431
EE+G G+FG+V++ V + T +V + +I + + KNE+ +++Q HH L+
Sbjct: 57 EELGSGAFGVVHRCVEKATGRVFVA----KFINTPYPLDKYTVKNEISIMNQLHHPKLIN 112
Query: 432 LLGFCDEGLNRLLVYEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHE 485
L ++ +L+ EFL+ G L + + K S N Q GL ++HE
Sbjct: 113 LHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE 167
>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine
Length = 306
Score = 46.6 bits (109), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 55/220 (25%), Positives = 93/220 (42%), Gaps = 43/220 (19%)
Query: 367 EATDNFK--EEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQT 424
E +NF+ E++G G++G+VYK + T +V+ + R + E+ ++ +
Sbjct: 7 EFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 66
Query: 425 HHKNLVRLLGFCDEGLNRLLVYEFLNNGTL----ASFLFGNLKPSWNLRTNIAFQIARGL 480
+H N+V+LL LV+EFL+ AS L G P L + FQ+ +GL
Sbjct: 67 NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGL 123
Query: 481 LY------LHEDCSSQIIL-----------YSYKRTEGY--------VAPEWFRNSTI-- 513
+ LH D Q +L + R G V W+R I
Sbjct: 124 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 183
Query: 514 -----TAKVDVYSFGFLLLEIISCRKSF--DIEMGEEYAI 546
+ VD++S G + E+++ R F D E+ + + I
Sbjct: 184 GXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 223
>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With
Irreversible Inhibitor
pdb|2QQ7|B Chain B, Crystal Structure Of Drug Resistant Src Kinase Domain With
Irreversible Inhibitor
pdb|2QI8|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain
pdb|2QI8|B Chain B, Crystal Structure Of Drug Resistant Src Kinase Domain
pdb|3F3W|A Chain A, Drug Resistant Csrc Kinase Domain In Complex With
Inhibitor Rl45 (Type Ii)
pdb|3F3W|B Chain B, Drug Resistant Csrc Kinase Domain In Complex With
Inhibitor Rl45 (Type Ii)
pdb|3LOK|A Chain A, Drug Resistant Csrc Kinase Domain In Complex With Covalent
Inhibitor Pd168393
pdb|3LOK|B Chain B, Drug Resistant Csrc Kinase Domain In Complex With Covalent
Inhibitor Pd168393
Length = 286
Score = 46.6 bits (109), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 49/191 (25%), Positives = 76/191 (39%), Gaps = 39/191 (20%)
Query: 375 EVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
++G+G FG V+ G T +V ++ + F E V+ + H+ LV+L
Sbjct: 25 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLR--TNIAFQIARGLLYL------HED 486
E +V E+++ G L FL G + L ++A QIA G+ Y+ H D
Sbjct: 81 VVSEE-PIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 487 CSSQIILY--------------------SYKRTEG------YVAPEWFRNSTITAKVDVY 520
+ IL Y +G + APE T K DV+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 521 SFGFLLLEIIS 531
SFG LL E+ +
Sbjct: 200 SFGILLTELTT 210
>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
Gleevec
pdb|3HMI|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
5-Amino-3-{[4-
(Aminosulfonyl)phenyl]amino}-N-(2,
6-Difluorophenyl)-1h-1,2,4- Triazole-1-Carbothioamide
pdb|2XYN|A Chain A, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|B Chain B, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|C Chain C, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
Length = 292
Score = 46.6 bits (109), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 50/210 (23%), Positives = 85/210 (40%), Gaps = 55/210 (26%)
Query: 365 LEEATDNFKEEVGRGSFGIVYKGV---------IQTTRQVLLQLQSRNWIVFQDGEREFK 415
+E K ++G G +G VY GV ++T ++ ++++ EF
Sbjct: 29 MERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVE------------EFL 76
Query: 416 NEVFVISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIA 473
E V+ + H NLV+LLG C +V E++ G L +L + + + +A
Sbjct: 77 KEAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMA 136
Query: 474 FQIARGLLYL------HEDCSSQIILY--------------------SYKRTEG------ 501
QI+ + YL H D +++ L +Y G
Sbjct: 137 TQISSAMEYLEKKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIK 196
Query: 502 YVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
+ APE +T + K DV++FG LL EI +
Sbjct: 197 WTAPESLAYNTFSIKSDVWAFGVLLWEIAT 226
>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
pdb|4FK3|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
Length = 292
Score = 46.6 bits (109), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 51/204 (25%), Positives = 86/204 (42%), Gaps = 59/204 (28%)
Query: 374 EEVGRGSFGIVYKG---------VIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQT 424
+ +G GSFG VYKG ++ T QLQ+ FKNEV V+ +T
Sbjct: 30 QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA------------FKNEVGVLRKT 77
Query: 425 HHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGL--- 480
H N++ +G+ + +V ++ +L L + K +IA Q ARG+
Sbjct: 78 RHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYL 136
Query: 481 --------------LYLHEDCSSQI----ILYSYKRTEG------------YVAPEWFR- 509
++LHED + +I + R G ++APE R
Sbjct: 137 HAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 196
Query: 510 --NSTITAKVDVYSFGFLLLEIIS 531
++ + + DVY+FG +L E+++
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMT 220
>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
Length = 299
Score = 46.6 bits (109), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 54/217 (24%), Positives = 92/217 (42%), Gaps = 43/217 (19%)
Query: 370 DNFK--EEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHK 427
+NF+ E++G G++G+VYK + T +V+ + R + E+ ++ + +H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 428 NLVRLLGFCDEGLNRLLVYEFLNNGTL----ASFLFGNLKPSWNLRTNIAFQIARGLLY- 482
N+V+LL LV+EFL+ AS L G P L + FQ+ +GL +
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFC 119
Query: 483 -----LHEDCSSQIIL-----------YSYKRTEGY--------VAPEWFRNSTI----- 513
LH D Q +L + R G V W+R I
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 179
Query: 514 --TAKVDVYSFGFLLLEIISCRKSF--DIEMGEEYAI 546
+ VD++S G + E+++ R F D E+ + + I
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 216
>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
Length = 298
Score = 46.6 bits (109), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 54/217 (24%), Positives = 92/217 (42%), Gaps = 43/217 (19%)
Query: 370 DNFK--EEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHK 427
+NF+ E++G G++G+VYK + T +V+ + R + E+ ++ + +H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 428 NLVRLLGFCDEGLNRLLVYEFLNNGTL----ASFLFGNLKPSWNLRTNIAFQIARGLLY- 482
N+V+LL LV+EFL+ AS L G P L + FQ+ +GL +
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFC 118
Query: 483 -----LHEDCSSQIIL-----------YSYKRTEGY--------VAPEWFRNSTI----- 513
LH D Q +L + R G V W+R I
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 514 --TAKVDVYSFGFLLLEIISCRKSF--DIEMGEEYAI 546
+ VD++S G + E+++ R F D E+ + + I
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 215
>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
pdb|4EOS|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
Length = 300
Score = 46.6 bits (109), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 54/219 (24%), Positives = 93/219 (42%), Gaps = 43/219 (19%)
Query: 368 ATDNFK--EEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTH 425
+ +NF+ E++G G++G+VYK + T +V+ + R + E+ ++ + +
Sbjct: 3 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 426 HKNLVRLLGFCDEGLNRLLVYEFLNNGTL----ASFLFGNLKPSWNLRTNIAFQIARGLL 481
H N+V+LL LV+EFL+ AS L G P L + FQ+ +GL
Sbjct: 63 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLA 119
Query: 482 Y------LHEDCSSQIIL-----------YSYKRTEGY--------VAPEWFRNSTI--- 513
+ LH D Q +L + R G V W+R I
Sbjct: 120 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 179
Query: 514 ----TAKVDVYSFGFLLLEIISCRKSF--DIEMGEEYAI 546
+ VD++S G + E+++ R F D E+ + + I
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 218
>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor
pdb|2HWO|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor
pdb|2HWP|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor Pd168393
pdb|2HWP|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor Pd168393
pdb|2QLQ|A Chain A, Crystal Structure Of Src Kinase Domain With Covalent
Inhibitor Rl3
pdb|2QLQ|B Chain B, Crystal Structure Of Src Kinase Domain With Covalent
Inhibitor Rl3
pdb|3F3T|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl38 (Type
Iii)
pdb|3F3T|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl38 (Type
Iii)
pdb|3F3U|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl37 (Type
Iii)
pdb|3F3U|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl37 (Type
Iii)
pdb|3F3V|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl45 (Type
Ii)
pdb|3F3V|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl45 (Type
Ii)
pdb|3G5D|A Chain A, Kinase Domain Of Csrc In Complex With Dasatinib
pdb|3G5D|B Chain B, Kinase Domain Of Csrc In Complex With Dasatinib
pdb|3TZ7|A Chain A, Kinase Domain Of Csrc In Complex With Rl103
pdb|3TZ7|B Chain B, Kinase Domain Of Csrc In Complex With Rl103
pdb|3TZ8|A Chain A, Kinase Domain Of Csrc In Complex With Rl104
pdb|3TZ8|B Chain B, Kinase Domain Of Csrc In Complex With Rl104
pdb|3TZ9|A Chain A, Kinase Domain Of Csrc In Complex With Rl130
pdb|3TZ9|B Chain B, Kinase Domain Of Csrc In Complex With Rl130
Length = 286
Score = 46.6 bits (109), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 49/191 (25%), Positives = 76/191 (39%), Gaps = 39/191 (20%)
Query: 375 EVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
++G+G FG V+ G T +V ++ + F E V+ + H+ LV+L
Sbjct: 25 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLR--TNIAFQIARGLLYL------HED 486
E +V E+++ G L FL G + L ++A QIA G+ Y+ H D
Sbjct: 81 VVSEE-PIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 487 CSSQIILY--------------------SYKRTEG------YVAPEWFRNSTITAKVDVY 520
+ IL Y +G + APE T K DV+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 521 SFGFLLLEIIS 531
SFG LL E+ +
Sbjct: 200 SFGILLTELTT 210
>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
pdb|3OG7|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
Length = 289
Score = 46.2 bits (108), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 51/204 (25%), Positives = 85/204 (41%), Gaps = 59/204 (28%)
Query: 374 EEVGRGSFGIVYKG---------VIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQT 424
+ +G GSFG VYKG ++ T QLQ+ FKNEV V+ +T
Sbjct: 30 QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA------------FKNEVGVLRKT 77
Query: 425 HHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGL--- 480
H N++ +G+ +V ++ +L L + K +IA Q ARG+
Sbjct: 78 RHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYL 136
Query: 481 --------------LYLHEDCSSQI----ILYSYKRTEG------------YVAPEWFR- 509
++LHED + +I + R G ++APE R
Sbjct: 137 HAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 196
Query: 510 --NSTITAKVDVYSFGFLLLEIIS 531
++ + + DVY+FG +L E+++
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMT 220
>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW6|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
Length = 302
Score = 46.2 bits (108), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 54/219 (24%), Positives = 93/219 (42%), Gaps = 43/219 (19%)
Query: 368 ATDNFK--EEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTH 425
+ +NF+ E++G G++G+VYK + T +V+ + R + E+ ++ + +
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 426 HKNLVRLLGFCDEGLNRLLVYEFLNNGTL----ASFLFGNLKPSWNLRTNIAFQIARGLL 481
H N+V+LL LV+EFL+ AS L G P L + FQ+ +GL
Sbjct: 64 HPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLP---LIKSYLFQLLQGLA 120
Query: 482 Y------LHEDCSSQIIL-----------YSYKRTEGY--------VAPEWFRNSTI--- 513
+ LH D Q +L + R G V W+R I
Sbjct: 121 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 180
Query: 514 ----TAKVDVYSFGFLLLEIISCRKSF--DIEMGEEYAI 546
+ VD++S G + E+++ R F D E+ + + I
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 219
>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1E9H|C Chain C, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1PKD|A Chain A, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
pdb|1PKD|C Chain C, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
Length = 297
Score = 46.2 bits (108), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 54/219 (24%), Positives = 93/219 (42%), Gaps = 43/219 (19%)
Query: 368 ATDNFK--EEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTH 425
+ +NF+ E++G G++G+VYK + T +V+ + R + E+ ++ + +
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 426 HKNLVRLLGFCDEGLNRLLVYEFLNNGTL----ASFLFGNLKPSWNLRTNIAFQIARGLL 481
H N+V+LL LV+EFL+ AS L G P L + FQ+ +GL
Sbjct: 61 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLA 117
Query: 482 Y------LHEDCSSQIIL-----------YSYKRTEGY--------VAPEWFRNSTI--- 513
+ LH D Q +L + R G V W+R I
Sbjct: 118 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 177
Query: 514 ----TAKVDVYSFGFLLLEIISCRKSF--DIEMGEEYAI 546
+ VD++S G + E+++ R F D E+ + + I
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 216
>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Cgp77675
pdb|1YOL|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Cgp77675
Length = 283
Score = 46.2 bits (108), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 49/191 (25%), Positives = 76/191 (39%), Gaps = 39/191 (20%)
Query: 375 EVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
++G+G FG V+ G T +V ++ + F E V+ + H+ LV+L
Sbjct: 22 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYA 77
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLR--TNIAFQIARGLLYL------HED 486
E +V E++N G+L FL G L +++ QIA G+ Y+ H D
Sbjct: 78 VVSEE-PIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYVHRD 136
Query: 487 CSSQIILY--------------------SYKRTEG------YVAPEWFRNSTITAKVDVY 520
+ IL Y +G + APE T K DV+
Sbjct: 137 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 196
Query: 521 SFGFLLLEIIS 531
SFG LL E+ +
Sbjct: 197 SFGILLTELTT 207
>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OGU|C Chain C, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OI9|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OI9|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
Length = 302
Score = 46.2 bits (108), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 54/219 (24%), Positives = 93/219 (42%), Gaps = 43/219 (19%)
Query: 368 ATDNFK--EEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTH 425
+ +NF+ E++G G++G+VYK + T +V+ + R + E+ ++ + +
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 426 HKNLVRLLGFCDEGLNRLLVYEFLNNGTL----ASFLFGNLKPSWNLRTNIAFQIARGLL 481
H N+V+LL LV+EFL+ AS L G P L + FQ+ +GL
Sbjct: 64 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLA 120
Query: 482 Y------LHEDCSSQIIL-----------YSYKRTEGY--------VAPEWFRNSTI--- 513
+ LH D Q +L + R G V W+R I
Sbjct: 121 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 180
Query: 514 ----TAKVDVYSFGFLLLEIISCRKSF--DIEMGEEYAI 546
+ VD++S G + E+++ R F D E+ + + I
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 219
>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
pdb|4EOQ|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
Length = 301
Score = 46.2 bits (108), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 54/219 (24%), Positives = 93/219 (42%), Gaps = 43/219 (19%)
Query: 368 ATDNFK--EEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTH 425
+ +NF+ E++G G++G+VYK + T +V+ + R + E+ ++ + +
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 426 HKNLVRLLGFCDEGLNRLLVYEFLNNGTL----ASFLFGNLKPSWNLRTNIAFQIARGLL 481
H N+V+LL LV+EFL+ AS L G P L + FQ+ +GL
Sbjct: 64 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLA 120
Query: 482 Y------LHEDCSSQIIL-----------YSYKRTEGY--------VAPEWFRNSTI--- 513
+ LH D Q +L + R G V W+R I
Sbjct: 121 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 180
Query: 514 ----TAKVDVYSFGFLLLEIISCRKSF--DIEMGEEYAI 546
+ VD++S G + E+++ R F D E+ + + I
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 219
>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCQ|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 301
Score = 46.2 bits (108), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 54/219 (24%), Positives = 93/219 (42%), Gaps = 43/219 (19%)
Query: 368 ATDNFK--EEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTH 425
+ +NF+ E++G G++G+VYK + T +V+ + R + E+ ++ + +
Sbjct: 3 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 426 HKNLVRLLGFCDEGLNRLLVYEFLNNGTL----ASFLFGNLKPSWNLRTNIAFQIARGLL 481
H N+V+LL LV+EFL+ AS L G P L + FQ+ +GL
Sbjct: 63 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLA 119
Query: 482 Y------LHEDCSSQIIL-----------YSYKRTEGY--------VAPEWFRNSTI--- 513
+ LH D Q +L + R G V W+R I
Sbjct: 120 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 179
Query: 514 ----TAKVDVYSFGFLLLEIISCRKSF--DIEMGEEYAI 546
+ VD++S G + E+++ R F D E+ + + I
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 218
>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1P|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1Q|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1Q|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1R|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1R|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1S|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H1S|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H24|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H24|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H25|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H25|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H26|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H26|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H27|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H27|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H28|A Chain A, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|1H28|C Chain C, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|2WMA|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMA|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
Length = 303
Score = 46.2 bits (108), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 54/219 (24%), Positives = 93/219 (42%), Gaps = 43/219 (19%)
Query: 368 ATDNFK--EEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTH 425
+ +NF+ E++G G++G+VYK + T +V+ + R + E+ ++ + +
Sbjct: 5 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 426 HKNLVRLLGFCDEGLNRLLVYEFLNNGTL----ASFLFGNLKPSWNLRTNIAFQIARGLL 481
H N+V+LL LV+EFL+ AS L G P L + FQ+ +GL
Sbjct: 65 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLA 121
Query: 482 Y------LHEDCSSQIIL-----------YSYKRTEGY--------VAPEWFRNSTI--- 513
+ LH D Q +L + R G V W+R I
Sbjct: 122 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 181
Query: 514 ----TAKVDVYSFGFLLLEIISCRKSF--DIEMGEEYAI 546
+ VD++S G + E+++ R F D E+ + + I
Sbjct: 182 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 220
>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E
pdb|4EOR|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
pdb|4EOR|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
Length = 298
Score = 46.2 bits (108), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 54/219 (24%), Positives = 93/219 (42%), Gaps = 43/219 (19%)
Query: 368 ATDNFK--EEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTH 425
+ +NF+ E++G G++G+VYK + T +V+ + R + E+ ++ + +
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 426 HKNLVRLLGFCDEGLNRLLVYEFLNNGTL----ASFLFGNLKPSWNLRTNIAFQIARGLL 481
H N+V+LL LV+EFL+ AS L G P L + FQ+ +GL
Sbjct: 61 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLA 117
Query: 482 Y------LHEDCSSQIIL-----------YSYKRTEGY--------VAPEWFRNSTI--- 513
+ LH D Q +L + R G V W+R I
Sbjct: 118 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 177
Query: 514 ----TAKVDVYSFGFLLLEIISCRKSF--DIEMGEEYAI 546
+ VD++S G + E+++ R F D E+ + + I
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 216
>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHT|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHU|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHU|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHV|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3BHV|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3MY5|A Chain A, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3MY5|C Chain C, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3TNW|A Chain A, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|3TNW|C Chain C, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|4BCO|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCO|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 300
Score = 46.2 bits (108), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 54/219 (24%), Positives = 93/219 (42%), Gaps = 43/219 (19%)
Query: 368 ATDNFK--EEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTH 425
+ +NF+ E++G G++G+VYK + T +V+ + R + E+ ++ + +
Sbjct: 2 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 426 HKNLVRLLGFCDEGLNRLLVYEFLNNGTL----ASFLFGNLKPSWNLRTNIAFQIARGLL 481
H N+V+LL LV+EFL+ AS L G P L + FQ+ +GL
Sbjct: 62 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLA 118
Query: 482 Y------LHEDCSSQIIL-----------YSYKRTEGY--------VAPEWFRNSTI--- 513
+ LH D Q +L + R G V W+R I
Sbjct: 119 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 178
Query: 514 ----TAKVDVYSFGFLLLEIISCRKSF--DIEMGEEYAI 546
+ VD++S G + E+++ R F D E+ + + I
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 217
>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720
pdb|3C4C|B Chain B, B-Raf Kinase In Complex With Plx4720
Length = 280
Score = 46.2 bits (108), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 51/204 (25%), Positives = 86/204 (42%), Gaps = 59/204 (28%)
Query: 374 EEVGRGSFGIVYKG---------VIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQT 424
+ +G GSFG VYKG ++ T QLQ+ FKNEV V+ +T
Sbjct: 18 QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA------------FKNEVGVLRKT 65
Query: 425 HHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYL 483
H N++ +G+ + +V ++ +L L + K +IA Q ARG+ YL
Sbjct: 66 RHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYL 124
Query: 484 HEDC-------SSQIILY-----------------------SYKRTEG---YVAPEWFR- 509
H S+ I L+ +++ G ++APE R
Sbjct: 125 HAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 184
Query: 510 --NSTITAKVDVYSFGFLLLEIIS 531
++ + + DVY+FG +L E+++
Sbjct: 185 QDSNPYSFQSDVYAFGIVLYELMT 208
>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex
With Staurosporine
Length = 287
Score = 46.2 bits (108), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 50/198 (25%), Positives = 85/198 (42%), Gaps = 47/198 (23%)
Query: 375 EVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGER----EFKNEVFVISQTHHKNLV 430
E+G G+FG V +GV + ++ Q+ ++ Q E+ E E ++ Q + +V
Sbjct: 17 ELGCGNFGSVRQGVYRMRKK---QIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73
Query: 431 RLLGFCD-EGLNRLLVYEFLNNGTLASFLFGNLK--PSWNLRTNIAFQIARGLLYL---- 483
RL+G C E L +LV E G L FL G + P N+ + Q++ G+ YL
Sbjct: 74 RLIGVCQAEAL--MLVMEMAGGGPLHKFLVGKREEIPVSNV-AELLHQVSMGMKYLEEKN 130
Query: 484 --HEDCSSQIIL-----------------------YSYKRTEG-----YVAPEWFRNSTI 513
H D +++ +L Y R+ G + APE
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 190
Query: 514 TAKVDVYSFGFLLLEIIS 531
+++ DV+S+G + E +S
Sbjct: 191 SSRSDVWSYGVTMWEALS 208
>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg-
1009247
Length = 270
Score = 46.2 bits (108), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 49/195 (25%), Positives = 76/195 (38%), Gaps = 39/195 (20%)
Query: 371 NFKEEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLV 430
++++G G FG V+ +V ++ + + F E V+ H LV
Sbjct: 18 KLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE----AFLAEANVMKTLQHDKLV 73
Query: 431 RLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF--QIARGLL------Y 482
+L + ++ EF+ G+L FL + L I F QIA G+ Y
Sbjct: 74 KLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY 132
Query: 483 LHEDCSSQIILYS--------------------YKRTEG------YVAPEWFRNSTITAK 516
+H D + IL S Y EG + APE + T K
Sbjct: 133 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 192
Query: 517 VDVYSFGFLLLEIIS 531
DV+SFG LL+EI++
Sbjct: 193 SDVWSFGILLMEIVT 207
>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B
Length = 289
Score = 46.2 bits (108), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 54/219 (24%), Positives = 93/219 (42%), Gaps = 43/219 (19%)
Query: 368 ATDNFK--EEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTH 425
+ +NF+ E++G G++G+VYK + T +V+ + R + E+ ++ + +
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 426 HKNLVRLLGFCDEGLNRLLVYEFLNNGTL----ASFLFGNLKPSWNLRTNIAFQIARGLL 481
H N+V+LL LV+EFL+ AS L G P L + FQ+ +GL
Sbjct: 61 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLA 117
Query: 482 Y------LHEDCSSQIIL-----------YSYKRTEGY--------VAPEWFRNSTI--- 513
+ LH D Q +L + R G V W+R I
Sbjct: 118 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 177
Query: 514 ----TAKVDVYSFGFLLLEIISCRKSF--DIEMGEEYAI 546
+ VD++S G + E+++ R F D E+ + + I
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 216
>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1QMZ|C Chain C, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1GY3|A Chain A, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1GY3|C Chain C, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1P5E|A Chain A, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|1P5E|C Chain C, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|2CCH|A Chain A, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCH|C Chain C, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCI|A Chain A, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2CCI|C Chain C, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2G9X|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|2G9X|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|3DDP|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDP|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDQ|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DDQ|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DOG|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
pdb|3DOG|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
Length = 299
Score = 46.2 bits (108), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 54/219 (24%), Positives = 93/219 (42%), Gaps = 43/219 (19%)
Query: 368 ATDNFK--EEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTH 425
+ +NF+ E++G G++G+VYK + T +V+ + R + E+ ++ + +
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 426 HKNLVRLLGFCDEGLNRLLVYEFLNNGTL----ASFLFGNLKPSWNLRTNIAFQIARGLL 481
H N+V+LL LV+EFL+ AS L G P L + FQ+ +GL
Sbjct: 61 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLA 117
Query: 482 Y------LHEDCSSQIIL-----------YSYKRTEGY--------VAPEWFRNSTI--- 513
+ LH D Q +L + R G V W+R I
Sbjct: 118 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 177
Query: 514 ----TAKVDVYSFGFLLLEIISCRKSF--DIEMGEEYAI 546
+ VD++S G + E+++ R F D E+ + + I
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 216
>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site
pdb|3EZV|A Chain A, Cdk-2 With Indazole Inhibitor 9 Bound At Its Active Site
Length = 300
Score = 46.2 bits (108), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 54/219 (24%), Positives = 93/219 (42%), Gaps = 43/219 (19%)
Query: 368 ATDNFK--EEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTH 425
+ +NF+ E++G G++G+VYK + T +V+ + R + E+ ++ + +
Sbjct: 2 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 426 HKNLVRLLGFCDEGLNRLLVYEFLNNGTL----ASFLFGNLKPSWNLRTNIAFQIARGLL 481
H N+V+LL LV+EFL+ AS L G P L + FQ+ +GL
Sbjct: 62 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLA 118
Query: 482 Y------LHEDCSSQIIL-----------YSYKRTEGY--------VAPEWFRNSTI--- 513
+ LH D Q +L + R G V W+R I
Sbjct: 119 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 178
Query: 514 ----TAKVDVYSFGFLLLEIISCRKSF--DIEMGEEYAI 546
+ VD++S G + E+++ R F D E+ + + I
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 217
>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
pdb|4I3Z|C Chain C, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
Length = 296
Score = 46.2 bits (108), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 54/217 (24%), Positives = 92/217 (42%), Gaps = 43/217 (19%)
Query: 370 DNFK--EEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHK 427
+NF+ E++G G++G+VYK + T +V+ + R + E+ ++ + +H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 428 NLVRLLGFCDEGLNRLLVYEFLNNGTL----ASFLFGNLKPSWNLRTNIAFQIARGLLY- 482
N+V+LL LV+EFL+ AS L G P L + FQ+ +GL +
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFC 118
Query: 483 -----LHEDCSSQIIL-----------YSYKRTEGY--------VAPEWFRNSTI----- 513
LH D Q +L + R G V W+R I
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 178
Query: 514 --TAKVDVYSFGFLLLEIISCRKSF--DIEMGEEYAI 546
+ VD++S G + E+++ R F D E+ + + I
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 215
>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In
Complex With Novel Allosteric Inhibitor
pdb|4EBV|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In
Complex With Novel Allosteric Inhibitor
Length = 304
Score = 46.2 bits (108), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 62/247 (25%), Positives = 100/247 (40%), Gaps = 61/247 (24%)
Query: 376 VGRGSFGIVYKGVIQTTRQVLLQLQSRNWI-VFQDGERE-FKNEVFVISQTHHKNLVRLL 433
+G G FG V++G+ + L + + D RE F E + Q H ++V+L+
Sbjct: 46 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 434 GFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI--AFQIARGLLYL------HE 485
G E ++ E G L SFL K S +L + I A+Q++ L YL H
Sbjct: 106 GVITEN-PVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKRFVHR 163
Query: 486 DCSSQIILYS---------------------YKRTEGYVAPEWFRNSTI-----TAKVDV 519
D +++ +L S YK ++G + +W +I T+ DV
Sbjct: 164 DIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDV 223
Query: 520 YSFGFLLLEII-SCRKSFD----------IEMGEE-----------YAILTD-WAFDCYR 556
+ FG + EI+ K F IE GE Y+++T WA+D R
Sbjct: 224 WMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSR 283
Query: 557 NGKLDDL 563
+ +L
Sbjct: 284 RPRFTEL 290
>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak)
pdb|4I4F|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In
Complex With An Allosteric Binding Pyrazolobenzothiazine
Compound
Length = 281
Score = 46.2 bits (108), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 62/247 (25%), Positives = 100/247 (40%), Gaps = 61/247 (24%)
Query: 376 VGRGSFGIVYKGVIQTTRQVLLQLQSRNWI-VFQDGERE-FKNEVFVISQTHHKNLVRLL 433
+G G FG V++G+ + L + + D RE F E + Q H ++V+L+
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 434 GFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI--AFQIARGLLYL------HE 485
G E ++ E G L SFL K S +L + I A+Q++ L YL H
Sbjct: 83 GVITEN-PVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKRFVHR 140
Query: 486 DCSSQIILYS---------------------YKRTEGYVAPEWFRNSTI-----TAKVDV 519
D +++ +L S YK ++G + +W +I T+ DV
Sbjct: 141 DIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDV 200
Query: 520 YSFGFLLLEII-SCRKSFD----------IEMGEE-----------YAILTD-WAFDCYR 556
+ FG + EI+ K F IE GE Y+++T WA+D R
Sbjct: 201 WMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSR 260
Query: 557 NGKLDDL 563
+ +L
Sbjct: 261 RPRFTEL 267
>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Pyrrolo[2,3- D]thiazole
pdb|3PXK|B Chain B, Focal Adhesion Kinase Catalytic Domain In Complex With
Pyrrolo[2,3- D]thiazole
Length = 282
Score = 46.2 bits (108), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 62/247 (25%), Positives = 100/247 (40%), Gaps = 61/247 (24%)
Query: 376 VGRGSFGIVYKGVIQTTRQVLLQLQSRNWI-VFQDGERE-FKNEVFVISQTHHKNLVRLL 433
+G G FG V++G+ + L + + D RE F E + Q H ++V+L+
Sbjct: 21 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 434 GFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI--AFQIARGLLYL------HE 485
G E ++ E G L SFL K S +L + I A+Q++ L YL H
Sbjct: 81 GVITEN-PVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKRFVHR 138
Query: 486 DCSSQIILYS---------------------YKRTEGYVAPEWFRNSTI-----TAKVDV 519
D +++ +L S YK ++G + +W +I T+ DV
Sbjct: 139 DIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDV 198
Query: 520 YSFGFLLLEII-SCRKSFD----------IEMGEE-----------YAILTD-WAFDCYR 556
+ FG + EI+ K F IE GE Y+++T WA+D R
Sbjct: 199 WMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSR 258
Query: 557 NGKLDDL 563
+ +L
Sbjct: 259 RPRFTEL 265
>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|1VYW|C Chain C, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|2C4G|A Chain A, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2C4G|C Chain C, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2BPM|A Chain A, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BPM|C Chain C, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BKZ|A Chain A, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2BKZ|C Chain C, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2WIH|A Chain A, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIH|C Chain C, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIP|A Chain A, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WIP|C Chain C, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WPA|A Chain A, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WPA|C Chain C, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WXV|A Chain A, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
pdb|2WXV|C Chain C, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
Length = 309
Score = 45.8 bits (107), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 54/217 (24%), Positives = 92/217 (42%), Gaps = 43/217 (19%)
Query: 370 DNFK--EEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHK 427
+NF+ E++G G++G+VYK + T +V+ + R + E+ ++ + +H
Sbjct: 7 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 428 NLVRLLGFCDEGLNRLLVYEFLNNGTL----ASFLFGNLKPSWNLRTNIAFQIARGLLY- 482
N+V+LL LV+EFL+ AS L G P L + FQ+ +GL +
Sbjct: 67 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFC 123
Query: 483 -----LHEDCSSQIIL-----------YSYKRTEGY--------VAPEWFRNSTI----- 513
LH D Q +L + R G V W+R I
Sbjct: 124 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 183
Query: 514 --TAKVDVYSFGFLLLEIISCRKSF--DIEMGEEYAI 546
+ VD++S G + E+++ R F D E+ + + I
Sbjct: 184 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 220
>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a)
Length = 306
Score = 45.8 bits (107), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 43/206 (20%), Positives = 87/206 (42%), Gaps = 37/206 (17%)
Query: 363 KALEEATDNFKEEVGRGSFGIVYKGVIQT--TRQVLLQLQSRNWIVFQDGEREFKNEVFV 420
K ++ + ++ +G G FG V G ++ R++ + +++ R+F +E +
Sbjct: 24 KEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASI 83
Query: 421 ISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLR-TNIAFQIARG 479
+ Q H N++ L G + +++ E++ NG+L +FL N ++ + I G
Sbjct: 84 MGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSG 143
Query: 480 LLYL------HEDCSSQIILY-----------------------SYKRTEG-----YVAP 505
+ YL H D +++ IL +Y G + AP
Sbjct: 144 MKYLSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAP 203
Query: 506 EWFRNSTITAKVDVYSFGFLLLEIIS 531
E T+ DV+S+G ++ E++S
Sbjct: 204 EAIAYRKFTSASDVWSYGIVMWEVMS 229
>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A
Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine
Length = 299
Score = 45.8 bits (107), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 54/217 (24%), Positives = 92/217 (42%), Gaps = 43/217 (19%)
Query: 370 DNFK--EEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHK 427
+NF+ E++G G++G+VYK + T +V+ + R + E+ ++ + +H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 428 NLVRLLGFCDEGLNRLLVYEFLNNGTL----ASFLFGNLKPSWNLRTNIAFQIARGLLY- 482
N+V+LL LV+EFL+ AS L G P L + FQ+ +GL +
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFC 119
Query: 483 -----LHEDCSSQIIL-----------YSYKRTEGY--------VAPEWFRNSTI----- 513
LH D Q +L + R G V W+R I
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 179
Query: 514 --TAKVDVYSFGFLLLEIISCRKSF--DIEMGEEYAI 546
+ VD++S G + E+++ R F D E+ + + I
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 216
>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHR|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
Length = 298
Score = 45.8 bits (107), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 54/217 (24%), Positives = 92/217 (42%), Gaps = 43/217 (19%)
Query: 370 DNFK--EEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHK 427
+NF+ E++G G++G+VYK + T +V+ + R + E+ ++ + +H
Sbjct: 4 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 428 NLVRLLGFCDEGLNRLLVYEFLNNGTL----ASFLFGNLKPSWNLRTNIAFQIARGLLY- 482
N+V+LL LV+EFL+ AS L G P L + FQ+ +GL +
Sbjct: 64 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFC 120
Query: 483 -----LHEDCSSQIIL-----------YSYKRTEGY--------VAPEWFRNSTI----- 513
LH D Q +L + R G V W+R I
Sbjct: 121 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 180
Query: 514 --TAKVDVYSFGFLLLEIISCRKSF--DIEMGEEYAI 546
+ VD++S G + E+++ R F D E+ + + I
Sbjct: 181 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 217
>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1
pdb|3FPQ|B Chain B, Crystal Structure Of The Kinase Domain Of Wnk1
Length = 290
Score = 45.8 bits (107), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 56/197 (28%), Positives = 79/197 (40%), Gaps = 43/197 (21%)
Query: 371 NFKEEVGRGSFGIVYKGV-IQTTRQVL-LQLQSRNWIVFQDGERE-FKNEVFVISQTHHK 427
F E+GRGSF VYKG+ +TT +V +LQ R ER+ FK E + H
Sbjct: 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK---LTKSERQRFKEEAEXLKGLQHP 85
Query: 428 NLVRLLGFCDEGLN----RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYL 483
N+VR + + +LV E +GTL ++L + + QI +GL +L
Sbjct: 86 NIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQFL 145
Query: 484 HE----------DCSSQII-------------LYSYKR---------TEGYVAPEWFRNS 511
H C + I L + KR T + APE +
Sbjct: 146 HTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFXAPEXYEEK 205
Query: 512 TITAKVDVYSFGFLLLE 528
VDVY+FG LE
Sbjct: 206 -YDESVDVYAFGXCXLE 221
>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain
Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative
pdb|2ETM|B Chain B, Crystal Structure Of Focal Adhesion Kinase Domain
Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative
pdb|2IJM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain With 2
Molecules In The Asymmetric Unit Complexed With Adp And
Atp
pdb|2IJM|B Chain B, Crystal Structure Of Focal Adhesion Kinase Domain With 2
Molecules In The Asymmetric Unit Complexed With Adp And
Atp
Length = 281
Score = 45.8 bits (107), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 62/247 (25%), Positives = 100/247 (40%), Gaps = 61/247 (24%)
Query: 376 VGRGSFGIVYKGVIQTTRQVLLQLQSRNWI-VFQDGERE-FKNEVFVISQTHHKNLVRLL 433
+G G FG V++G+ + L + + D RE F E + Q H ++V+L+
Sbjct: 20 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 434 GFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI--AFQIARGLLYL------HE 485
G E ++ E G L SFL K S +L + I A+Q++ L YL H
Sbjct: 80 GVITEN-PVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKRFVHR 137
Query: 486 DCSSQIILYS---------------------YKRTEGYVAPEWFRNSTI-----TAKVDV 519
D +++ +L S YK ++G + +W +I T+ DV
Sbjct: 138 DIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDV 197
Query: 520 YSFGFLLLEII-SCRKSFD----------IEMGEE-----------YAILTD-WAFDCYR 556
+ FG + EI+ K F IE GE Y+++T WA+D R
Sbjct: 198 WMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSR 257
Query: 557 NGKLDDL 563
+ +L
Sbjct: 258 RPRFTEL 264
>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src
pdb|2SRC|A Chain A, Crystal Structure Of Human Tyrosine-protein Kinase C-src,
In Complex With Amp-pnp
Length = 452
Score = 45.8 bits (107), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 49/191 (25%), Positives = 76/191 (39%), Gaps = 39/191 (20%)
Query: 375 EVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
++G+G FG V+ G T +V ++ + F E V+ + H+ LV+L
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYA 246
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLR--TNIAFQIARGLLYL------HED 486
E +V E+++ G+L FL G L ++A QIA G+ Y+ H D
Sbjct: 247 VVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 305
Query: 487 CSSQIILY--------------------SYKRTEG------YVAPEWFRNSTITAKVDVY 520
+ IL Y +G + APE T K DV+
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 365
Query: 521 SFGFLLLEIIS 531
SFG LL E+ +
Sbjct: 366 SFGILLTELTT 376
>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3-
Methoxybenzyl)-7-Azaindole
pdb|3C4F|B Chain B, Fgfr Tyrosine Kinase Domain In Complex With 3-(3-
Methoxybenzyl)-7-Azaindole
Length = 302
Score = 45.8 bits (107), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 40/155 (25%), Positives = 64/155 (41%), Gaps = 49/155 (31%)
Query: 426 HKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGN--------LKPSWNLRTNI----- 472
HKN++ LLG C + ++ E+ + G L +L PS N +
Sbjct: 78 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDL 137
Query: 473 ---AFQIARGLLYL------HEDCSSQIILYS---------------------YKRTEG- 501
A+Q+ARG+ YL H D +++ +L + YK+T
Sbjct: 138 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 502 -----YVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
++APE + T + DV+SFG LL EI +
Sbjct: 198 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232
>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2
Complexed With A Nucleoside Inhibitor
Length = 298
Score = 45.8 bits (107), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 54/217 (24%), Positives = 92/217 (42%), Gaps = 43/217 (19%)
Query: 370 DNFK--EEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHK 427
+NF+ E++G G++G+VYK + T +V+ + R + E+ ++ + +H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 428 NLVRLLGFCDEGLNRLLVYEFLNNGTL----ASFLFGNLKPSWNLRTNIAFQIARGLLY- 482
N+V+LL LV+EFL+ AS L G P L + FQ+ +GL +
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFC 118
Query: 483 -----LHEDCSSQIIL-----------YSYKRTEGY--------VAPEWFRNSTI----- 513
LH D Q +L + R G V W+R I
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 514 --TAKVDVYSFGFLLLEIISCRKSF--DIEMGEEYAI 546
+ VD++S G + E+++ R F D E+ + + I
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 215
>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain
pdb|2IVU|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain Complexed With The Inhibitor Zd6474
pdb|2X2K|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2L|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2M|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2M|B Chain B, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
Length = 314
Score = 45.8 bits (107), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 42/178 (23%), Positives = 74/178 (41%), Gaps = 57/178 (32%)
Query: 412 REFKNEVFVISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLK-------- 463
R+ +E V+ Q +H ++++L G C + LL+ E+ G+L FL + K
Sbjct: 71 RDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGS 130
Query: 464 -----------PSWNLRT-----NIAFQIARGLLYL------HEDCSSQIILYS------ 495
P T + A+QI++G+ YL H D +++ IL +
Sbjct: 131 GGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMK 190
Query: 496 ----------------YKRTEGYVAPEWFRNSTI-----TAKVDVYSFGFLLLEIISC 532
KR++G + +W ++ T + DV+SFG LL EI++
Sbjct: 191 ISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTL 248
>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide,
Compound (S)-8b
pdb|3IG7|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efp With Cdk-2
pdb|3IGG|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efq With Cdk-2
pdb|1B38|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1B39|A Chain A, Human Cyclin-Dependent Kinase 2 Phosphorylated On Thr 160
pdb|1E1V|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu2058
pdb|1E1X|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu6027
pdb|1H00|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H07|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H08|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|2R3R|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|4ACM|A Chain A, Cdk2 In Complex With
3-Amino-6-(4-{[2-(Dimethylamino)ethyl]
Sulfamoyl}-Phenyl)-N-Pyridin-3-Ylpyrazine-2-Carboxamide
pdb|3SW4|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|3SW7|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|1OIQ|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
pdb|1V1K|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1URW|A Chain A, Cdk2 In Complex With An Imidazo[1,2-B]pyridazine
pdb|2VV9|A Chain A, Cdk2 In Complex With An Imidazole Piperazine
pdb|2W06|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5c
pdb|2R3G|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3H|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3F|A Chain A, Crystal Structure Of Cyclin-dependent Kinase 2 With
Inhibitor
Length = 299
Score = 45.8 bits (107), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 54/217 (24%), Positives = 92/217 (42%), Gaps = 43/217 (19%)
Query: 370 DNFK--EEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHK 427
+NF+ E++G G++G+VYK + T +V+ + R + E+ ++ + +H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 428 NLVRLLGFCDEGLNRLLVYEFLNNGTL----ASFLFGNLKPSWNLRTNIAFQIARGLLY- 482
N+V+LL LV+EFL+ AS L G P L + FQ+ +GL +
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFC 119
Query: 483 -----LHEDCSSQIIL-----------YSYKRTEGY--------VAPEWFRNSTI----- 513
LH D Q +L + R G V W+R I
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 179
Query: 514 --TAKVDVYSFGFLLLEIISCRKSF--DIEMGEEYAI 546
+ VD++S G + E+++ R F D E+ + + I
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 216
>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|E Chain E, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|D Chain D, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4N|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 49
pdb|4E4N|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 49
pdb|4E5W|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 26
pdb|4E5W|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 26
pdb|4EHZ|A Chain A, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|B Chain B, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|C Chain C, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|D Chain D, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EI4|A Chain A, Jak1 Kinase (jh1 Domain) In Complex With Compound 20
pdb|4EI4|B Chain B, Jak1 Kinase (jh1 Domain) In Complex With Compound 20
pdb|4FK6|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 72
pdb|4FK6|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 72
Length = 302
Score = 45.8 bits (107), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 40/157 (25%), Positives = 66/157 (42%), Gaps = 39/157 (24%)
Query: 413 EFKNEVFVISQTHHKNLVRLLGFCDE--GLNRLLVYEFLNNGTLASFLFGNLKPSWNLRT 470
+ K E+ ++ +H+N+V+ G C E G L+ EFL +G+L +L N K NL+
Sbjct: 69 DLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN-KNKINLKQ 127
Query: 471 NI--AFQIARGLLYL------HEDCSSQIILYSYKRTEG--------------------- 501
+ A QI +G+ YL H D +++ +L +
Sbjct: 128 QLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKD 187
Query: 502 -------YVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
+ APE S DV+SFG L E+++
Sbjct: 188 DRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224
>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1FIN|C Chain C, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1CKP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Purvalanol B
pdb|1BUH|A Chain A, Crystal Structure Of The Human Cdk2 Kinase Complex With
Cell Cycle-Regulatory Protein Ckshs1
pdb|1DM2|A Chain A, Human Cyclin-Dependent Kinase 2 Complexed With The
Inhibitor Hymenialdisine
pdb|1DI8|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With
4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline
pdb|1F5Q|A Chain A, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1F5Q|C Chain C, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1FVT|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With An Oxindole Inhibitor
pdb|1FVV|A Chain A, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1FVV|C Chain C, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1JSV|A Chain A, The Structure Of Cyclin-dependent Kinase 2 (cdk2) In
Complex With 4-[(6-amino-4-pyrimidinyl)
Amino]benzenesulfonamide
pdb|1G5S|A Chain A, Crystal Structure Of Human Cyclin Dependent Kinase 2
(Cdk2) In Complex With The Inhibitor H717
pdb|1JVP|P Chain P, Crystal Structure Of Human Cdk2 (Unphosphorylated) In
Complex With Pkf049-365
pdb|1GIH|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1KE5|A Chain A, Cdk2 Complexed With N-methyl-4-{[(2-oxo-1,2-dihydro-3h-
Indol-3-ylidene)methyl]amino}benzenesulfonamide
pdb|1KE6|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
N-Methyl-{4-
[2-(7-Oxo-6,7-Dihydro-8h-[1,3]thiazolo[5,4-E]indol-8-
Ylidene)hydrazino]phenyl}methanesulfonamide
pdb|1KE7|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[(2,2-
Dioxido-1,
3-Dihydro-2-Benzothien-5-Yl)amino]methylene}-5-
(1,3-Oxazol-5-Yl)-1,3-Dihydro-2h-Indol-2-One
pdb|1KE8|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
4-{[(2-Oxo-
1,2-Dihydro-3h-Indol-3-Ylidene)methyl]amino}-N-(1,3-
Thiazol-2-Yl)benzenesulfonamide
pdb|1KE9|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[4-
({[amino(Imino)methyl]aminosulfonyl)anilino]methylene}-
2- Oxo-2,3-Dihydro-1h-Indole
pdb|1H0V|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor
2-Amino-6-[(R)-Pyrrolidino-5'-Yl]methoxypurine
pdb|1H0W|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 2-Amino-6-[cyclohex-3-Enyl]methoxypurine
pdb|1P2A|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Trisubstituted Naphthostyril Inhibitor
pdb|1OKV|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKV|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKW|A Chain A, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OKW|C Chain C, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OL1|A Chain A, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL1|C Chain C, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL2|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1OL2|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1PW2|A Chain A, Apo Structure Of Human Cyclin-Dependent Kinase 2
pdb|1PXI|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-(2,5-dichloro-thiophen-3-yl)-pyrimidin-2-
Ylamine
pdb|1PXJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine
pdb|1PXK|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-dimethyl-thiazol-5-yl)pyrimidin-2-yl]-
N'-hydroxyiminoformamide
pdb|1PXL|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-yl]-
(4-trifluoromethyl-phenyl)-amine
pdb|1R78|A Chain A, Cdk2 Complex With A 4-alkynyl Oxindole Inhibitor
pdb|1PXM|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-
Ylamino]-Phenol
pdb|1PXN|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-
Pyrimidin-2-Ylamino]-Phenol
pdb|1PXO|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-
Yl]-(3-Nitro-Phenyl)-Amine
pdb|1PXP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-
N',N'-Dimethyl-Benzene-1,4-Diamine
pdb|1VYZ|A Chain A, Structure Of Cdk2 Complexed With Pnu-181227
pdb|1PYE|A Chain A, Crystal Structure Of Cdk2 With Inhibitor
pdb|1URC|A Chain A, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1URC|C Chain C, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1W0X|C Chain C, Crystals Structure Of Human Cdk2 In Complex With The
Inhibitor Olomoucine.
pdb|1WCC|A Chain A, Screening For Fragment Binding By X-Ray Crystallography
pdb|1Y8Y|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|1Y91|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|2BHE|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 5-Bromo-Indirubine
pdb|2BHH|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 4-Hydroxypiperindinesulfonyl-Indirubine
pdb|2B52|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Dph-
042562
pdb|2B53|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Din-
234325
pdb|2B54|A Chain A, Human Cyclin Dependent Kinase 2 (Ckd2)complexed With Din-
232305
pdb|2B55|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With
Indenopyraxole Din-101312
pdb|2BTR|A Chain A, Structure Of Cdk2 Complexed With Pnu-198873
pdb|2BTS|A Chain A, Structure Of Cdk2 Complexed With Pnu-230032
pdb|2C68|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C69|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6I|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6K|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6L|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6M|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6O|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2EXM|A Chain A, Human Cdk2 In Complex With Isopentenyladenine
pdb|1YKR|A Chain A, Crystal Structure Of Cdk2 With An Aminoimidazo Pyridine
Inhibitor
pdb|2A0C|X Chain X, Human Cdk2 In Complex With Olomoucine Ii, A Novel 2,6,9-
Trisubstituted Purine Cyclin-Dependent Kinase Inhibitor
pdb|2C5N|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5N|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5Y|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2A4L|A Chain A, Human Cyclin-Dependent Kinase 2 In Complex With
Roscovitine
pdb|2FVD|A Chain A, Cyclin Dependent Kinase 2 (Cdk2) With Diaminopyrimidine
Inhibitor
pdb|2I40|A Chain A, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2I40|C Chain C, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2CLX|A Chain A, 4-Arylazo-3,5-Diamino-1h-Pyrazole Cdk Inhibitors: Sar
Study, Crystal Structure In Complex With Cdk2,
Selectivity, And Cellular Effects
pdb|2DUV|A Chain A, Structure Of Cdk2 With A 3-Hydroxychromones
pdb|2UUE|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UUE|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UZN|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZO|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2V0D|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|1AQ1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Staurosporine
pdb|1HCK|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1HCL|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|2J9M|A Chain A, Crystal Structure Of Cdk2 In Complex With Macrocyclic
Aminopyrimidine
pdb|2V22|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2V22|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2VTA|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTH|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design
pdb|2VTI|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTJ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTL|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTM|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTN|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTO|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTP|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTQ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTR|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTS|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTT|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VU3|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2R64|A Chain A, Crystal Structure Of A 3-Aminoindazole Compound With Cdk2
pdb|2W05|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5b
pdb|3EID|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EID|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EOC|A Chain A, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|3EOC|C Chain C, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|2W1H|A Chain A, Fragment-Based Discovery Of The Pyrazol-4-Yl Urea
(At9283), A Multi-Targeted Kinase Inhibitor With Potent
Aurora Kinase Activity
pdb|3F5X|A Chain A, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3F5X|C Chain C, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3FZ1|A Chain A, Crystal Structure Of A Benzthiophene Inhibitor Bound To
Human Cyclin-Dependent Kinase-2 (Cdk-2)
pdb|2WEV|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WEV|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|3LFN|A Chain A, Crystal Structure Of Cdk2 With Sar57, An Aminoindazole
Type Inhibitor
pdb|3LFQ|A Chain A, Crystal Structure Of Cdk2 With Sar60, An Aminoindazole
Type Inhibitor
pdb|3LFS|A Chain A, Crystal Structure Of Cdk2 With Sar37, An Aminoindazole
Type Inhibitor
pdb|2XMY|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|2XNB|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|3LE6|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Pyrazolobenzodiazepine Inhibitor
pdb|3NS9|A Chain A, Crystal Structure Of Cdk2 In Complex With Inhibitor Bs-194
pdb|3S2P|A Chain A, Crystal Structure Of Cdk2 With A 2-Aminopyrimidine
Compound
pdb|3UNJ|A Chain A, Cdk2 In Complex With Inhibitor Yl1-038-31
pdb|3UNK|A Chain A, Cdk2 In Complex With Inhibitor Yl5-083
pdb|3TI1|A Chain A, Cdk2 In Complex With Sunitinib
pdb|3TIY|A Chain A, Cdk2 In Complex With Nsc 35676
pdb|3TIZ|A Chain A, Cdk2 In Complex With Nsc 111848
Length = 298
Score = 45.8 bits (107), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 54/217 (24%), Positives = 92/217 (42%), Gaps = 43/217 (19%)
Query: 370 DNFK--EEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHK 427
+NF+ E++G G++G+VYK + T +V+ + R + E+ ++ + +H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 428 NLVRLLGFCDEGLNRLLVYEFLNNGTL----ASFLFGNLKPSWNLRTNIAFQIARGLLY- 482
N+V+LL LV+EFL+ AS L G P L + FQ+ +GL +
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFC 118
Query: 483 -----LHEDCSSQIIL-----------YSYKRTEGY--------VAPEWFRNSTI----- 513
LH D Q +L + R G V W+R I
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 514 --TAKVDVYSFGFLLLEIISCRKSF--DIEMGEEYAI 546
+ VD++S G + E+++ R F D E+ + + I
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 215
>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An
Inhibitor
Length = 452
Score = 45.8 bits (107), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 49/191 (25%), Positives = 76/191 (39%), Gaps = 39/191 (20%)
Query: 375 EVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
++G+G FG V+ G T +V ++ + F E V+ + H+ LV+L
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYA 246
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLR--TNIAFQIARGLLYL------HED 486
E +V E+++ G+L FL G L ++A QIA G+ Y+ H D
Sbjct: 247 VVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 305
Query: 487 CSSQIILY--------------------SYKRTEG------YVAPEWFRNSTITAKVDVY 520
+ IL Y +G + APE T K DV+
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 365
Query: 521 SFGFLLLEIIS 531
SFG LL E+ +
Sbjct: 366 SFGILLTELTT 376
>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451
pdb|2BDF|B Chain B, Src Kinase In Complex With Inhibitor Ap23451
pdb|2BDJ|A Chain A, Src Kinase In Complex With Inhibitor Ap23464
Length = 279
Score = 45.8 bits (107), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 49/191 (25%), Positives = 76/191 (39%), Gaps = 39/191 (20%)
Query: 375 EVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
++G+G FG V+ G T +V ++ + F E V+ + H+ LV+L
Sbjct: 18 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYA 73
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLR--TNIAFQIARGLLYL------HED 486
E +V E+++ G+L FL G L ++A QIA G+ Y+ H D
Sbjct: 74 VVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 132
Query: 487 CSSQIILY--------------------SYKRTEG------YVAPEWFRNSTITAKVDVY 520
+ IL Y +G + APE T K DV+
Sbjct: 133 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 192
Query: 521 SFGFLLLEIIS 531
SFG LL E+ +
Sbjct: 193 SFGILLTELTT 203
>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JST|C Chain C, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JSU|A Chain A, P27(Kip1)CYCLIN ACDK2 COMPLEX
pdb|1FQ1|B Chain B, Crystal Structure Of Kinase Associated Phosphatase (Kap)
In Complex With Phospho-Cdk2
pdb|2C6T|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6T|C Chain C, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2CJM|A Chain A, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2CJM|C Chain C, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2UZB|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZB|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|4II5|A Chain A, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
pdb|4II5|C Chain C, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
Length = 298
Score = 45.8 bits (107), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 54/217 (24%), Positives = 92/217 (42%), Gaps = 43/217 (19%)
Query: 370 DNFK--EEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHK 427
+NF+ E++G G++G+VYK + T +V+ + R + E+ ++ + +H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 428 NLVRLLGFCDEGLNRLLVYEFLNNGTL----ASFLFGNLKPSWNLRTNIAFQIARGLLY- 482
N+V+LL LV+EFL+ AS L G P L + FQ+ +GL +
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFC 118
Query: 483 -----LHEDCSSQIIL-----------YSYKRTEGY--------VAPEWFRNSTI----- 513
LH D Q +L + R G V W+R I
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 178
Query: 514 --TAKVDVYSFGFLLLEIISCRKSF--DIEMGEEYAI 546
+ VD++S G + E+++ R F D E+ + + I
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 215
>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain Complexed With The Inhibitor Pp1
Length = 314
Score = 45.8 bits (107), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 42/178 (23%), Positives = 74/178 (41%), Gaps = 57/178 (32%)
Query: 412 REFKNEVFVISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLK-------- 463
R+ +E V+ Q +H ++++L G C + LL+ E+ G+L FL + K
Sbjct: 71 RDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGS 130
Query: 464 -----------PSWNLRT-----NIAFQIARGLLYL------HEDCSSQIILYS------ 495
P T + A+QI++G+ YL H D +++ IL +
Sbjct: 131 GGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMK 190
Query: 496 ----------------YKRTEGYVAPEWFRNSTI-----TAKVDVYSFGFLLLEIISC 532
KR++G + +W ++ T + DV+SFG LL EI++
Sbjct: 191 ISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTL 248
>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine
Kinase Domain
pdb|2IVS|B Chain B, Crystal Structure Of Non-Phosphorylated Ret Tyrosine
Kinase Domain
Length = 314
Score = 45.8 bits (107), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 42/178 (23%), Positives = 74/178 (41%), Gaps = 57/178 (32%)
Query: 412 REFKNEVFVISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLK-------- 463
R+ +E V+ Q +H ++++L G C + LL+ E+ G+L FL + K
Sbjct: 71 RDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGS 130
Query: 464 -----------PSWNLRT-----NIAFQIARGLLYL------HEDCSSQIILYS------ 495
P T + A+QI++G+ YL H D +++ IL +
Sbjct: 131 GGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMK 190
Query: 496 ----------------YKRTEGYVAPEWFRNSTI-----TAKVDVYSFGFLLLEIISC 532
KR++G + +W ++ T + DV+SFG LL EI++
Sbjct: 191 ISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTL 248
>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A
Methanesulfonamide Diaminopyrimidine Inhibitor
Length = 276
Score = 45.8 bits (107), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 62/247 (25%), Positives = 100/247 (40%), Gaps = 61/247 (24%)
Query: 376 VGRGSFGIVYKGVIQTTRQVLLQLQSRNWI-VFQDGERE-FKNEVFVISQTHHKNLVRLL 433
+G G FG V++G+ + L + + D RE F E + Q H ++V+L+
Sbjct: 15 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 434 GFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI--AFQIARGLLYL------HE 485
G E ++ E G L SFL K S +L + I A+Q++ L YL H
Sbjct: 75 GVITEN-PVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKRFVHR 132
Query: 486 DCSSQIILYS---------------------YKRTEGYVAPEWFRNSTI-----TAKVDV 519
D +++ +L S YK ++G + +W +I T+ DV
Sbjct: 133 DIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDV 192
Query: 520 YSFGFLLLEII-SCRKSFD----------IEMGEE-----------YAILTD-WAFDCYR 556
+ FG + EI+ K F IE GE Y+++T WA+D R
Sbjct: 193 WMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSR 252
Query: 557 NGKLDDL 563
+ +L
Sbjct: 253 RPRFTEL 259
>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And
Kinase Domains Of Focal Adhesion Kinase.
pdb|2JKQ|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
Length = 276
Score = 45.8 bits (107), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 62/247 (25%), Positives = 100/247 (40%), Gaps = 61/247 (24%)
Query: 376 VGRGSFGIVYKGVIQTTRQVLLQLQSRNWI-VFQDGERE-FKNEVFVISQTHHKNLVRLL 433
+G G FG V++G+ + L + + D RE F E + Q H ++V+L+
Sbjct: 18 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 434 GFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI--AFQIARGLLYL------HE 485
G E ++ E G L SFL K S +L + I A+Q++ L YL H
Sbjct: 78 GVITEN-PVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKRFVHR 135
Query: 486 DCSSQIILYS---------------------YKRTEGYVAPEWFRNSTI-----TAKVDV 519
D +++ +L S YK ++G + +W +I T+ DV
Sbjct: 136 DIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDV 195
Query: 520 YSFGFLLLEII-SCRKSFD----------IEMGEE-----------YAILTD-WAFDCYR 556
+ FG + EI+ K F IE GE Y+++T WA+D R
Sbjct: 196 WMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSR 255
Query: 557 NGKLDDL 563
+ +L
Sbjct: 256 RPRFTEL 262
>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
pdb|3GQL|B Chain B, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
pdb|3GQL|C Chain C, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
Length = 326
Score = 45.4 bits (106), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 40/155 (25%), Positives = 64/155 (41%), Gaps = 49/155 (31%)
Query: 426 HKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGN--------LKPSWNLRTNI----- 472
HKN++ LLG C + ++ E+ + G L +L PS N +
Sbjct: 93 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDL 152
Query: 473 ---AFQIARGLLYL------HEDCSSQIILYS---------------------YKRTEG- 501
A+Q+ARG+ YL H D +++ +L + YK+T
Sbjct: 153 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 502 -----YVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
++APE + T + DV+SFG LL EI +
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247
>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549h Mutation Responsible For
Crouzon Syndrome.
pdb|2PWL|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549h Mutation Responsible For
Crouzon Syndrome
Length = 324
Score = 45.4 bits (106), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 37/155 (23%), Positives = 62/155 (40%), Gaps = 49/155 (31%)
Query: 426 HKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI------------- 472
HKN++ LLG C + ++ E+ + G L +L P +I
Sbjct: 100 HKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 473 ---AFQIARGLLYL------HEDCSSQIILYS---------------------YKRTEG- 501
+Q+ARG+ YL H D +++ +L + YK+T
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 502 -----YVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
++APE + T + DV+SFG L+ EI +
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine
pdb|2R3Q|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3M|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3I|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3N|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3O|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3P|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3K|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3J|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3L|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|1W8C|A Chain A, Co-crystal Structure Of
6-cyclohexylmethoxy-8-isopropyl-9h- Purin-2-ylamine And
Monomeric Cdk2
Length = 299
Score = 45.4 bits (106), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 54/217 (24%), Positives = 92/217 (42%), Gaps = 43/217 (19%)
Query: 370 DNFK--EEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHK 427
+NF+ E++G G++G+VYK + T +V+ + R + E+ ++ + +H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 428 NLVRLLGFCDEGLNRLLVYEFLNNGTL----ASFLFGNLKPSWNLRTNIAFQIARGLLY- 482
N+V+LL LV+EFL+ AS L G P L + FQ+ +GL +
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFC 119
Query: 483 -----LHEDCSSQIIL-----------YSYKRTEGY--------VAPEWFRNSTI----- 513
LH D Q +L + R G V W+R I
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXK 179
Query: 514 --TAKVDVYSFGFLLLEIISCRKSF--DIEMGEEYAI 546
+ VD++S G + E+++ R F D E+ + + I
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 216
>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
pdb|4EOJ|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
Length = 302
Score = 45.4 bits (106), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 54/219 (24%), Positives = 93/219 (42%), Gaps = 43/219 (19%)
Query: 368 ATDNFK--EEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTH 425
+ +NF+ E++G G++G+VYK + T +V+ + R + E+ ++ + +
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 426 HKNLVRLLGFCDEGLNRLLVYEFLNNGTL----ASFLFGNLKPSWNLRTNIAFQIARGLL 481
H N+V+LL LV+EFL+ AS L G P L + FQ+ +GL
Sbjct: 64 HPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLP---LIKSYLFQLLQGLA 120
Query: 482 Y------LHEDCSSQIIL-----------YSYKRTEGY--------VAPEWFRNSTI--- 513
+ LH D Q +L + R G V W+R I
Sbjct: 121 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 180
Query: 514 ----TAKVDVYSFGFLLLEIISCRKSF--DIEMGEEYAI 546
+ VD++S G + E+++ R F D E+ + + I
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 219
>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3EYH|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 290
Score = 45.4 bits (106), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 40/157 (25%), Positives = 66/157 (42%), Gaps = 39/157 (24%)
Query: 413 EFKNEVFVISQTHHKNLVRLLGFCDE--GLNRLLVYEFLNNGTLASFLFGNLKPSWNLRT 470
+ K E+ ++ +H+N+V+ G C E G L+ EFL +G+L +L N K NL+
Sbjct: 57 DLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN-KNKINLKQ 115
Query: 471 NI--AFQIARGLLYL------HEDCSSQIILYSYKRTEG--------------------- 501
+ A QI +G+ YL H D +++ +L +
Sbjct: 116 QLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKD 175
Query: 502 -------YVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
+ APE S DV+SFG L E+++
Sbjct: 176 DRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 212
>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOK|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOL|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOL|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 45.4 bits (106), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 54/219 (24%), Positives = 93/219 (42%), Gaps = 43/219 (19%)
Query: 368 ATDNFK--EEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTH 425
+ +NF+ E++G G++G+VYK + T +V+ + R + E+ ++ + +
Sbjct: 3 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 426 HKNLVRLLGFCDEGLNRLLVYEFLNNGTL----ASFLFGNLKPSWNLRTNIAFQIARGLL 481
H N+V+LL LV+EFL+ AS L G P L + FQ+ +GL
Sbjct: 63 HPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLP---LIKSYLFQLLQGLA 119
Query: 482 Y------LHEDCSSQIIL-----------YSYKRTEGY--------VAPEWFRNSTI--- 513
+ LH D Q +L + R G V W+R I
Sbjct: 120 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 179
Query: 514 ----TAKVDVYSFGFLLLEIISCRKSF--DIEMGEEYAI 546
+ VD++S G + E+++ R F D E+ + + I
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 218
>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3O8U|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 45.4 bits (106), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 49/199 (24%), Positives = 83/199 (41%), Gaps = 43/199 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
VG G++G V +T +V ++ SR + +R ++ E+ ++ H+N++ LL
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLH-- 484
+ E N+ L + L G N+ L + + +QI RGL Y+H
Sbjct: 89 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 485 ---------------EDCSSQIILYSYKR-----TEGYVAPEWFRNSTIT-------AKV 517
EDC +I+ Y R GYVA W+R I V
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTV 204
Query: 518 DVYSFGFLLLEIISCRKSF 536
D++S G ++ E+++ R F
Sbjct: 205 DIWSVGCIMAELLTGRTLF 223
>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-dependent Kinase Inhibitors Identified Through
Structure-based Hybridisation
Length = 299
Score = 45.1 bits (105), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 54/217 (24%), Positives = 92/217 (42%), Gaps = 43/217 (19%)
Query: 370 DNFK--EEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHK 427
+NF+ E++G G++G+VYK + T +V+ + R + E+ ++ + +H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 428 NLVRLLGFCDEGLNRLLVYEFLNNGTL----ASFLFGNLKPSWNLRTNIAFQIARGLLY- 482
N+V+LL LV+EFL+ AS L G P L + FQ+ +GL +
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLSFC 119
Query: 483 -----LHEDCSSQIIL-----------YSYKRTEGY--------VAPEWFRNSTI----- 513
LH D Q +L + R G V W+R I
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 179
Query: 514 --TAKVDVYSFGFLLLEIISCRKSF--DIEMGEEYAI 546
+ VD++S G + E+++ R F D E+ + + I
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 216
>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly
Mutant) In Complex With N6-Benzyl Adp
Length = 452
Score = 45.1 bits (105), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 49/191 (25%), Positives = 76/191 (39%), Gaps = 39/191 (20%)
Query: 375 EVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
++G+G FG V+ G T +V ++ + F E V+ + H+ LV+L
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYA 246
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLR--TNIAFQIARGLLYL------HED 486
E +V E+++ G+L FL G L ++A QIA G+ Y+ H D
Sbjct: 247 VVSEE-PIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 305
Query: 487 CSSQIILY--------------------SYKRTEG------YVAPEWFRNSTITAKVDVY 520
+ IL Y +G + APE T K DV+
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 365
Query: 521 SFGFLLLEIIS 531
SFG LL E+ +
Sbjct: 366 SFGILLTELTT 376
>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K526e Mutation Responsible For
Crouzon Syndrome
pdb|2PZP|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K526e Mutation Responsible For
Crouzon Syndrome
Length = 324
Score = 45.1 bits (105), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 37/155 (23%), Positives = 62/155 (40%), Gaps = 49/155 (31%)
Query: 426 HKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI------------- 472
HKN++ LLG C + ++ E+ + G L +L P +I
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 473 ---AFQIARGLLYL------HEDCSSQIILYS---------------------YKRTEG- 501
+Q+ARG+ YL H D +++ +L + YK+T
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 502 -----YVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
++APE + T + DV+SFG L+ EI +
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549t Mutation Responsible For
Pfeiffer Syndrome
pdb|2PZ5|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549t Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 45.1 bits (105), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 37/155 (23%), Positives = 62/155 (40%), Gaps = 49/155 (31%)
Query: 426 HKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI------------- 472
HKN++ LLG C + ++ E+ + G L +L P +I
Sbjct: 100 HKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 473 ---AFQIARGLLYL------HEDCSSQIILYS---------------------YKRTEG- 501
+Q+ARG+ YL H D +++ +L + YK+T
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 502 -----YVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
++APE + T + DV+SFG L+ EI +
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase
In Complex With Arq 069
pdb|3RI1|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase
In Complex With Arq 069
Length = 313
Score = 45.1 bits (105), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 37/155 (23%), Positives = 62/155 (40%), Gaps = 49/155 (31%)
Query: 426 HKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI------------- 472
HKN++ LLG C + ++ E+ + G L +L P +I
Sbjct: 89 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 148
Query: 473 ---AFQIARGLLYL------HEDCSSQIILYS---------------------YKRTEG- 501
+Q+ARG+ YL H D +++ +L + YK+T
Sbjct: 149 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 208
Query: 502 -----YVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
++APE + T + DV+SFG L+ EI +
Sbjct: 209 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243
>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp
Length = 298
Score = 45.1 bits (105), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 47/206 (22%), Positives = 86/206 (41%), Gaps = 41/206 (19%)
Query: 366 EEATDNFKEEVGRGSFGIVYKG--VIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQ 423
E + +G+G FG+VY G + Q ++ ++S + I F E ++
Sbjct: 19 ERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRG 78
Query: 424 THHKNLVRLLGFC--DEGLNRLLVYEFLNNGTLASFLFGNLK-PSWNLRTNIAFQIARGL 480
+H N++ L+G EGL +L+ ++ +G L F+ + P+ + Q+ARG+
Sbjct: 79 LNHPNVLALIGIMLPPEGLPHVLL-PYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGM 137
Query: 481 LYL------HEDCSSQIIL-----------------------YSYKRTE------GYVAP 505
YL H D +++ + YS ++ + A
Sbjct: 138 EYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTAL 197
Query: 506 EWFRNSTITAKVDVYSFGFLLLEIIS 531
E + T K DV+SFG LL E+++
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLT 223
>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K641r Mutation Responsible For
Pfeiffer Syndrome
pdb|2PZR|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K641r Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 45.1 bits (105), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 37/155 (23%), Positives = 62/155 (40%), Gaps = 49/155 (31%)
Query: 426 HKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI------------- 472
HKN++ LLG C + ++ E+ + G L +L P +I
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 473 ---AFQIARGLLYL------HEDCSSQIILYS---------------------YKRTEG- 501
+Q+ARG+ YL H D +++ +L + YK+T
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNG 219
Query: 502 -----YVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
++APE + T + DV+SFG L+ EI +
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild
Type Fgf Receptor 2 (Fgfr2) Kinase Domain
pdb|2PSQ|B Chain B, Crystal Structure Of Unphosphorylated Unactivated Wild
Type Fgf Receptor 2 (Fgfr2) Kinase Domain
Length = 370
Score = 45.1 bits (105), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 37/155 (23%), Positives = 62/155 (40%), Gaps = 49/155 (31%)
Query: 426 HKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI------------- 472
HKN++ LLG C + ++ E+ + G L +L P +I
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 473 ---AFQIARGLLYL------HEDCSSQIILYS---------------------YKRTEG- 501
+Q+ARG+ YL H D +++ +L + YK+T
Sbjct: 206 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265
Query: 502 -----YVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
++APE + T + DV+SFG L+ EI +
Sbjct: 266 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain
pdb|1OEC|A Chain A, Fgfr2 Kinase Domain
Length = 316
Score = 45.1 bits (105), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 37/155 (23%), Positives = 62/155 (40%), Gaps = 49/155 (31%)
Query: 426 HKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI------------- 472
HKN++ LLG C + ++ E+ + G L +L P +I
Sbjct: 92 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 151
Query: 473 ---AFQIARGLLYL------HEDCSSQIILYS---------------------YKRTEG- 501
+Q+ARG+ YL H D +++ +L + YK+T
Sbjct: 152 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 211
Query: 502 -----YVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
++APE + T + DV+SFG L+ EI +
Sbjct: 212 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246
>pdb|3B2T|A Chain A, Structure Of Phosphotransferase
pdb|3B2T|B Chain B, Structure Of Phosphotransferase
Length = 311
Score = 45.1 bits (105), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 37/155 (23%), Positives = 62/155 (40%), Gaps = 49/155 (31%)
Query: 426 HKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI------------- 472
HKN++ LLG C + ++ E+ + G L +L P +I
Sbjct: 87 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 146
Query: 473 ---AFQIARGLLYL------HEDCSSQIILYS---------------------YKRTEG- 501
+Q+ARG+ YL H D +++ +L + YK+T
Sbjct: 147 VSCTYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 206
Query: 502 -----YVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
++APE + T + DV+SFG L+ EI +
Sbjct: 207 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241
>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase
Kinase 5
pdb|2CLQ|B Chain B, Structure Of Mitogen-Activated Protein Kinase Kinase
Kinase 5
Length = 295
Score = 45.1 bits (105), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 55/238 (23%), Positives = 99/238 (41%), Gaps = 49/238 (20%)
Query: 350 DGTVETNLRCFSYKALEEATDNFKEEVGRGSFGIVYKG--VIQTTRQVLLQLQSRNWIVF 407
+G E++L + Y+ E + +G+G++GIVY G + R + ++ R+
Sbjct: 7 EGDCESDLLEYDYEYDENGD---RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYS 63
Query: 408 QDGEREFKNEVFVISQTHHKNLVRLLG-FCDEGLNRLLVYEFLNNGTLASFLFGNLKPSW 466
Q E+ + HKN+V+ LG F + G ++ + E + G+L++ L P
Sbjct: 64 Q----PLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFM-EQVPGGSLSALLRSKWGPLK 118
Query: 467 NLRTNIAF---QIARGLLYLHEDC-------SSQIILYSY------------KRTEG--- 501
+ I F QI GL YLH++ +++ +Y KR G
Sbjct: 119 DNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178
Query: 502 ----------YVAPEWFRNST--ITAKVDVYSFGFLLLEIISCRKSFDIEMGEEYAIL 547
Y+APE D++S G ++E+ + + F E+GE A +
Sbjct: 179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPF-YELGEPQAAM 235
>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOP|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 300
Score = 45.1 bits (105), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 53/219 (24%), Positives = 93/219 (42%), Gaps = 43/219 (19%)
Query: 368 ATDNFK--EEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTH 425
+ +NF+ E++G G++G+VYK + T +V+ + R + E+ ++ + +
Sbjct: 3 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 426 HKNLVRLLGFCDEGLNRLLVYEFLNNGTL----ASFLFGNLKPSWNLRTNIAFQIARGLL 481
H N+V+LL LV+EFL+ AS L G P L + FQ+ +GL
Sbjct: 63 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLA 119
Query: 482 Y------LHEDCSSQIIL-----------YSYKRTEGY--------VAPEWFRNSTI--- 513
+ LH D + +L + R G V W+R I
Sbjct: 120 FCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 179
Query: 514 ----TAKVDVYSFGFLLLEIISCRKSF--DIEMGEEYAI 546
+ VD++S G + E+++ R F D E+ + + I
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 218
>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70
Length = 613
Score = 45.1 bits (105), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 49/198 (24%), Positives = 85/198 (42%), Gaps = 47/198 (23%)
Query: 375 EVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGER----EFKNEVFVISQTHHKNLV 430
E+G G+FG V +GV + ++ Q+ ++ Q E+ E E ++ Q + +V
Sbjct: 343 ELGCGNFGSVRQGVYRMRKK---QIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 399
Query: 431 RLLGFCD-EGLNRLLVYEFLNNGTLASFLFGNLK--PSWNLRTNIAFQIARGLLYL---- 483
RL+G C E L +LV E G L FL G + P N+ + Q++ G+ YL
Sbjct: 400 RLIGVCQAEAL--MLVMEMAGGGPLHKFLVGKREEIPVSNV-AELLHQVSMGMKYLEEKN 456
Query: 484 --HEDCSSQIIL-----------------------YSYKRTEG-----YVAPEWFRNSTI 513
H + +++ +L Y R+ G + APE
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 516
Query: 514 TAKVDVYSFGFLLLEIIS 531
+++ DV+S+G + E +S
Sbjct: 517 SSRSDVWSYGVTMWEALS 534
>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
Length = 276
Score = 45.1 bits (105), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 61/247 (24%), Positives = 100/247 (40%), Gaps = 61/247 (24%)
Query: 376 VGRGSFGIVYKGVIQTTRQVLLQLQSRNWI-VFQDGERE-FKNEVFVISQTHHKNLVRLL 433
+G G FG V++G+ + + + + D RE F E + Q H ++V+L+
Sbjct: 18 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 434 GFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI--AFQIARGLLYL------HE 485
G E ++ E G L SFL K S +L + I A+Q++ L YL H
Sbjct: 78 GVITEN-PVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKRFVHR 135
Query: 486 DCSSQIILYS---------------------YKRTEGYVAPEWFRNSTI-----TAKVDV 519
D +++ +L S YK ++G + +W +I T+ DV
Sbjct: 136 DIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDV 195
Query: 520 YSFGFLLLEII-SCRKSFD----------IEMGEE-----------YAILTD-WAFDCYR 556
+ FG + EI+ K F IE GE Y+++T WA+D R
Sbjct: 196 WMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSR 255
Query: 557 NGKLDDL 563
+ +L
Sbjct: 256 RPRFTEL 262
>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
pdb|4EOO|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
Length = 299
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 53/219 (24%), Positives = 93/219 (42%), Gaps = 43/219 (19%)
Query: 368 ATDNFK--EEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTH 425
+ +NF+ E++G G++G+VYK + T +V+ + R + E+ ++ + +
Sbjct: 2 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 426 HKNLVRLLGFCDEGLNRLLVYEFLNNGTL----ASFLFGNLKPSWNLRTNIAFQIARGLL 481
H N+V+LL LV+EFL+ AS L G P L + FQ+ +GL
Sbjct: 62 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLA 118
Query: 482 Y------LHEDCSSQIIL-----------YSYKRTEGY--------VAPEWFRNSTI--- 513
+ LH D + +L + R G V W+R I
Sbjct: 119 FCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 178
Query: 514 ----TAKVDVYSFGFLLLEIISCRKSF--DIEMGEEYAI 546
+ VD++S G + E+++ R F D E+ + + I
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 217
>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk
Docking Partner
Length = 380
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 48/199 (24%), Positives = 83/199 (41%), Gaps = 43/199 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
VG G++G V +T +V ++ SR + +R ++ E+ ++ H+N++ LL
Sbjct: 50 VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 108
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLH-- 484
+ E N+ L + L G N+ L + + +QI RGL Y+H
Sbjct: 109 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 164
Query: 485 ---------------EDCSSQIILYSYKR-----TEGYVAPEWFRNSTIT-------AKV 517
EDC +I+ + R GYVA W+R I V
Sbjct: 165 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTV 224
Query: 518 DVYSFGFLLLEIISCRKSF 536
D++S G ++ E+++ R F
Sbjct: 225 DIWSVGCIMAELLTGRTLF 243
>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655
pdb|1P38|A Chain A, The Structure Of The Map Kinase P38 At 2.1 Angstoms
Resolution
Length = 379
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 48/199 (24%), Positives = 83/199 (41%), Gaps = 43/199 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
VG G++G V +T +V ++ SR + +R ++ E+ ++ H+N++ LL
Sbjct: 49 VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 107
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLH-- 484
+ E N+ L + L G N+ L + + +QI RGL Y+H
Sbjct: 108 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 163
Query: 485 ---------------EDCSSQIILYSYKR-----TEGYVAPEWFRNSTIT-------AKV 517
EDC +I+ + R GYVA W+R I V
Sbjct: 164 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTV 223
Query: 518 DVYSFGFLLLEIISCRKSF 536
D++S G ++ E+++ R F
Sbjct: 224 DIWSVGCIMAELLTGRTLF 242
>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In
Phosphorylated P38a And In Solution
Length = 370
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 48/199 (24%), Positives = 83/199 (41%), Gaps = 43/199 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
VG G++G V +T +V ++ SR + +R ++ E+ ++ H+N++ LL
Sbjct: 40 VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 98
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLH-- 484
+ E N+ L + L G N+ L + + +QI RGL Y+H
Sbjct: 99 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 154
Query: 485 ---------------EDCSSQIILYSYKR-----TEGYVAPEWFRNSTIT-------AKV 517
EDC +I+ + R GYVA W+R I V
Sbjct: 155 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTV 214
Query: 518 DVYSFGFLLLEIISCRKSF 536
D++S G ++ E+++ R F
Sbjct: 215 DIWSVGCIMAELLTGRTLF 233
>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain
pdb|1YOJ|B Chain B, Crystal Structure Of Src Kinase Domain
pdb|1YOM|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Purvalanol A
pdb|1YOM|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Purvalanol A
Length = 283
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 48/191 (25%), Positives = 76/191 (39%), Gaps = 39/191 (20%)
Query: 375 EVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
++G+G FG V+ G T +V ++ + F E V+ + H+ LV+L
Sbjct: 22 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYA 77
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLR--TNIAFQIARGLL------YLHED 486
E +V E++N G+L FL G L +++ QIA G+ Y+H D
Sbjct: 78 VVSEE-PIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYVHRD 136
Query: 487 CSSQIILY--------------------SYKRTEG------YVAPEWFRNSTITAKVDVY 520
+ IL + +G + APE T K DV+
Sbjct: 137 LRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGRFTIKSDVW 196
Query: 521 SFGFLLLEIIS 531
SFG LL E+ +
Sbjct: 197 SFGILLTELTT 207
>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOI|C Chain C, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 299
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 53/219 (24%), Positives = 93/219 (42%), Gaps = 43/219 (19%)
Query: 368 ATDNFK--EEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTH 425
+ +NF+ E++G G++G+VYK + T +V+ + R + E+ ++ + +
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 426 HKNLVRLLGFCDEGLNRLLVYEFLNNGTL----ASFLFGNLKPSWNLRTNIAFQIARGLL 481
H N+V+LL LV+EFL+ AS L G P L + FQ+ +GL
Sbjct: 61 HPNIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLP---LIKSYLFQLLQGLA 117
Query: 482 Y------LHEDCSSQIIL-----------YSYKRTEGY--------VAPEWFRNSTI--- 513
+ LH D + +L + R G V W+R I
Sbjct: 118 FCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 177
Query: 514 ----TAKVDVYSFGFLLLEIISCRKSF--DIEMGEEYAI 546
+ VD++S G + E+++ R F D E+ + + I
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 216
>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With
Inhibitor Pg-892579
pdb|2GTN|A Chain A, Mutated Map Kinase P38 (mus Musculus) In Complex With
Inhbitor Pg-951717
Length = 348
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 48/199 (24%), Positives = 83/199 (41%), Gaps = 43/199 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
VG G++G V +T +V ++ SR + +R ++ E+ ++ H+N++ LL
Sbjct: 26 VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 84
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLH-- 484
+ E N+ L + L G N+ L + + +QI RGL Y+H
Sbjct: 85 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 140
Query: 485 ---------------EDCSSQIILYSYKR-----TEGYVAPEWFRNSTIT-------AKV 517
EDC +I+ + R GYVA W+R I V
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTV 200
Query: 518 DVYSFGFLLLEIISCRKSF 536
D++S G ++ E+++ R F
Sbjct: 201 DIWSVGCIMAELLTGRTLF 219
>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P-
Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl-
Pyridin-3-Yl)naphthalen-1-Yl]urea
pdb|3CTQ|A Chain A, Structure Of Map Kinase P38 In Complex With A
1-O-Tolyl-1,2, 3-Triazole-4-Carboxamide
Length = 348
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 48/199 (24%), Positives = 83/199 (41%), Gaps = 43/199 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
VG G++G V +T +V ++ SR + +R ++ E+ ++ H+N++ LL
Sbjct: 26 VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 84
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLH-- 484
+ E N+ L + L G N+ L + + +QI RGL Y+H
Sbjct: 85 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQILRGLKYIHSA 140
Query: 485 ---------------EDCSSQIILYSYKR-----TEGYVAPEWFRNSTIT-------AKV 517
EDC +I+ + R GYVA W+R I V
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTV 200
Query: 518 DVYSFGFLLLEIISCRKSF 536
D++S G ++ E+++ R F
Sbjct: 201 DIWSVGCIMAELLTGRTLF 219
>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The
Docking Site On Its Nuclear Substrate Mef2a
pdb|1LEZ|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The
Docking Site On Its Activator Mkk3b
Length = 360
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 48/199 (24%), Positives = 83/199 (41%), Gaps = 43/199 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
VG G++G V +T +V ++ SR + +R ++ E+ ++ H+N++ LL
Sbjct: 30 VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLH-- 484
+ E N+ L + L G N+ L + + +QI RGL Y+H
Sbjct: 89 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 485 ---------------EDCSSQIILYSYKR-----TEGYVAPEWFRNSTIT-------AKV 517
EDC +I+ + R GYVA W+R I V
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTV 204
Query: 518 DVYSFGFLLLEIISCRKSF 536
D++S G ++ E+++ R F
Sbjct: 205 DIWSVGCIMAELLTGRTLF 223
>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
pdb|2JKO|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
Length = 276
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 61/247 (24%), Positives = 100/247 (40%), Gaps = 61/247 (24%)
Query: 376 VGRGSFGIVYKGVIQTTRQVLLQLQSRNWI-VFQDGERE-FKNEVFVISQTHHKNLVRLL 433
+G G FG V++G+ + + + + D RE F E + Q H ++V+L+
Sbjct: 18 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 434 GFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI--AFQIARGLLYL------HE 485
G E ++ E G L SFL K S +L + I A+Q++ L YL H
Sbjct: 78 GVITEN-PVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESKRFVHR 135
Query: 486 DCSSQIILYS---------------------YKRTEGYVAPEWFRNSTI-----TAKVDV 519
D +++ +L S YK ++G + +W +I T+ DV
Sbjct: 136 DIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDV 195
Query: 520 YSFGFLLLEII-SCRKSFD----------IEMGEE-----------YAILTD-WAFDCYR 556
+ FG + EI+ K F IE GE Y+++T WA+D R
Sbjct: 196 WMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSR 255
Query: 557 NGKLDDL 563
+ +L
Sbjct: 256 RPRFTEL 262
>pdb|2OZA|B Chain B, Structure Of P38alpha Complex
pdb|3P78|A Chain A, P38 Inhibitor-Bound
pdb|3P79|A Chain A, P38 Inhibitor-Bound
pdb|3P7A|A Chain A, P38 Inhibitor-Bound
pdb|3P7B|A Chain A, P38 Inhibitor-Bound
pdb|3P7C|A Chain A, P38 Inhibitor-Bound
pdb|3P5K|A Chain A, P38 Inhibitor-Bound
Length = 366
Score = 44.7 bits (104), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 48/199 (24%), Positives = 83/199 (41%), Gaps = 43/199 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
VG G++G V +T +V ++ SR + +R ++ E+ ++ H+N++ LL
Sbjct: 36 VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 94
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLH-- 484
+ E N+ L + L G N+ L + + +QI RGL Y+H
Sbjct: 95 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 150
Query: 485 ---------------EDCSSQIILYSYKR-----TEGYVAPEWFRNSTIT-------AKV 517
EDC +I+ + R GYVA W+R I V
Sbjct: 151 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTV 210
Query: 518 DVYSFGFLLLEIISCRKSF 536
D++S G ++ E+++ R F
Sbjct: 211 DIWSVGCIMAELLTGRTLF 229
>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
Length = 326
Score = 44.7 bits (104), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 40/155 (25%), Positives = 64/155 (41%), Gaps = 49/155 (31%)
Query: 426 HKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFG--------NLKPSWNLRTNI----- 472
HKN++ LLG C + ++ E+ + G L +L + PS N +
Sbjct: 93 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDL 152
Query: 473 ---AFQIARGLLYL------HEDCSSQIILYS----------------------YKRTEG 501
A+Q+ARG+ YL H D +++ +L + K T G
Sbjct: 153 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 502 -----YVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
++APE + T + DV+SFG LL EI +
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247
>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r
In Complex With Dasatinib
Length = 265
Score = 44.3 bits (103), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 44/198 (22%), Positives = 81/198 (40%), Gaps = 39/198 (19%)
Query: 371 NFKEEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLV 430
F +E+G G FG+V G + V +++ + E EF E V+ H+ LV
Sbjct: 12 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHEKLV 67
Query: 431 RLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI--------AFQIARGLLY 482
+L G C + ++ E++ NG L ++L ++ + + + A + +
Sbjct: 68 QLYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLESKQF 126
Query: 483 LHEDCSSQIILYS--------------------YKRTEG------YVAPEWFRNSTITAK 516
LH D +++ L + Y + G + PE S ++K
Sbjct: 127 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMYSKFSSK 186
Query: 517 VDVYSFGFLLLEIISCRK 534
D+++FG L+ EI S K
Sbjct: 187 SDIWAFGVLMWEIYSLGK 204
>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer
Length = 319
Score = 44.3 bits (103), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 33/113 (29%), Positives = 52/113 (46%), Gaps = 6/113 (5%)
Query: 374 EEVGRGSFGIVYKGVIQTTRQV-LLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRL 432
E +G+G FG VY G + L+ ++ N +D + FK EV QT H+N+V
Sbjct: 39 ELIGKGRFGQVYHGRWHGEVAIRLIDIERDN----EDQLKAFKREVMAYRQTRHENVVLF 94
Query: 433 LGFCDEGLNRLLVYEFLNNGTLASFLF-GNLKPSWNLRTNIAFQIARGLLYLH 484
+G C + ++ TL S + + N IA +I +G+ YLH
Sbjct: 95 MGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH 147
>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo
Form)
pdb|4FVQ|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain
(Mg-Atp-Bound Form)
Length = 289
Score = 44.3 bits (103), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 40/144 (27%), Positives = 66/144 (45%), Gaps = 31/144 (21%)
Query: 372 FKEEVGRGSFGIVYKGVIQTT--------RQVLLQLQSRNWIVFQDGEREFKNEVF---- 419
F E +G+G+F ++KGV + +VLL+ V R + F
Sbjct: 12 FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLK-------VLDKAHRNYSESFFEAAS 64
Query: 420 VISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGN---LKPSWNLRTNIAFQI 476
++S+ HK+LV G C G +LV EF+ G+L ++L N + W L +A Q+
Sbjct: 65 MMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLE--VAKQL 122
Query: 477 ARGLLYLHED-------CSSQIIL 493
A + +L E+ C+ I+L
Sbjct: 123 AAAMHFLEENTLIHGNVCAKNILL 146
>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex
With Amp-Pnp
pdb|3LMG|B Chain B, Crystal Structure Of The Erbb3 Kinase Domain In Complex
With Amp-Pnp
Length = 344
Score = 44.3 bits (103), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 37/116 (31%), Positives = 55/116 (47%), Gaps = 9/116 (7%)
Query: 376 VGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFK---NEVFVISQTHHKNLVRL 432
+G G FG V+KGV + + I + G + F+ + + I H ++VRL
Sbjct: 39 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 98
Query: 433 LGFCDEGLNRLLVYEFLNNGTLASFL---FGNLKPSWNLRTNIAFQIARGLLYLHE 485
LG C G + LV ++L G+L + G L P L N QIA+G+ YL E
Sbjct: 99 LGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGP--QLLLNWGVQIAKGMYYLEE 151
>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2
With A [1, 3]thiazolo[5,4-B]pyridine Derivative
Length = 318
Score = 44.3 bits (103), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 55/211 (26%), Positives = 86/211 (40%), Gaps = 55/211 (26%)
Query: 376 VGRGSFGIVYK----GVIQTTRQVLLQLQSRNWIVFQDGEREFKNEV-FVISQTHHKNLV 430
+GRG+FG V + G+ +T + ++ R +E+ +I HH N+V
Sbjct: 37 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 431 RLLGFCDE-GLNRLLVYEFLNNGTLASFLFGN--------------LKPSWNLRTNI--A 473
LLG C + G +++ EF G L+++L K L I +
Sbjct: 97 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYS 156
Query: 474 FQIARGLLYL------HEDCSSQIILYSYK---------------RTEGYV--------- 503
FQ+A+G+ +L H D +++ IL S K + YV
Sbjct: 157 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 216
Query: 504 ---APEWFRNSTITAKVDVYSFGFLLLEIIS 531
APE + T + DV+SFG LL EI S
Sbjct: 217 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 247
>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine
Kinase Bound To A Pyrrolopyrimidine-Containing Compound
Length = 283
Score = 44.3 bits (103), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 44/198 (22%), Positives = 81/198 (40%), Gaps = 39/198 (19%)
Query: 371 NFKEEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLV 430
F +E+G G FG+V G + V +++ + E EF E V+ H+ LV
Sbjct: 27 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHEKLV 82
Query: 431 RLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI--------AFQIARGLLY 482
+L G C + ++ E++ NG L ++L ++ + + + A + +
Sbjct: 83 QLYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLESKQF 141
Query: 483 LHEDCSSQIILYS--------------------YKRTEG------YVAPEWFRNSTITAK 516
LH D +++ L + Y + G + PE S ++K
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 201
Query: 517 VDVYSFGFLLLEIISCRK 534
D+++FG L+ EI S K
Sbjct: 202 SDIWAFGVLMWEIYSLGK 219
>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl
Amide Inhibitor
Length = 360
Score = 44.3 bits (103), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 48/199 (24%), Positives = 83/199 (41%), Gaps = 43/199 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
VG G++G V +T +V ++ SR + +R ++ E+ ++ H+N++ LL
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLH-- 484
+ E N+ L + L G N+ L + + +QI RGL Y+H
Sbjct: 89 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 485 ---------------EDCSSQIILYSYKR-----TEGYVAPEWFRNSTIT-------AKV 517
EDC +I+ + R GYVA W+R I V
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTV 204
Query: 518 DVYSFGFLLLEIISCRKSF 536
D++S G ++ E+++ R F
Sbjct: 205 DIWSVGCIMAELLTGRTLF 223
>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase
1)
Length = 294
Score = 44.3 bits (103), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 46/190 (24%), Positives = 79/190 (41%), Gaps = 39/190 (20%)
Query: 374 EEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLL 433
+ +G+GSFG VYKG+ T++V+ ++ + +D + + E+ V+SQ + R
Sbjct: 25 DRIGKGSFGEVYKGIDNHTKEVV-AIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYF 83
Query: 434 GFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF---QIARGLLYLHED---- 486
G + ++ E+L G+ L KP T IA +I +GL YLH +
Sbjct: 84 GSYLKSTKLWIIMEYLGGGSALDLL----KPGPLEETYIATILREILKGLDYLHSERKIH 139
Query: 487 ----------------------CSSQIILYSYKR-----TEGYVAPEWFRNSTITAKVDV 519
+ Q+ KR T ++APE + S K D+
Sbjct: 140 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDFKADI 199
Query: 520 YSFGFLLLEI 529
+S G +E+
Sbjct: 200 WSLGITAIEL 209
>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In
Complex With P38 Map Kinase
Length = 360
Score = 44.3 bits (103), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 49/199 (24%), Positives = 85/199 (42%), Gaps = 43/199 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
VG G++G V +T +V ++ SR + +R ++ E+ ++ H+N++ LL
Sbjct: 30 VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLH-- 484
+ E N+ L + L G N+ L + + +QI RGL Y+H
Sbjct: 89 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 485 ---------------EDCSSQII-LYSYKRTE----GYVAPEWFRNSTIT-------AKV 517
EDC +I+ Y + T+ GYVA W+R I V
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTV 204
Query: 518 DVYSFGFLLLEIISCRKSF 536
D++S G ++ E+++ R F
Sbjct: 205 DIWSVGCIMAELLTGRTLF 223
>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha
pdb|3OHT|B Chain B, Crystal Structure Of Salmo Salar P38alpha
Length = 389
Score = 44.3 bits (103), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 46/199 (23%), Positives = 84/199 (42%), Gaps = 43/199 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
VG G++G V +++ ++ ++ SR + +R ++ E+ ++ H+N++ LL
Sbjct: 59 VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 117
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLH-- 484
+ E N+ L + L G N+ L + + +QI RGL Y+H
Sbjct: 118 VFTPATS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 173
Query: 485 ---------------EDCSSQIILYSYKR-----TEGYVAPEWFRNSTIT-------AKV 517
EDC +I+ + R GYVA W+R I V
Sbjct: 174 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNMTV 233
Query: 518 DVYSFGFLLLEIISCRKSF 536
D++S G ++ E+++ R F
Sbjct: 234 DIWSVGCIMAELLTGRTLF 252
>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase
Containing The Ferm And Kinase Domains
Length = 656
Score = 44.3 bits (103), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 61/247 (24%), Positives = 100/247 (40%), Gaps = 61/247 (24%)
Query: 376 VGRGSFGIVYKGVIQTTRQVLLQLQSRNWI-VFQDGERE-FKNEVFVISQTHHKNLVRLL 433
+G G FG V++G+ + + + + D RE F E + Q H ++V+L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 434 GFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI--AFQIARGLLYL------HE 485
G E ++ E G L SFL K S +L + I A+Q++ L YL H
Sbjct: 458 GVITEN-PVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESKRFVHR 515
Query: 486 DCSSQIILYS---------------------YKRTEGYVAPEWFRNSTI-----TAKVDV 519
D +++ +L S YK ++G + +W +I T+ DV
Sbjct: 516 DIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDV 575
Query: 520 YSFGFLLLEII-SCRKSFD----------IEMGEE-----------YAILTD-WAFDCYR 556
+ FG + EI+ K F IE GE Y+++T WA+D R
Sbjct: 576 WMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSR 635
Query: 557 NGKLDDL 563
+ +L
Sbjct: 636 RPRFTEL 642
>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase
Containing The Ferm And Kinase Domains.
pdb|2J0K|B Chain B, Crystal Structure Of A Fragment Of Focal Adhesion Kinase
Containing The Ferm And Kinase Domains
Length = 656
Score = 44.3 bits (103), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 61/247 (24%), Positives = 100/247 (40%), Gaps = 61/247 (24%)
Query: 376 VGRGSFGIVYKGVIQTTRQVLLQLQSRNWI-VFQDGERE-FKNEVFVISQTHHKNLVRLL 433
+G G FG V++G+ + + + + D RE F E + Q H ++V+L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 434 GFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI--AFQIARGLLYL------HE 485
G E ++ E G L SFL K S +L + I A+Q++ L YL H
Sbjct: 458 GVITEN-PVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESKRFVHR 515
Query: 486 DCSSQIILYS---------------------YKRTEGYVAPEWFRNSTI-----TAKVDV 519
D +++ +L S YK ++G + +W +I T+ DV
Sbjct: 516 DIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDV 575
Query: 520 YSFGFLLLEII-SCRKSFD----------IEMGEE-----------YAILTD-WAFDCYR 556
+ FG + EI+ K F IE GE Y+++T WA+D R
Sbjct: 576 WMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSR 635
Query: 557 NGKLDDL 563
+ +L
Sbjct: 636 RPRFTEL 642
>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr)
Kinase Domain
Length = 316
Score = 44.3 bits (103), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 53/211 (25%), Positives = 85/211 (40%), Gaps = 55/211 (26%)
Query: 376 VGRGSFGIVYK----GVIQTTRQVLLQLQSRNWIVFQDGEREFKNEV-FVISQTHHKNLV 430
+GRG+FG V + G+ +T + ++ R +E+ +I HH N+V
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 431 RLLGFCDE-GLNRLLVYEFLNNGTLASFLFGN--------------LKPSWNLRTNI--A 473
LLG C + G +++ EF G L+++L K L I +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 474 FQIARGLLYL------HEDCSSQIILYSYKRTE--------------------------- 500
FQ+A+G+ +L H D +++ IL S K
Sbjct: 155 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARLPL 214
Query: 501 GYVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
++APE + T + DV+SFG LL EI S
Sbjct: 215 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy)
Quinolin-4-Yloxy)benzofuran-3-Carboxamide)
pdb|4AG8|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Axitinib (Ag-013736)
(N-Methyl-2-(3-((E)-2-Pyridin-2-
Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)-Benzamide)
Length = 316
Score = 44.3 bits (103), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 55/211 (26%), Positives = 86/211 (40%), Gaps = 55/211 (26%)
Query: 376 VGRGSFGIVYK----GVIQTTRQVLLQLQSRNWIVFQDGEREFKNEV-FVISQTHHKNLV 430
+GRG+FG V + G+ +T + ++ R +E+ +I HH N+V
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 431 RLLGFCDE-GLNRLLVYEFLNNGTLASFLFGN--------------LKPSWNLRTNI--A 473
LLG C + G +++ EF G L+++L K L I +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 474 FQIARGLLYL------HEDCSSQIILYSYK---------------RTEGYV--------- 503
FQ+A+G+ +L H D +++ IL S K + YV
Sbjct: 155 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 214
Query: 504 ---APEWFRNSTITAKVDVYSFGFLLLEIIS 531
APE + T + DV+SFG LL EI S
Sbjct: 215 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
pdb|4EOM|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
Length = 301
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 53/219 (24%), Positives = 93/219 (42%), Gaps = 43/219 (19%)
Query: 368 ATDNFK--EEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTH 425
+ +NF+ E++G G++G+VYK + T +V+ + R + E+ ++ + +
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 426 HKNLVRLLGFCDEGLNRLLVYEFLNNGTL----ASFLFGNLKPSWNLRTNIAFQIARGLL 481
H N+V+LL LV+EFL+ AS L G P L + FQ+ +GL
Sbjct: 64 HPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLP---LIKSYLFQLLQGLA 120
Query: 482 Y------LHEDCSSQIIL-----------YSYKRTEGY--------VAPEWFRNSTI--- 513
+ LH D + +L + R G V W+R I
Sbjct: 121 FCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 180
Query: 514 ----TAKVDVYSFGFLLLEIISCRKSF--DIEMGEEYAI 546
+ VD++S G + E+++ R F D E+ + + I
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 219
>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase
Domain Of The Human Epidermal Growth Factor Receptor 3
(Her3)
pdb|3KEX|B Chain B, Crystal Structure Of The Catalytically Inactive Kinase
Domain Of The Human Epidermal Growth Factor Receptor 3
(Her3)
Length = 325
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 37/116 (31%), Positives = 55/116 (47%), Gaps = 9/116 (7%)
Query: 376 VGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFK---NEVFVISQTHHKNLVRL 432
+G G FG V+KGV + + I + G + F+ + + I H ++VRL
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 433 LGFCDEGLNRLLVYEFLNNGTLASFL---FGNLKPSWNLRTNIAFQIARGLLYLHE 485
LG C G + LV ++L G+L + G L P L N QIA+G+ YL E
Sbjct: 81 LGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGP--QLLLNWGVQIAKGMYYLEE 133
>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase
Length = 362
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 48/199 (24%), Positives = 83/199 (41%), Gaps = 43/199 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
VG G++G V +T +V ++ SR + +R ++ E+ ++ H+N++ LL
Sbjct: 32 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 90
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLH-- 484
+ E N+ L + L G N+ L + + +QI RGL Y+H
Sbjct: 91 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 146
Query: 485 ---------------EDCSSQIILYSYKR-----TEGYVAPEWFRNSTIT-------AKV 517
EDC +I+ + R GYVA W+R I V
Sbjct: 147 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTV 206
Query: 518 DVYSFGFLLLEIISCRKSF 536
D++S G ++ E+++ R F
Sbjct: 207 DIWSVGCIMAELLTGRTLF 225
>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel
4-amino-furo[2,3-d]pyrimidine
Length = 316
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 53/211 (25%), Positives = 85/211 (40%), Gaps = 55/211 (26%)
Query: 376 VGRGSFGIVYK----GVIQTTRQVLLQLQSRNWIVFQDGEREFKNEV-FVISQTHHKNLV 430
+GRG+FG V + G+ +T + ++ R +E+ +I HH N+V
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 431 RLLGFCDE-GLNRLLVYEFLNNGTLASFLFGN--------------LKPSWNLRTNI--A 473
LLG C + G +++ EF G L+++L K L I +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 474 FQIARGLLYL------HEDCSSQIILYSYKRTE--------------------------- 500
FQ+A+G+ +L H D +++ IL S K
Sbjct: 155 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPL 214
Query: 501 GYVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
++APE + T + DV+SFG LL EI S
Sbjct: 215 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase
Length = 360
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 48/199 (24%), Positives = 83/199 (41%), Gaps = 43/199 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
VG G++G V +T +V ++ SR + +R ++ E+ ++ H+N++ LL
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLH-- 484
+ E N+ L + L G N+ L + + +QI RGL Y+H
Sbjct: 89 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 485 ---------------EDCSSQIILYSYKR-----TEGYVAPEWFRNSTIT-------AKV 517
EDC +I+ + R GYVA W+R I V
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNAMHYNQTV 204
Query: 518 DVYSFGFLLLEIISCRKSF 536
D++S G ++ E+++ R F
Sbjct: 205 DIWSVGCIMAELLTGRTLF 223
>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955
Length = 350
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 48/199 (24%), Positives = 83/199 (41%), Gaps = 43/199 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
VG G++G V +T +V ++ SR + +R ++ E+ ++ H+N++ LL
Sbjct: 28 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 86
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLH-- 484
+ E N+ L + L G N+ L + + +QI RGL Y+H
Sbjct: 87 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 142
Query: 485 ---------------EDCSSQIILYSYKR-----TEGYVAPEWFRNSTIT-------AKV 517
EDC +I+ + R GYVA W+R I V
Sbjct: 143 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTV 202
Query: 518 DVYSFGFLLLEIISCRKSF 536
D++S G ++ E+++ R F
Sbjct: 203 DIWSVGCIMAELLTGRTLF 221
>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole
Inhibitor
Length = 372
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 48/199 (24%), Positives = 83/199 (41%), Gaps = 43/199 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
VG G++G V +T +V ++ SR + +R ++ E+ ++ H+N++ LL
Sbjct: 42 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 100
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLH-- 484
+ E N+ L + L G N+ L + + +QI RGL Y+H
Sbjct: 101 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 156
Query: 485 ---------------EDCSSQIILYSYKR-----TEGYVAPEWFRNSTIT-------AKV 517
EDC +I+ + R GYVA W+R I V
Sbjct: 157 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTV 216
Query: 518 DVYSFGFLLLEIISCRKSF 536
D++S G ++ E+++ R F
Sbjct: 217 DIWSVGCIMAELLTGRTLF 235
>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195
pdb|3FKL|A Chain A, P38 Kinase Crystal Structure In Complex With Ro9552
pdb|3FKN|A Chain A, P38 Kinase Crystal Structure In Complex With Ro7125
pdb|3FL4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro5634
pdb|3FLQ|A Chain A, P38 Kinase Crystal Structure In Complex With 6-(2,4-
Difluoro-Phenoxy)-2-((S)-2-Methanesulfonyl-1-Methyl-
Ethylamino)-8-Methyl-8h-Pyrido[2,3-D]pyrimidin
pdb|3FLS|A Chain A, P38 Kinase Crystal Structure In Complex With 6-(2,4-
Difluoro-Phenoxy)-2-((R)-2-Methanesulfonyl-1-Methyl-
Ethylamino)-8-Methyl-8h-Pyrido[2,3-D]pyrimidin-7-One
pdb|3FLW|A Chain A, P38 Kinase Crystal Structure In Complex With Pamapimod
pdb|3FLY|A Chain A, P38 Kinase Crystal Structure In Complex With 6-(2,4-
Difluoro-Phenoxy)-2-Isopropylamino-8-Methyl-8h-Pyrido[2,
3- D]pyrimidin-7-One
pdb|3FLZ|A Chain A, P38 Kinase Crystal Structure In Complex With
8-Methyl-6-Phenoxy-2-
(Tetrahydro-Pyran-4-Ylamino)-8h-Pyrido[2,
3-D]pyrimidin-7-One
pdb|3FMH|A Chain A, P38 Kinase Crystal Structure In Complex With
6-(2,4-Difluoro-Phenoxy)-
8-Methyl-2-((R)-1-Methyl-2-Tetrazol-2-Yl-Ethylamino)-8h-
Pyrido[2,3- D]pyrimidin-7-One
pdb|3FMJ|A Chain A, P38 Kinase Crystal Structure In Complex With
4-(5-Methyl-3-Phenyl- Isoxazol-4-Yl)-Pyrimidin-2-Ylamine
pdb|3FMK|A Chain A, P38 Kinase Crystal Structure In Complex With
6-(2,4-Difluoro-Phenoxy)-
8-Methyl-2-((S)-1-Methyl-2-Tetrazol-2-Yl-Ethylamino)-8h-
Pyrido[2,3- D]pyrimidin-7-One
pdb|3FML|A Chain A, P38 Kinase Crystal Structure In Complex With Ro6224
pdb|3FMM|A Chain A, P38 Kinase Crystal Structure In Complex With Ro6226
pdb|3FMN|A Chain A, P38 Kinase Crystal Structure In Complex With Ro2530
pdb|3FSF|A Chain A, P38 Kinase Crystal Structure In Complex With 3-(2,6-
Dichloro-Phenyl)-7-[4-(2-Diethylamino-Ethoxy)-
Phenylamino]-
1-Methyl-3,4-Dihydro-1h-Pyrimido[4,5-D]pyrimidin-2-One
pdb|3FSK|A Chain A, P38 Kinase Crystal Structure In Complex With Ro6257
Length = 372
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 48/199 (24%), Positives = 83/199 (41%), Gaps = 43/199 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
VG G++G V +T +V ++ SR + +R ++ E+ ++ H+N++ LL
Sbjct: 42 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 100
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLH-- 484
+ E N+ L + L G N+ L + + +QI RGL Y+H
Sbjct: 101 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 156
Query: 485 ---------------EDCSSQIILYSYKR-----TEGYVAPEWFRNSTIT-------AKV 517
EDC +I+ + R GYVA W+R I V
Sbjct: 157 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTV 216
Query: 518 DVYSFGFLLLEIISCRKSF 536
D++S G ++ E+++ R F
Sbjct: 217 DIWSVGCIMAELLTGRTLF 235
>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48
pdb|3GCU|B Chain B, Human P38 Map Kinase In Complex With Rl48
pdb|3HV4|A Chain A, Human P38 Map Kinase In Complex With Rl51
pdb|3HV4|B Chain B, Human P38 Map Kinase In Complex With Rl51
pdb|3HV5|A Chain A, Human P38 Map Kinase In Complex With Rl24
pdb|3HV5|B Chain B, Human P38 Map Kinase In Complex With Rl24
pdb|3HV6|A Chain A, Human P38 Map Kinase In Complex With Rl39
pdb|3HV7|A Chain A, Human P38 Map Kinase In Complex With Rl38
pdb|3HUC|A Chain A, Human P38 Map Kinase In Complex With Rl40
pdb|3LFA|A Chain A, Human P38 Map Kinase In Complex With Dasatinib
pdb|3QUE|A Chain A, Human P38 Map Kinase In Complex With Skepinone-L
pdb|3QUD|A Chain A, Human P38 Map Kinase In Complex With
2-Amino-Phenylamino-Benzophenone
pdb|3UVP|A Chain A, Human P38 Map Kinase In Complex With A Benzamide
Substituted Benzosuberone
pdb|3UVQ|A Chain A, Human P38 Map Kinase In Complex With A Dibenzosuberone
Derivative
pdb|4EH2|A Chain A, Human P38 Map Kinase In Complex With Np-F1 And Rl87
pdb|4EH3|A Chain A, Human P38 Map Kinase In Complex With Np-F2 And Rl87
pdb|4EH4|A Chain A, Human P38 Map Kinase In Complex With Np-F3 And Rl87
pdb|4EH5|A Chain A, Human P38 Map Kinase In Complex With Np-F4 And Rl87
pdb|4EH6|A Chain A, Human P38 Map Kinase In Complex With Np-F5 And Rl87
pdb|4EH7|A Chain A, Human P38 Map Kinase In Complex With Np-F6 And Rl87
pdb|4EH8|A Chain A, Human P38 Map Kinase In Complex With Np-F7 And Rl87
pdb|4EH9|A Chain A, Human P38 Map Kinase In Complex With Np-F11 And Rl87
pdb|4EHV|A Chain A, Human P38 Map Kinase In Complex With Np-F10 And Rl87
pdb|3UVR|A Chain A, Human P38 Map Kinase In Complex With Km064
pdb|4DLI|A Chain A, Human P38 Map Kinase In Complex With Rl87
pdb|4DLJ|A Chain A, Human P38 Map Kinase In Complex With Rl163
Length = 360
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 48/199 (24%), Positives = 83/199 (41%), Gaps = 43/199 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
VG G++G V +T +V ++ SR + +R ++ E+ ++ H+N++ LL
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLH-- 484
+ E N+ L + L G N+ L + + +QI RGL Y+H
Sbjct: 89 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 485 ---------------EDCSSQIILYSYKR-----TEGYVAPEWFRNSTIT-------AKV 517
EDC +I+ + R GYVA W+R I V
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTV 204
Query: 518 DVYSFGFLLLEIISCRKSF 536
D++S G ++ E+++ R F
Sbjct: 205 DIWSVGCIMAELLTGRTLF 223
>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor
Length = 383
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 48/199 (24%), Positives = 83/199 (41%), Gaps = 43/199 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
VG G++G V +T +V ++ SR + +R ++ E+ ++ H+N++ LL
Sbjct: 53 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 111
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLH-- 484
+ E N+ L + L G N+ L + + +QI RGL Y+H
Sbjct: 112 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 167
Query: 485 ---------------EDCSSQIILYSYKR-----TEGYVAPEWFRNSTIT-------AKV 517
EDC +I+ + R GYVA W+R I V
Sbjct: 168 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTV 227
Query: 518 DVYSFGFLLLEIISCRKSF 536
D++S G ++ E+++ R F
Sbjct: 228 DIWSVGCIMAELLTGRTLF 246
>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121
Length = 362
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 48/199 (24%), Positives = 83/199 (41%), Gaps = 43/199 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
VG G++G V +T +V ++ SR + +R ++ E+ ++ H+N++ LL
Sbjct: 32 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 90
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLH-- 484
+ E N+ L + L G N+ L + + +QI RGL Y+H
Sbjct: 91 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 146
Query: 485 ---------------EDCSSQIILYSYKR-----TEGYVAPEWFRNSTIT-------AKV 517
EDC +I+ + R GYVA W+R I V
Sbjct: 147 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTV 206
Query: 518 DVYSFGFLLLEIISCRKSF 536
D++S G ++ E+++ R F
Sbjct: 207 DIWSVGCIMAELLTGRTLF 225
>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea
pdb|2BAK|A Chain A, P38alpha Map Kinase Bound To Mpaq
pdb|4A9Y|A Chain A, P38alpha Map Kinase Bound To Cmpd 8
pdb|4AA0|A Chain A, P38alpha Map Kinase Bound To Cmpd 2
pdb|4AA4|A Chain A, P38alpha Map Kinase Bound To Cmpd 22
pdb|4AAC|A Chain A, P38alpha Map Kinase Bound To Cmpd 29
Length = 365
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 48/199 (24%), Positives = 83/199 (41%), Gaps = 43/199 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
VG G++G V +T +V ++ SR + +R ++ E+ ++ H+N++ LL
Sbjct: 35 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 93
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLH-- 484
+ E N+ L + L G N+ L + + +QI RGL Y+H
Sbjct: 94 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 149
Query: 485 ---------------EDCSSQIILYSYKR-----TEGYVAPEWFRNSTIT-------AKV 517
EDC +I+ + R GYVA W+R I V
Sbjct: 150 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTV 209
Query: 518 DVYSFGFLLLEIISCRKSF 536
D++S G ++ E+++ R F
Sbjct: 210 DIWSVGCIMAELLTGRTLF 228
>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant
Length = 360
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 48/199 (24%), Positives = 83/199 (41%), Gaps = 43/199 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
VG G++G V +T +V ++ SR + +R ++ E+ ++ H+N++ LL
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLH-- 484
+ E N+ L + L G N+ L + + +QI RGL Y+H
Sbjct: 89 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 485 ---------------EDCSSQIILYSYKR-----TEGYVAPEWFRNSTIT-------AKV 517
EDC +I+ + R GYVA W+R I V
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTV 204
Query: 518 DVYSFGFLLLEIISCRKSF 536
D++S G ++ E+++ R F
Sbjct: 205 DIWSVGCIMAELLTGRTLF 223
>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|3MW1|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|2YIS|A Chain A, Triazolopyridine Inhibitors Of P38 Kinase.
pdb|2YIW|A Chain A, Triazolopyridine Inhibitors Of P38 Kinase
Length = 359
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 48/199 (24%), Positives = 83/199 (41%), Gaps = 43/199 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
VG G++G V +T +V ++ SR + +R ++ E+ ++ H+N++ LL
Sbjct: 29 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 87
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLH-- 484
+ E N+ L + L G N+ L + + +QI RGL Y+H
Sbjct: 88 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 143
Query: 485 ---------------EDCSSQIILYSYKR-----TEGYVAPEWFRNSTIT-------AKV 517
EDC +I+ + R GYVA W+R I V
Sbjct: 144 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTV 203
Query: 518 DVYSFGFLLLEIISCRKSF 536
D++S G ++ E+++ R F
Sbjct: 204 DIWSVGCIMAELLTGRTLF 222
>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995
pdb|1BL7|A Chain A, The Complex Structure Of The Map Kinase P38SB220025
pdb|2EWA|A Chain A, Dual Binding Mode Of Pyridinylimidazole To Map Kinase P38
pdb|1A9U|A Chain A, The Complex Structure Of The Map Kinase P38SB203580
pdb|3HA8|A Chain A, The Complex Structure Of The Map Kinase P38COMPOUND 14B
Length = 379
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 48/199 (24%), Positives = 83/199 (41%), Gaps = 43/199 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
VG G++G V +T +V ++ SR + +R ++ E+ ++ H+N++ LL
Sbjct: 49 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 107
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLH-- 484
+ E N+ L + L G N+ L + + +QI RGL Y+H
Sbjct: 108 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 163
Query: 485 ---------------EDCSSQIILYSYKR-----TEGYVAPEWFRNSTIT-------AKV 517
EDC +I+ + R GYVA W+R I V
Sbjct: 164 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTV 223
Query: 518 DVYSFGFLLLEIISCRKSF 536
D++S G ++ E+++ R F
Sbjct: 224 DIWSVGCIMAELLTGRTLF 242
>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1-
Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3-
Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide
Length = 380
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 48/199 (24%), Positives = 83/199 (41%), Gaps = 43/199 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
VG G++G V +T +V ++ SR + +R ++ E+ ++ H+N++ LL
Sbjct: 50 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 108
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLH-- 484
+ E N+ L + L G N+ L + + +QI RGL Y+H
Sbjct: 109 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 164
Query: 485 ---------------EDCSSQIILYSYKR-----TEGYVAPEWFRNSTIT-------AKV 517
EDC +I+ + R GYVA W+R I V
Sbjct: 165 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTV 224
Query: 518 DVYSFGFLLLEIISCRKSF 536
D++S G ++ E+++ R F
Sbjct: 225 DIWSVGCIMAELLTGRTLF 243
>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715
pdb|3ZSH|A Chain A, X-Ray Structure Of P38alpha Bound To Scio-469
pdb|3ZSI|A Chain A, X-Ray Structure Of P38alpha Bound To Vx-745
pdb|3ZS5|A Chain A, Structural Basis For Kinase Selectivity Of Three Clinical
P38alpha Inhibitors
Length = 362
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 48/199 (24%), Positives = 83/199 (41%), Gaps = 43/199 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
VG G++G V +T +V ++ SR + +R ++ E+ ++ H+N++ LL
Sbjct: 32 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 90
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLH-- 484
+ E N+ L + L G N+ L + + +QI RGL Y+H
Sbjct: 91 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 146
Query: 485 ---------------EDCSSQIILYSYKR-----TEGYVAPEWFRNSTIT-------AKV 517
EDC +I+ + R GYVA W+R I V
Sbjct: 147 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTV 206
Query: 518 DVYSFGFLLLEIISCRKSF 536
D++S G ++ E+++ R F
Sbjct: 207 DIWSVGCIMAELLTGRTLF 225
>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A
Pyrrole-2- Carboxamide Inhibitor
Length = 371
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 48/199 (24%), Positives = 83/199 (41%), Gaps = 43/199 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
VG G++G V +T +V ++ SR + +R ++ E+ ++ H+N++ LL
Sbjct: 41 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 99
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLH-- 484
+ E N+ L + L G N+ L + + +QI RGL Y+H
Sbjct: 100 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 155
Query: 485 ---------------EDCSSQIILYSYKR-----TEGYVAPEWFRNSTIT-------AKV 517
EDC +I+ + R GYVA W+R I V
Sbjct: 156 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTV 215
Query: 518 DVYSFGFLLLEIISCRKSF 536
D++S G ++ E+++ R F
Sbjct: 216 DIWSVGCIMAELLTGRTLF 234
>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase
Length = 367
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 48/199 (24%), Positives = 83/199 (41%), Gaps = 43/199 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
VG G++G V +T +V ++ SR + +R ++ E+ ++ H+N++ LL
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 95
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLH-- 484
+ E N+ L + L G N+ L + + +QI RGL Y+H
Sbjct: 96 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 151
Query: 485 ---------------EDCSSQIILYSYKR-----TEGYVAPEWFRNSTIT-------AKV 517
EDC +I+ + R GYVA W+R I V
Sbjct: 152 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTV 211
Query: 518 DVYSFGFLLLEIISCRKSF 536
D++S G ++ E+++ R F
Sbjct: 212 DIWSVGCIMAELLTGRTLF 230
>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EON|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 53/219 (24%), Positives = 93/219 (42%), Gaps = 43/219 (19%)
Query: 368 ATDNFK--EEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTH 425
+ +NF+ E++G G++G+VYK + T +V+ + R + E+ ++ + +
Sbjct: 2 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 426 HKNLVRLLGFCDEGLNRLLVYEFLNNGTL----ASFLFGNLKPSWNLRTNIAFQIARGLL 481
H N+V+LL LV+EFL+ AS L G P L + FQ+ +GL
Sbjct: 62 HPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLP---LIKSYLFQLLQGLA 118
Query: 482 Y------LHEDCSSQIIL-----------YSYKRTEGY--------VAPEWFRNSTI--- 513
+ LH D + +L + R G V W+R I
Sbjct: 119 FCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 178
Query: 514 ----TAKVDVYSFGFLLLEIISCRKSF--DIEMGEEYAI 546
+ VD++S G + E+++ R F D E+ + + I
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 217
>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based
Inhibitor
Length = 383
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 48/199 (24%), Positives = 83/199 (41%), Gaps = 43/199 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
VG G++G V +T +V ++ SR + +R ++ E+ ++ H+N++ LL
Sbjct: 53 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 111
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLH-- 484
+ E N+ L + L G N+ L + + +QI RGL Y+H
Sbjct: 112 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 167
Query: 485 ---------------EDCSSQIILYSYKR-----TEGYVAPEWFRNSTIT-------AKV 517
EDC +I+ + R GYVA W+R I V
Sbjct: 168 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGYVATRWYRAPEIMLNWMHYNQTV 227
Query: 518 DVYSFGFLLLEIISCRKSF 536
D++S G ++ E+++ R F
Sbjct: 228 DIWSVGCIMAELLTGRTLF 246
>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a)
Activating Mutant
Length = 367
Score = 43.9 bits (102), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 48/199 (24%), Positives = 83/199 (41%), Gaps = 43/199 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
VG G++G V +T +V ++ SR + +R ++ E+ ++ H+N++ LL
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 95
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLH-- 484
+ E N+ L + L G N+ L + + +QI RGL Y+H
Sbjct: 96 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 151
Query: 485 ---------------EDCSSQIILYSYKR-----TEGYVAPEWFRNSTIT-------AKV 517
EDC +I+ + R GYVA W+R I V
Sbjct: 152 DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRWYRAPEIMLNWMHYNQTV 211
Query: 518 DVYSFGFLLLEIISCRKSF 536
D++S G ++ E+++ R F
Sbjct: 212 DIWSVGCIMAELLTGRTLF 230
>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine
pdb|2YIX|A Chain A, Triazolopyridine Inhibitors Of P38
Length = 351
Score = 43.9 bits (102), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 48/199 (24%), Positives = 83/199 (41%), Gaps = 43/199 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
VG G++G V +T +V ++ SR + +R ++ E+ ++ H+N++ LL
Sbjct: 27 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 85
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLH-- 484
+ E N+ L + L G N+ L + + +QI RGL Y+H
Sbjct: 86 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 141
Query: 485 ---------------EDCSSQIILYSYKR-----TEGYVAPEWFRNSTIT-------AKV 517
EDC +I+ + R GYVA W+R I V
Sbjct: 142 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTV 201
Query: 518 DVYSFGFLLLEIISCRKSF 536
D++S G ++ E+++ R F
Sbjct: 202 DIWSVGCIMAELLTGRTLF 220
>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating
Kinase 1 (Ask1) With Imidazopyridine Inhibitor
pdb|3VW6|B Chain B, Crystal Structure Of Human Apoptosis Signal-Regulating
Kinase 1 (Ask1) With Imidazopyridine Inhibitor
Length = 269
Score = 43.9 bits (102), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 50/212 (23%), Positives = 88/212 (41%), Gaps = 46/212 (21%)
Query: 376 VGRGSFGIVYKG--VIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLL 433
+G+G++GIVY G + R + ++ R+ Q E+ + HKN+V+ L
Sbjct: 16 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQ----PLHEEIALHKHLKHKNIVQYL 71
Query: 434 G-FCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF---QIARGLLYLHEDC-- 487
G F + G ++ + E + G+L++ L P + I F QI GL YLH++
Sbjct: 72 GSFSENGFIKIFM-EQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIV 130
Query: 488 -----SSQIILYSY------------KRTEG-------------YVAPEWFRNST--ITA 515
+++ +Y KR G Y+APE
Sbjct: 131 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGK 190
Query: 516 KVDVYSFGFLLLEIISCRKSFDIEMGEEYAIL 547
D++S G ++E+ + + F E+GE A +
Sbjct: 191 AADIWSLGCTIIEMATGKPPF-YELGEPQAAM 221
>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A
Dihydroquinazolinone Inhibitor
pdb|1OUK|A Chain A, The Structure Of P38 Alpha In Complex With A
Pyridinylimidazole Inhibitor
pdb|1OUY|A Chain A, The Structure Of P38 Alpha In Complex With A
Dihydropyrido- Pyrimidine Inhibitor
pdb|1R39|A Chain A, The Structure Of P38alpha
pdb|1YQJ|A Chain A, Crystal Structure Of P38 Alpha In Complex With A Selective
Pyridazine Inhibitor
pdb|2OKR|A Chain A, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|2OKR|D Chain D, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|2ONL|A Chain A, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|2ONL|B Chain B, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|1WFC|A Chain A, Structure Of Apo, Unphosphorylated, P38 Mitogen Activated
Protein Kinase P38 (P38 Map Kinase) The Mammalian
Homologue Of The Yeast Hog1 Protein
pdb|3DS6|A Chain A, P38 Complex With A Phthalazine Inhibitor
pdb|3DS6|B Chain B, P38 Complex With A Phthalazine Inhibitor
pdb|3DS6|C Chain C, P38 Complex With A Phthalazine Inhibitor
pdb|3DS6|D Chain D, P38 Complex With A Phthalazine Inhibitor
pdb|3FC1|X Chain X, Crystal Structure Of P38 Kinase Bound To
Pyrimido-Pyridazinone Inhibitor
pdb|3GFE|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein Kinase
In Complex With A Pyrazolopyridinone Inhibitor
pdb|3ITZ|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein Kinase
In Complex With A Pyrazolopyridazine Inhibitor
pdb|3LHJ|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein Kinase
In Complex With A Pyrazolopyridinone Inhibitor.
pdb|3ZYA|A Chain A, Human P38 Map Kinase In Complex With 2-Amino-Phenylamino-
Dibenzosuberone
pdb|3U8W|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein Kinase
In Complex With A Triazolopyridazinone Inhibitor
Length = 366
Score = 43.9 bits (102), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 48/199 (24%), Positives = 83/199 (41%), Gaps = 43/199 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
VG G++G V +T +V ++ SR + +R ++ E+ ++ H+N++ LL
Sbjct: 36 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 94
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLH-- 484
+ E N+ L + L G N+ L + + +QI RGL Y+H
Sbjct: 95 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 150
Query: 485 ---------------EDCSSQIILYSYKR-----TEGYVAPEWFRNSTIT-------AKV 517
EDC +I+ + R GYVA W+R I V
Sbjct: 151 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTV 210
Query: 518 DVYSFGFLLLEIISCRKSF 536
D++S G ++ E+++ R F
Sbjct: 211 DIWSVGCIMAELLTGRTLF 229
>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant
Length = 360
Score = 43.9 bits (102), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 48/199 (24%), Positives = 83/199 (41%), Gaps = 43/199 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
VG G++G V +T +V ++ SR + +R ++ E+ ++ H+N++ LL
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLH-- 484
+ E N+ L + L G N+ L + + +QI RGL Y+H
Sbjct: 89 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 485 ---------------EDCSSQIILYSYKR-----TEGYVAPEWFRNSTIT-------AKV 517
EDC +I+ + R GYVA W+R I V
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTV 204
Query: 518 DVYSFGFLLLEIISCRKSF 536
D++S G ++ E+++ R F
Sbjct: 205 DIWSVGCIMAELLTGRTLF 223
>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant
Length = 360
Score = 43.9 bits (102), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 48/199 (24%), Positives = 83/199 (41%), Gaps = 43/199 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
VG G++G V +T +V ++ SR + +R ++ E+ ++ H+N++ LL
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLH-- 484
+ E N+ L + L G N+ L + + +QI RGL Y+H
Sbjct: 89 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 485 ---------------EDCSSQIILYSYKR-----TEGYVAPEWFRNSTIT-------AKV 517
EDC +I+ + R GYVA W+R I V
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTV 204
Query: 518 DVYSFGFLLLEIISCRKSF 536
D++S G ++ E+++ R F
Sbjct: 205 DIWSVGCIMAELLTGRTLF 223
>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In
Complex With 4-[3-Methylsulfanylanilino]-6,7-
Dimethoxyquinazoline
pdb|1KV1|A Chain A, P38 Map Kinase In Complex With Inhibitor 1
pdb|1KV2|A Chain A, Human P38 Map Kinase In Complex With Birb 796
pdb|1WBO|A Chain A, Fragment Based P38 Inhibitors
pdb|1W7H|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1W82|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1W83|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1W84|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1ZZ2|A Chain A, Two Classes Of P38alpha Map Kinase Inhibitors Having A
Common Diphenylether Core But Exhibiting Divergent
Binding Modes
pdb|1WBN|A Chain A, Fragment Based P38 Inhibitors
pdb|1WBS|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-Based Lead Generation.
pdb|1WBT|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-based Lead Generation.
pdb|1WBV|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-Based Lead Generation.
pdb|1WBW|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-Based Lead Generation.
pdb|1ZYJ|A Chain A, Human P38 Map Kinase In Complex With Inhibitor 1a
pdb|2ZAZ|A Chain A, Crystal Structure Of P38 In Complex With 4-Anilino
Quinoline Inhibitor
pdb|2ZB0|A Chain A, Crystal Structure Of P38 In Complex With Biphenyl Amide
Inhibitor
pdb|2ZB1|A Chain A, Crystal Structure Of P38 In Complex With Biphenyl Amide
Inhibitor
pdb|3HL7|A Chain A, Crystal Structure Of Human P38alpha Complexed With Sd-0006
pdb|3HLL|A Chain A, Crystal Structure Of Human P38alpha Complexed With
Ph-797804
pdb|3HP2|A Chain A, Crystal Structure Of Human P38alpha Complexed With A
Pyridinone Compound
pdb|3HP5|A Chain A, Crystal Structure Of Human P38alpha Complexed With A
Pyrimidopyridazinone Compound
pdb|3KF7|A Chain A, Crystal Structure Of Human P38alpha Complexed With A
Triazolopyrimidine Compound
pdb|3MGY|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3ROC|A Chain A, Crystal Structure Of Human P38 Alpha Complexed With A
Pyrimidinone Compound
pdb|3RIN|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|4E5B|A Chain A, Structure Of P38a Map Kinase Without Bog
pdb|4E6A|A Chain A, P38a-Pia23 Complex
pdb|4E6C|A Chain A, P38a-perifosine Complex
pdb|4E8A|A Chain A, The Crystal Structure Of P38a Map Kinase In Complex With
Pia24
Length = 360
Score = 43.9 bits (102), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 48/199 (24%), Positives = 83/199 (41%), Gaps = 43/199 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
VG G++G V +T +V ++ SR + +R ++ E+ ++ H+N++ LL
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLH-- 484
+ E N+ L + L G N+ L + + +QI RGL Y+H
Sbjct: 89 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 485 ---------------EDCSSQIILYSYKR-----TEGYVAPEWFRNSTIT-------AKV 517
EDC +I+ + R GYVA W+R I V
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTV 204
Query: 518 DVYSFGFLLLEIISCRKSF 536
D++S G ++ E+++ R F
Sbjct: 205 DIWSVGCIMAELLTGRTLF 223
>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
Length = 349
Score = 43.9 bits (102), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 48/199 (24%), Positives = 83/199 (41%), Gaps = 43/199 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
VG G++G V +T +V ++ SR + +R ++ E+ ++ H+N++ LL
Sbjct: 27 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 85
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLH-- 484
+ E N+ L + L G N+ L + + +QI RGL Y+H
Sbjct: 86 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 141
Query: 485 ---------------EDCSSQIILYSYKR-----TEGYVAPEWFRNSTIT-------AKV 517
EDC +I+ + R GYVA W+R I V
Sbjct: 142 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTV 201
Query: 518 DVYSFGFLLLEIISCRKSF 536
D++S G ++ E+++ R F
Sbjct: 202 DIWSVGCIMAELLTGRTLF 220
>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|C Chain C, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|D Chain D, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome
Length = 324
Score = 43.9 bits (102), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 37/155 (23%), Positives = 61/155 (39%), Gaps = 49/155 (31%)
Query: 426 HKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI------------- 472
HKN++ LLG C + ++ E+ + G L +L P +I
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 473 ---AFQIARGLLYL------HEDCSSQIILYS---------------------YKRTEG- 501
+Q+ARG+ YL H D +++ +L + YK T
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNG 219
Query: 502 -----YVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
++APE + T + DV+SFG L+ EI +
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map
Kinase
Length = 360
Score = 43.9 bits (102), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 48/199 (24%), Positives = 83/199 (41%), Gaps = 43/199 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
VG G++G V +T +V ++ SR + +R ++ E+ ++ H+N++ LL
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLH-- 484
+ E N+ L + L G N+ L + + +QI RGL Y+H
Sbjct: 89 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 485 ---------------EDCSSQIILYSYKR-----TEGYVAPEWFRNSTIT-------AKV 517
EDC +I+ + R GYVA W+R I V
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTV 204
Query: 518 DVYSFGFLLLEIISCRKSF 536
D++S G ++ E+++ R F
Sbjct: 205 DIWSVGCIMAELLTGRTLF 223
>pdb|3HEC|A Chain A, P38 In Complex With Imatinib
pdb|3HEG|A Chain A, P38 In Complex With Sorafenib
Length = 348
Score = 43.9 bits (102), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 48/199 (24%), Positives = 83/199 (41%), Gaps = 43/199 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
VG G++G V +T +V ++ SR + +R ++ E+ ++ H+N++ LL
Sbjct: 26 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 84
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLH-- 484
+ E N+ L + L G N+ L + + +QI RGL Y+H
Sbjct: 85 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 140
Query: 485 ---------------EDCSSQIILYSYKR-----TEGYVAPEWFRNSTIT-------AKV 517
EDC +I+ + R GYVA W+R I V
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTV 200
Query: 518 DVYSFGFLLLEIISCRKSF 536
D++S G ++ E+++ R F
Sbjct: 201 DIWSVGCIMAELLTGRTLF 219
>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s)
Activating Mutant Form-A
pdb|2FSM|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s)
Activating Mutant Form-B
Length = 367
Score = 43.9 bits (102), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 48/199 (24%), Positives = 83/199 (41%), Gaps = 43/199 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
VG G++G V +T +V ++ SR + +R ++ E+ ++ H+N++ LL
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 95
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLH-- 484
+ E N+ L + L G N+ L + + +QI RGL Y+H
Sbjct: 96 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 151
Query: 485 ---------------EDCSSQIILYSYKR-----TEGYVAPEWFRNSTIT-------AKV 517
EDC +I+ + R GYVA W+R I V
Sbjct: 152 DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRWYRAPEIMLNWMHYNQTV 211
Query: 518 DVYSFGFLLLEIISCRKSF 536
D++S G ++ E+++ R F
Sbjct: 212 DIWSVGCIMAELLTGRTLF 230
>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A
Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE
COMPLEX IN Solution
Length = 359
Score = 43.9 bits (102), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 48/199 (24%), Positives = 83/199 (41%), Gaps = 43/199 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
VG G++G V +T +V ++ SR + +R ++ E+ ++ H+N++ LL
Sbjct: 35 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 93
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLH-- 484
+ E N+ L + L G N+ L + + +QI RGL Y+H
Sbjct: 94 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 149
Query: 485 ---------------EDCSSQIILYSYKR-----TEGYVAPEWFRNSTIT-------AKV 517
EDC +I+ + R GYVA W+R I V
Sbjct: 150 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTV 209
Query: 518 DVYSFGFLLLEIISCRKSF 536
D++S G ++ E+++ R F
Sbjct: 210 DIWSVGCIMAELLTGRTLF 228
>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Axitinib (Ag-013736)
(N-Methyl-2-(
3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)-
Benzamide)
pdb|4AGD|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Sunitinib (Su11248) (N-2-
Diethylaminoethyl)-5-((Z)-(5-Fluoro-2-Oxo-1h-Indol-3-
Ylidene)methyl)-2,4-Dimethyl-1h-Pyrrole-3-Carboxamide)
pdb|4ASD|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Sorafenib (Bay 43-9006)
pdb|4ASE|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Tivozanib (Av-951)
Length = 353
Score = 43.5 bits (101), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 55/211 (26%), Positives = 86/211 (40%), Gaps = 55/211 (26%)
Query: 376 VGRGSFGIVYK----GVIQTTRQVLLQLQSRNWIVFQDGEREFKNEV-FVISQTHHKNLV 430
+GRG+FG V + G+ +T + ++ R +E+ +I HH N+V
Sbjct: 72 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 431 RLLGFCDE-GLNRLLVYEFLNNGTLASFLFGN--------------LKPSWNLRTNI--A 473
LLG C + G +++ EF G L+++L K L I +
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 191
Query: 474 FQIARGLLYL------HEDCSSQIILYSYK---------------RTEGYV--------- 503
FQ+A+G+ +L H D +++ IL S K + YV
Sbjct: 192 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 251
Query: 504 ---APEWFRNSTITAKVDVYSFGFLLLEIIS 531
APE + T + DV+SFG LL EI S
Sbjct: 252 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282
>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376
pdb|3NNV|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp437
pdb|3NNW|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp802
Length = 354
Score = 43.5 bits (101), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 48/199 (24%), Positives = 83/199 (41%), Gaps = 43/199 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
VG G++G V +T +V ++ SR + +R ++ E+ ++ H+N++ LL
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLH-- 484
+ E N+ L + L G N+ L + + +QI RGL Y+H
Sbjct: 89 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 485 ---------------EDCSSQIILYSYKR-----TEGYVAPEWFRNSTIT-------AKV 517
EDC +I+ + R GYVA W+R I V
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTV 204
Query: 518 DVYSFGFLLLEIISCRKSF 536
D++S G ++ E+++ R F
Sbjct: 205 DIWSVGCIMAELLTGRTLF 223
>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l)
Activating Mutant
Length = 367
Score = 43.5 bits (101), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 48/199 (24%), Positives = 83/199 (41%), Gaps = 43/199 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
VG G++G V +T +V ++ SR + +R ++ E+ ++ H+N++ LL
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 95
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLH-- 484
+ E N+ L + L G N+ L + + +QI RGL Y+H
Sbjct: 96 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 151
Query: 485 ---------------EDCSSQIILYSYKR-----TEGYVAPEWFRNSTIT-------AKV 517
EDC +I+ + R GYVA W+R I V
Sbjct: 152 DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRWYRAPEIMLNWMHYNQTV 211
Query: 518 DVYSFGFLLLEIISCRKSF 536
D++S G ++ E+++ R F
Sbjct: 212 DIWSVGCIMAELLTGRTLF 230
>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
pdb|3MPA|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 43.5 bits (101), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 48/199 (24%), Positives = 83/199 (41%), Gaps = 43/199 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
VG G++G V +T +V ++ SR + +R ++ E+ ++ H+N++ LL
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLH-- 484
+ E N+ L + L G N+ L + + +QI RGL Y+H
Sbjct: 89 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 485 ---------------EDCSSQIILYSYKR-----TEGYVAPEWFRNSTIT-------AKV 517
EDC +I+ + R GYVA W+R I V
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTV 204
Query: 518 DVYSFGFLLLEIISCRKSF 536
D++S G ++ E+++ R F
Sbjct: 205 DIWSVGCIMAELLTGRTLF 223
>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-Isopropyl-7-
(4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3-
Ylamino)-2h- Phthalazin-1-One
pdb|3PIY|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With R406
pdb|3PIZ|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
(5-Amino-1-O-
Tolyl-1h-Pyrazol-4-Yl)-[3-(1-Methanesulfonyl-Piperidin-
4-Yl)-Phenyl]- Methanone
pdb|3PJ1|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
3-(2,6-Dichloro-
Phenyl)-7-[4-(2-Diethylamino-Ethoxy)-Phenylamino]-1-
Methyl-3,4- Dihydro-1h-Pyrimido[4,5-D]pyrimidin-2-One
pdb|3PJ2|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-[4-(2-
Diethylamino-Ethoxy)-Phenylamino]-6-(4-Fluoro-Phenoxy)-
8-Methyl-8h- Pyrido[2,3-D]pyrimidin-7-One
pdb|3PJ3|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-Methyl-5-[(E)-
(3-Phenyl-Acryloyl)amino]-N-(2-Phenyl-3h-Imidazo[4,
5-B]pyridin-6-Yl)- Benzamide
Length = 274
Score = 43.5 bits (101), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 44/198 (22%), Positives = 81/198 (40%), Gaps = 39/198 (19%)
Query: 371 NFKEEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLV 430
F +E+G G FG+V G + V +++ + E EF E V+ H+ LV
Sbjct: 18 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHEKLV 73
Query: 431 RLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI--------AFQIARGLLY 482
+L G C + ++ E++ NG L ++L ++ + + + A + +
Sbjct: 74 QLYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLESKQF 132
Query: 483 LHEDCSSQIILYS--------------------YKRTEG------YVAPEWFRNSTITAK 516
LH D +++ L + Y + G + PE S ++K
Sbjct: 133 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 192
Query: 517 VDVYSFGFLLLEIISCRK 534
D+++FG L+ EI S K
Sbjct: 193 SDIWAFGVLMWEIYSLGK 210
>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Nicotinamide Inhibitor
pdb|2P2I|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Nicotinamide Inhibitor
pdb|3EFL|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Motesanib
pdb|3EFL|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Motesanib
Length = 314
Score = 43.5 bits (101), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 53/211 (25%), Positives = 85/211 (40%), Gaps = 55/211 (26%)
Query: 376 VGRGSFGIVYK----GVIQTTRQVLLQLQSRNWIVFQDGEREFKNEV-FVISQTHHKNLV 430
+GRG+FG V + G+ +T + ++ R +E+ +I HH N+V
Sbjct: 26 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 431 RLLGFCDE-GLNRLLVYEFLNNGTLASFLFGN--------------LKPSWNLRTNI--A 473
LLG C + G +++ EF G L+++L K L I +
Sbjct: 86 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 474 FQIARGLLYL------HEDCSSQIILYSYKRTE--------------------------- 500
FQ+A+G+ +L H D +++ IL S K
Sbjct: 146 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPL 205
Query: 501 GYVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
++APE + T + DV+SFG LL EI S
Sbjct: 206 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236
>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300
Length = 280
Score = 43.5 bits (101), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 45/198 (22%), Positives = 78/198 (39%), Gaps = 30/198 (15%)
Query: 376 VGRGSFGIVYKGVIQTTRQVL-LQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
+G+G FG VY + ++ +L L++ + + E + + EV + S H N++RL G
Sbjct: 16 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLY------LHEDCS 488
+ + L+ E+ GT+ L K ++A L Y +H D
Sbjct: 76 YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIK 135
Query: 489 SQIILY------------------SYKRTE-----GYVAPEWFRNSTITAKVDVYSFGFL 525
+ +L S +RTE Y+ PE KVD++S G L
Sbjct: 136 PENLLLGSAGELKIADFGWSVHAPSSRRTELCGTLDYLPPEMIEGRMHDEKVDLWSLGVL 195
Query: 526 LLEIISCRKSFDIEMGEE 543
E + + F+ +E
Sbjct: 196 CYEFLVGKPPFEANTYQE 213
>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex
pdb|2QD9|A Chain A, P38 Alpha Map Kinase Inhibitor Based On Heterobicyclic
Scaffolds
pdb|2RG5|A Chain A, Phenylalanine Pyrrolotriazine P38 Alpha Map Kinase
Inhibitor Compound 11b
pdb|2RG6|A Chain A, Phenylalanine Pyrrolotriazine P38 Alpha Map Kinase
Inhibitor Compound 11j
pdb|3C5U|A Chain A, P38 Alpha Map Kinase Complexed With A Benzothiazole Based
Inhibitor
pdb|3BV2|A Chain A, Morpholino Pyrrolotriazine P38 Alpha Map Kinase Inhibitor
Compound 30
pdb|3BV3|A Chain A, Morpholino Pyrrolotriazine P38 Alpha Map Kinase Inhibitor
Compound 2
pdb|3BX5|A Chain A, P38 Alpha Map Kinase Complexed With Bms-640994
pdb|3L8X|A Chain A, P38 Alpha Kinase Complexed With A Pyrazolo-Pyrimidine
Based Inhibitor
pdb|3NWW|A Chain A, P38 Alpha Kinase Complexed With A
2-Aminothiazol-5-Yl-Pyrimidine Based Inhibitor
pdb|3MVL|A Chain A, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7k
pdb|3MVL|B Chain B, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7k
pdb|3MVM|A Chain A, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7v
pdb|3MVM|B Chain B, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7v
pdb|3OCG|A Chain A, P38 Alpha Kinase Complexed With A 5-Amino-Pyrazole Based
Inhibitor
pdb|3S4Q|A Chain A, P38 Alpha Kinase Complexed With A Pyrazolo-Triazine Based
Inhibitor
Length = 366
Score = 43.5 bits (101), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 48/199 (24%), Positives = 83/199 (41%), Gaps = 43/199 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
VG G++G V +T +V ++ SR + +R ++ E+ ++ H+N++ LL
Sbjct: 36 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 94
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLH-- 484
+ E N+ L + L G N+ L + + +QI RGL Y+H
Sbjct: 95 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 150
Query: 485 ---------------EDCSSQIILYSYKR-----TEGYVAPEWFRNSTIT-------AKV 517
EDC +I+ + R GYVA W+R I V
Sbjct: 151 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTV 210
Query: 518 DVYSFGFLLLEIISCRKSF 536
D++S G ++ E+++ R F
Sbjct: 211 DIWSVGCIMAELLTGRTLF 229
>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain
pdb|3P08|B Chain B, Crystal Structure Of The Human Btk Kinase Domain
Length = 267
Score = 43.5 bits (101), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 44/198 (22%), Positives = 81/198 (40%), Gaps = 39/198 (19%)
Query: 371 NFKEEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLV 430
F +E+G G FG+V G + V +++ + E EF E V+ H+ LV
Sbjct: 11 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHEKLV 66
Query: 431 RLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI--------AFQIARGLLY 482
+L G C + ++ E++ NG L ++L ++ + + + A + +
Sbjct: 67 QLYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLESKQF 125
Query: 483 LHEDCSSQIILYS--------------------YKRTEG------YVAPEWFRNSTITAK 516
LH D +++ L + Y + G + PE S ++K
Sbjct: 126 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 185
Query: 517 VDVYSFGFLLLEIISCRK 534
D+++FG L+ EI S K
Sbjct: 186 SDIWAFGVLMWEIYSLGK 203
>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyrazolone Inhibitor
Length = 314
Score = 43.5 bits (101), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 53/211 (25%), Positives = 85/211 (40%), Gaps = 55/211 (26%)
Query: 376 VGRGSFGIVYK----GVIQTTRQVLLQLQSRNWIVFQDGEREFKNEV-FVISQTHHKNLV 430
+GRG+FG V + G+ +T + ++ R +E+ +I HH N+V
Sbjct: 26 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 431 RLLGFCDE-GLNRLLVYEFLNNGTLASFLFGN--------------LKPSWNLRTNI--A 473
LLG C + G +++ EF G L+++L K L I +
Sbjct: 86 NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 474 FQIARGLLYL------HEDCSSQIILYSYKRTE--------------------------- 500
FQ+A+G+ +L H D +++ IL S K
Sbjct: 146 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 205
Query: 501 GYVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
++APE + T + DV+SFG LL EI S
Sbjct: 206 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236
>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridinyl-Triazine Inhibitor
pdb|2QU5|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzimidazole Inhibitor
pdb|2QU6|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzoxazole Inhibitor
pdb|2QU6|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzoxazole Inhibitor
pdb|3B8Q|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8Q|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8R|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8R|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|2RL5|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A 2,3-Dihydro-1,4-Benzoxazine Inhibitor
pdb|3BE2|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzamide Inhibitor
pdb|3CP9|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CP9|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CPB|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Bisamide Inhibitor
pdb|3CPB|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Bisamide Inhibitor
pdb|3CPC|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CPC|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3DTW|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzisoxazole Inhibitor
pdb|3DTW|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzisoxazole Inhibitor
Length = 314
Score = 43.5 bits (101), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 53/211 (25%), Positives = 85/211 (40%), Gaps = 55/211 (26%)
Query: 376 VGRGSFGIVYK----GVIQTTRQVLLQLQSRNWIVFQDGEREFKNEV-FVISQTHHKNLV 430
+GRG+FG V + G+ +T + ++ R +E+ +I HH N+V
Sbjct: 26 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 431 RLLGFCDE-GLNRLLVYEFLNNGTLASFLFGN--------------LKPSWNLRTNI--A 473
LLG C + G +++ EF G L+++L K L I +
Sbjct: 86 NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 474 FQIARGLLYL------HEDCSSQIILYSYKRTE--------------------------- 500
FQ+A+G+ +L H D +++ IL S K
Sbjct: 146 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPL 205
Query: 501 GYVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
++APE + T + DV+SFG LL EI S
Sbjct: 206 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236
>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex
With Inhibitor Cgi1746
Length = 271
Score = 43.5 bits (101), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 44/198 (22%), Positives = 81/198 (40%), Gaps = 39/198 (19%)
Query: 371 NFKEEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLV 430
F +E+G G FG+V G + V +++ + E EF E V+ H+ LV
Sbjct: 12 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHEKLV 67
Query: 431 RLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI--------AFQIARGLLY 482
+L G C + ++ E++ NG L ++L ++ + + + A + +
Sbjct: 68 QLYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLESKQF 126
Query: 483 LHEDCSSQIILYS--------------------YKRTEG------YVAPEWFRNSTITAK 516
LH D +++ L + Y + G + PE S ++K
Sbjct: 127 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 186
Query: 517 VDVYSFGFLLLEIISCRK 534
D+++FG L+ EI S K
Sbjct: 187 SDIWAFGVLMWEIYSLGK 204
>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans
(Fn31-Nl-Kin-Crd-Ig26)
pdb|3UTO|B Chain B, Twitchin Kinase Region From C.Elegans
(Fn31-Nl-Kin-Crd-Ig26)
Length = 573
Score = 43.5 bits (101), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 32/137 (23%), Positives = 65/137 (47%), Gaps = 11/137 (8%)
Query: 371 NFKEEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGERE-FKNEVFVISQTHHKNL 429
+ EE+G G+FG+V++ T R ++ + + ++E + E+ +S H L
Sbjct: 160 DIHEELGTGAFGVVHR---VTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 430 VRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNL-KPSWNLRTNIAFQIARGLLYLHE--- 485
V L ++ +++YEF++ G L + K S + Q+ +GL ++HE
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNY 276
Query: 486 ---DCSSQIILYSYKRT 499
D + I+++ KR+
Sbjct: 277 VHLDLKPENIMFTTKRS 293
>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridyl-Pyrimidine Benzimidazole Inhibitor
Length = 314
Score = 43.1 bits (100), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 53/211 (25%), Positives = 85/211 (40%), Gaps = 55/211 (26%)
Query: 376 VGRGSFGIVYK----GVIQTTRQVLLQLQSRNWIVFQDGEREFKNEV-FVISQTHHKNLV 430
+GRG+FG V + G+ +T + ++ R +E+ +I HH N+V
Sbjct: 26 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 431 RLLGFCDE-GLNRLLVYEFLNNGTLASFLFGN--------------LKPSWNLRTNI--A 473
LLG C + G +++ EF G L+++L K L I +
Sbjct: 86 NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 474 FQIARGLLYL------HEDCSSQIILYSYKRTE--------------------------- 500
FQ+A+G+ +L H D +++ IL S K
Sbjct: 146 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 205
Query: 501 GYVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
++APE + T + DV+SFG LL EI S
Sbjct: 206 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236
>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf
Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp
Analog And Substrate Peptide
Length = 334
Score = 43.1 bits (100), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 37/155 (23%), Positives = 61/155 (39%), Gaps = 49/155 (31%)
Query: 426 HKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI------------- 472
HKN++ LLG C + ++ E+ + G L +L P +I
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDL 159
Query: 473 ---AFQIARGLLYL------HEDCSSQIILYS----------------------YKRTEG 501
+Q+ARG+ YL H D +++ +L + K T G
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 502 -----YVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
++APE + T + DV+SFG L+ EI +
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With
Inhibitor Pg-874743
pdb|2GHM|A Chain A, Mutated Map Kinase P38 (Mus Musculus) In Complex With
Inhbitor Pg-895449
Length = 348
Score = 43.1 bits (100), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 47/199 (23%), Positives = 83/199 (41%), Gaps = 43/199 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
VG G++G V +T +V ++ SR + +R ++ E+ ++ H+N++ LL
Sbjct: 26 VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 84
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLH-- 484
+ E N+ L + L G N+ L + + +QI RGL Y+H
Sbjct: 85 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 140
Query: 485 ---------------EDCSSQIILYSYKR-----TEGYVAPEWFRNSTIT-------AKV 517
EDC +I+ + R G+VA W+R I V
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATRWYRAPEIMLNWMHYNQTV 200
Query: 518 DVYSFGFLLLEIISCRKSF 536
D++S G ++ E+++ R F
Sbjct: 201 DIWSVGCIMAELLTGRTLF 219
>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant
V617f (Mg- Atp-Bound Form)
Length = 289
Score = 43.1 bits (100), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 40/144 (27%), Positives = 66/144 (45%), Gaps = 31/144 (21%)
Query: 372 FKEEVGRGSFGIVYKGVIQTT--------RQVLLQLQSRNWIVFQDGEREFKNEVF---- 419
F E +G+G+F ++KGV + +VLL+ V R + F
Sbjct: 12 FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLK-------VLDKAHRNYSESFFEAAS 64
Query: 420 VISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGN---LKPSWNLRTNIAFQI 476
++S+ HK+LV G C G +LV EF+ G+L ++L N + W L +A Q+
Sbjct: 65 MMSKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLE--VAKQL 122
Query: 477 ARGLLYLHED-------CSSQIIL 493
A + +L E+ C+ I+L
Sbjct: 123 AWAMHFLEENTLIHGNVCAKNILL 146
>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain
pdb|1K2P|B Chain B, Crystal Structure Of Bruton's Tyrosine Kinase Domain
Length = 263
Score = 43.1 bits (100), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 44/198 (22%), Positives = 81/198 (40%), Gaps = 39/198 (19%)
Query: 371 NFKEEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLV 430
F +E+G G FG+V G + V +++ + E EF E V+ H+ LV
Sbjct: 7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHEKLV 62
Query: 431 RLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI--------AFQIARGLLY 482
+L G C + ++ E++ NG L ++L ++ + + + A + +
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLESKQF 121
Query: 483 LHEDCSSQIILYS--------------------YKRTEG------YVAPEWFRNSTITAK 516
LH D +++ L + Y + G + PE S ++K
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 181
Query: 517 VDVYSFGFLLLEIISCRK 534
D+++FG L+ EI S K
Sbjct: 182 SDIWAFGVLMWEIYSLGK 199
>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii
Inhibtor Nvp-Bbt594
Length = 295
Score = 43.1 bits (100), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 50/209 (23%), Positives = 89/209 (42%), Gaps = 47/209 (22%)
Query: 366 EEATDNFKEEVGRGSFGIV----YKGVIQTTRQVLL--QLQSRNWIVFQDGEREFKNEVF 419
EE F +++G+G+FG V Y + T +V+ +LQ ++ R+F+ E+
Sbjct: 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST----EEHLRDFEREIE 63
Query: 420 VISQTHHKNLVRLLGFCDEGLNR--LLVYEFLNNGTLASFLFGNLKPSWNLR-TNIAFQI 476
++ H N+V+ G C R L+ E+L G+L +L + + +++ QI
Sbjct: 64 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 123
Query: 477 ARGLLYL------HEDCSSQIILYS----------------------YKRTEG------Y 502
+G+ YL H D +++ IL +K E +
Sbjct: 124 CKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFW 183
Query: 503 VAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
APE S + DV+SFG +L E+ +
Sbjct: 184 YAPESLTESKFSVASDVWSFGVVLYELFT 212
>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
Length = 636
Score = 43.1 bits (100), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 50/197 (25%), Positives = 78/197 (39%), Gaps = 43/197 (21%)
Query: 374 EEVGRGSFGIVYKGVIQTTRQVL-----LQLQSRNWIVFQDGEREFKNEVFVISQTHHKN 428
+E+G G+FG V KG Q + V + N +D E E V+ Q +
Sbjct: 376 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD---ELLAEANVMQQLDNPY 432
Query: 429 LVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYL----- 483
+VR++G C E + +LV E G L +L N + Q++ G+ YL
Sbjct: 433 IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 491
Query: 484 -HEDCSSQIIL-----------------------YSYKRTEG-----YVAPEWFRNSTIT 514
H D +++ +L Y +T G + APE +
Sbjct: 492 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 551
Query: 515 AKVDVYSFGFLLLEIIS 531
+K DV+SFG L+ E S
Sbjct: 552 SKSDVWSFGVLMWEAFS 568
>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1)
pdb|3OMV|B Chain B, Crystal Structure Of C-Raf (Raf-1)
Length = 307
Score = 43.1 bits (100), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 54/208 (25%), Positives = 87/208 (41%), Gaps = 43/208 (20%)
Query: 362 YKALEEATDNFKEEVGRGSFGIVYKGVIQTTRQV-LLQLQSRNWIVFQDGEREFKNEVFV 420
Y +E + +G GSFG VYKG V +L++ FQ F+NEV V
Sbjct: 30 YWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQ----AFRNEVAV 85
Query: 421 ISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFL-FGNLKPSWNLRTNIAFQIARG 479
+ +T H N++ +G+ + N +V ++ +L L K +IA Q A+G
Sbjct: 86 LRKTRHVNILLFMGYMTKD-NLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQG 144
Query: 480 LLYLHED-------CSSQIILYS--------------YKRTEG------------YVAPE 506
+ YLH S+ I L+ R G ++APE
Sbjct: 145 MDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPE 204
Query: 507 WFR---NSTITAKVDVYSFGFLLLEIIS 531
R N+ + + DVYS+G +L E+++
Sbjct: 205 VIRMQDNNPFSFQSDVYSYGIVLYELMT 232
>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38)
Length = 360
Score = 43.1 bits (100), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 47/199 (23%), Positives = 83/199 (41%), Gaps = 43/199 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
VG G++G V +T +V ++ SR + +R ++ E+ ++ H+N++ LL
Sbjct: 30 VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLH-- 484
+ E N+ L + L G N+ L + + +QI RGL Y+H
Sbjct: 89 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 485 ---------------EDCSSQIILYSYKR-----TEGYVAPEWFRNSTIT-------AKV 517
EDC +I+ + R G+VA W+R I V
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATRWYRAPEIMLNWMHYNQTV 204
Query: 518 DVYSFGFLLLEIISCRKSF 536
D++S G ++ E+++ R F
Sbjct: 205 DIWSVGCIMAELLTGRTLF 223
>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain
pdb|2XA4|B Chain B, Inhibitors Of Jak2 Kinase Domain
Length = 298
Score = 43.1 bits (100), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 49/209 (23%), Positives = 89/209 (42%), Gaps = 47/209 (22%)
Query: 366 EEATDNFKEEVGRGSFGIV----YKGVIQTTRQVLL--QLQSRNWIVFQDGEREFKNEVF 419
EE F +++G+G+FG V Y + T +V+ +LQ ++ R+F+ E+
Sbjct: 11 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST----EEHLRDFEREIE 66
Query: 420 VISQTHHKNLVRLLGFCDEG--LNRLLVYEFLNNGTLASFLFGNLKPSWNLR-TNIAFQI 476
++ H N+V+ G C N L+ E+L G+L +L + + +++ QI
Sbjct: 67 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQI 126
Query: 477 ARGLLYL------HEDCSSQIILYSYK-----------------------RTEG-----Y 502
+G+ YL H D +++ IL + + G +
Sbjct: 127 CKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 186
Query: 503 VAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
APE S + DV+SFG +L E+ +
Sbjct: 187 YAPESLTESKFSVASDVWSFGVVLYELFT 215
>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain
Of Csf-1r
Length = 329
Score = 43.1 bits (100), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 47/209 (22%), Positives = 87/209 (41%), Gaps = 48/209 (22%)
Query: 371 NFKEEVGRGSFGIVYK----GVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQT-H 425
F + +G G+FG V + G+ + + + ++ D + +E+ ++S
Sbjct: 49 QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 426 HKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWN--------LRTNIAF--Q 475
H+N+V LLG C G L++ E+ G L +FL + + LR + F Q
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQ 168
Query: 476 IARGLLYL------HEDCSSQIILYS---------------------------YKRTEGY 502
+A+G+ +L H D +++ +L + + +
Sbjct: 169 VAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKW 228
Query: 503 VAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
+APE + T + DV+S+G LL EI S
Sbjct: 229 MAPESIFDCVYTVQSDVWSYGILLWEIFS 257
>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated
Protein Kinase And Immunoglobulin Domains
Length = 491
Score = 43.1 bits (100), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 32/137 (23%), Positives = 65/137 (47%), Gaps = 11/137 (8%)
Query: 371 NFKEEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGERE-FKNEVFVISQTHHKNL 429
+ EE+G G+FG+V++ T R ++ + + ++E + E+ +S H L
Sbjct: 54 DIHEELGTGAFGVVHR---VTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 110
Query: 430 VRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNL-KPSWNLRTNIAFQIARGLLYLHE--- 485
V L ++ +++YEF++ G L + K S + Q+ +GL ++HE
Sbjct: 111 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNY 170
Query: 486 ---DCSSQIILYSYKRT 499
D + I+++ KR+
Sbjct: 171 VHLDLKPENIMFTTKRS 187
>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain
In Complex With A Monocyclic Pyrazolone Inhibitor
Length = 360
Score = 43.1 bits (100), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 47/199 (23%), Positives = 83/199 (41%), Gaps = 43/199 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
VG G++G V +T +V ++ SR + +R ++ E+ ++ H+N++ LL
Sbjct: 30 VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLH-- 484
+ E N+ L + L G N+ L + + +QI RGL Y+H
Sbjct: 89 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 485 ---------------EDCSSQIILYSYKR-----TEGYVAPEWFRNSTIT-------AKV 517
EDC +I+ + R G+VA W+R I V
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATRWYRAPEIMLNWMHYNQTV 204
Query: 518 DVYSFGFLLLEIISCRKSF 536
D++S G ++ E+++ R F
Sbjct: 205 DIWSVGCIMAELLTGRTLF 223
>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains
Trapped In Trans-Phosphorylation Reaction
Length = 334
Score = 43.1 bits (100), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 37/155 (23%), Positives = 61/155 (39%), Gaps = 49/155 (31%)
Query: 426 HKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI------------- 472
HKN++ LLG C + ++ E+ + G L +L P +I
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 473 ---AFQIARGLLYL------HEDCSSQIILYS----------------------YKRTEG 501
+Q+ARG+ YL H D +++ +L + K T G
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 502 -----YVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
++APE + T + DV+SFG L+ EI +
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta
pdb|3ZHP|D Chain D, Human Mst3 (stk24) In Complex With Mo25beta
Length = 294
Score = 43.1 bits (100), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 43/190 (22%), Positives = 81/190 (42%), Gaps = 39/190 (20%)
Query: 374 EEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLL 433
E++G+GSFG V+KG+ T++V + ++ + +D + + E+ V+SQ + +
Sbjct: 33 EKIGKGSFGEVFKGIDNRTQKV-VAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 91
Query: 434 GFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF---QIARGLLYLHED---- 486
G + ++ E+L G+ L+P T IA +I +GL YLH +
Sbjct: 92 GSYLKDTKLWIIMEYLGGGSALDL----LEPGPLDETQIATILREILKGLDYLHSEKKIH 147
Query: 487 ---------------------------CSSQIILYSYKRTEGYVAPEWFRNSTITAKVDV 519
+QI ++ T ++APE + S +K D+
Sbjct: 148 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADI 207
Query: 520 YSFGFLLLEI 529
+S G +E+
Sbjct: 208 WSLGITAIEL 217
>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
Length = 635
Score = 43.1 bits (100), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 50/197 (25%), Positives = 78/197 (39%), Gaps = 43/197 (21%)
Query: 374 EEVGRGSFGIVYKGVIQTTRQVL-----LQLQSRNWIVFQDGEREFKNEVFVISQTHHKN 428
+E+G G+FG V KG Q + V + N +D E E V+ Q +
Sbjct: 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD---ELLAEANVMQQLDNPY 431
Query: 429 LVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYL----- 483
+VR++G C E + +LV E G L +L N + Q++ G+ YL
Sbjct: 432 IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 490
Query: 484 -HEDCSSQIIL-----------------------YSYKRTEG-----YVAPEWFRNSTIT 514
H D +++ +L Y +T G + APE +
Sbjct: 491 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 550
Query: 515 AKVDVYSFGFLLLEIIS 531
+K DV+SFG L+ E S
Sbjct: 551 SKSDVWSFGVLMWEAFS 567
>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An
Arylamide Inhibitor
Length = 333
Score = 42.7 bits (99), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 49/216 (22%), Positives = 88/216 (40%), Gaps = 58/216 (26%)
Query: 371 NFKEEVGRGSFGIVYK----GVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQT-H 425
F + +G G+FG V + G+ + + + ++ D + +E+ ++S
Sbjct: 49 QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 426 HKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF----------- 474
H+N+V LLG C G L++ E+ G L +FL + S L T+ AF
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFL---RRKSRVLETDPAFAIANSTASTRD 165
Query: 475 ------QIARGLLYL------HEDCSSQIILYS--------------------------- 495
Q+A+G+ +L H D +++ +L +
Sbjct: 166 LLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 225
Query: 496 YKRTEGYVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
+ ++APE + T + DV+S+G LL EI S
Sbjct: 226 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565a Mutation Responsible For
Pfeiffer Syndrome
pdb|2Q0B|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565a Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 42.7 bits (99), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 36/155 (23%), Positives = 61/155 (39%), Gaps = 49/155 (31%)
Query: 426 HKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI------------- 472
HKN++ LLG C + ++ + + G L +L P +I
Sbjct: 100 HKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 473 ---AFQIARGLLYL------HEDCSSQIILYS---------------------YKRTEG- 501
+Q+ARG+ YL H D +++ +L + YK+T
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 502 -----YVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
++APE + T + DV+SFG L+ EI +
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3,
Stk24)
Length = 304
Score = 42.7 bits (99), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 43/190 (22%), Positives = 81/190 (42%), Gaps = 39/190 (20%)
Query: 374 EEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLL 433
E++G+GSFG V+KG+ T++V + ++ + +D + + E+ V+SQ + +
Sbjct: 13 EKIGKGSFGEVFKGIDNRTQKV-VAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 71
Query: 434 GFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF---QIARGLLYLHED---- 486
G + ++ E+L G+ L+P T IA +I +GL YLH +
Sbjct: 72 GSYLKDTKLWIIMEYLGGGSALDL----LEPGPLDETQIATILREILKGLDYLHSEKKIH 127
Query: 487 ---------------------------CSSQIILYSYKRTEGYVAPEWFRNSTITAKVDV 519
+QI ++ T ++APE + S +K D+
Sbjct: 128 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADI 187
Query: 520 YSFGFLLLEI 529
+S G +E+
Sbjct: 188 WSLGITAIEL 197
>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase
Domain
Length = 317
Score = 42.7 bits (99), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 47/209 (22%), Positives = 87/209 (41%), Gaps = 48/209 (22%)
Query: 371 NFKEEVGRGSFGIVYK----GVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQT-H 425
F + +G G+FG V + G+ + + + ++ D + +E+ ++S
Sbjct: 41 QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 100
Query: 426 HKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWN--------LRTNIAF--Q 475
H+N+V LLG C G L++ E+ G L +FL + + LR + F Q
Sbjct: 101 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQ 160
Query: 476 IARGLLYL------HEDCSSQIILYS---------------------------YKRTEGY 502
+A+G+ +L H D +++ +L + + +
Sbjct: 161 VAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKW 220
Query: 503 VAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
+APE + T + DV+S+G LL EI S
Sbjct: 221 MAPESIFDCVYTVQSDVWSYGILLWEIFS 249
>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And
Inactive Conformations Suggests A Mechanism Of
Activation For Tec Family Kinases
Length = 283
Score = 42.7 bits (99), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 44/198 (22%), Positives = 80/198 (40%), Gaps = 39/198 (19%)
Query: 371 NFKEEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLV 430
F +E+G G FG+V G + V +++ + E EF E V+ H+ LV
Sbjct: 27 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHEKLV 82
Query: 431 RLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI--------AFQIARGLLY 482
+L G C + ++ E++ NG L ++L ++ + + + A + +
Sbjct: 83 QLYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLESKQF 141
Query: 483 LHEDCSSQ--------IILYSYKRTEGYV------------------APEWFRNSTITAK 516
LH D +++ ++ S YV PE S ++K
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYSKFSSK 201
Query: 517 VDVYSFGFLLLEIISCRK 534
D+++FG L+ EI S K
Sbjct: 202 SDIWAFGVLMWEIYSLGK 219
>pdb|3A7F|A Chain A, Human Mst3 Kinase
pdb|3A7G|A Chain A, Human Mst3 Kinase
pdb|3A7G|B Chain B, Human Mst3 Kinase
pdb|3A7H|A Chain A, Human Mst3 Kinase In Complex With Atp
pdb|3A7H|B Chain B, Human Mst3 Kinase In Complex With Atp
pdb|3A7I|A Chain A, Human Mst3 Kinase In Complex With Adenine
pdb|3A7J|A Chain A, Human Mst3 Kinase In Complex With Mnadp
Length = 303
Score = 42.7 bits (99), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 44/190 (23%), Positives = 81/190 (42%), Gaps = 39/190 (20%)
Query: 374 EEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLL 433
E++G+GSFG V+KG+ T++V + ++ + +D + + E+ V+SQ + +
Sbjct: 28 EKIGKGSFGEVFKGIDNRTQKV-VAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 86
Query: 434 GFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF---QIARGLLYLHED---- 486
G + ++ E+L G+ L+P T IA +I +GL YLH +
Sbjct: 87 GSYLKDTKLWIIMEYLGGGSALDL----LEPGPLDETQIATILREILKGLDYLHSEKKIH 142
Query: 487 ----------------------CSSQIILYSYKR-----TEGYVAPEWFRNSTITAKVDV 519
+ Q+ KR T ++APE + S +K D+
Sbjct: 143 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSKADI 202
Query: 520 YSFGFLLLEI 529
+S G +E+
Sbjct: 203 WSLGITAIEL 212
>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
Length = 298
Score = 42.7 bits (99), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 50/209 (23%), Positives = 89/209 (42%), Gaps = 47/209 (22%)
Query: 366 EEATDNFKEEVGRGSFGIV----YKGVIQTTRQVLL--QLQSRNWIVFQDGEREFKNEVF 419
EE F +++G+G+FG V Y + T +V+ +LQ ++ R+F+ E+
Sbjct: 9 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST----EEHLRDFEREIE 64
Query: 420 VISQTHHKNLVRLLGFCDEGLNR--LLVYEFLNNGTLASFLFGNLKPSWNLR-TNIAFQI 476
++ H N+V+ G C R L+ E+L G+L +L + + +++ QI
Sbjct: 65 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 124
Query: 477 ARGLLYL------HEDCSSQIILYS----------------------YKRTEG------Y 502
+G+ YL H + +++ IL YK E +
Sbjct: 125 CKGMEYLGTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFW 184
Query: 503 VAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
APE S + DV+SFG +L E+ +
Sbjct: 185 YAPESLTESKFSVASDVWSFGVVLYELFT 213
>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7-
Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2-
Phenylcyclopropyl)urea
Length = 293
Score = 42.7 bits (99), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 49/194 (25%), Positives = 77/194 (39%), Gaps = 37/194 (19%)
Query: 374 EEVGRGSFGIVYKGVIQTTRQVLLQLQS--RNWIVFQDGEREFKNEVFVISQTHHKNLVR 431
+E+G G+FG V KG Q + V +N + E E V+ Q + +VR
Sbjct: 33 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 92
Query: 432 LLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYL------HE 485
++G C E + +LV E G L +L N + Q++ G+ YL H
Sbjct: 93 MIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 151
Query: 486 DCSSQIIL-----------------------YSYKRTEG-----YVAPEWFRNSTITAKV 517
D +++ +L Y +T G + APE ++K
Sbjct: 152 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKS 211
Query: 518 DVYSFGFLLLEIIS 531
DV+SFG L+ E S
Sbjct: 212 DVWSFGVLMWEAFS 225
>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic
Domain With Pyrazolylbenzimidazole Inhibitor 416
pdb|3VF9|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic
Domain With Thienopyrazolylindole Inhibitor 027
pdb|3TUC|A Chain A, Crystal Structure Of Syk Kinase Domain With
1-Benzyl-N-(5-(6,7-
Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-2-Oxo-1,
2-Dihydropyridine-3- Carboxamide
pdb|3TUD|A Chain A, Crystal Structure Of Syk Kinase Domain With
N-(4-Methyl-3-(8-Methyl-7-
Oxo-2-(Phenylamino)-7,8-Dihydropyrido[2,
3-D]pyrimidin-6-Yl)phenyl)-3- (Trifluoromethyl)benzamide
Length = 299
Score = 42.7 bits (99), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 49/194 (25%), Positives = 77/194 (39%), Gaps = 37/194 (19%)
Query: 374 EEVGRGSFGIVYKGVIQTTRQVLLQLQS--RNWIVFQDGEREFKNEVFVISQTHHKNLVR 431
+E+G G+FG V KG Q + V +N + E E V+ Q + +VR
Sbjct: 33 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 92
Query: 432 LLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYL------HE 485
++G C E + +LV E G L +L N + Q++ G+ YL H
Sbjct: 93 MIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 151
Query: 486 DCSSQIIL-----------------------YSYKRTEG-----YVAPEWFRNSTITAKV 517
D +++ +L Y +T G + APE ++K
Sbjct: 152 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKS 211
Query: 518 DVYSFGFLLLEIIS 531
DV+SFG L+ E S
Sbjct: 212 DVWSFGVLMWEAFS 225
>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2-
Phenylaminopyrimidines As Potent Inhibitors Of Spleen
Tyrosine Kinase (Syk)
Length = 291
Score = 42.7 bits (99), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 49/194 (25%), Positives = 77/194 (39%), Gaps = 37/194 (19%)
Query: 374 EEVGRGSFGIVYKGVIQTTRQVLLQLQS--RNWIVFQDGEREFKNEVFVISQTHHKNLVR 431
+E+G G+FG V KG Q + V +N + E E V+ Q + +VR
Sbjct: 31 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 90
Query: 432 LLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYL------HE 485
++G C E + +LV E G L +L N + Q++ G+ YL H
Sbjct: 91 MIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 149
Query: 486 DCSSQIIL-----------------------YSYKRTEG-----YVAPEWFRNSTITAKV 517
D +++ +L Y +T G + APE ++K
Sbjct: 150 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKS 209
Query: 518 DVYSFGFLLLEIIS 531
DV+SFG L+ E S
Sbjct: 210 DVWSFGVLMWEAFS 223
>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A
Pyrimidinopyridone Inhibitor
Length = 333
Score = 42.7 bits (99), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 49/216 (22%), Positives = 88/216 (40%), Gaps = 58/216 (26%)
Query: 371 NFKEEVGRGSFGIVYK----GVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQT-H 425
F + +G G+FG V + G+ + + + ++ D + +E+ ++S
Sbjct: 49 QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 426 HKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF----------- 474
H+N+V LLG C G L++ E+ G L +FL + S L T+ AF
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFL---RRKSRVLETDPAFAIANSTLSTRD 165
Query: 475 ------QIARGLLYL------HEDCSSQIILYS--------------------------- 495
Q+A+G+ +L H D +++ +L +
Sbjct: 166 LLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 225
Query: 496 YKRTEGYVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
+ ++APE + T + DV+S+G LL EI S
Sbjct: 226 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
pdb|2IW8|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
Length = 302
Score = 42.7 bits (99), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 52/219 (23%), Positives = 92/219 (42%), Gaps = 43/219 (19%)
Query: 368 ATDNFK--EEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTH 425
+ +NF+ E++G G++G+VYK + T +V+ + R + E+ ++ + +
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 426 HKNLVRLLGFCDEGLNRLLVYEFLNNGTL----ASFLFGNLKPSWNLRTNIAFQIARGLL 481
H N+V+LL LV+E ++ AS L G P L + FQ+ +GL
Sbjct: 64 HPNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLA 120
Query: 482 Y------LHEDCSSQIIL-----------YSYKRTEGY--------VAPEWFRNSTI--- 513
+ LH D Q +L + R G V W+R I
Sbjct: 121 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 180
Query: 514 ----TAKVDVYSFGFLLLEIISCRKSF--DIEMGEEYAI 546
+ VD++S G + E+++ R F D E+ + + I
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 219
>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499
pdb|3FKO|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3668
pdb|3FLN|C Chain C, P38 Kinase Crystal Structure In Complex With R1487
Length = 372
Score = 42.7 bits (99), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 47/199 (23%), Positives = 83/199 (41%), Gaps = 43/199 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
VG G++G V +T +V ++ S+ + +R ++ E+ ++ H+N++ LL
Sbjct: 42 VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 100
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLH-- 484
+ E N+ L + L G N+ L + + +QI RGL Y+H
Sbjct: 101 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 156
Query: 485 ---------------EDCSSQIILYSYKR-----TEGYVAPEWFRNSTIT-------AKV 517
EDC +I+ + R GYVA W+R I V
Sbjct: 157 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTV 216
Query: 518 DVYSFGFLLLEIISCRKSF 536
D++S G ++ E+++ R F
Sbjct: 217 DIWSVGCIMAELLTGRTLF 235
>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In
Complex With A Diaminopyrimidine Carboxamide Inhibitor
Length = 277
Score = 42.4 bits (98), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 49/194 (25%), Positives = 77/194 (39%), Gaps = 37/194 (19%)
Query: 374 EEVGRGSFGIVYKGVIQTTRQVLLQLQS--RNWIVFQDGEREFKNEVFVISQTHHKNLVR 431
+E+G G+FG V KG Q + V +N + E E V+ Q + +VR
Sbjct: 17 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 76
Query: 432 LLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYL------HE 485
++G C E + +LV E G L +L N + Q++ G+ YL H
Sbjct: 77 MIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 135
Query: 486 DCSSQIIL-----------------------YSYKRTEG-----YVAPEWFRNSTITAKV 517
D +++ +L Y +T G + APE ++K
Sbjct: 136 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKS 195
Query: 518 DVYSFGFLLLEIIS 531
DV+SFG L+ E S
Sbjct: 196 DVWSFGVLMWEAFS 209
>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5
pdb|2F57|B Chain B, Crystal Structure Of The Human P21-activated Kinase 5
Length = 317
Score = 42.4 bits (98), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 47/188 (25%), Positives = 73/188 (38%), Gaps = 36/188 (19%)
Query: 375 EVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFK-NEVFVISQTHHKNLVRLL 433
++G GS GIV I T + Q+ + + + RE NEV ++ HH N+V +
Sbjct: 52 KIGEGSTGIV---CIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMY 108
Query: 434 GFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYL------HEDC 487
G +V EFL G L + + T + + R L YL H D
Sbjct: 109 SSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT-VCLSVLRALSYLHNQGVIHRDI 167
Query: 488 SSQIILYSY--------------------KR-----TEGYVAPEWFRNSTITAKVDVYSF 522
S IL + KR T ++APE +VD++S
Sbjct: 168 KSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLPYGTEVDIWSL 227
Query: 523 GFLLLEII 530
G +++E+I
Sbjct: 228 GIMVIEMI 235
>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone
Inhibitor
pdb|2I0Y|A Chain A, Cfms Tyrosine Kinase (Fgf Kid) In Complex With An
Arylamide Inhibitor
pdb|3DPK|A Chain A, Cfms Tyrosine Kinase In Complex With A Pyridopyrimidinone
Inhibitor
pdb|3KRJ|A Chain A, Cfms Tyrosine Kinase In Complex With
4-Cyano-1h-Imidazole-2-Carboxylic Acid
(2-Cyclohex-1-Enyl-4-Piperidin-4-Yl-Phenyl)-Amide
pdb|3KRL|A Chain A, Cfms Tyrosine Kinase In Complex With
5-Cyano-Furan-2-Carboxylic Acid
[4-(4-Methyl-Piperazin-1-Yl)-2-Piperidin-1-Yl-Phenyl]-
Amide
Length = 335
Score = 42.4 bits (98), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 48/215 (22%), Positives = 87/215 (40%), Gaps = 54/215 (25%)
Query: 371 NFKEEVGRGSFGIVYK----GVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQT-H 425
F + +G G+FG V + G+ + + + ++ D + +E+ ++S
Sbjct: 49 QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 426 HKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKP----SWNLRTN---------- 471
H+N+V LLG C G L++ E+ G L +FL P S+N N
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDL 168
Query: 472 --IAFQIARGLLYL------HEDCSSQIILYS---------------------------Y 496
+ Q+A+G+ +L H D +++ +L +
Sbjct: 169 LHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 228
Query: 497 KRTEGYVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
+ ++APE + T + DV+S+G LL EI S
Sbjct: 229 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263
>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3O8T|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg-Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 42.4 bits (98), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 48/199 (24%), Positives = 82/199 (41%), Gaps = 43/199 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
VG G++G V +T +V ++ SR + +R ++ E+ ++ H+N++ LL
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLH-- 484
+ E N+ L + L G N+ L + + +QI RGL Y+H
Sbjct: 89 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 485 ---------------EDCSSQIILYSYKR-----TEGYVAPEWFRNSTIT-------AKV 517
EDC +I+ R GYVA W+R I V
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTV 204
Query: 518 DVYSFGFLLLEIISCRKSF 536
D++S G ++ E+++ R F
Sbjct: 205 DIWSVGCIMAELLTGRTLF 223
>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6D|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6Q|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
pdb|4E6Q|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
Length = 298
Score = 42.4 bits (98), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 50/209 (23%), Positives = 88/209 (42%), Gaps = 47/209 (22%)
Query: 366 EEATDNFKEEVGRGSFGIV----YKGVIQTTRQVLL--QLQSRNWIVFQDGEREFKNEVF 419
EE F ++G+G+FG V Y + T +V+ +LQ ++ R+F+ E+
Sbjct: 11 EERHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST----EEHLRDFEREIE 66
Query: 420 VISQTHHKNLVRLLGFCDEGLNR--LLVYEFLNNGTLASFLFGNLKPSWNLR-TNIAFQI 476
++ H N+V+ G C R L+ EFL G+L +L + + +++ QI
Sbjct: 67 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQI 126
Query: 477 ARGLLYL------HEDCSSQIILYSYK-----------------------RTEG-----Y 502
+G+ YL H D +++ IL + + G +
Sbjct: 127 CKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 186
Query: 503 VAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
APE S + DV+SFG +L E+ +
Sbjct: 187 YAPESLTESKFSVASDVWSFGVVLYELFT 215
>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3,
Stk24) In Complex With Staurosporine
Length = 304
Score = 42.4 bits (98), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 44/190 (23%), Positives = 81/190 (42%), Gaps = 39/190 (20%)
Query: 374 EEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLL 433
E++G+GSFG V+KG+ T++V + ++ + +D + + E+ V+SQ + +
Sbjct: 13 EKIGKGSFGEVFKGIDNRTQKV-VAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 71
Query: 434 GFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF---QIARGLLYLHED---- 486
G + ++ E+L G+ L+P T IA +I +GL YLH +
Sbjct: 72 GSYLKDTKLWIIMEYLGGGSALDL----LEPGPLDETQIATILREILKGLDYLHSEKKIH 127
Query: 487 ----------------------CSSQIILYSYKR-----TEGYVAPEWFRNSTITAKVDV 519
+ Q+ KR T ++APE + S +K D+
Sbjct: 128 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSKADI 187
Query: 520 YSFGFLLLEI 529
+S G +E+
Sbjct: 188 WSLGITAIEL 197
>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|D Chain D, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|E Chain E, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4F08|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F08|B Chain B, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F09|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
Length = 302
Score = 42.4 bits (98), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 49/209 (23%), Positives = 89/209 (42%), Gaps = 47/209 (22%)
Query: 366 EEATDNFKEEVGRGSFGIV----YKGVIQTTRQVLL--QLQSRNWIVFQDGEREFKNEVF 419
EE F +++G+G+FG V Y + T +V+ +LQ ++ R+F+ E+
Sbjct: 15 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST----EEHLRDFEREIE 70
Query: 420 VISQTHHKNLVRLLGFCDEGLNR--LLVYEFLNNGTLASFLFGNLKPSWNLR-TNIAFQI 476
++ H N+V+ G C R L+ E+L G+L +L + + +++ QI
Sbjct: 71 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 130
Query: 477 ARGLLYL------HEDCSSQIILYSYK-----------------------RTEG-----Y 502
+G+ YL H D +++ IL + + G +
Sbjct: 131 CKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 190
Query: 503 VAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
APE S + DV+SFG +L E+ +
Sbjct: 191 YAPESLTESKFSVASDVWSFGVVLYELFT 219
>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2
pdb|3ZZW|B Chain B, Crystal Structure Of The Kinase Domain Of Ror2
Length = 289
Score = 42.4 bits (98), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 49/225 (21%), Positives = 92/225 (40%), Gaps = 59/225 (26%)
Query: 363 KALEEATDNFKEEVGRGSFGIVYKGVI-------QTTRQVLLQLQSRNWIVFQDGEREFK 415
K + + F EE+G FG VYKG + QT + L+ + ++ EF+
Sbjct: 4 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLRE---EFR 60
Query: 416 NEVFVISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLF-----GNLKPSWNLRT 470
+E + ++ H N+V LLG + +++ + ++G L FL ++ + + RT
Sbjct: 61 HEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 120
Query: 471 -----------NIAFQIARGLLYL------HEDCSSQIILY------------------- 494
++ QIA G+ YL H+D +++ +L
Sbjct: 121 VKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYA 180
Query: 495 -SYKRTEG-------YVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
Y + G ++APE + D++S+G +L E+ S
Sbjct: 181 ADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights
Into Receptor Autoregulation
Length = 343
Score = 42.4 bits (98), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 22/91 (24%), Positives = 48/91 (52%), Gaps = 4/91 (4%)
Query: 372 FKEEVGRGSFGIVYK----GVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHK 427
+ ++G G+FG V++ G++ ++ ++ D + +F+ E ++++ +
Sbjct: 51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110
Query: 428 NLVRLLGFCDEGLNRLLVYEFLNNGTLASFL 458
N+V+LLG C G L++E++ G L FL
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFL 141
>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836
Length = 273
Score = 42.4 bits (98), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 49/194 (25%), Positives = 77/194 (39%), Gaps = 37/194 (19%)
Query: 374 EEVGRGSFGIVYKGVIQTTRQVLLQLQS--RNWIVFQDGEREFKNEVFVISQTHHKNLVR 431
+E+G G+FG V KG Q + V +N + E E V+ Q + +VR
Sbjct: 11 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 70
Query: 432 LLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYL------HE 485
++G C E + +LV E G L +L N + Q++ G+ YL H
Sbjct: 71 MIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 129
Query: 486 DCSSQIIL-----------------------YSYKRTEG-----YVAPEWFRNSTITAKV 517
D +++ +L Y +T G + APE ++K
Sbjct: 130 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKS 189
Query: 518 DVYSFGFLLLEIIS 531
DV+SFG L+ E S
Sbjct: 190 DVWSFGVLMWEAFS 203
>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3OBJ|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Mutants In
Response To Inhibitor Binding
Length = 360
Score = 42.4 bits (98), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 48/199 (24%), Positives = 82/199 (41%), Gaps = 43/199 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
VG G++G V +T +V ++ SR + +R ++ E+ ++ H+N++ LL
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLH-- 484
+ E N+ L + L G N+ L + + +QI RGL Y+H
Sbjct: 89 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 485 ---------------EDCSSQIILYSYKR-----TEGYVAPEWFRNSTIT-------AKV 517
EDC +I+ R GYVA W+R I V
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTV 204
Query: 518 DVYSFGFLLLEIISCRKSF 536
D++S G ++ E+++ R F
Sbjct: 205 DIWSVGCIMAELLTGRTLF 223
>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565g Mutation Responsible For
Pfeiffer Syndrome
pdb|2PY3|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565g Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 42.4 bits (98), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 36/155 (23%), Positives = 61/155 (39%), Gaps = 49/155 (31%)
Query: 426 HKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI------------- 472
HKN++ LLG C + ++ + + G L +L P +I
Sbjct: 100 HKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 473 ---AFQIARGLLYL------HEDCSSQIILYS---------------------YKRTEG- 501
+Q+ARG+ YL H D +++ +L + YK+T
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 502 -----YVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
++APE + T + DV+SFG L+ EI +
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
pdb|4G9R|B Chain B, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
Length = 307
Score = 42.0 bits (97), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 50/204 (24%), Positives = 84/204 (41%), Gaps = 59/204 (28%)
Query: 374 EEVGRGSFGIVYKG---------VIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQT 424
+ +G GSFG VYKG ++ T QLQ+ FKNEV V+ +T
Sbjct: 42 QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA------------FKNEVGVLRKT 89
Query: 425 HHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFL-FGNLKPSWNLRTNIAFQIARGL--- 480
H N++ +G+ + +V ++ +L L K +IA Q A+G+
Sbjct: 90 RHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 148
Query: 481 --------------LYLHEDCSSQI----ILYSYKRTEG------------YVAPEWFR- 509
++LHED + +I + R G ++APE R
Sbjct: 149 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 208
Query: 510 --NSTITAKVDVYSFGFLLLEIIS 531
+ + + DVY+FG +L E+++
Sbjct: 209 QDKNPYSFQSDVYAFGIVLYELMT 232
>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain
pdb|4BBM|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain With
Bound Tcs 2312
pdb|4BBM|B Chain B, Crystal Structure Of The Human Cdkl2 Kinase Domain With
Bound Tcs 2312
Length = 331
Score = 42.0 bits (97), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 52/212 (24%), Positives = 89/212 (41%), Gaps = 44/212 (20%)
Query: 376 VGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKN----EVFVISQTHHKNLVR 431
VG GS+G+V K + T +++ + + D ++ K E+ ++ Q H+NLV
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIV----AIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVN 88
Query: 432 LLGFCDEGLNRLLVYEFLNNGTLASF-LFGNLKPSWNLRTNIAFQIARGLLY------LH 484
LL C + LV+EF+++ L LF N + + FQI G+ + +H
Sbjct: 89 LLEVCKKKKRWYLVFEFVDHTILDDLELFPN-GLDYQVVQKYLFQIINGIGFCHSHNIIH 147
Query: 485 EDCSSQIILYS-----------YKRT--------EGYVAPEWFRNSTITA-------KVD 518
D + IL S + RT + VA W+R + VD
Sbjct: 148 RDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVD 207
Query: 519 VYSFGFLLLEIISCRKSF--DIEMGEEYAILT 548
V++ G L+ E+ F D ++ + Y I+
Sbjct: 208 VWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMM 239
>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1I|B Chain B, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 326
Score = 42.0 bits (97), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 49/209 (23%), Positives = 89/209 (42%), Gaps = 47/209 (22%)
Query: 366 EEATDNFKEEVGRGSFGIV----YKGVIQTTRQVLL--QLQSRNWIVFQDGEREFKNEVF 419
EE F +++G+G+FG V Y + T +V+ +LQ ++ R+F+ E+
Sbjct: 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST----EEHLRDFEREIE 94
Query: 420 VISQTHHKNLVRLLGFCDEGLNR--LLVYEFLNNGTLASFLFGNLKPSWNLR-TNIAFQI 476
++ H N+V+ G C R L+ E+L G+L +L + + +++ QI
Sbjct: 95 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 154
Query: 477 ARGLLYL------HEDCSSQIILYSYK-----------------------RTEG-----Y 502
+G+ YL H D +++ IL + + G +
Sbjct: 155 CKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 214
Query: 503 VAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
APE S + DV+SFG +L E+ +
Sbjct: 215 YAPESLTESKFSVASDVWSFGVVLYELFT 243
>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A
Inhibitors: Structure Basis For Potency And Specificity
pdb|3K5U|A Chain A, Identification, Sar Studies And X-Ray Cocrystal Analysis
Of A Novel Furano-Pyrimidine Aurora Kinase A Inhibitor
pdb|3M11|A Chain A, Crystal Structure Of Aurora A Kinase Complexed With
Inhibitor
Length = 279
Score = 42.0 bits (97), Expect = 9e-04, Method: Compositional matrix adjust.
Identities = 44/198 (22%), Positives = 78/198 (39%), Gaps = 30/198 (15%)
Query: 376 VGRGSFGIVYKGVIQTTRQVL-LQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
+G+G FG VY + ++ +L L++ + + E + + EV + S H N++RL G
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLY------LHEDCS 488
+ + L+ E+ GT+ L K ++A L Y +H D
Sbjct: 77 YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIK 136
Query: 489 SQIILY------------------SYKRTE-----GYVAPEWFRNSTITAKVDVYSFGFL 525
+ +L S +RT+ Y+ PE KVD++S G L
Sbjct: 137 PENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVL 196
Query: 526 LLEIISCRKSFDIEMGEE 543
E + + F+ +E
Sbjct: 197 CYEFLVGKPPFEANTYQE 214
>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
pdb|4HGE|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
Length = 300
Score = 42.0 bits (97), Expect = 9e-04, Method: Compositional matrix adjust.
Identities = 49/209 (23%), Positives = 89/209 (42%), Gaps = 47/209 (22%)
Query: 366 EEATDNFKEEVGRGSFGIV----YKGVIQTTRQVLL--QLQSRNWIVFQDGEREFKNEVF 419
EE F +++G+G+FG V Y + T +V+ +LQ ++ R+F+ E+
Sbjct: 13 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST----EEHLRDFEREIE 68
Query: 420 VISQTHHKNLVRLLGFCDEGLNR--LLVYEFLNNGTLASFLFGNLKPSWNLR-TNIAFQI 476
++ H N+V+ G C R L+ E+L G+L +L + + +++ QI
Sbjct: 69 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 128
Query: 477 ARGLLYL------HEDCSSQIILYSYK-----------------------RTEG-----Y 502
+G+ YL H D +++ IL + + G +
Sbjct: 129 CKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 188
Query: 503 VAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
APE S + DV+SFG +L E+ +
Sbjct: 189 YAPESLTESKFSVASDVWSFGVVLYELFT 217
>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
pdb|4AQC|B Chain B, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
Length = 301
Score = 42.0 bits (97), Expect = 9e-04, Method: Compositional matrix adjust.
Identities = 49/209 (23%), Positives = 89/209 (42%), Gaps = 47/209 (22%)
Query: 366 EEATDNFKEEVGRGSFGIV----YKGVIQTTRQVLL--QLQSRNWIVFQDGEREFKNEVF 419
EE F +++G+G+FG V Y + T +V+ +LQ ++ R+F+ E+
Sbjct: 14 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST----EEHLRDFEREIE 69
Query: 420 VISQTHHKNLVRLLGFCDEGLNR--LLVYEFLNNGTLASFLFGNLKPSWNLR-TNIAFQI 476
++ H N+V+ G C R L+ E+L G+L +L + + +++ QI
Sbjct: 70 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 129
Query: 477 ARGLLYL------HEDCSSQIILYSYK-----------------------RTEG-----Y 502
+G+ YL H D +++ IL + + G +
Sbjct: 130 CKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 189
Query: 503 VAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
APE S + DV+SFG +L E+ +
Sbjct: 190 YAPESLTESKFSVASDVWSFGVVLYELFT 218
>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A
5-Aminopyrimidinyl Quinazoline Inhibitor
pdb|2C6E|B Chain B, Aurora A Kinase Activated Mutant (T287d) In Complex With A
5-Aminopyrimidinyl Quinazoline Inhibitor
Length = 283
Score = 42.0 bits (97), Expect = 9e-04, Method: Compositional matrix adjust.
Identities = 44/198 (22%), Positives = 78/198 (39%), Gaps = 30/198 (15%)
Query: 376 VGRGSFGIVYKGVIQTTRQVL-LQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
+G+G FG VY + ++ +L L++ + + E + + EV + S H N++RL G
Sbjct: 21 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLY------LHEDCS 488
+ + L+ E+ GT+ L K ++A L Y +H D
Sbjct: 81 YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIK 140
Query: 489 SQIILY------------------SYKRTE-----GYVAPEWFRNSTITAKVDVYSFGFL 525
+ +L S +RT+ Y+ PE KVD++S G L
Sbjct: 141 PENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVL 200
Query: 526 LLEIISCRKSFDIEMGEE 543
E + + F+ +E
Sbjct: 201 CYEFLVGKPPFEANTYQE 218
>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain
pdb|1XBB|A Chain A, Crystal Structure Of The Syk Tyrosine Kinase Domain With
Gleevec
pdb|1XBC|A Chain A, Crystal Structure Of The Syk Tyrosine Kinase Domain With
Staurosporin
pdb|3FQE|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
Ym193306
pdb|3FQH|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A 2-Substituted 7-Azaindole
pdb|3FQH|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A 2-Substituted 7-Azaindole
pdb|3FQS|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
R406
pdb|4FL1|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
pdb|4FYN|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
3-(8-{4-
[ethyl-(2-hydroxy-ethyl)-amino]-phenylamino}-imidazo[1,
2-a]pyrazin-5- Yl)-phenol
pdb|4FYO|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
N-{(s)-1-
[7-(3,4-dimethoxy-phenylamino)-thiazolo[5,
4-d]pyrimidin-5-yl]- Pyrrolidin-3-yl}-terephthalamic
Acid
pdb|4FZ6|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
[6-((s)-2-
Methyl-pyrrolidin-1-yl)-pyridin-2-yl]-(6-phenyl-
imidazo[1,2- B]pyridazin-8-yl)-amine
Length = 291
Score = 42.0 bits (97), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 49/194 (25%), Positives = 77/194 (39%), Gaps = 37/194 (19%)
Query: 374 EEVGRGSFGIVYKGVIQTTRQVLLQLQS--RNWIVFQDGEREFKNEVFVISQTHHKNLVR 431
+E+G G+FG V KG Q + V +N + E E V+ Q + +VR
Sbjct: 23 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82
Query: 432 LLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYL------HE 485
++G C E + +LV E G L +L N + Q++ G+ YL H
Sbjct: 83 MIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 141
Query: 486 DCSSQIIL-----------------------YSYKRTEG-----YVAPEWFRNSTITAKV 517
D +++ +L Y +T G + APE ++K
Sbjct: 142 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKS 201
Query: 518 DVYSFGFLLLEIIS 531
DV+SFG L+ E S
Sbjct: 202 DVWSFGVLMWEAFS 215
>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3OBG|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Mutants In
Response To Inhibitor Binding
pdb|3OC1|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 42.0 bits (97), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 47/199 (23%), Positives = 83/199 (41%), Gaps = 43/199 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
VG G++G V +T +V ++ SR + +R ++ E+ ++ H+N++ LL
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLH-- 484
+ E N+ L + L G N+ L + + +QI RGL Y+H
Sbjct: 89 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 485 ---------------EDCSSQII-----LYSYKRTEGYVAPEWFRNSTIT-------AKV 517
EDC +I+ ++ GYVA W+R I V
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTV 204
Query: 518 DVYSFGFLLLEIISCRKSF 536
D++S G ++ E+++ R F
Sbjct: 205 DIWSVGCIMAELLTGRTLF 223
>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With
Adpnp
Length = 275
Score = 42.0 bits (97), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 44/198 (22%), Positives = 78/198 (39%), Gaps = 30/198 (15%)
Query: 376 VGRGSFGIVYKGVIQTTRQVL-LQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
+G+G FG VY + ++ +L L++ + + E + + EV + S H N++RL G
Sbjct: 16 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLY------LHEDCS 488
+ + L+ E+ GT+ L K ++A L Y +H D
Sbjct: 76 YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIK 135
Query: 489 SQIILY------------------SYKRTE-----GYVAPEWFRNSTITAKVDVYSFGFL 525
+ +L S +RT+ Y+ PE KVD++S G L
Sbjct: 136 PENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVL 195
Query: 526 LLEIISCRKSFDIEMGEE 543
E + + F+ +E
Sbjct: 196 CYEFLVGKPPFEANTYQE 213
>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A Sulfonamidopyrazine Piperidine Inhibitor
pdb|4DFN|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
An Adamantylpyrazine Inhibitor
Length = 274
Score = 42.0 bits (97), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 49/194 (25%), Positives = 77/194 (39%), Gaps = 37/194 (19%)
Query: 374 EEVGRGSFGIVYKGVIQTTRQVLLQLQS--RNWIVFQDGEREFKNEVFVISQTHHKNLVR 431
+E+G G+FG V KG Q + V +N + E E V+ Q + +VR
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 432 LLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYL------HE 485
++G C E + +LV E G L +L N + Q++ G+ YL H
Sbjct: 73 MIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 131
Query: 486 DCSSQIIL-----------------------YSYKRTEG-----YVAPEWFRNSTITAKV 517
D +++ +L Y +T G + APE ++K
Sbjct: 132 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKS 191
Query: 518 DVYSFGFLLLEIIS 531
DV+SFG L+ E S
Sbjct: 192 DVWSFGVLMWEAFS 205
>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase
Length = 380
Score = 42.0 bits (97), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 47/199 (23%), Positives = 82/199 (41%), Gaps = 43/199 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
VG G++G V +T +V ++ SR + +R ++ E+ ++ H+N++ LL
Sbjct: 50 VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 108
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLH-- 484
+ E N+ L + L G N+ L + + +QI RGL Y+H
Sbjct: 109 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 164
Query: 485 ---------------EDCSSQIILYSYKR-----TEGYVAPEWFRNSTIT-------AKV 517
EDC +I+ + R G VA W+R I V
Sbjct: 165 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGXVATRWYRAPEIMLNWMHYNQTV 224
Query: 518 DVYSFGFLLLEIISCRKSF 536
D++S G ++ E+++ R F
Sbjct: 225 DIWSVGCIMAELLTGRTLF 243
>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
pdb|2FB8|B Chain B, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
Length = 281
Score = 42.0 bits (97), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 49/204 (24%), Positives = 86/204 (42%), Gaps = 59/204 (28%)
Query: 374 EEVGRGSFGIVYKG---------VIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQT 424
+ +G GSFG VYKG ++ T QLQ+ FKNEV V+ +T
Sbjct: 19 QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA------------FKNEVGVLRKT 66
Query: 425 HHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFL-FGNLKPSWNLRTNIAFQIARGL--- 480
H N++ +G+ + +V ++ +L L K +IA Q A+G+
Sbjct: 67 RHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 125
Query: 481 --------------LYLHEDCSSQII-------------LYSYKRTEG---YVAPEWFR- 509
++LHED + +I + +++ G ++APE R
Sbjct: 126 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 185
Query: 510 --NSTITAKVDVYSFGFLLLEIIS 531
+ + + DVY+FG +L E+++
Sbjct: 186 QDKNPYSFQSDVYAFGIVLYELMT 209
>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJC|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJD|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 19
pdb|3TJD|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 19
Length = 298
Score = 42.0 bits (97), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 49/209 (23%), Positives = 89/209 (42%), Gaps = 47/209 (22%)
Query: 366 EEATDNFKEEVGRGSFGIV----YKGVIQTTRQVLL--QLQSRNWIVFQDGEREFKNEVF 419
EE F +++G+G+FG V Y + T +V+ +LQ ++ R+F+ E+
Sbjct: 11 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST----EEHLRDFEREIE 66
Query: 420 VISQTHHKNLVRLLGFCDEGLNR--LLVYEFLNNGTLASFLFGNLKPSWNLR-TNIAFQI 476
++ H N+V+ G C R L+ E+L G+L +L + + +++ QI
Sbjct: 67 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 126
Query: 477 ARGLLYL------HEDCSSQIILYSYK-----------------------RTEG-----Y 502
+G+ YL H D +++ IL + + G +
Sbjct: 127 CKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 186
Query: 503 VAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
APE S + DV+SFG +L E+ +
Sbjct: 187 YAPESLTESKFSVASDVWSFGVVLYELFT 215
>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|2B7A|B Chain B, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|3FUP|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3FUP|B Chain B, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 293
Score = 42.0 bits (97), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 49/209 (23%), Positives = 89/209 (42%), Gaps = 47/209 (22%)
Query: 366 EEATDNFKEEVGRGSFGIV----YKGVIQTTRQVLL--QLQSRNWIVFQDGEREFKNEVF 419
EE F +++G+G+FG V Y + T +V+ +LQ ++ R+F+ E+
Sbjct: 6 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST----EEHLRDFEREIE 61
Query: 420 VISQTHHKNLVRLLGFCDEGLNR--LLVYEFLNNGTLASFLFGNLKPSWNLR-TNIAFQI 476
++ H N+V+ G C R L+ E+L G+L +L + + +++ QI
Sbjct: 62 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 121
Query: 477 ARGLLYL------HEDCSSQIILYSYK-----------------------RTEG-----Y 502
+G+ YL H D +++ IL + + G +
Sbjct: 122 CKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 181
Query: 503 VAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
APE S + DV+SFG +L E+ +
Sbjct: 182 YAPESLTESKFSVASDVWSFGVVLYELFT 210
>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain
pdb|4GT4|B Chain B, Structure Of Unliganded, Inactive Ror2 Kinase Domain
Length = 308
Score = 42.0 bits (97), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 49/225 (21%), Positives = 92/225 (40%), Gaps = 59/225 (26%)
Query: 363 KALEEATDNFKEEVGRGSFGIVYKGVI-------QTTRQVLLQLQSRNWIVFQDGEREFK 415
K + + F EE+G FG VYKG + QT + L+ + ++ EF+
Sbjct: 21 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLRE---EFR 77
Query: 416 NEVFVISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLF-----GNLKPSWNLRT 470
+E + ++ H N+V LLG + +++ + ++G L FL ++ + + RT
Sbjct: 78 HEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 137
Query: 471 -----------NIAFQIARGLLYL------HEDCSSQIILY------------------- 494
++ QIA G+ YL H+D +++ +L
Sbjct: 138 VKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYA 197
Query: 495 -SYKRTEG-------YVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
Y + G ++APE + D++S+G +L E+ S
Sbjct: 198 ADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242
>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
pdb|3Q32|B Chain B, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
Length = 301
Score = 42.0 bits (97), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 49/209 (23%), Positives = 89/209 (42%), Gaps = 47/209 (22%)
Query: 366 EEATDNFKEEVGRGSFGIV----YKGVIQTTRQVLL--QLQSRNWIVFQDGEREFKNEVF 419
EE F +++G+G+FG V Y + T +V+ +LQ ++ R+F+ E+
Sbjct: 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST----EEHLRDFEREIE 63
Query: 420 VISQTHHKNLVRLLGFCDEGLNR--LLVYEFLNNGTLASFLFGNLKPSWNLR-TNIAFQI 476
++ H N+V+ G C R L+ E+L G+L +L + + +++ QI
Sbjct: 64 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 123
Query: 477 ARGLLYL------HEDCSSQIILYSYK-----------------------RTEG-----Y 502
+G+ YL H D +++ IL + + G +
Sbjct: 124 CKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 183
Query: 503 VAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
APE S + DV+SFG +L E+ +
Sbjct: 184 YAPESLTESKFSVASDVWSFGVVLYELFT 212
>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
pdb|3IDP|B Chain B, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
Length = 300
Score = 42.0 bits (97), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 50/204 (24%), Positives = 84/204 (41%), Gaps = 59/204 (28%)
Query: 374 EEVGRGSFGIVYKG---------VIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQT 424
+ +G GSFG VYKG ++ T QLQ+ FKNEV V+ +T
Sbjct: 34 QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA------------FKNEVGVLRKT 81
Query: 425 HHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFL-FGNLKPSWNLRTNIAFQIARGL--- 480
H N++ +G+ + +V ++ +L L K +IA Q A+G+
Sbjct: 82 RHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 140
Query: 481 --------------LYLHEDCSSQI----ILYSYKRTEG------------YVAPEWFR- 509
++LHED + +I + R G ++APE R
Sbjct: 141 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 200
Query: 510 --NSTITAKVDVYSFGFLLLEIIS 531
+ + + DVY+FG +L E+++
Sbjct: 201 QDKNPYSFQSDVYAFGIVLYELMT 224
>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
pdb|3II5|B Chain B, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
Length = 306
Score = 42.0 bits (97), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 49/204 (24%), Positives = 86/204 (42%), Gaps = 59/204 (28%)
Query: 374 EEVGRGSFGIVYKG---------VIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQT 424
+ +G GSFG VYKG ++ T QLQ+ FKNEV V+ +T
Sbjct: 41 QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA------------FKNEVGVLRKT 88
Query: 425 HHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFL-FGNLKPSWNLRTNIAFQIARGL--- 480
H N++ +G+ + +V ++ +L L K +IA Q A+G+
Sbjct: 89 RHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 147
Query: 481 --------------LYLHEDCSSQII-------------LYSYKRTEG---YVAPEWFR- 509
++LHED + +I + +++ G ++APE R
Sbjct: 148 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 207
Query: 510 --NSTITAKVDVYSFGFLLLEIIS 531
+ + + DVY+FG +L E+++
Sbjct: 208 QDKNPYSFQSDVYAFGIVLYELMT 231
>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3D4Q|B Chain B, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3PSB|A Chain A, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PSB|B Chain B, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PPJ|A Chain A, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPJ|B Chain B, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPK|A Chain A, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PPK|B Chain B, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PRF|A Chain A, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRF|B Chain B, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRI|A Chain A, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3PRI|B Chain B, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3Q4C|A Chain A, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3Q4C|B Chain B, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3PSD|A Chain A, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3PSD|B Chain B, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3SKC|A Chain A, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3SKC|B Chain B, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3TV4|A Chain A, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV4|B Chain B, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV6|A Chain A, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|3TV6|B Chain B, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|4E26|A Chain A, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E26|B Chain B, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E4X|A Chain A, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4E4X|B Chain B, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4G9C|A Chain A, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
pdb|4G9C|B Chain B, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
Length = 307
Score = 42.0 bits (97), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 49/204 (24%), Positives = 86/204 (42%), Gaps = 59/204 (28%)
Query: 374 EEVGRGSFGIVYKG---------VIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQT 424
+ +G GSFG VYKG ++ T QLQ+ FKNEV V+ +T
Sbjct: 42 QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA------------FKNEVGVLRKT 89
Query: 425 HHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFL-FGNLKPSWNLRTNIAFQIARGL--- 480
H N++ +G+ + +V ++ +L L K +IA Q A+G+
Sbjct: 90 RHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 148
Query: 481 --------------LYLHEDCSSQII-------------LYSYKRTEG---YVAPEWFR- 509
++LHED + +I + +++ G ++APE R
Sbjct: 149 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 208
Query: 510 --NSTITAKVDVYSFGFLLLEIIS 531
+ + + DVY+FG +L E+++
Sbjct: 209 QDKNPYSFQSDVYAFGIVLYELMT 232
>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1GIJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|2DS1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
Length = 298
Score = 42.0 bits (97), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 52/217 (23%), Positives = 91/217 (41%), Gaps = 43/217 (19%)
Query: 370 DNFK--EEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHK 427
+NF+ E++G G++G+VYK + T +V+ + R + E+ ++ + +H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 428 NLVRLLGFCDEGLNRLLVYEFLNNGTL----ASFLFGNLKPSWNLRTNIAFQIARGLLY- 482
N+V+LL LV+E ++ AS L G P L + FQ+ +GL +
Sbjct: 62 NIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLP---LIKSYLFQLLQGLAFC 118
Query: 483 -----LHEDCSSQIIL-----------YSYKRTEGY--------VAPEWFRNSTI----- 513
LH D Q +L + R G V W+R I
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 514 --TAKVDVYSFGFLLLEIISCRKSF--DIEMGEEYAI 546
+ VD++S G + E+++ R F D E+ + + I
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 215
>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3LPB|B Chain B, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3KRR|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
Quinoxaline Atp Site Inhibitor
Length = 295
Score = 42.0 bits (97), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 49/209 (23%), Positives = 89/209 (42%), Gaps = 47/209 (22%)
Query: 366 EEATDNFKEEVGRGSFGIV----YKGVIQTTRQVLL--QLQSRNWIVFQDGEREFKNEVF 419
EE F +++G+G+FG V Y + T +V+ +LQ ++ R+F+ E+
Sbjct: 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST----EEHLRDFEREIE 63
Query: 420 VISQTHHKNLVRLLGFCDEGLNR--LLVYEFLNNGTLASFLFGNLKPSWNLR-TNIAFQI 476
++ H N+V+ G C R L+ E+L G+L +L + + +++ QI
Sbjct: 64 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 123
Query: 477 ARGLLYL------HEDCSSQIILYSYK-----------------------RTEG-----Y 502
+G+ YL H D +++ IL + + G +
Sbjct: 124 CKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 183
Query: 503 VAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
APE S + DV+SFG +L E+ +
Sbjct: 184 YAPESLTESKFSVASDVWSFGVVLYELFT 212
>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626
pdb|2J4Z|B Chain B, Structure Of Aurora-2 In Complex With Pha-680626
Length = 306
Score = 42.0 bits (97), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 44/198 (22%), Positives = 77/198 (38%), Gaps = 30/198 (15%)
Query: 376 VGRGSFGIVYKGVIQTTRQVL-LQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
+G+G FG VY + ++ +L L++ + + E + + EV + S H N++RL G
Sbjct: 42 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLY------LHEDCS 488
+ + L+ E+ GT+ L K ++A L Y +H D
Sbjct: 102 YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIK 161
Query: 489 SQIILY------------------SYKRTE-----GYVAPEWFRNSTITAKVDVYSFGFL 525
+ +L S +RT Y+ PE KVD++S G L
Sbjct: 162 PENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVL 221
Query: 526 LLEIISCRKSFDIEMGEE 543
E + + F+ +E
Sbjct: 222 CYEFLVGKPPFEANTYQE 239
>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E63|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E64|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
Length = 293
Score = 41.6 bits (96), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 49/209 (23%), Positives = 89/209 (42%), Gaps = 47/209 (22%)
Query: 366 EEATDNFKEEVGRGSFGIV----YKGVIQTTRQVLL--QLQSRNWIVFQDGEREFKNEVF 419
EE F +++G+G+FG V Y + T +V+ +LQ ++ R+F+ E+
Sbjct: 7 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST----EEHLRDFEREIE 62
Query: 420 VISQTHHKNLVRLLGFCDEGLNR--LLVYEFLNNGTLASFLFGNLKPSWNLR-TNIAFQI 476
++ H N+V+ G C R L+ E+L G+L +L + + +++ QI
Sbjct: 63 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 122
Query: 477 ARGLLYL------HEDCSSQIILYSYK-----------------------RTEG-----Y 502
+G+ YL H D +++ IL + + G +
Sbjct: 123 CKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 182
Query: 503 VAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
APE S + DV+SFG +L E+ +
Sbjct: 183 YAPESLTESKFSVASDVWSFGVVLYELFT 211
>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The
Kinase Domain Of Focal Adhesion Kinase With A
Phosphorylated Activation Loop
Length = 276
Score = 41.6 bits (96), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 60/247 (24%), Positives = 99/247 (40%), Gaps = 61/247 (24%)
Query: 376 VGRGSFGIVYKGVIQTTRQVLLQLQSRNWI-VFQDGERE-FKNEVFVISQTHHKNLVRLL 433
+G G FG V++G+ + + + + D RE F E + Q H ++V+L+
Sbjct: 18 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 434 GFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI--AFQIARGLLYL------HE 485
G E ++ E G L SFL K S +L + I A+Q++ L YL H
Sbjct: 78 GVITEN-PVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESKRFVHR 135
Query: 486 DCSSQIILYS---------------------YKRTEGYVAPEWFRNSTI-----TAKVDV 519
D +++ +L S K ++G + +W +I T+ DV
Sbjct: 136 DIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESINFRRFTSASDV 195
Query: 520 YSFGFLLLEII-SCRKSFD----------IEMGEE-----------YAILTD-WAFDCYR 556
+ FG + EI+ K F IE GE Y+++T WA+D R
Sbjct: 196 WMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSR 255
Query: 557 NGKLDDL 563
+ +L
Sbjct: 256 RPRFTEL 262
>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A
Gsk3beta Inhibitor
Length = 287
Score = 41.6 bits (96), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 44/198 (22%), Positives = 78/198 (39%), Gaps = 30/198 (15%)
Query: 376 VGRGSFGIVYKGVIQTTRQVL-LQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
+G+G FG VY + ++ +L L++ + + E + + EV + S H N++RL G
Sbjct: 16 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLY------LHEDCS 488
+ + L+ E+ GT+ L K ++A L Y +H D
Sbjct: 76 YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIK 135
Query: 489 SQIILY------------------SYKRTE-----GYVAPEWFRNSTITAKVDVYSFGFL 525
+ +L S +RT+ Y+ PE KVD++S G L
Sbjct: 136 PENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVL 195
Query: 526 LLEIISCRKSFDIEMGEE 543
E + + F+ +E
Sbjct: 196 CYEFLVGKPPFEANTYQE 213
>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006
pdb|1UWJ|B Chain B, The Complex Of Mutant V599e B-raf And Bay439006
Length = 276
Score = 41.6 bits (96), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 50/204 (24%), Positives = 84/204 (41%), Gaps = 59/204 (28%)
Query: 374 EEVGRGSFGIVYKG---------VIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQT 424
+ +G GSFG VYKG ++ T QLQ+ FKNEV V+ +T
Sbjct: 14 QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA------------FKNEVGVLRKT 61
Query: 425 HHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFL-FGNLKPSWNLRTNIAFQIARGL--- 480
H N++ +G+ + +V ++ +L L K +IA Q A+G+
Sbjct: 62 RHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 120
Query: 481 --------------LYLHEDCSSQI----ILYSYKRTEG------------YVAPEWFR- 509
++LHED + +I + R G ++APE R
Sbjct: 121 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 510 --NSTITAKVDVYSFGFLLLEIIS 531
+ + + DVY+FG +L E+++
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMT 204
>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
pdb|4DBN|B Chain B, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
Length = 284
Score = 41.6 bits (96), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 49/204 (24%), Positives = 86/204 (42%), Gaps = 59/204 (28%)
Query: 374 EEVGRGSFGIVYKG---------VIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQT 424
+ +G GSFG VYKG ++ T QLQ+ FKNEV V+ +T
Sbjct: 19 QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA------------FKNEVGVLRKT 66
Query: 425 HHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFL-FGNLKPSWNLRTNIAFQIARGL--- 480
H N++ +G+ + +V ++ +L L K +IA Q A+G+
Sbjct: 67 RHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 125
Query: 481 --------------LYLHEDCSSQII-------------LYSYKRTEG---YVAPEWFR- 509
++LHED + +I + +++ G ++APE R
Sbjct: 126 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 185
Query: 510 --NSTITAKVDVYSFGFLLLEIIS 531
+ + + DVY+FG +L E+++
Sbjct: 186 QDKNPYSFQSDVYAFGIVLYELMT 209
>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A
1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor
Length = 303
Score = 41.6 bits (96), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 49/209 (23%), Positives = 89/209 (42%), Gaps = 47/209 (22%)
Query: 366 EEATDNFKEEVGRGSFGIV----YKGVIQTTRQVLL--QLQSRNWIVFQDGEREFKNEVF 419
EE F +++G+G+FG V Y + T +V+ +LQ ++ R+F+ E+
Sbjct: 12 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST----EEHLRDFEREIE 67
Query: 420 VISQTHHKNLVRLLGFCDEGLNR--LLVYEFLNNGTLASFLFGNLKPSWNLR-TNIAFQI 476
++ H N+V+ G C R L+ E+L G+L +L + + +++ QI
Sbjct: 68 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 127
Query: 477 ARGLLYL------HEDCSSQIILYSYK-----------------------RTEG-----Y 502
+G+ YL H D +++ IL + + G +
Sbjct: 128 CKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 187
Query: 503 VAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
APE S + DV+SFG +L E+ +
Sbjct: 188 YAPESLTESKFSVASDVWSFGVVLYELFT 216
>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
pdb|3Q96|B Chain B, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
Length = 282
Score = 41.6 bits (96), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 49/204 (24%), Positives = 86/204 (42%), Gaps = 59/204 (28%)
Query: 374 EEVGRGSFGIVYKG---------VIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQT 424
+ +G GSFG VYKG ++ T QLQ+ FKNEV V+ +T
Sbjct: 16 QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA------------FKNEVGVLRKT 63
Query: 425 HHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFL-FGNLKPSWNLRTNIAFQIARGL--- 480
H N++ +G+ + +V ++ +L L K +IA Q A+G+
Sbjct: 64 RHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 122
Query: 481 --------------LYLHEDCSSQII-------------LYSYKRTEG---YVAPEWFR- 509
++LHED + +I + +++ G ++APE R
Sbjct: 123 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 182
Query: 510 --NSTITAKVDVYSFGFLLLEIIS 531
+ + + DVY+FG +L E+++
Sbjct: 183 QDKNPYSFQSDVYAFGIVLYELMT 206
>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3KCK|A Chain A, A Novel Chemotype Of Kinase Inhibitors
Length = 313
Score = 41.6 bits (96), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 49/209 (23%), Positives = 89/209 (42%), Gaps = 47/209 (22%)
Query: 366 EEATDNFKEEVGRGSFGIV----YKGVIQTTRQVLL--QLQSRNWIVFQDGEREFKNEVF 419
EE F +++G+G+FG V Y + T +V+ +LQ ++ R+F+ E+
Sbjct: 26 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST----EEHLRDFEREIE 81
Query: 420 VISQTHHKNLVRLLGFCDEGLNR--LLVYEFLNNGTLASFLFGNLKPSWNLR-TNIAFQI 476
++ H N+V+ G C R L+ E+L G+L +L + + +++ QI
Sbjct: 82 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 141
Query: 477 ARGLLYL------HEDCSSQIILYSYK-----------------------RTEG-----Y 502
+G+ YL H D +++ IL + + G +
Sbjct: 142 CKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 201
Query: 503 VAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
APE S + DV+SFG +L E+ +
Sbjct: 202 YAPESLTESKFSVASDVWSFGVVLYELFT 230
>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|B Chain B, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|C Chain C, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|D Chain D, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|E Chain E, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|F Chain F, Aurora-2 T287d T288d Complexed With Pha-680632
Length = 306
Score = 41.6 bits (96), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 44/198 (22%), Positives = 77/198 (38%), Gaps = 30/198 (15%)
Query: 376 VGRGSFGIVYKGVIQTTRQVL-LQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
+G+G FG VY + ++ +L L++ + + E + + EV + S H N++RL G
Sbjct: 42 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLY------LHEDCS 488
+ + L+ E+ GT+ L K ++A L Y +H D
Sbjct: 102 YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIK 161
Query: 489 SQIILY------------------SYKR-----TEGYVAPEWFRNSTITAKVDVYSFGFL 525
+ +L S +R T Y+ PE KVD++S G L
Sbjct: 162 PENLLLGSAGELKIADFGWSVHAPSSRRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVL 221
Query: 526 LLEIISCRKSFDIEMGEE 543
E + + F+ +E
Sbjct: 222 CYEFLVGKPPFEANTYQE 239
>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The
Phosphate-responsive Signal Transduction Pathway
pdb|2PK9|C Chain C, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The
Phosphate-responsive Signal Transduction Pathway
pdb|2PMI|A Chain A, Structure Of The Pho85-Pho80 Cdk-Cyclin Complex Of The
Phosphate- Responsive Signal Transduction Pathway With
Bound Atp-Gamma-S
pdb|2PMI|C Chain C, Structure Of The Pho85-Pho80 Cdk-Cyclin Complex Of The
Phosphate- Responsive Signal Transduction Pathway With
Bound Atp-Gamma-S
Length = 317
Score = 41.6 bits (96), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 48/200 (24%), Positives = 83/200 (41%), Gaps = 38/200 (19%)
Query: 374 EEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLL 433
E++G G++ VYKG+ +TT V + L+ + E+ ++ + H+N+VRL
Sbjct: 11 EKLGNGTYATVYKGLNKTT-GVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLY 69
Query: 434 GFCDEGLNRLLVYEFLNNGT---LASFLFGNLKP--SWNLRTNIAFQIARGLLY------ 482
LV+EF++N + S GN NL +Q+ +GL +
Sbjct: 70 DVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKI 129
Query: 483 LHEDCSSQIIL-----------YSYKRTEGY--------VAPEWFR-------NSTITAK 516
LH D Q +L + R G V W+R + T +
Sbjct: 130 LHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTS 189
Query: 517 VDVYSFGFLLLEIISCRKSF 536
+D++S G +L E+I+ + F
Sbjct: 190 IDIWSCGCILAEMITGKPLF 209
>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From
Par-3
Length = 396
Score = 41.6 bits (96), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 49/197 (24%), Positives = 78/197 (39%), Gaps = 35/197 (17%)
Query: 376 VGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREF-KNEVFVISQTHHKNLVRLLG 434
+GRGS+ V ++ T ++ + +V D + ++ + E V Q + + L
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119
Query: 435 FCDEGLNRLL-VYEFLNNGTLASFLFGNLK-PSWNLRTNIAFQIARGLLYLHE------- 485
C + +RL V E++N G L + K P + R A +I+ L YLHE
Sbjct: 120 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHERGIIYRD 178
Query: 486 --------DCSSQIILYSYKR----------------TEGYVAPEWFRNSTITAKVDVYS 521
D I L Y T Y+APE R VD ++
Sbjct: 179 LKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWA 238
Query: 522 FGFLLLEIISCRKSFDI 538
G L+ E+++ R FDI
Sbjct: 239 LGVLMFEMMAGRSPFDI 255
>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors
Length = 311
Score = 41.6 bits (96), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 49/209 (23%), Positives = 89/209 (42%), Gaps = 47/209 (22%)
Query: 366 EEATDNFKEEVGRGSFGIV----YKGVIQTTRQVLL--QLQSRNWIVFQDGEREFKNEVF 419
EE F +++G+G+FG V Y + T +V+ +LQ ++ R+F+ E+
Sbjct: 26 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST----EEHLRDFEREIE 81
Query: 420 VISQTHHKNLVRLLGFCDEGLNR--LLVYEFLNNGTLASFLFGNLKPSWNLR-TNIAFQI 476
++ H N+V+ G C R L+ E+L G+L +L + + +++ QI
Sbjct: 82 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 141
Query: 477 ARGLLYL------HEDCSSQIILYSYK-----------------------RTEG-----Y 502
+G+ YL H D +++ IL + + G +
Sbjct: 142 CKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 201
Query: 503 VAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
APE S + DV+SFG +L E+ +
Sbjct: 202 YAPESLTESKFSVASDVWSFGVVLYELFT 230
>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of
CalciumCALMODULIN ACTIVATED KINASE II
pdb|2BDW|B Chain B, Crystal Structure Of The Auto-Inhibited Kinase Domain Of
CalciumCALMODULIN ACTIVATED KINASE II
Length = 362
Score = 41.6 bits (96), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 51/234 (21%), Positives = 93/234 (39%), Gaps = 44/234 (18%)
Query: 360 FSYKALEEATDNF--KEEVGRGSFGIVYKGVIQTT----RQVLLQLQSRNWIVFQDGERE 413
F A + +DN+ KEE+G+G+F +V + V +TT ++ + + FQ ERE
Sbjct: 19 FMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLERE 78
Query: 414 FKNEVFVISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA 473
+ + + H N+VRL E LV++ + G L + S ++
Sbjct: 79 AR----ICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCI 134
Query: 474 FQIARGLLY------LHEDCSSQIILYSYKR---------------------------TE 500
QI + Y +H + + +L + K T
Sbjct: 135 QQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTP 194
Query: 501 GYVAPEWFRNSTITAKVDVYSFGFLLLEIISCRKSF-DIEMGEEYAILTDWAFD 553
GY++PE + + VD+++ G +L ++ F D + YA + A+D
Sbjct: 195 GYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 248
>pdb|4H58|A Chain A, Braf In Complex With Compound 3
pdb|4H58|B Chain B, Braf In Complex With Compound 3
pdb|4H58|C Chain C, Braf In Complex With Compound 3
Length = 275
Score = 41.6 bits (96), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 49/204 (24%), Positives = 86/204 (42%), Gaps = 59/204 (28%)
Query: 374 EEVGRGSFGIVYKG---------VIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQT 424
+ +G GSFG VYKG ++ T QLQ+ FKNEV V+ +T
Sbjct: 14 QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA------------FKNEVGVLRKT 61
Query: 425 HHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFL-FGNLKPSWNLRTNIAFQIARGL--- 480
H N++ +G+ + +V ++ +L L K +IA Q A+G+
Sbjct: 62 RHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 120
Query: 481 --------------LYLHEDCSSQII-------------LYSYKRTEG---YVAPEWFR- 509
++LHED + +I + +++ G ++APE R
Sbjct: 121 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 510 --NSTITAKVDVYSFGFLLLEIIS 531
+ + + DVY+FG +L E+++
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMT 204
>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571
Inhibition Of C-kit Tyrosine Kinase
Length = 313
Score = 41.6 bits (96), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 49/217 (22%), Positives = 89/217 (41%), Gaps = 56/217 (25%)
Query: 371 NFKEEVGRGSFGIVYK----GVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQT-H 425
+F + +G G+FG V + G+I++ + + ++ +E+ V+S +
Sbjct: 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 85
Query: 426 HKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFL------FGNLKPSWNLR---------- 469
H N+V LLG C G L++ E+ G L +FL F K S +
Sbjct: 86 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 470 --TNIAFQIARGLLYL------HEDCSSQIILYSYKRTE--------------------- 500
+ ++Q+A+G+ +L H D +++ IL ++ R
Sbjct: 146 DLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 501 ------GYVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
++APE N T + DV+S+G L E+ S
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain
pdb|3A8W|B Chain B, Crystal Structure Of Pkciota Kinase Domain
pdb|3A8X|A Chain A, Crystal Structure Of Pkciota Kinase Domain
pdb|3A8X|B Chain B, Crystal Structure Of Pkciota Kinase Domain
Length = 345
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 49/197 (24%), Positives = 78/197 (39%), Gaps = 35/197 (17%)
Query: 376 VGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREF-KNEVFVISQTHHKNLVRLLG 434
+GRGS+ V ++ T ++ + +V D + ++ + E V Q + + L
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76
Query: 435 FCDEGLNRLL-VYEFLNNGTLASFLFGNLK-PSWNLRTNIAFQIARGLLYLHE------- 485
C + +RL V E++N G L + K P + R A +I+ L YLHE
Sbjct: 77 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHERGIIYRD 135
Query: 486 --------DCSSQIILYSYKR----------------TEGYVAPEWFRNSTITAKVDVYS 521
D I L Y T Y+APE R VD ++
Sbjct: 136 LKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWA 195
Query: 522 FGFLLLEIISCRKSFDI 538
G L+ E+++ R FDI
Sbjct: 196 LGVLMFEMMAGRSPFDI 212
>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In
Complex With A Diaminopyrimidine Carboxamide Inhibitor
Length = 277
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 50/194 (25%), Positives = 78/194 (40%), Gaps = 37/194 (19%)
Query: 374 EEVGRGSFGIVYKGVIQTTRQVLLQLQS--RNWIVFQDGEREFKNEVFVISQTHHKNLVR 431
+E+G G+FG V KG Q + V +N + E E V+ Q + +VR
Sbjct: 17 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 76
Query: 432 LLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYL------HE 485
++G C E + +LV E G L +L N + Q++ G+ YL H
Sbjct: 77 MIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 135
Query: 486 DCSSQIILY----------------------SYK-RTEG-----YVAPEWFRNSTITAKV 517
D +++ +L YK +T G + APE ++K
Sbjct: 136 DLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINYYKFSSKS 195
Query: 518 DVYSFGFLLLEIIS 531
DV+SFG L+ E S
Sbjct: 196 DVWSFGVLMWEAFS 209
>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine-
Threonine Kinase
Length = 297
Score = 41.2 bits (95), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 44/198 (22%), Positives = 77/198 (38%), Gaps = 30/198 (15%)
Query: 376 VGRGSFGIVYKGVIQTTRQVL-LQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
+G+G FG VY + ++ +L L++ + + E + + EV + S H N++RL G
Sbjct: 33 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 92
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLY------LHEDCS 488
+ + L+ E+ GT+ L K ++A L Y +H D
Sbjct: 93 YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIK 152
Query: 489 SQIILY------------------SYKRTE-----GYVAPEWFRNSTITAKVDVYSFGFL 525
+ +L S +RT Y+ PE KVD++S G L
Sbjct: 153 PENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVL 212
Query: 526 LLEIISCRKSFDIEMGEE 543
E + + F+ +E
Sbjct: 213 CYEFLVGKPPFEANTYQE 230
>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358
pdb|2J50|B Chain B, Structure Of Aurora-2 In Complex With Pha-739358
Length = 280
Score = 41.2 bits (95), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 44/198 (22%), Positives = 77/198 (38%), Gaps = 30/198 (15%)
Query: 376 VGRGSFGIVYKGVIQTTRQVL-LQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
+G+G FG VY + ++ +L L++ + + E + + EV + S H N++RL G
Sbjct: 16 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLY------LHEDCS 488
+ + L+ E+ GT+ L K ++A L Y +H D
Sbjct: 76 YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIK 135
Query: 489 SQIILY------------------SYKRTE-----GYVAPEWFRNSTITAKVDVYSFGFL 525
+ +L S +RT Y+ PE KVD++S G L
Sbjct: 136 PENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVL 195
Query: 526 LLEIISCRKSFDIEMGEE 543
E + + F+ +E
Sbjct: 196 CYEFLVGKPPFEANTYQE 213
>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical
Protein Kinase C-Iota
Length = 364
Score = 41.2 bits (95), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 49/197 (24%), Positives = 78/197 (39%), Gaps = 35/197 (17%)
Query: 376 VGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREF-KNEVFVISQTHHKNLVRLLG 434
+GRGS+ V ++ T ++ + +V D + ++ + E V Q + + L
Sbjct: 28 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 87
Query: 435 FCDEGLNRLL-VYEFLNNGTLASFLFGNLK-PSWNLRTNIAFQIARGLLYLHE------- 485
C + +RL V E++N G L + K P + R A +I+ L YLHE
Sbjct: 88 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHERGIIYRD 146
Query: 486 --------DCSSQIILYSYKR----------------TEGYVAPEWFRNSTITAKVDVYS 521
D I L Y T Y+APE R VD ++
Sbjct: 147 LKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWA 206
Query: 522 FGFLLLEIISCRKSFDI 538
G L+ E+++ R FDI
Sbjct: 207 LGVLMFEMMAGRSPFDI 223
>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor
pdb|2X6E|A Chain A, Aurora-A Bound To An Inhibitor
Length = 285
Score = 41.2 bits (95), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 44/198 (22%), Positives = 77/198 (38%), Gaps = 30/198 (15%)
Query: 376 VGRGSFGIVYKGVIQTTRQVL-LQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
+G+G FG VY + ++ +L L++ + + E + + EV + S H N++RL G
Sbjct: 21 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLY------LHEDCS 488
+ + L+ E+ GT+ L K ++A L Y +H D
Sbjct: 81 YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIK 140
Query: 489 SQIILY------------------SYKRTE-----GYVAPEWFRNSTITAKVDVYSFGFL 525
+ +L S +RT Y+ PE KVD++S G L
Sbjct: 141 PENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVL 200
Query: 526 LLEIISCRKSFDIEMGEE 543
E + + F+ +E
Sbjct: 201 CYEFLVGKPPFEANTYQE 218
>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 306
Score = 41.2 bits (95), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 50/206 (24%), Positives = 80/206 (38%), Gaps = 49/206 (23%)
Query: 375 EVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFK----NEVFVISQTH---HK 427
E+G G++G VYK + + L+S + +GE EV ++ + H
Sbjct: 11 EIGVGAYGTVYKARDPHSGH-FVALKS---VRVPNGEEGLPISTVREVALLRRLEAFEHP 66
Query: 428 NLVRLLGFC-----DEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGL 480
N+VRL+ C D + LV+E ++ L ++L P T ++ Q RGL
Sbjct: 67 NVVRLMDVCATSRTDREIKVTLVFEHVDQD-LRTYLDKAPPPGLPAETIKDLMRQFLRGL 125
Query: 481 LYLHEDC------------------------------SSQIILYSYKRTEGYVAPEWFRN 510
+LH +C S Q+ L+ T Y APE
Sbjct: 126 DFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVVTLWYRAPEVLLQ 185
Query: 511 STITAKVDVYSFGFLLLEIISCRKSF 536
ST VD++S G + E+ + F
Sbjct: 186 STYATPVDMWSVGCIFAEMFRRKPLF 211
>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor
pdb|3ZH8|B Chain B, A Novel Small Molecule Apkc Inhibitor
pdb|3ZH8|C Chain C, A Novel Small Molecule Apkc Inhibitor
Length = 349
Score = 41.2 bits (95), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 49/197 (24%), Positives = 78/197 (39%), Gaps = 35/197 (17%)
Query: 376 VGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREF-KNEVFVISQTHHKNLVRLLG 434
+GRGS+ V ++ T ++ + +V D + ++ + E V Q + + L
Sbjct: 13 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 72
Query: 435 FCDEGLNRLL-VYEFLNNGTLASFLFGNLK-PSWNLRTNIAFQIARGLLYLHE------- 485
C + +RL V E++N G L + K P + R A +I+ L YLHE
Sbjct: 73 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHERGIIYRD 131
Query: 486 --------DCSSQIILYSYKR----------------TEGYVAPEWFRNSTITAKVDVYS 521
D I L Y T Y+APE R VD ++
Sbjct: 132 LKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWA 191
Query: 522 FGFLLLEIISCRKSFDI 538
G L+ E+++ R FDI
Sbjct: 192 LGVLMFEMMAGRSPFDI 208
>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex
pdb|1PKG|B Chain B, Structure Of A C-kit Kinase Product Complex
Length = 329
Score = 41.2 bits (95), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 47/217 (21%), Positives = 87/217 (40%), Gaps = 56/217 (25%)
Query: 371 NFKEEVGRGSFGIVYK----GVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQT-H 425
+F + +G G+FG V + G+I++ + + ++ +E+ V+S +
Sbjct: 42 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 101
Query: 426 HKNLVRLLGFCDEGLNRLLVYEFLNNGTLA--------SFLFGNLKPS----------WN 467
H N+V LLG C G L++ E+ G L SF+ P+
Sbjct: 102 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 161
Query: 468 LRTNIAFQIARGLLYL------HEDCSSQIILYSYKRTE--------------------- 500
+ ++Q+A+G+ +L H D +++ IL ++ R
Sbjct: 162 DLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 221
Query: 501 ------GYVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
++APE N T + DV+S+G L E+ S
Sbjct: 222 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 258
>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine
Inhibitor
Length = 283
Score = 41.2 bits (95), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 44/198 (22%), Positives = 77/198 (38%), Gaps = 30/198 (15%)
Query: 376 VGRGSFGIVYKGVIQTTRQVL-LQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
+G+G FG VY + ++ +L L++ + + E + + EV + S H N++RL G
Sbjct: 19 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLY------LHEDCS 488
+ + L+ E+ GT+ L K ++A L Y +H D
Sbjct: 79 YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIK 138
Query: 489 SQIILY------------------SYKRTE-----GYVAPEWFRNSTITAKVDVYSFGFL 525
+ +L S +RT Y+ PE KVD++S G L
Sbjct: 139 PENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVL 198
Query: 526 LLEIISCRKSFDIEMGEE 543
E + + F+ +E
Sbjct: 199 CYEFLVGKPPFEANTYQE 216
>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006
pdb|1UWH|B Chain B, The Complex Of Wild Type B-Raf And Bay439006
Length = 276
Score = 41.2 bits (95), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 49/204 (24%), Positives = 85/204 (41%), Gaps = 59/204 (28%)
Query: 374 EEVGRGSFGIVYKG---------VIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQT 424
+ +G GSFG VYKG ++ T QLQ+ FKNEV V+ +T
Sbjct: 14 QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA------------FKNEVGVLRKT 61
Query: 425 HHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFL-FGNLKPSWNLRTNIAFQIARGL--- 480
H N++ +G+ +V ++ +L L K +IA Q A+G+
Sbjct: 62 RHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 120
Query: 481 --------------LYLHEDCSSQI-------------ILYSYKRTEG---YVAPEWFR- 509
++LHED + +I + +++ G ++APE R
Sbjct: 121 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 510 --NSTITAKVDVYSFGFLLLEIIS 531
+ + + DVY+FG +L E+++
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMT 204
>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A
Diaminopyrimidine
Length = 281
Score = 40.8 bits (94), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 44/198 (22%), Positives = 77/198 (38%), Gaps = 30/198 (15%)
Query: 376 VGRGSFGIVYKGVIQTTRQVL-LQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
+G+G FG VY + ++ +L L++ + + E + + EV + S H N++RL G
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLY------LHEDCS 488
+ + L+ E+ GT+ L K ++A L Y +H D
Sbjct: 77 YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIK 136
Query: 489 SQIILY------------------SYKRTE-----GYVAPEWFRNSTITAKVDVYSFGFL 525
+ +L S +RT Y+ PE KVD++S G L
Sbjct: 137 PENLLLGSAGELKIADFGWSCHAPSSRRTTLSGTLDYLPPEMIEGRMHDEKVDLWSLGVL 196
Query: 526 LLEIISCRKSFDIEMGEE 543
E + + F+ +E
Sbjct: 197 CYEFLVGKPPFEANTYQE 214
>pdb|3KK9|A Chain A, Camkii Substrate Complex B
Length = 282
Score = 40.8 bits (94), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 49/225 (21%), Positives = 90/225 (40%), Gaps = 44/225 (19%)
Query: 369 TDNF--KEEVGRGSFGIVYKGVIQTT----RQVLLQLQSRNWIVFQDGEREFKNEVFVIS 422
+DN+ KEE+G+G+F +V + V +TT ++ + + FQ ERE + +
Sbjct: 4 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREAR----ICR 59
Query: 423 QTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLY 482
+ H N+VRL E LV++ + G L + S ++ QI + Y
Sbjct: 60 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAY 119
Query: 483 ------LHEDCSSQIILYSYKR---------------------------TEGYVAPEWFR 509
+H + + +L + K T GY++PE +
Sbjct: 120 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLK 179
Query: 510 NSTITAKVDVYSFGFLLLEIISCRKSF-DIEMGEEYAILTDWAFD 553
+ VD+++ G +L ++ F D + YA + A+D
Sbjct: 180 KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 224
>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib
Length = 336
Score = 40.8 bits (94), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 49/217 (22%), Positives = 89/217 (41%), Gaps = 56/217 (25%)
Query: 371 NFKEEVGRGSFGIVYK----GVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQT-H 425
+F + +G G+FG V + G+I++ + + ++ +E+ V+S +
Sbjct: 49 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 108
Query: 426 HKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFL------FGNLKPSWNLR---------- 469
H N+V LLG C G L++ E+ G L +FL F K S +
Sbjct: 109 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 168
Query: 470 --TNIAFQIARGLLYL------HEDCSSQIILYSYKRTE--------------------- 500
+ ++Q+A+G+ +L H D +++ IL ++ R
Sbjct: 169 DLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 228
Query: 501 ------GYVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
++APE N T + DV+S+G L E+ S
Sbjct: 229 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265
>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a
Length = 282
Score = 40.8 bits (94), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 44/198 (22%), Positives = 77/198 (38%), Gaps = 30/198 (15%)
Query: 376 VGRGSFGIVYKGVIQTTRQVL-LQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
+G+G FG VY + ++ +L L++ + + E + + EV + S H N++RL G
Sbjct: 18 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLY------LHEDCS 488
+ + L+ E+ GT+ L K ++A L Y +H D
Sbjct: 78 YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIK 137
Query: 489 SQIILY------------------SYKRTE-----GYVAPEWFRNSTITAKVDVYSFGFL 525
+ +L S +RT Y+ PE KVD++S G L
Sbjct: 138 PENLLLGSAGELKIANFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVL 197
Query: 526 LLEIISCRKSFDIEMGEE 543
E + + F+ +E
Sbjct: 198 CYEFLVGKPPFEANTYQE 215
>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat
Length = 332
Score = 40.8 bits (94), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 42/199 (21%), Positives = 79/199 (39%), Gaps = 36/199 (18%)
Query: 362 YKALEEATD--NFKEEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVF 419
+K E+ D +F++ +G G+F V + T Q L+ ++ + E +NE+
Sbjct: 10 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRT-QKLVAIKCIAKKALEGKEGSMENEIA 68
Query: 420 VISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARG 479
V+ + H N+V L + G + L+ + ++ G L + + + + FQ+
Sbjct: 69 VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDA 128
Query: 480 LLYLHE------------------DCSSQIILYSYKR---------------TEGYVAPE 506
+ YLH+ D S+I++ + T GYVAPE
Sbjct: 129 VKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE 188
Query: 507 WFRNSTITAKVDVYSFGFL 525
+ VD +S G +
Sbjct: 189 VLAQKPYSKAVDCWSIGVI 207
>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580
pdb|3GCQ|A Chain A, Human P38 Map Kinase In Complex With Rl45
pdb|3GCS|A Chain A, Human P38 Map Kinase In Complex With Sorafenib
pdb|3GCV|A Chain A, Human P38 Map Kinase In Complex With Rl62
pdb|3HV3|A Chain A, Human P38 Map Kinase In Complex With Rl49
pdb|3IW5|A Chain A, Human P38 Map Kinase In Complex With An Indole Derivative
pdb|3IW6|A Chain A, Human P38 Map Kinase In Complex With A Benzylpiperazin-
Pyrrol
pdb|3IW7|A Chain A, Human P38 Map Kinase In Complex With An Imidazo-Pyridine
pdb|3IW8|A Chain A, Structure Of Inactive Human P38 Map Kinase In Complex With
A Thiazole-Urea
pdb|3HUB|A Chain A, Human P38 Map Kinase In Complex With Scios-469
pdb|3L8S|A Chain A, Human P38 Map Kinase In Complex With Cp-547632
pdb|3LFB|A Chain A, Human P38 Map Kinase In Complex With Rl98
pdb|3LFC|A Chain A, Human P38 Map Kinase In Complex With Rl99
pdb|3LFD|A Chain A, Human P38 Map Kinase In Complex With Rl113
pdb|3LFE|A Chain A, Human P38 Map Kinase In Complex With Rl116
pdb|3LFF|A Chain A, Human P38 Map Kinase In Complex With Rl166
pdb|3PG3|A Chain A, Human P38 Map Kinase In Complex With Rl182
Length = 360
Score = 40.8 bits (94), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 48/199 (24%), Positives = 83/199 (41%), Gaps = 43/199 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
VG G++G V +T +V ++ SR + +R ++ E+ ++ H+N++ LL
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLH-- 484
+ E N+ L + L G N+ S L + + +QI RGL Y+H
Sbjct: 89 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 485 ---------------EDCSSQIILYSYKR-----TEGYVAPEWFRNSTIT-------AKV 517
ED +I+ + R GYVA W+R I V
Sbjct: 145 DIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMTGYVATRWYRAPEIMLNWMHYNQTV 204
Query: 518 DVYSFGFLLLEIISCRKSF 536
D++S G ++ E+++ R F
Sbjct: 205 DIWSVGCIMAELLTGRTLF 223
>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex
pdb|3KL8|C Chain C, Camkiintide Inhibitor Complex
pdb|3KL8|E Chain E, Camkiintide Inhibitor Complex
pdb|3KL8|G Chain G, Camkiintide Inhibitor Complex
pdb|3KL8|I Chain I, Camkiintide Inhibitor Complex
Length = 269
Score = 40.8 bits (94), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 49/225 (21%), Positives = 90/225 (40%), Gaps = 44/225 (19%)
Query: 369 TDNF--KEEVGRGSFGIVYKGVIQTT----RQVLLQLQSRNWIVFQDGEREFKNEVFVIS 422
+DN+ KEE+G+G+F +V + V +TT ++ + + FQ ERE + +
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREAR----ICR 60
Query: 423 QTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLY 482
+ H N+VRL E LV++ + G L + S ++ QI + Y
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAY 120
Query: 483 ------LHEDCSSQIILYSYKR---------------------------TEGYVAPEWFR 509
+H + + +L + K T GY++PE +
Sbjct: 121 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLK 180
Query: 510 NSTITAKVDVYSFGFLLLEIISCRKSF-DIEMGEEYAILTDWAFD 553
+ VD+++ G +L ++ F D + YA + A+D
Sbjct: 181 KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 225
>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571
Inhibition Of C- Kit Tyrosine Kinase
Length = 331
Score = 40.8 bits (94), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 49/217 (22%), Positives = 89/217 (41%), Gaps = 56/217 (25%)
Query: 371 NFKEEVGRGSFGIVYK----GVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQT-H 425
+F + +G G+FG V + G+I++ + + ++ +E+ V+S +
Sbjct: 44 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 103
Query: 426 HKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFL------FGNLKPSWNLR---------- 469
H N+V LLG C G L++ E+ G L +FL F K S +
Sbjct: 104 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 163
Query: 470 --TNIAFQIARGLLYL------HEDCSSQIILYSYKRTE--------------------- 500
+ ++Q+A+G+ +L H D +++ IL ++ R
Sbjct: 164 DLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 223
Query: 501 ------GYVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
++APE N T + DV+S+G L E+ S
Sbjct: 224 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 260
>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib
pdb|3G0F|B Chain B, Kit Kinase Domain Mutant D816h In Complex With Sunitinib
Length = 336
Score = 40.8 bits (94), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 49/217 (22%), Positives = 89/217 (41%), Gaps = 56/217 (25%)
Query: 371 NFKEEVGRGSFGIVYK----GVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQT-H 425
+F + +G G+FG V + G+I++ + + ++ +E+ V+S +
Sbjct: 49 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 108
Query: 426 HKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFL------FGNLKPSWNLR---------- 469
H N+V LLG C G L++ E+ G L +FL F K S +
Sbjct: 109 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 168
Query: 470 --TNIAFQIARGLLYL------HEDCSSQIILYSYKRTE--------------------- 500
+ ++Q+A+G+ +L H D +++ IL ++ R
Sbjct: 169 DLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKG 228
Query: 501 ------GYVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
++APE N T + DV+S+G L E+ S
Sbjct: 229 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265
>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex
With Dp802
Length = 354
Score = 40.8 bits (94), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 47/199 (23%), Positives = 82/199 (41%), Gaps = 43/199 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
VG G++G V +T +V ++ SR + +R ++ E+ ++ H+N++ LL
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLH-- 484
+ E N+ L + L G N+ L + + +QI RGL Y+H
Sbjct: 89 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 485 ---------------EDCSSQIILYSYKR-----TEGYVAPEWFRNSTIT-------AKV 517
EDC +I+ + R G VA W+R I V
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGXVATRWYRAPEIMLNWMHYNQTV 204
Query: 518 DVYSFGFLLLEIISCRKSF 536
D++S G ++ E+++ R F
Sbjct: 205 DIWSVGCIMAELLTGRTLF 223
>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp
Length = 285
Score = 40.8 bits (94), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 44/198 (22%), Positives = 77/198 (38%), Gaps = 30/198 (15%)
Query: 376 VGRGSFGIVYKGVIQTTRQVL-LQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
+G+G FG VY + ++ +L L++ + + E + + EV + S H N++RL G
Sbjct: 21 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLY------LHEDCS 488
+ + L+ E+ GT+ L K ++A L Y +H D
Sbjct: 81 YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIK 140
Query: 489 SQIILY------------------SYKRTE-----GYVAPEWFRNSTITAKVDVYSFGFL 525
+ +L S +RT Y+ PE KVD++S G L
Sbjct: 141 PENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEXIEGRXHDEKVDLWSLGVL 200
Query: 526 LLEIISCRKSFDIEMGEE 543
E + + F+ +E
Sbjct: 201 CYEFLVGKPPFEANTYQE 218
>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|B Chain B, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|C Chain C, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|D Chain D, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|E Chain E, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|F Chain F, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
Length = 294
Score = 40.8 bits (94), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 38/167 (22%), Positives = 63/167 (37%), Gaps = 32/167 (19%)
Query: 412 REFKNEVFVISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN 471
+ F+ EV SQ H+N+V ++ +E LV E++ TL+ ++ + S + N
Sbjct: 56 KRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAIN 115
Query: 472 IAFQIARGLLY------LHEDCSSQIILYSYKRT-------------------------- 499
QI G+ + +H D Q IL +T
Sbjct: 116 FTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGT 175
Query: 500 EGYVAPEWFRNSTITAKVDVYSFGFLLLEIISCRKSFDIEMGEEYAI 546
Y +PE + D+YS G +L E++ F+ E AI
Sbjct: 176 VQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAI 222
>pdb|3KK8|A Chain A, Camkii Substrate Complex A
Length = 284
Score = 40.8 bits (94), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 49/225 (21%), Positives = 90/225 (40%), Gaps = 44/225 (19%)
Query: 369 TDNF--KEEVGRGSFGIVYKGVIQTT----RQVLLQLQSRNWIVFQDGEREFKNEVFVIS 422
+DN+ KEE+G+G+F +V + V +TT ++ + + FQ ERE + +
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREAR----ICR 60
Query: 423 QTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLY 482
+ H N+VRL E LV++ + G L + S ++ QI + Y
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAY 120
Query: 483 ------LHEDCSSQIILYSYKR---------------------------TEGYVAPEWFR 509
+H + + +L + K T GY++PE +
Sbjct: 121 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLK 180
Query: 510 NSTITAKVDVYSFGFLLLEIISCRKSF-DIEMGEEYAILTDWAFD 553
+ VD+++ G +L ++ F D + YA + A+D
Sbjct: 181 KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 225
>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And
Tpx2
Length = 268
Score = 40.8 bits (94), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 44/198 (22%), Positives = 77/198 (38%), Gaps = 30/198 (15%)
Query: 376 VGRGSFGIVYKGVIQTTRQVL-LQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
+G+G FG VY + ++ +L L++ + + E + + EV + S H N++RL G
Sbjct: 16 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLY------LHEDCS 488
+ + L+ E+ GT+ L K ++A L Y +H D
Sbjct: 76 YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIK 135
Query: 489 SQIILY------------------SYKRTE-----GYVAPEWFRNSTITAKVDVYSFGFL 525
+ +L S +RT Y+ PE KVD++S G L
Sbjct: 136 PENLLLGSAGELKIADFGWSVHAPSSRRTXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVL 195
Query: 526 LLEIISCRKSFDIEMGEE 543
E + + F+ +E
Sbjct: 196 CYEFLVGKPPFEANTYQE 213
>pdb|2BFX|A Chain A, Mechanism Of Aurora-B Activation By Incenp And Inhibition
By Hesperidin.
pdb|2BFX|B Chain B, Mechanism Of Aurora-B Activation By Incenp And Inhibition
By Hesperidin.
pdb|2VGP|A Chain A, Crystal Structure Of Aurora B Kinase In Complex With A
Aminothiazole Inhibitor
pdb|2VGP|B Chain B, Crystal Structure Of Aurora B Kinase In Complex With A
Aminothiazole Inhibitor
pdb|2VGO|A Chain A, Crystal Structure Of Aurora B Kinase In Complex With
Reversine Inhibitor
pdb|2VGO|B Chain B, Crystal Structure Of Aurora B Kinase In Complex With
Reversine Inhibitor
pdb|3ZTX|A Chain A, Aurora Kinase Selective Inhibitors Identified Using A
Taxol- Induced Checkpoint Sensitivity Screen.
pdb|3ZTX|B Chain B, Aurora Kinase Selective Inhibitors Identified Using A
Taxol- Induced Checkpoint Sensitivity Screen
Length = 284
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 41/192 (21%), Positives = 73/192 (38%), Gaps = 30/192 (15%)
Query: 376 VGRGSFGIVYKGVIQTTRQVL-LQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
+G+G FG VY + + ++ L++ ++ + + E + + E+ + S H N++R+
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHE------DCS 488
+ + L+ EF G L L + + ++A L Y HE D
Sbjct: 82 YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIK 141
Query: 489 SQIILYSYKR-----------------------TEGYVAPEWFRNSTITAKVDVYSFGFL 525
+ +L YK T Y+ PE T KVD++ G L
Sbjct: 142 PENLLMGYKGELKIADFGWSVHAPSLRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVL 201
Query: 526 LLEIISCRKSFD 537
E + FD
Sbjct: 202 CYEFLVGMPPFD 213
>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439
pdb|2VRX|B Chain B, Structure Of Aurora B Kinase In Complex With Zm447439
Length = 285
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 41/192 (21%), Positives = 73/192 (38%), Gaps = 30/192 (15%)
Query: 376 VGRGSFGIVYKGVIQTTRQVL-LQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
+G+G FG VY + + ++ L++ ++ + + E + + E+ + S H N++R+
Sbjct: 23 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 82
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHE------DCS 488
+ + L+ EF G L L + + ++A L Y HE D
Sbjct: 83 YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIK 142
Query: 489 SQIILYSYKR-----------------------TEGYVAPEWFRNSTITAKVDVYSFGFL 525
+ +L YK T Y+ PE T KVD++ G L
Sbjct: 143 PENLLMGYKGELKIADFGWSVHAPSLRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVL 202
Query: 526 LLEIISCRKSFD 537
E + FD
Sbjct: 203 CYEFLVGMPPFD 214
>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase
pdb|2NP8|A Chain A, Structural Basis For The Inhibition Of Aurora A Kinase By
A Novel Class Of High Affinity Disubstituted Pyrimidine
Inhibitors
pdb|2X81|A Chain A, Structure Of Aurora A In Complex With Mln8054
pdb|3MYG|A Chain A, Aurora A Kinase Complexed With Sch 1473759
pdb|3VAP|A Chain A, Synthesis And Sar Studies Of Imidazo-[1,2-A]-Pyrazine
Aurora Kinase Inhibitors With Improved Off Target Kinase
Selectivity
Length = 272
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 44/198 (22%), Positives = 77/198 (38%), Gaps = 30/198 (15%)
Query: 376 VGRGSFGIVYKGVIQTTRQVL-LQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
+G+G FG VY + ++ +L L++ + + E + + EV + S H N++RL G
Sbjct: 20 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLY------LHEDCS 488
+ + L+ E+ GT+ L K ++A L Y +H D
Sbjct: 80 YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIK 139
Query: 489 SQIILY------------------SYKRTE-----GYVAPEWFRNSTITAKVDVYSFGFL 525
+ +L S +RT Y+ PE KVD++S G L
Sbjct: 140 PENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVL 199
Query: 526 LLEIISCRKSFDIEMGEE 543
E + + F+ +E
Sbjct: 200 CYEFLVGKPPFEANTYQE 217
>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679
pdb|3UNZ|B Chain B, Aurora A In Complex With Rpm1679
pdb|3UO4|A Chain A, Aurora A In Complex With Rpm1680
pdb|3UO5|A Chain A, Aurora A In Complex With Yl1-038-31
pdb|3UO6|A Chain A, Aurora A In Complex With Yl5-083
pdb|3UO6|B Chain B, Aurora A In Complex With Yl5-083
pdb|3UOD|A Chain A, Aurora A In Complex With Rpm1693
pdb|3UOH|A Chain A, Aurora A In Complex With Rpm1722
pdb|3UOH|B Chain B, Aurora A In Complex With Rpm1722
pdb|3UOJ|A Chain A, Aurora A In Complex With Rpm1715
pdb|3UOJ|B Chain B, Aurora A In Complex With Rpm1715
pdb|3UOK|A Chain A, Aurora A In Complex With Yl5-81-1
pdb|3UOK|B Chain B, Aurora A In Complex With Yl5-81-1
pdb|3UOL|A Chain A, Aurora A In Complex With So2-162
pdb|3UOL|B Chain B, Aurora A In Complex With So2-162
pdb|3UP2|A Chain A, Aurora A In Complex With Rpm1686
pdb|3UP7|A Chain A, Aurora A In Complex With Yl1-038-09
pdb|4DEA|A Chain A, Aurora A In Complex With Yl1-038-18
pdb|4DEB|A Chain A, Aurora A In Complex With Rk2-17-01
pdb|4DED|A Chain A, Aurora A In Complex With Yl1-038-21
pdb|4DEE|A Chain A, Aurora A In Complex With Adp
Length = 279
Score = 40.4 bits (93), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 44/198 (22%), Positives = 77/198 (38%), Gaps = 30/198 (15%)
Query: 376 VGRGSFGIVYKGVIQTTRQVL-LQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
+G+G FG VY + ++ +L L++ + + E + + EV + S H N++RL G
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLY------LHEDCS 488
+ + L+ E+ GT+ L K ++A L Y +H D
Sbjct: 77 YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIK 136
Query: 489 SQIILY------------------SYKR-----TEGYVAPEWFRNSTITAKVDVYSFGFL 525
+ +L S +R T Y+ PE KVD++S G L
Sbjct: 137 PENLLLGSAGELKIADFGWSVHAPSSRRDTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVL 196
Query: 526 LLEIISCRKSFDIEMGEE 543
E + + F+ +E
Sbjct: 197 CYEFLVGKPPFEANTYQE 214
>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-293 In Complex With Atp
Length = 293
Score = 40.4 bits (93), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 41/200 (20%), Positives = 83/200 (41%), Gaps = 38/200 (19%)
Query: 362 YKALEEATD--NFKEEVGRGSFG-IVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEV 418
+K E+ D +F++ +G G+F ++ +T + V ++ ++ + ++G E NE+
Sbjct: 10 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSME--NEI 67
Query: 419 FVISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIAR 478
V+ + H N+V L + G + L+ + ++ G L + + + + FQ+
Sbjct: 68 AVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLD 127
Query: 479 GLLYLHE------------------DCSSQIILYSYKR---------------TEGYVAP 505
+ YLH+ D S+I++ + T GYVAP
Sbjct: 128 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAP 187
Query: 506 EWFRNSTITAKVDVYSFGFL 525
E + VD +S G +
Sbjct: 188 EVLAQKPYSKAVDCWSIGVI 207
>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa
pdb|3O50|B Chain B, Crystal Structure Of Benzamide 9 Bound To Auroraa
pdb|3O51|A Chain A, Crystal Structure Of Anthranilamide 10 Bound To Auroraa
pdb|3EFW|A Chain A, Structure Of Auroraa With Pyridyl-Pyrimidine Urea
Inhibitor
pdb|3EFW|B Chain B, Structure Of Auroraa With Pyridyl-Pyrimidine Urea
Inhibitor
Length = 267
Score = 40.4 bits (93), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 44/198 (22%), Positives = 77/198 (38%), Gaps = 30/198 (15%)
Query: 376 VGRGSFGIVYKGVIQTTRQVL-LQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
+G+G FG VY + ++ +L L++ + + E + + EV + S H N++RL G
Sbjct: 15 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 74
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLY------LHEDCS 488
+ + L+ E+ GT+ L K ++A L Y +H D
Sbjct: 75 YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIK 134
Query: 489 SQIILY------------------SYKRTE-----GYVAPEWFRNSTITAKVDVYSFGFL 525
+ +L S +RT Y+ PE KVD++S G L
Sbjct: 135 PENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVL 194
Query: 526 LLEIISCRKSFDIEMGEE 543
E + + F+ +E
Sbjct: 195 CYEFLVGKPPFEANTYQE 212
>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta
(I4122)
Length = 677
Score = 40.4 bits (93), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 56/211 (26%), Positives = 85/211 (40%), Gaps = 49/211 (23%)
Query: 371 NFKEEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLV 430
KE +G G FG V + + Q T + + Q R + ++ ER + E+ ++ + +H N+V
Sbjct: 18 EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRER-WCLEIQIMKKLNHPNVV 76
Query: 431 RLLGFCDEGLNR-------LLVYEFLNNGTLASFL--FGN---LKPSWNLRTNIAFQIAR 478
D GL + LL E+ G L +L F N LK +RT ++ I+
Sbjct: 77 SAREVPD-GLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG-PIRTLLS-DISS 133
Query: 479 GLLYLHED--------------------CSSQIILYSYKR-------------TEGYVAP 505
L YLHE+ +II Y + T Y+AP
Sbjct: 134 ALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAP 193
Query: 506 EWFRNSTITAKVDVYSFGFLLLEIISCRKSF 536
E T VD +SFG L E I+ + F
Sbjct: 194 ELLEQKKYTVTVDYWSFGTLAFECITGFRPF 224
>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors
Length = 283
Score = 40.4 bits (93), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 44/198 (22%), Positives = 77/198 (38%), Gaps = 30/198 (15%)
Query: 376 VGRGSFGIVYKGVIQTTRQVL-LQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
+G+G FG VY + ++ +L L++ + + E + + EV + S H N++RL G
Sbjct: 19 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLY------LHEDCS 488
+ + L+ E+ GT+ L K ++A L Y +H D
Sbjct: 79 YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIK 138
Query: 489 SQIILY------------------SYKR-----TEGYVAPEWFRNSTITAKVDVYSFGFL 525
+ +L S +R T Y+ PE KVD++S G L
Sbjct: 139 PENLLLGSAGELKIADFGWSVHAPSSRRAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVL 198
Query: 526 LLEIISCRKSFDIEMGEE 543
E + + F+ +E
Sbjct: 199 CYEFLVGKPPFEANTYQE 216
>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine
Inhibitor
Length = 272
Score = 40.4 bits (93), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 44/198 (22%), Positives = 77/198 (38%), Gaps = 30/198 (15%)
Query: 376 VGRGSFGIVYKGVIQTTRQVL-LQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
+G+G FG VY + ++ +L L++ + + E + + EV + S H N++RL G
Sbjct: 19 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLY------LHEDCS 488
+ + L+ E+ GT+ L K ++A L Y +H D
Sbjct: 79 YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIK 138
Query: 489 SQIILY------------------SYKRTE-----GYVAPEWFRNSTITAKVDVYSFGFL 525
+ +L S +RT Y+ PE KVD++S G L
Sbjct: 139 PENLLLGSAGELKIANFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVL 198
Query: 526 LLEIISCRKSFDIEMGEE 543
E + + F+ +E
Sbjct: 199 CYEFLVGKPPFEANTYQE 216
>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|B Chain B, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|C Chain C, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|D Chain D, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|E Chain E, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|F Chain F, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|G Chain G, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|H Chain H, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
Length = 676
Score = 40.4 bits (93), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 56/211 (26%), Positives = 85/211 (40%), Gaps = 49/211 (23%)
Query: 371 NFKEEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLV 430
KE +G G FG V + + Q T + + Q R + ++ ER + E+ ++ + +H N+V
Sbjct: 17 EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRER-WCLEIQIMKKLNHPNVV 75
Query: 431 RLLGFCDEGLNR-------LLVYEFLNNGTLASFL--FGN---LKPSWNLRTNIAFQIAR 478
D GL + LL E+ G L +L F N LK +RT ++ I+
Sbjct: 76 SAREVPD-GLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG-PIRTLLS-DISS 132
Query: 479 GLLYLHED--------------------CSSQIILYSYKR-------------TEGYVAP 505
L YLHE+ +II Y + T Y+AP
Sbjct: 133 ALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAP 192
Query: 506 EWFRNSTITAKVDVYSFGFLLLEIISCRKSF 536
E T VD +SFG L E I+ + F
Sbjct: 193 ELLEQKKYTVTVDYWSFGTLAFECITGFRPF 223
>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form)
Length = 285
Score = 40.4 bits (93), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 43/198 (21%), Positives = 76/198 (38%), Gaps = 30/198 (15%)
Query: 376 VGRGSFGIVYKGVIQTTRQVL-LQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
+G+G FG VY + ++ +L L++ + + E + + EV + S H N++RL G
Sbjct: 21 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLY------LHEDCS 488
+ + L+ E+ G + L K ++A L Y +H D
Sbjct: 81 YFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIK 140
Query: 489 SQIILY------------------SYKRTE-----GYVAPEWFRNSTITAKVDVYSFGFL 525
+ +L S +RT Y+ PE KVD++S G L
Sbjct: 141 PENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVL 200
Query: 526 LLEIISCRKSFDIEMGEE 543
E + + F+ +E
Sbjct: 201 CYEFLVGKPPFEANTYQE 218
>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1E|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1F|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 275
Score = 40.4 bits (93), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 44/198 (22%), Positives = 77/198 (38%), Gaps = 30/198 (15%)
Query: 376 VGRGSFGIVYKGVIQTTRQVL-LQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
+G+G FG VY + ++ +L L++ + + E + + EV + S H N++RL G
Sbjct: 19 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLY------LHEDCS 488
+ + L+ E+ GT+ L K ++A L Y +H D
Sbjct: 79 YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIK 138
Query: 489 SQIILY------------------SYKRTE-----GYVAPEWFRNSTITAKVDVYSFGFL 525
+ +L S +RT Y+ PE KVD++S G L
Sbjct: 139 PENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVL 198
Query: 526 LLEIISCRKSFDIEMGEE 543
E + + F+ +E
Sbjct: 199 CYEFLVGKPPFEANTYQE 216
>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of
Pyrazolopyridine- Sulfonamides As Potent
Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I)
pdb|3R22|A Chain A, Design, Synthesis, And Biological Evaluation Of
Pyrazolopyridine- Sulfonamides As Potent
Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I)
pdb|4DHF|A Chain A, Structure Of Aurora A Mutant Bound To Biogenidec Cpd 15
pdb|4DHF|B Chain B, Structure Of Aurora A Mutant Bound To Biogenidec Cpd 15
Length = 271
Score = 40.4 bits (93), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 44/198 (22%), Positives = 77/198 (38%), Gaps = 30/198 (15%)
Query: 376 VGRGSFGIVYKGVIQTTRQVL-LQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
+G+G FG VY + ++ +L L++ + + E + + EV + S H N++RL G
Sbjct: 19 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLY------LHEDCS 488
+ + L+ E+ GT+ L K ++A L Y +H D
Sbjct: 79 YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIK 138
Query: 489 SQIILY------------------SYKR-----TEGYVAPEWFRNSTITAKVDVYSFGFL 525
+ +L S +R T Y+ PE KVD++S G L
Sbjct: 139 PENLLLGSAGELKIADFGWSVHAPSSRRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVL 198
Query: 526 LLEIISCRKSFDIEMGEE 543
E + + F+ +E
Sbjct: 199 CYEFLVGKPPFEANTYQE 216
>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287,
Thr288 And Bound To Tpx2 1-43
pdb|1OL7|A Chain A, Structure Of Human Aurora-A 122-403 Phosphorylated On
Thr287, Thr288
Length = 282
Score = 40.4 bits (93), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 44/198 (22%), Positives = 77/198 (38%), Gaps = 30/198 (15%)
Query: 376 VGRGSFGIVYKGVIQTTRQVL-LQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
+G+G FG VY + ++ +L L++ + + E + + EV + S H N++RL G
Sbjct: 18 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLY------LHEDCS 488
+ + L+ E+ GT+ L K ++A L Y +H D
Sbjct: 78 YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIK 137
Query: 489 SQIILY------------------SYKR-----TEGYVAPEWFRNSTITAKVDVYSFGFL 525
+ +L S +R T Y+ PE KVD++S G L
Sbjct: 138 PENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVL 197
Query: 526 LLEIISCRKSFDIEMGEE 543
E + + F+ +E
Sbjct: 198 CYEFLVGKPPFEANTYQE 215
>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum,
Cgd2_1960
pdb|3OZ6|B Chain B, Crystal Structure Of Mapk From Cryptosporidium Parvum,
Cgd2_1960
Length = 388
Score = 40.4 bits (93), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 28/116 (24%), Positives = 60/116 (51%), Gaps = 9/116 (7%)
Query: 374 EEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQ---DGEREFKNEVFVISQTHHKNLV 430
+++G+G++GIV+K + + T +V+ + + FQ D +R F+ + + + H+N+V
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVV--AVKKIFDAFQNSTDAQRTFREIMILTELSGHENIV 72
Query: 431 RLLGF--CDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 484
LL D + LV++++ A L+P + + +Q+ + + YLH
Sbjct: 73 NLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVH--KQYVVYQLIKVIKYLH 126
>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin.
pdb|2BFY|B Chain B, Complex Of Aurora-B With Incenp And Hesperidin
Length = 284
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 41/192 (21%), Positives = 73/192 (38%), Gaps = 30/192 (15%)
Query: 376 VGRGSFGIVYKGVIQTTRQVL-LQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
+G+G FG VY + + ++ L++ ++ + + E + + E+ + S H N++R+
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHE------DCS 488
+ + L+ EF G L L + + ++A L Y HE D
Sbjct: 82 YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIK 141
Query: 489 SQIILYSYKR-----------------------TEGYVAPEWFRNSTITAKVDVYSFGFL 525
+ +L YK T Y+ PE T KVD++ G L
Sbjct: 142 PENLLMGYKGELKIADFGWSVHAPSLRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVL 201
Query: 526 LLEIISCRKSFD 537
E + FD
Sbjct: 202 CYEFLVGMPPFD 213
>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase
Domain Of Csf-1r
Length = 324
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 50/222 (22%), Positives = 88/222 (39%), Gaps = 61/222 (27%)
Query: 371 NFKEEVGRGSFGIVYK----GVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQT-H 425
F + +G G+FG V + G+ + + + ++ D + +E+ ++S
Sbjct: 34 QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 93
Query: 426 HKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLF----GNLKPS---------------- 465
H+N+V LLG C G L++ E+ G L +FL L PS
Sbjct: 94 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGR 153
Query: 466 -WNLRTNIAF--QIARGLLYL------HEDCSSQIILYS--------------------- 495
LR + F Q+A+G+ +L H D +++ +L +
Sbjct: 154 PLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 213
Query: 496 ------YKRTEGYVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
+ ++APE + T + DV+S+G LL EI S
Sbjct: 214 YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255
>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|B Chain B, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|C Chain C, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H10|A Chain A, Aurora A Inhibitor Complex
pdb|3H10|B Chain B, Aurora A Inhibitor Complex
pdb|3H10|D Chain D, Aurora A Inhibitor Complex
pdb|3P9J|A Chain A, Aurora A Kinase Domain With Phthalazinone Pyrazole
Inhibitor
Length = 268
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 44/198 (22%), Positives = 77/198 (38%), Gaps = 30/198 (15%)
Query: 376 VGRGSFGIVYKGVIQTTRQVL-LQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
+G+G FG VY + ++ +L L++ + + E + + EV + S H N++RL G
Sbjct: 16 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLY------LHEDCS 488
+ + L+ E+ GT+ L K ++A L Y +H D
Sbjct: 76 YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIK 135
Query: 489 SQIILY------------------SYKR-----TEGYVAPEWFRNSTITAKVDVYSFGFL 525
+ +L S +R T Y+ PE KVD++S G L
Sbjct: 136 PENLLLGSAGELKIADFGWSVHAPSSRRAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVL 195
Query: 526 LLEIISCRKSFDIEMGEE 543
E + + F+ +E
Sbjct: 196 CYEFLVGKPPFEANTYQE 213
>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-315 In Complex With Atp
pdb|4FG8|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-315 In Complex With Atp
Length = 315
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 41/200 (20%), Positives = 83/200 (41%), Gaps = 38/200 (19%)
Query: 362 YKALEEATD--NFKEEVGRGSFG-IVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEV 418
+K E+ D +F++ +G G+F ++ +T + V ++ ++ + ++G E NE+
Sbjct: 10 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSME--NEI 67
Query: 419 FVISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIAR 478
V+ + H N+V L + G + L+ + ++ G L + + + + FQ+
Sbjct: 68 AVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLD 127
Query: 479 GLLYLHE------------------DCSSQIILYSYKR---------------TEGYVAP 505
+ YLH+ D S+I++ + T GYVAP
Sbjct: 128 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAP 187
Query: 506 EWFRNSTITAKVDVYSFGFL 525
E + VD +S G +
Sbjct: 188 EVLAQKPYSKAVDCWSIGVI 207
>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk
Docking Peptide
Length = 362
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 47/199 (23%), Positives = 82/199 (41%), Gaps = 43/199 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
VG G++G V +T +V ++ SR + +R ++ E+ ++ H+N++ LL
Sbjct: 32 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 90
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLH-- 484
+ E N+ L + L G N+ L + + +QI RGL Y+H
Sbjct: 91 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 146
Query: 485 ---------------EDCSSQIILYSYKR-----TEGYVAPEWFRNSTIT-------AKV 517
ED +I+ + R GYVA W+R I V
Sbjct: 147 DIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTV 206
Query: 518 DVYSFGFLLLEIISCRKSF 536
D++S G ++ E+++ R F
Sbjct: 207 DIWSVGCIMAELLTGRTLF 225
>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Adp Bound
Length = 311
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 48/201 (23%), Positives = 79/201 (39%), Gaps = 45/201 (22%)
Query: 374 EEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGERE-----FKNEVFVISQTHHKN 428
E+VG G++G+VYK R V L+ + D E E E+ ++ + HH N
Sbjct: 27 EKVGEGTYGVVYKAKDSQGRIVALKR------IRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 429 LVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI-AFQIARGLLY----- 482
+V L+ LV+EF+ L L N + + I +Q+ RG+ +
Sbjct: 81 IVSLIDVIHSERCLTLVFEFMEKD-LKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR 139
Query: 483 -LHEDCSSQIIL-----------YSYKRTEGY--------VAPEWFRNSTI-------TA 515
LH D Q +L + R G V W+R + +
Sbjct: 140 ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYST 199
Query: 516 KVDVYSFGFLLLEIISCRKSF 536
VD++S G + E+I+ + F
Sbjct: 200 SVDIWSIGCIFAEMITGKPLF 220
>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-320 In Complex With Atp
pdb|4FG9|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-320 In Complex With Atp
pdb|4FGB|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I Apo Form
Length = 320
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 41/200 (20%), Positives = 83/200 (41%), Gaps = 38/200 (19%)
Query: 362 YKALEEATD--NFKEEVGRGSFG-IVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEV 418
+K E+ D +F++ +G G+F ++ +T + V ++ ++ + ++G E NE+
Sbjct: 10 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSME--NEI 67
Query: 419 FVISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIAR 478
V+ + H N+V L + G + L+ + ++ G L + + + + FQ+
Sbjct: 68 AVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLD 127
Query: 479 GLLYLHE------------------DCSSQIILYSYKR---------------TEGYVAP 505
+ YLH+ D S+I++ + T GYVAP
Sbjct: 128 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAP 187
Query: 506 EWFRNSTITAKVDVYSFGFL 525
E + VD +S G +
Sbjct: 188 EVLAQKPYSKAVDCWSIGVI 207
>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point
Mutations (K299r, T423e)
pdb|2HY8|1 Chain 1, Pak1 Complex With St2001
Length = 297
Score = 40.0 bits (92), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 44/194 (22%), Positives = 74/194 (38%), Gaps = 46/194 (23%)
Query: 374 EEVGRGSFGIVYKGVIQTT------RQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHK 427
E++G+G+ G VY + T RQ+ LQ Q + ++ NE+ V+ + +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII--------NEILVMRENKNP 77
Query: 428 NLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYL---- 483
N+V L G +V E+L G+L + + + + + L +L
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALEFLHSNQ 136
Query: 484 --HEDCSS--------------------QIILYSYKRTEGYVAPEWFRNSTIT-----AK 516
H D S QI KR+E P W +T K
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRKAYGPK 196
Query: 517 VDVYSFGFLLLEII 530
VD++S G + +E+I
Sbjct: 197 VDIWSLGIMAIEMI 210
>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A
Dihydroquinolinone
pdb|1R3C|A Chain A, The Structure Of P38alpha C162s Mutant
pdb|2I0H|A Chain A, The Structure Of P38alpha In Complex With An
Arylpyridazinone
pdb|3GC7|A Chain A, The Structure Of P38alpha In Complex With A
Dihydroquinazolinone
pdb|3NEW|A Chain A, P38-Alpha Complexed With Compound 10
Length = 366
Score = 40.0 bits (92), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 47/199 (23%), Positives = 82/199 (41%), Gaps = 43/199 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
VG G++G V +T +V ++ SR + +R ++ E+ ++ H+N++ LL
Sbjct: 36 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 94
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLH-- 484
+ E N+ L + L G N+ L + + +QI RGL Y+H
Sbjct: 95 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 150
Query: 485 ---------------EDCSSQIILYSYKR-----TEGYVAPEWFRNSTIT-------AKV 517
ED +I+ + R GYVA W+R I V
Sbjct: 151 DIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTV 210
Query: 518 DVYSFGFLLLEIISCRKSF 536
D++S G ++ E+++ R F
Sbjct: 211 DIWSVGCIMAELLTGRTLF 229
>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl
Amide Inhibitor
pdb|3IPH|A Chain A, Crystal Structure Of P38 In Complex With A Biphenylamide
Inhibitor
Length = 360
Score = 40.0 bits (92), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 47/199 (23%), Positives = 82/199 (41%), Gaps = 43/199 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
VG G++G V +T +V ++ SR + +R ++ E+ ++ H+N++ LL
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLH-- 484
+ E N+ L + L G N+ L + + +QI RGL Y+H
Sbjct: 89 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 485 ---------------EDCSSQIILYSYKR-----TEGYVAPEWFRNSTIT-------AKV 517
ED +I+ + R GYVA W+R I V
Sbjct: 145 DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTV 204
Query: 518 DVYSFGFLLLEIISCRKSF 536
D++S G ++ E+++ R F
Sbjct: 205 DIWSVGCIMAELLTGRTLF 223
>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And
Compound 10
Length = 268
Score = 40.0 bits (92), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 44/198 (22%), Positives = 77/198 (38%), Gaps = 30/198 (15%)
Query: 376 VGRGSFGIVYKGVIQTTRQVL-LQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
+G+G FG VY + ++ +L L++ + + E + + EV + S H N++RL G
Sbjct: 16 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLY------LHEDCS 488
+ + L+ E+ GT+ L K ++A L Y +H D
Sbjct: 76 YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIK 135
Query: 489 SQIILY------------------SYKR-----TEGYVAPEWFRNSTITAKVDVYSFGFL 525
+ +L S +R T Y+ PE KVD++S G L
Sbjct: 136 PENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVL 195
Query: 526 LLEIISCRKSFDIEMGEE 543
E + + F+ +E
Sbjct: 196 CYEFLVGKPPFEANTYQE 213
>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A
Pentacyclic Inhibitor
pdb|3COH|B Chain B, Crystal Structure Of Aurora-A In Complex With A
Pentacyclic Inhibitor
Length = 268
Score = 40.0 bits (92), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 43/192 (22%), Positives = 75/192 (39%), Gaps = 30/192 (15%)
Query: 376 VGRGSFGIVYKGVIQTTRQVL-LQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
+G+G FG VY + ++ +L L++ + + E + + EV + S H N++RL G
Sbjct: 16 LGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLY------LHEDCS 488
+ + L+ E+ GT+ L K ++A L Y +H D
Sbjct: 76 YFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKKVIHRDIK 135
Query: 489 SQIILY------------------SYKR-----TEGYVAPEWFRNSTITAKVDVYSFGFL 525
+ +L S +R T Y+ PE KVD++S G L
Sbjct: 136 PENLLLGSAGELKIADFGWSVHAPSSRRAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVL 195
Query: 526 LLEIISCRKSFD 537
E + + F+
Sbjct: 196 CYEFLVGKPPFE 207
>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Indirubin 3'-Monoxime Bound
Length = 313
Score = 40.0 bits (92), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 48/201 (23%), Positives = 79/201 (39%), Gaps = 45/201 (22%)
Query: 374 EEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGERE-----FKNEVFVISQTHHKN 428
E+VG G++G+VYK R V L+ + D E E E+ ++ + HH N
Sbjct: 27 EKVGEGTYGVVYKAKDSQGRIVALKR------IRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 429 LVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI-AFQIARGLLY----- 482
+V L+ LV+EF+ L L N + + I +Q+ RG+ +
Sbjct: 81 IVSLIDVIHSERCLTLVFEFMEKD-LKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR 139
Query: 483 -LHEDCSSQIIL-----------YSYKRTEGY--------VAPEWFRNSTI-------TA 515
LH D Q +L + R G V W+R + +
Sbjct: 140 ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYST 199
Query: 516 KVDVYSFGFLLLEIISCRKSF 536
VD++S G + E+I+ + F
Sbjct: 200 SVDIWSIGCIFAEMITGKPLF 220
>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl
Amide Inhibitor
pdb|3E93|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl
Amide Inhibitor
Length = 371
Score = 39.7 bits (91), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 47/199 (23%), Positives = 82/199 (41%), Gaps = 43/199 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
VG G++G V +T +V ++ SR + +R ++ E+ ++ H+N++ LL
Sbjct: 41 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 99
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLH-- 484
+ E N+ L + L G N+ L + + +QI RGL Y+H
Sbjct: 100 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 155
Query: 485 ---------------EDCSSQIILYSYKR-----TEGYVAPEWFRNSTIT-------AKV 517
ED +I+ + R GYVA W+R I V
Sbjct: 156 DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTV 215
Query: 518 DVYSFGFLLLEIISCRKSF 536
D++S G ++ E+++ R F
Sbjct: 216 DIWSVGCIMAELLTGRTLF 234
>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure
pdb|2WTV|B Chain B, Aurora-A Inhibitor Structure
pdb|2WTV|C Chain C, Aurora-A Inhibitor Structure
pdb|2WTV|D Chain D, Aurora-A Inhibitor Structure
Length = 285
Score = 39.7 bits (91), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 43/198 (21%), Positives = 76/198 (38%), Gaps = 30/198 (15%)
Query: 376 VGRGSFGIVYKGVIQTTRQVL-LQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
+G+G FG VY + ++ +L L++ + + E + + EV + S H N++RL G
Sbjct: 21 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLY------LHEDCS 488
+ + L+ E+ G + L K ++A L Y +H D
Sbjct: 81 YFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIK 140
Query: 489 SQIILY------------------SYKR-----TEGYVAPEWFRNSTITAKVDVYSFGFL 525
+ +L S +R T Y+ PE KVD++S G L
Sbjct: 141 PENLLLGSAGELKIADFGWSVHAPSSRRXXLXGTLDYLPPEMIEGRMHDEKVDLWSLGVL 200
Query: 526 LLEIISCRKSFDIEMGEE 543
E + + F+ +E
Sbjct: 201 CYEFLVGKPPFEANTYQE 218
>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine
pdb|4AA5|A Chain A, P38alpha Map Kinase Bound To Cmpd 33
Length = 365
Score = 39.7 bits (91), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 47/199 (23%), Positives = 82/199 (41%), Gaps = 43/199 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
VG G++G V +T +V ++ SR + +R ++ E+ ++ H+N++ LL
Sbjct: 35 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 93
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLH-- 484
+ E N+ L + L G N+ L + + +QI RGL Y+H
Sbjct: 94 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 149
Query: 485 ---------------EDCSSQIILYSYKR-----TEGYVAPEWFRNSTIT-------AKV 517
ED +I+ + R GYVA W+R I V
Sbjct: 150 DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTV 209
Query: 518 DVYSFGFLLLEIISCRKSF 536
D++S G ++ E+++ R F
Sbjct: 210 DIWSVGCIMAELLTGRTLF 228
>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1G|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 275
Score = 39.7 bits (91), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 44/198 (22%), Positives = 77/198 (38%), Gaps = 30/198 (15%)
Query: 376 VGRGSFGIVYKGVIQTTRQVL-LQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
+G+G FG VY + ++ +L L++ + + E + + EV + S H N++RL G
Sbjct: 19 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLY------LHEDCS 488
+ + L+ E+ GT+ L K ++A L Y +H D
Sbjct: 79 YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIK 138
Query: 489 SQIILY------------------SYKR-----TEGYVAPEWFRNSTITAKVDVYSFGFL 525
+ +L S +R T Y+ PE KVD++S G L
Sbjct: 139 PENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVL 198
Query: 526 LLEIISCRKSFDIEMGEE 543
E + + F+ +E
Sbjct: 199 CYEFLVGKPPFEANTYQE 216
>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
pdb|2W9Z|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 306
Score = 39.7 bits (91), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 50/206 (24%), Positives = 79/206 (38%), Gaps = 49/206 (23%)
Query: 375 EVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFK----NEVFVISQTH---HK 427
E+G G++G VYK + + L+S + +GE EV ++ + H
Sbjct: 11 EIGVGAYGTVYKARDPHSGH-FVALKS---VRVPNGEEGLPISTVREVALLRRLEAFEHP 66
Query: 428 NLVRLLGFC-----DEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGL 480
N+VRL+ C D + LV+E ++ L ++L P T ++ Q RGL
Sbjct: 67 NVVRLMDVCATSRTDREIKVTLVFEHVDQD-LRTYLDKAPPPGLPAETIKDLMRQFLRGL 125
Query: 481 LYLHEDC------------------------------SSQIILYSYKRTEGYVAPEWFRN 510
+LH +C S Q+ L T Y APE
Sbjct: 126 DFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVVTLWYRAPEVLLQ 185
Query: 511 STITAKVDVYSFGFLLLEIISCRKSF 536
ST VD++S G + E+ + F
Sbjct: 186 STYATPVDMWSVGCIFAEMFRRKPLF 211
>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|B Chain B, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|C Chain C, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|D Chain D, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|E Chain E, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
Length = 326
Score = 39.3 bits (90), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 39/126 (30%), Positives = 61/126 (48%), Gaps = 22/126 (17%)
Query: 374 EEVGRGSFGIVYKGV-IQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQ-THHKNLVR 431
E VG G++G VYKG ++T + +++ V D E E K E+ ++ + +HH+N+
Sbjct: 30 ELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSHHRNIAT 85
Query: 432 LLGF--------CDEGLNRLLVYEFLNNGTLASFL---FGN-LKPSWNLRTNIAFQIARG 479
G D+ L LV EF G++ + GN LK W I +I RG
Sbjct: 86 YYGAFIKKNPPGMDDQL--WLVMEFCGAGSVTDLIKNTKGNTLKEEWI--AYICREILRG 141
Query: 480 LLYLHE 485
L +LH+
Sbjct: 142 LSHLHQ 147
>pdb|4FIE|A Chain A, Full-Length Human Pak4
pdb|4FIE|B Chain B, Full-Length Human Pak4
Length = 423
Score = 39.3 bits (90), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 44/197 (22%), Positives = 81/197 (41%), Gaps = 45/197 (22%)
Query: 370 DNFKEEVGRGSFGIVYKGVIQTTRQVL------LQLQSRNWIVFQDGEREFKNEVFVISQ 423
DNF + +G GS GIV ++++ +++ L+ Q R ++F NEV ++
Sbjct: 154 DNFIK-IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF--------NEVVIMRD 204
Query: 424 THHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFL-FGNLKPSWNLRTNIAFQIARGLLY 482
H+N+V + G +V EFL G L + + +A A +L+
Sbjct: 205 YQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLH 264
Query: 483 ----LHEDCSSQIILYSY--------------------KR-----TEGYVAPEWFRNSTI 513
+H D S IL ++ +R T ++APE
Sbjct: 265 AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY 324
Query: 514 TAKVDVYSFGFLLLEII 530
+VD++S G +++E++
Sbjct: 325 GPEVDIWSLGIMVIEMV 341
>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant
Length = 262
Score = 39.3 bits (90), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 46/203 (22%), Positives = 78/203 (38%), Gaps = 40/203 (19%)
Query: 376 VGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDG------EREFKNEVFVISQTHHKNL 429
+G+G FG VY + R+ +L L+ ++F+ E + + EV + S H N+
Sbjct: 13 LGKGKFGNVYLAR-EKQRKFILALK----VLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 67
Query: 430 VRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLY------L 483
+RL G+ + L+ E+ GT+ L K ++A L Y +
Sbjct: 68 LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVI 127
Query: 484 HEDCSSQIILY------------------SYKRTE-----GYVAPEWFRNSTITAKVDVY 520
H D + +L S +RT Y+ PE KVD++
Sbjct: 128 HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLW 187
Query: 521 SFGFLLLEIISCRKSFDIEMGEE 543
S G L E + + F+ +E
Sbjct: 188 SLGVLCYEFLVGKPPFEANTYQE 210
>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195
Length = 365
Score = 39.3 bits (90), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 46/199 (23%), Positives = 82/199 (41%), Gaps = 43/199 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
+G G++G V +T +V ++ SR + +R ++ E+ ++ H+N++ LL
Sbjct: 35 IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 93
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLH-- 484
+ E N+ L + L G N+ L + + +QI RGL Y+H
Sbjct: 94 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 149
Query: 485 ---------------EDCSSQIILYSYKR-----TEGYVAPEWFRNSTIT-------AKV 517
ED +I+ + R GYVA W+R I V
Sbjct: 150 DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTV 209
Query: 518 DVYSFGFLLLEIISCRKSF 536
D++S G ++ E+++ R F
Sbjct: 210 DIWSVGCIMAELLTGRTLF 228
>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 306
Score = 38.9 bits (89), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 50/206 (24%), Positives = 79/206 (38%), Gaps = 49/206 (23%)
Query: 375 EVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFK----NEVFVISQTH---HK 427
E+G G++G VYK + + L+S + +GE EV ++ + H
Sbjct: 11 EIGVGAYGTVYKARDPHSGH-FVALKS---VRVPNGEEGLPISTVREVALLRRLEAFEHP 66
Query: 428 NLVRLLGFC-----DEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGL 480
N+VRL+ C D + LV+E ++ L ++L P T ++ Q RGL
Sbjct: 67 NVVRLMDVCATSRTDREIKVTLVFEHVDQD-LRTYLDKAPPPGLPAETIKDLMRQFLRGL 125
Query: 481 LYLHEDC------------------------------SSQIILYSYKRTEGYVAPEWFRN 510
+LH +C S Q+ L T Y APE
Sbjct: 126 DFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVVTLWYRAPEVLLQ 185
Query: 511 STITAKVDVYSFGFLLLEIISCRKSF 536
ST VD++S G + E+ + F
Sbjct: 186 STYATPVDMWSVGCIFAEMFRRKPLF 211
>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein
Kinase 11 (p38 Beta) In Complex With Nilotinib
Length = 348
Score = 38.9 bits (89), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 45/195 (23%), Positives = 75/195 (38%), Gaps = 35/195 (17%)
Query: 376 VGRGSFGIVYKGVIQTTRQ-VLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
VG G++G V RQ V ++ SR + R ++ E+ ++ H+N++ LL
Sbjct: 28 VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYR-ELRLLKHLKHENVIGLLD 86
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN----IAFQIARGLLYLH------ 484
+ E TL N+ L + +Q+ RGL Y+H
Sbjct: 87 VFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAGIIH 146
Query: 485 -----------EDCSSQIILYSYKR-----TEGYVAPEWFRNSTIT-------AKVDVYS 521
EDC +I+ + R GYVA W+R I VD++S
Sbjct: 147 RDLKPSNVAVNEDCELRILDFGLARQADEEMTGYVATRWYRAPEIMLNWMHYNQTVDIWS 206
Query: 522 FGFLLLEIISCRKSF 536
G ++ E++ + F
Sbjct: 207 VGCIMAELLQGKALF 221
>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of
The Tyrosine Kinase Ack1
pdb|1U46|B Chain B, Crystal Structure Of The Unphosphorylated Kinase Domain Of
The Tyrosine Kinase Ack1
pdb|1U4D|A Chain A, Structure Of The Ack1 Kinase Domain Bound To
Debromohymenialdisine
pdb|1U4D|B Chain B, Structure Of The Ack1 Kinase Domain Bound To
Debromohymenialdisine
pdb|1U54|B Chain B, Crystal Structures Of The Phosphorylated And
Unphosphorylated Kinase Domains Of The Cdc42-Associated
Tyrosine Kinase Ack1 Bound To Amp-Pcp
Length = 291
Score = 38.9 bits (89), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 53/231 (22%), Positives = 88/231 (38%), Gaps = 59/231 (25%)
Query: 347 SPGDGTVETNLRCFSYKALEEATDNFKEEVGRGSFGIVYKGVIQT----TRQVLLQLQSR 402
S G+G +++ L C + E E++G GSFG+V +G T V ++
Sbjct: 2 SAGEGPLQS-LTCL----IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKP 56
Query: 403 NWIVFQDGEREFKNEVFVISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTL-------- 454
+ + + +F EV + H+NL+RL G + +V E G+L
Sbjct: 57 DVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQ 115
Query: 455 ASFLFGNLKPSWNLRTNIAFQIARGLLYL------HEDCSSQIILYS------------- 495
FL G L + A Q+A G+ YL H D +++ +L +
Sbjct: 116 GHFLLGTL-------SRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM 168
Query: 496 ---------YKRTE------GYVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
Y E + APE + T + D + FG L E+ +
Sbjct: 169 RALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219
>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIF|B Chain B, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIG|A Chain A, Catalytic Domain Of Human Pak4
pdb|4FIG|B Chain B, Catalytic Domain Of Human Pak4
pdb|4FIH|A Chain A, Catalytic Domain Of Human Pak4 With Qkftglprqw Peptide
pdb|4FII|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIJ|A Chain A, Catalytic Domain Of Human Pak4
Length = 346
Score = 38.9 bits (89), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 44/197 (22%), Positives = 81/197 (41%), Gaps = 45/197 (22%)
Query: 370 DNFKEEVGRGSFGIVYKGVIQTTRQVL------LQLQSRNWIVFQDGEREFKNEVFVISQ 423
DNF + +G GS GIV ++++ +++ L+ Q R ++F NEV ++
Sbjct: 77 DNFIK-IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF--------NEVVIMRD 127
Query: 424 THHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFL-FGNLKPSWNLRTNIAFQIARGLLY 482
H+N+V + G +V EFL G L + + +A A +L+
Sbjct: 128 YQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLH 187
Query: 483 ----LHEDCSSQIILYSY--------------------KR-----TEGYVAPEWFRNSTI 513
+H D S IL ++ +R T ++APE
Sbjct: 188 AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY 247
Query: 514 TAKVDVYSFGFLLLEII 530
+VD++S G +++E++
Sbjct: 248 GPEVDIWSLGIMVIEMV 264
>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And
Unphosphorylated Kinase Domains Of The Cdc42-Associated
Tyrosine Kinase Ack1 Bound To Amp-Pcp
Length = 291
Score = 38.9 bits (89), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 52/231 (22%), Positives = 87/231 (37%), Gaps = 59/231 (25%)
Query: 347 SPGDGTVETNLRCFSYKALEEATDNFKEEVGRGSFGIVYKGVIQT----TRQVLLQLQSR 402
S G+G +++ L C + E E++G GSFG+V +G T V ++
Sbjct: 2 SAGEGPLQS-LTCL----IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKP 56
Query: 403 NWIVFQDGEREFKNEVFVISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTL-------- 454
+ + + +F EV + H+NL+RL G + +V E G+L
Sbjct: 57 DVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQ 115
Query: 455 ASFLFGNLKPSWNLRTNIAFQIARGLLYL------HEDCSSQIILYS------------- 495
FL G L + A Q+A G+ YL H D +++ +L +
Sbjct: 116 GHFLLGTL-------SRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM 168
Query: 496 ---------------YKRTEGYVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
K + APE + T + D + FG L E+ +
Sbjct: 169 RALPQNDDHXVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219
>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly,
Lys240->arg, Met302- >leu) In Complex With
1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]-
Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea
pdb|3DJ5|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 290.
pdb|3DJ6|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 823.
pdb|3DJ7|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 130.
pdb|3D15|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With
1-(3-Chloro-Phenyl)-3-
{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)-
Ethyl]-Thiazol-2- Yl}-Urea [sns-314]
pdb|3D2I|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With 1-{5-[2-(1-Methyl-1h-
Pyrazolo[4,
3-D]pyrimidin-7-Ylamino)-Ethyl]-Thiazol-2-Yl}-3-
(3-Trifluoromethyl-Phenyl)-Urea
pdb|3D2K|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With
[7-(2-{2-[3-(3-Chloro-
Phenyl)-Ureido]-Thiazol-5-Yl}-Ethylamino)-Pyrazolo[4,3-
D]pyrimidin-1-Yl]-Acetic Acid
Length = 272
Score = 38.9 bits (89), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 43/198 (21%), Positives = 76/198 (38%), Gaps = 30/198 (15%)
Query: 376 VGRGSFGIVYKGVIQTTRQVL-LQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
+G+G FG VY + ++ +L L++ + + E + + EV + S H N++RL G
Sbjct: 20 LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLY------LHEDCS 488
+ + L+ E+ GT+ L + ++A L Y +H D
Sbjct: 80 YFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKRVIHRDIK 139
Query: 489 SQIILY------------------SYKRTE-----GYVAPEWFRNSTITAKVDVYSFGFL 525
+ +L S +RT Y+ PE KVD++S G L
Sbjct: 140 PENLLLGSNGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVL 199
Query: 526 LLEIISCRKSFDIEMGEE 543
E + F+ +E
Sbjct: 200 CYEFLVGMPPFEAHTYQE 217
>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a
pdb|4H1M|A Chain A, Crystal Structure Of Pyk2 With The Indole 10c
Length = 293
Score = 38.5 bits (88), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 43/192 (22%), Positives = 80/192 (41%), Gaps = 38/192 (19%)
Query: 376 VGRGSFGIVYKGVIQTTR--QVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLL 433
+G G FG VY+GV + ++ + +++ D + +F +E ++ H ++V+L+
Sbjct: 32 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 91
Query: 434 GFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI--AFQIARGLLYL------HE 485
G +E ++ E G L +L N K S + T + + QI + + YL H
Sbjct: 92 GIIEEE-PTWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLESINCVHR 149
Query: 486 DCSSQIILYS---------------------YKRTEGYVAPEWFRNSTI-----TAKVDV 519
D + + IL + YK + + +W +I T DV
Sbjct: 150 DIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDV 209
Query: 520 YSFGFLLLEIIS 531
+ F + EI+S
Sbjct: 210 WMFAVCMWEILS 221
>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine
Kinase 2 Beta (ptk2b)
Length = 281
Score = 38.5 bits (88), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 43/192 (22%), Positives = 80/192 (41%), Gaps = 38/192 (19%)
Query: 376 VGRGSFGIVYKGVIQTTR--QVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLL 433
+G G FG VY+GV + ++ + +++ D + +F +E ++ H ++V+L+
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 434 GFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI--AFQIARGLLYL------HE 485
G +E ++ E G L +L N K S + T + + QI + + YL H
Sbjct: 80 GIIEEE-PTWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLESINCVHR 137
Query: 486 DCSSQIILYS---------------------YKRTEGYVAPEWFRNSTI-----TAKVDV 519
D + + IL + YK + + +W +I T DV
Sbjct: 138 DIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDV 197
Query: 520 YSFGFLLLEIIS 531
+ F + EI+S
Sbjct: 198 WMFAVCMWEILS 209
>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine
Kinase
pdb|3FZP|A Chain A, Crystal Structure Of Pyk2 Complexed With Atpgs
pdb|3FZR|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-431396
pdb|3FZS|A Chain A, Crystal Structure Of Pyk2 Complexed With Birb796
pdb|3FZT|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-4618433
pdb|3H3C|A Chain A, Crystal Structure Of Pyk2 In Complex With Sulfoximine-
Substituted Trifluoromethylpyrimidine Analog
pdb|3ET7|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-2318841
Length = 277
Score = 38.5 bits (88), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 43/192 (22%), Positives = 80/192 (41%), Gaps = 38/192 (19%)
Query: 376 VGRGSFGIVYKGVIQTTR--QVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLL 433
+G G FG VY+GV + ++ + +++ D + +F +E ++ H ++V+L+
Sbjct: 16 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 75
Query: 434 GFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI--AFQIARGLLYL------HE 485
G +E ++ E G L +L N K S + T + + QI + + YL H
Sbjct: 76 GIIEEE-PTWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLESINCVHR 133
Query: 486 DCSSQIILYS---------------------YKRTEGYVAPEWFRNSTI-----TAKVDV 519
D + + IL + YK + + +W +I T DV
Sbjct: 134 DIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDV 193
Query: 520 YSFGFLLLEIIS 531
+ F + EI+S
Sbjct: 194 WMFAVCMWEILS 205
>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex
pdb|1H4L|B Chain B, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex
Length = 292
Score = 38.5 bits (88), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 32/128 (25%), Positives = 57/128 (44%), Gaps = 10/128 (7%)
Query: 374 EEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLL 433
E++G G++G V+K + T +++ + R + E+ ++ + HKN+VRL
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 434 GFCDEGLNRLLVYEFLNNGTLASF--LFGNLKPSWNLRTNIAFQIARGLLY------LHE 485
LV+EF + F G+L P + + FQ+ +GL + LH
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPE--IVKSFLFQLLKGLGFCHSRNVLHR 125
Query: 486 DCSSQIIL 493
D Q +L
Sbjct: 126 DLKPQNLL 133
>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNG|B Chain B, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNH|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNH|B Chain B, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNL|A Chain A, Structural Mechanism For The Inhibition Of Cd5-P25 From
The Roscovitine, Aloisine And Indirubin.
pdb|1UNL|B Chain B, Structural Mechanism For The Inhibition Of Cd5-P25 From
The Roscovitine, Aloisine And Indirubin.
pdb|3O0G|A Chain A, Crystal Structure Of Cdk5:p25 In Complex With An Atp
Analogue
pdb|3O0G|B Chain B, Crystal Structure Of Cdk5:p25 In Complex With An Atp
Analogue
Length = 292
Score = 38.5 bits (88), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 32/128 (25%), Positives = 57/128 (44%), Gaps = 10/128 (7%)
Query: 374 EEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLL 433
E++G G++G V+K + T +++ + R + E+ ++ + HKN+VRL
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 434 GFCDEGLNRLLVYEFLNNGTLASF--LFGNLKPSWNLRTNIAFQIARGLLY------LHE 485
LV+EF + F G+L P + + FQ+ +GL + LH
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPE--IVKSFLFQLLKGLGFCHSRNVLHR 125
Query: 486 DCSSQIIL 493
D Q +L
Sbjct: 126 DLKPQNLL 133
>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino(
Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6-
Difluoro-Phenyl)-Amide)
Length = 349
Score = 38.5 bits (88), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 43/207 (20%), Positives = 77/207 (37%), Gaps = 37/207 (17%)
Query: 371 NFKEEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLV 430
+ E+GRG+ IVY+ Q Q L+ V ++ + E+ V+ + H N++
Sbjct: 56 EVESELGRGATSIVYR-CKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNII 111
Query: 431 RLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHED---- 486
+L + LV E + G L + S + QI + YLHE+
Sbjct: 112 KLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVH 171
Query: 487 -----------------------------CSSQIILYSYKRTEGYVAPEWFRNSTITAKV 517
Q+++ + T GY APE R +V
Sbjct: 172 RDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEV 231
Query: 518 DVYSFGFLLLEIISCRKSFDIEMGEEY 544
D++S G + ++ + F E G+++
Sbjct: 232 DMWSVGIITYILLCGFEPFYDERGDQF 258
>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4
pdb|2BVA|B Chain B, Crystal Structure Of The Human P21-Activated Kinase 4
Length = 292
Score = 38.5 bits (88), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 44/197 (22%), Positives = 81/197 (41%), Gaps = 45/197 (22%)
Query: 370 DNFKEEVGRGSFGIVYKGVIQTTRQVL------LQLQSRNWIVFQDGEREFKNEVFVISQ 423
DNF + +G GS GIV ++++ +++ L+ Q R ++F NEV ++
Sbjct: 23 DNFIK-IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF--------NEVVIMRD 73
Query: 424 THHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFL-FGNLKPSWNLRTNIAFQIARGLLY 482
H+N+V + G +V EFL G L + + +A A +L+
Sbjct: 74 YQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLH 133
Query: 483 ----LHEDCSSQIILYSY--------------------KR-----TEGYVAPEWFRNSTI 513
+H D S IL ++ +R T ++APE
Sbjct: 134 AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY 193
Query: 514 TAKVDVYSFGFLLLEII 530
+VD++S G +++E++
Sbjct: 194 GPEVDIWSLGIMVIEMV 210
>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With Cgp74514a
pdb|2J0I|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4
Length = 303
Score = 38.1 bits (87), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 44/197 (22%), Positives = 81/197 (41%), Gaps = 45/197 (22%)
Query: 370 DNFKEEVGRGSFGIVYKGVIQTTRQVL------LQLQSRNWIVFQDGEREFKNEVFVISQ 423
DNF + +G GS GIV ++++ +++ L+ Q R ++F NEV ++
Sbjct: 34 DNFIK-IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF--------NEVVIMRD 84
Query: 424 THHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFL-FGNLKPSWNLRTNIAFQIARGLLY 482
H+N+V + G +V EFL G L + + +A A +L+
Sbjct: 85 YQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLH 144
Query: 483 ----LHEDCSSQIILYSY--------------------KR-----TEGYVAPEWFRNSTI 513
+H D S IL ++ +R T ++APE
Sbjct: 145 AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY 204
Query: 514 TAKVDVYSFGFLLLEII 530
+VD++S G +++E++
Sbjct: 205 GPEVDIWSLGIMVIEMV 221
>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With Pf-03758309
pdb|4APP|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With (S)-N-(5-(3-Benzyl-1-Methylpiperazine-4-
Carbonyl)-6,6-Dimethyl-1,4,5,6-Tetrahydropyrrolo(3,4-C)
Pyrazol-3-Yl)-3-Phenoxybenzamide
Length = 296
Score = 38.1 bits (87), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 44/197 (22%), Positives = 81/197 (41%), Gaps = 45/197 (22%)
Query: 370 DNFKEEVGRGSFGIVYKGVIQTTRQVL------LQLQSRNWIVFQDGEREFKNEVFVISQ 423
DNF + +G GS GIV ++++ +++ L+ Q R ++F NEV ++
Sbjct: 27 DNFIK-IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF--------NEVVIMRD 77
Query: 424 THHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFL-FGNLKPSWNLRTNIAFQIARGLLY 482
H+N+V + G +V EFL G L + + +A A +L+
Sbjct: 78 YQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLH 137
Query: 483 ----LHEDCSSQIILYSY--------------------KR-----TEGYVAPEWFRNSTI 513
+H D S IL ++ +R T ++APE
Sbjct: 138 AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY 197
Query: 514 TAKVDVYSFGFLLLEII 530
+VD++S G +++E++
Sbjct: 198 GPEVDIWSLGIMVIEMV 214
>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor
Discovered Through Site-Directed Dynamic Tethering
Length = 272
Score = 38.1 bits (87), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 43/198 (21%), Positives = 76/198 (38%), Gaps = 30/198 (15%)
Query: 376 VGRGSFGIVYKGVIQTTRQVL-LQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
+G+G FG VY + ++ +L L++ + + E + + EV + S H N++RL G
Sbjct: 20 LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLY------LHEDCS 488
+ + L+ E+ GT+ L + ++A L Y +H D
Sbjct: 80 YFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKRVIHRDIK 139
Query: 489 SQIILY------------------SYKR-----TEGYVAPEWFRNSTITAKVDVYSFGFL 525
+ +L S +R T Y+ PE KVD++S G L
Sbjct: 140 PENLLLGSNGELKIADFGWSVHAPSSRRDTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVL 199
Query: 526 LLEIISCRKSFDIEMGEE 543
E + F+ +E
Sbjct: 200 CYEFLVGMPPFEAHTYQE 217
>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The
Gefitinib/erlotinib Resistant Egfr Kinase Domain
L858r+t790m
pdb|4I22|A Chain A, Structure Of The Monomeric (v948r)gefitinib/erlotinib
Resistant Double Mutant (l858r+t790m) Egfr Kinase Domain
Co-crystallized With Gefitinib
Length = 329
Score = 38.1 bits (87), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 43/195 (22%), Positives = 83/195 (42%), Gaps = 42/195 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNW--IVFQDGEREFKNEVFVISQTHHKNLVRL 432
+G G+FG VYKG+ I +V + + + +E +E +V++ + ++ RL
Sbjct: 25 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 433 LGFCDEGLNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYL------ 483
LG C +L++ + + G L ++ N+ + L N QIA+G+ YL
Sbjct: 85 LGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYLEDRRLV 141
Query: 484 HEDCSSQIILY----------------------SYKRTEGYVAPEWFRNSTITAKV---- 517
H D +++ +L Y G V +W +I ++
Sbjct: 142 HRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ 201
Query: 518 -DVYSFGFLLLEIIS 531
DV+S+G + E+++
Sbjct: 202 SDVWSYGVTVWELMT 216
>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In
Complex With A Consensus Peptide
Length = 301
Score = 38.1 bits (87), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 44/197 (22%), Positives = 81/197 (41%), Gaps = 45/197 (22%)
Query: 370 DNFKEEVGRGSFGIVYKGVIQTTRQVL------LQLQSRNWIVFQDGEREFKNEVFVISQ 423
DNF + +G GS GIV ++++ +++ L+ Q R ++F NEV ++
Sbjct: 32 DNFIK-IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF--------NEVVIMRD 82
Query: 424 THHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFL-FGNLKPSWNLRTNIAFQIARGLLY 482
H+N+V + G +V EFL G L + + +A A +L+
Sbjct: 83 YQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLH 142
Query: 483 ----LHEDCSSQIILYSY--------------------KR-----TEGYVAPEWFRNSTI 513
+H D S IL ++ +R T ++APE
Sbjct: 143 AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY 202
Query: 514 TAKVDVYSFGFLLLEII 530
+VD++S G +++E++
Sbjct: 203 GPEVDIWSLGIMVIEMV 219
>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain
pdb|3Q4Z|B Chain B, Structure Of Unphosphorylated Pak1 Kinase Domain
Length = 306
Score = 38.1 bits (87), Expect = 0.013, Method: Compositional matrix adjust.
Identities = 44/193 (22%), Positives = 74/193 (38%), Gaps = 44/193 (22%)
Query: 374 EEVGRGSFGIVYKGVIQTT------RQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHK 427
E++G+G+ G VY + T RQ+ LQ Q + ++ NE+ V+ + +
Sbjct: 27 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII--------NEILVMRENKNP 78
Query: 428 NLVRLLGFCDEGLNRLLVYEFLNNGTLA------------------------SFLFGNLK 463
N+V L G +V E+L G+L FL N
Sbjct: 79 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQV 138
Query: 464 PSWNLRT-NIAFQIARGLLYLHEDCSSQIILYSYKRTEGYVAPEWFRNSTIT-----AKV 517
N+++ NI + + +QI KR+ P W +T KV
Sbjct: 139 IHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 198
Query: 518 DVYSFGFLLLEII 530
D++S G + +E+I
Sbjct: 199 DIWSLGIMAIEMI 211
>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680
Length = 292
Score = 38.1 bits (87), Expect = 0.013, Method: Compositional matrix adjust.
Identities = 49/229 (21%), Positives = 89/229 (38%), Gaps = 41/229 (17%)
Query: 341 KKWIRNSPGDGTVETNLRCFSYKALEEATDNFK--EEVGRGSFGIVYKGVIQTTR-QVLL 397
+K + NS G + T R F+ D+F+ +G+G FG VY + + V L
Sbjct: 3 QKVMENSSGTPDILT--RHFT-------IDDFEIGRPLGKGKFGNVYLAREKKSHFIVAL 53
Query: 398 QLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASF 457
++ ++ I + E + + E+ + + HH N++RL + + L+ E+ G L
Sbjct: 54 KVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKE 113
Query: 458 LFGNLKPSWNLRTNIAFQIARGLLY------LHEDCSSQ------------------IIL 493
L + I ++A L+Y +H D + +
Sbjct: 114 LQKSCTFDEQRTATIMEELADALMYCHGKKVIHRDIKPENLLLGLKGELKIADFGWSVHA 173
Query: 494 YSYKR-----TEGYVAPEWFRNSTITAKVDVYSFGFLLLEIISCRKSFD 537
S +R T Y+ PE KVD++ G L E++ F+
Sbjct: 174 PSLRRKTMCGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFE 222
>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently
Binding To Wz4002
pdb|3IKA|B Chain B, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently
Binding To Wz4002
Length = 331
Score = 38.1 bits (87), Expect = 0.013, Method: Compositional matrix adjust.
Identities = 43/195 (22%), Positives = 83/195 (42%), Gaps = 42/195 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNW--IVFQDGEREFKNEVFVISQTHHKNLVRL 432
+G G+FG VYKG+ I +V + + + +E +E +V++ + ++ RL
Sbjct: 27 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 86
Query: 433 LGFCDEGLNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYL------ 483
LG C +L++ + + G L ++ N+ + L N QIA+G+ YL
Sbjct: 87 LGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYLEDRRLV 143
Query: 484 HEDCSSQIILY----------------------SYKRTEGYVAPEWFRNSTITAKV---- 517
H D +++ +L Y G V +W +I ++
Sbjct: 144 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ 203
Query: 518 -DVYSFGFLLLEIIS 531
DV+S+G + E+++
Sbjct: 204 SDVWSYGVTVWELMT 218
>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With
Dacomitinib
pdb|4I24|B Chain B, Structure Of T790m Egfr Kinase Domain Co-crystallized With
Dacomitinib
Length = 329
Score = 38.1 bits (87), Expect = 0.013, Method: Compositional matrix adjust.
Identities = 43/195 (22%), Positives = 83/195 (42%), Gaps = 42/195 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNW--IVFQDGEREFKNEVFVISQTHHKNLVRL 432
+G G+FG VYKG+ I +V + + + +E +E +V++ + ++ RL
Sbjct: 25 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 433 LGFCDEGLNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYL------ 483
LG C +L++ + + G L ++ N+ + L N QIA+G+ YL
Sbjct: 85 LGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYLEDRRLV 141
Query: 484 HEDCSSQIILY----------------------SYKRTEGYVAPEWFRNSTITAKV---- 517
H D +++ +L Y G V +W +I ++
Sbjct: 142 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ 201
Query: 518 -DVYSFGFLLLEIIS 531
DV+S+G + E+++
Sbjct: 202 SDVWSYGVTVWELMT 216
>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In
Complex With Mig6 Peptide
pdb|4I21|B Chain B, Crystal Structure Of L858r + T790m Egfr Kinase Domain In
Complex With Mig6 Peptide
Length = 329
Score = 38.1 bits (87), Expect = 0.014, Method: Compositional matrix adjust.
Identities = 43/195 (22%), Positives = 83/195 (42%), Gaps = 42/195 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNW--IVFQDGEREFKNEVFVISQTHHKNLVRL 432
+G G+FG VYKG+ I +V + + + +E +E +V++ + ++ RL
Sbjct: 25 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 433 LGFCDEGLNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYL------ 483
LG C +L++ + + G L ++ N+ + L N QIA+G+ YL
Sbjct: 85 LGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYLEDRRLV 141
Query: 484 HEDCSSQIILY----------------------SYKRTEGYVAPEWFRNSTITAKV---- 517
H D +++ +L Y G V +W +I ++
Sbjct: 142 HRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ 201
Query: 518 -DVYSFGFLLLEIIS 531
DV+S+G + E+++
Sbjct: 202 SDVWSYGVTVWELMT 216
>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Complex With Aee788
pdb|2JIU|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Complex With Aee788
Length = 328
Score = 38.1 bits (87), Expect = 0.014, Method: Compositional matrix adjust.
Identities = 43/195 (22%), Positives = 83/195 (42%), Gaps = 42/195 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNW--IVFQDGEREFKNEVFVISQTHHKNLVRL 432
+G G+FG VYKG+ I +V + + + +E +E +V++ + ++ RL
Sbjct: 24 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 83
Query: 433 LGFCDEGLNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYL------ 483
LG C +L++ + + G L ++ N+ + L N QIA+G+ YL
Sbjct: 84 LGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYLEDRRLV 140
Query: 484 HEDCSSQIILY----------------------SYKRTEGYVAPEWFRNSTITAKV---- 517
H D +++ +L Y G V +W +I ++
Sbjct: 141 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ 200
Query: 518 -DVYSFGFLLLEIIS 531
DV+S+G + E+++
Sbjct: 201 SDVWSYGVTVWELMT 215
>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1
pdb|1F3M|D Chain D, Crystal Structure Of Human SerineTHREONINE KINASE PAK1
pdb|1YHW|A Chain A, Crystal Structure Of Pak1 Kinase Domain With One Point
Mutations (K299r)
Length = 297
Score = 38.1 bits (87), Expect = 0.015, Method: Compositional matrix adjust.
Identities = 45/194 (23%), Positives = 77/194 (39%), Gaps = 46/194 (23%)
Query: 374 EEVGRGSFGIVYKGVIQTT------RQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHK 427
E++G+G+ G VY + T RQ+ LQ Q + ++ NE+ V+ + +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII--------NEILVMRENKNP 77
Query: 428 NLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYL---- 483
N+V L G +V E+L G+L + + + + + L +L
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALEFLHSNQ 136
Query: 484 --HEDCSSQIILY----SYKRTE----GYVAPEWFRNSTITA-----------------K 516
H D S IL S K T+ + PE + ST+ K
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 196
Query: 517 VDVYSFGFLLLEII 530
VD++S G + +E+I
Sbjct: 197 VDIWSLGIMAIEMI 210
>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With
Bibw2992
pdb|4G5P|B Chain B, Crystal Structure Of Egfr Kinase T790m In Complex With
Bibw2992
Length = 330
Score = 38.1 bits (87), Expect = 0.015, Method: Compositional matrix adjust.
Identities = 43/195 (22%), Positives = 83/195 (42%), Gaps = 42/195 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNW--IVFQDGEREFKNEVFVISQTHHKNLVRL 432
+G G+FG VYKG+ I +V + + + +E +E +V++ + ++ RL
Sbjct: 26 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 433 LGFCDEGLNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYL------ 483
LG C +L++ + + G L ++ N+ + L N QIA+G+ YL
Sbjct: 86 LGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYLEDRRLV 142
Query: 484 HEDCSSQIILY----------------------SYKRTEGYVAPEWFRNSTITAKV---- 517
H D +++ +L Y G V +W +I ++
Sbjct: 143 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ 202
Query: 518 -DVYSFGFLLLEIIS 531
DV+S+G + E+++
Sbjct: 203 SDVWSYGVTVWELMT 217
>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
pdb|2JIV|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
Length = 328
Score = 38.1 bits (87), Expect = 0.015, Method: Compositional matrix adjust.
Identities = 43/195 (22%), Positives = 83/195 (42%), Gaps = 42/195 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNW--IVFQDGEREFKNEVFVISQTHHKNLVRL 432
+G G+FG VYKG+ I +V + + + +E +E +V++ + ++ RL
Sbjct: 24 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 83
Query: 433 LGFCDEGLNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYL------ 483
LG C +L++ + + G L ++ N+ + L N QIA+G+ YL
Sbjct: 84 LGICLTSTVQLIM-QLMPFGXLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYLEDRRLV 140
Query: 484 HEDCSSQIILY----------------------SYKRTEGYVAPEWFRNSTITAKV---- 517
H D +++ +L Y G V +W +I ++
Sbjct: 141 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ 200
Query: 518 -DVYSFGFLLLEIIS 531
DV+S+G + E+++
Sbjct: 201 SDVWSYGVTVWELMT 215
>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285
pdb|3W2P|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Compound 2
pdb|3W2Q|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Hki-272
pdb|3W2R|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Compound 4
Length = 331
Score = 37.7 bits (86), Expect = 0.015, Method: Compositional matrix adjust.
Identities = 43/195 (22%), Positives = 83/195 (42%), Gaps = 42/195 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNW--IVFQDGEREFKNEVFVISQTHHKNLVRL 432
+G G+FG VYKG+ I +V + + + +E +E +V++ + ++ RL
Sbjct: 27 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 86
Query: 433 LGFCDEGLNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYL------ 483
LG C +L++ + + G L ++ N+ + L N QIA+G+ YL
Sbjct: 87 LGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYLEDRRLV 143
Query: 484 HEDCSSQIILY----------------------SYKRTEGYVAPEWFRNSTITAKV---- 517
H D +++ +L Y G V +W +I ++
Sbjct: 144 HRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ 203
Query: 518 -DVYSFGFLLLEIIS 531
DV+S+G + E+++
Sbjct: 204 SDVWSYGVTVWELMT 218
>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain
Kinase Loc340156.
pdb|2X4F|B Chain B, The Crystal Structure Of The Human Myosin Light Chain
Kinase Loc340156
Length = 373
Score = 37.7 bits (86), Expect = 0.015, Method: Compositional matrix adjust.
Identities = 35/116 (30%), Positives = 59/116 (50%), Gaps = 9/116 (7%)
Query: 374 EEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLL 433
E +G G FG V+K +T + L + +D E E KNE+ V++Q H NL++L
Sbjct: 95 EILGGGRFGQVHK-CEETATGLKLAAKIIKTRGMKDKE-EVKNEISVMNQLDHANLIQLY 152
Query: 434 GFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAF--QIARGLLYLHE 485
+ + +LV E+++ G L + + S+NL I F QI G+ ++H+
Sbjct: 153 DAFESKNDIVLVMEYVDGGELFDRI---IDESYNLTELDTILFMKQICEGIRHMHQ 205
>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation
pdb|2JIT|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation
Length = 327
Score = 37.7 bits (86), Expect = 0.016, Method: Compositional matrix adjust.
Identities = 43/195 (22%), Positives = 83/195 (42%), Gaps = 42/195 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNW--IVFQDGEREFKNEVFVISQTHHKNLVRL 432
+G G+FG VYKG+ I +V + + + +E +E +V++ + ++ RL
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 433 LGFCDEGLNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYL------ 483
LG C +L++ + + G L ++ N+ + L N QIA+G+ YL
Sbjct: 83 LGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYLEDRRLV 139
Query: 484 HEDCSSQIILY----------------------SYKRTEGYVAPEWFRNSTITAKV---- 517
H D +++ +L Y G V +W +I ++
Sbjct: 140 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ 199
Query: 518 -DVYSFGFLLLEIIS 531
DV+S+G + E+++
Sbjct: 200 SDVWSYGVTVWELMT 214
>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor-
Gw572016
Length = 352
Score = 37.7 bits (86), Expect = 0.017, Method: Compositional matrix adjust.
Identities = 43/195 (22%), Positives = 82/195 (42%), Gaps = 42/195 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNW--IVFQDGEREFKNEVFVISQTHHKNLVRL 432
+G G+FG VYKG+ I +V + + + +E +E +V++ + ++ RL
Sbjct: 48 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 107
Query: 433 LGFCDEGLNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYL------ 483
LG C +L+ + + G L ++ N+ + L N QIA+G+ YL
Sbjct: 108 LGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYLEDRRLV 164
Query: 484 HEDCSSQIILY----------------------SYKRTEGYVAPEWFRNSTITAKV---- 517
H D +++ +L Y G V +W +I ++
Sbjct: 165 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ 224
Query: 518 -DVYSFGFLLLEIIS 531
DV+S+G + E+++
Sbjct: 225 SDVWSYGVTVWELMT 239
>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic
Mutant L858r Egfr Kinase Domain
Length = 329
Score = 37.7 bits (86), Expect = 0.017, Method: Compositional matrix adjust.
Identities = 43/195 (22%), Positives = 82/195 (42%), Gaps = 42/195 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNW--IVFQDGEREFKNEVFVISQTHHKNLVRL 432
+G G+FG VYKG+ I +V + + + +E +E +V++ + ++ RL
Sbjct: 25 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 433 LGFCDEGLNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYL------ 483
LG C +L+ + + G L ++ N+ + L N QIA+G+ YL
Sbjct: 85 LGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYLEDRRLV 141
Query: 484 HEDCSSQIILY----------------------SYKRTEGYVAPEWFRNSTITAKV---- 517
H D +++ +L Y G V +W +I ++
Sbjct: 142 HRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ 201
Query: 518 -DVYSFGFLLLEIIS 531
DV+S+G + E+++
Sbjct: 202 SDVWSYGVTVWELMT 216
>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From
Cryptosporidium Parvum, Cgd7_40
Length = 345
Score = 37.7 bits (86), Expect = 0.018, Method: Compositional matrix adjust.
Identities = 26/88 (29%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 371 NFKEEVGRGSFGIVYKGVIQTTRQV-LLQLQSRNWIVF---QDGEREFKNEVFVISQTHH 426
+ K +G+GS+G+V + TR + +++ ++N I +D ER K EV ++ + HH
Sbjct: 29 HLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVER-IKTEVRLMKKLHH 87
Query: 427 KNLVRLLGFCDEGLNRLLVYEFLNNGTL 454
N+ RL ++ LV E + G L
Sbjct: 88 PNIARLYEVYEDEQYICLVMELCHGGHL 115
>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|2GS7|B Chain B, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|B Chain B, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|C Chain C, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|D Chain D, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
Length = 330
Score = 37.7 bits (86), Expect = 0.019, Method: Compositional matrix adjust.
Identities = 43/195 (22%), Positives = 82/195 (42%), Gaps = 42/195 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNW--IVFQDGEREFKNEVFVISQTHHKNLVRL 432
+G G+FG VYKG+ I +V + + + +E +E +V++ + ++ RL
Sbjct: 26 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 433 LGFCDEGLNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYL------ 483
LG C +L+ + + G L ++ N+ + L N QIA+G+ YL
Sbjct: 86 LGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYLEDRRLV 142
Query: 484 HEDCSSQIILY----------------------SYKRTEGYVAPEWFRNSTITAKV---- 517
H D +++ +L Y G V +W +I ++
Sbjct: 143 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ 202
Query: 518 -DVYSFGFLLLEIIS 531
DV+S+G + E+++
Sbjct: 203 SDVWSYGVTVWELMT 217
>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor
Receptor
pdb|1M17|A Chain A, Epidermal Growth Factor Receptor Tyrosine Kinase Domain
With 4-Anilinoquinazoline Inhibitor Erlotinib
Length = 333
Score = 37.7 bits (86), Expect = 0.019, Method: Compositional matrix adjust.
Identities = 43/195 (22%), Positives = 82/195 (42%), Gaps = 42/195 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNW--IVFQDGEREFKNEVFVISQTHHKNLVRL 432
+G G+FG VYKG+ I +V + + + +E +E +V++ + ++ RL
Sbjct: 29 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 88
Query: 433 LGFCDEGLNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYL------ 483
LG C +L+ + + G L ++ N+ + L N QIA+G+ YL
Sbjct: 89 LGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYLEDRRLV 145
Query: 484 HEDCSSQIILY----------------------SYKRTEGYVAPEWFRNSTITAKV---- 517
H D +++ +L Y G V +W +I ++
Sbjct: 146 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ 205
Query: 518 -DVYSFGFLLLEIIS 531
DV+S+G + E+++
Sbjct: 206 SDVWSYGVTVWELMT 220
>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In
Complex With Amppnp
Length = 334
Score = 37.7 bits (86), Expect = 0.019, Method: Compositional matrix adjust.
Identities = 43/195 (22%), Positives = 82/195 (42%), Gaps = 42/195 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNW--IVFQDGEREFKNEVFVISQTHHKNLVRL 432
+G G+FG VYKG+ I +V + + + +E +E +V++ + ++ RL
Sbjct: 30 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 433 LGFCDEGLNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYL------ 483
LG C +L+ + + G L ++ N+ + L N QIA+G+ YL
Sbjct: 90 LGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYLEDRRLV 146
Query: 484 HEDCSSQIILY----------------------SYKRTEGYVAPEWFRNSTITAKV---- 517
H D +++ +L Y G V +W +I ++
Sbjct: 147 HRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ 206
Query: 518 -DVYSFGFLLLEIIS 531
DV+S+G + E+++
Sbjct: 207 SDVWSYGVTVWELMT 221
>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992
Length = 330
Score = 37.7 bits (86), Expect = 0.020, Method: Compositional matrix adjust.
Identities = 43/195 (22%), Positives = 82/195 (42%), Gaps = 42/195 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNW--IVFQDGEREFKNEVFVISQTHHKNLVRL 432
+G G+FG VYKG+ I +V + + + +E +E +V++ + ++ RL
Sbjct: 26 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 433 LGFCDEGLNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYL------ 483
LG C +L+ + + G L ++ N+ + L N QIA+G+ YL
Sbjct: 86 LGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYLEDRRLV 142
Query: 484 HEDCSSQIILY----------------------SYKRTEGYVAPEWFRNSTITAKV---- 517
H D +++ +L Y G V +W +I ++
Sbjct: 143 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ 202
Query: 518 -DVYSFGFLLLEIIS 531
DV+S+G + E+++
Sbjct: 203 SDVWSYGVTVWELMT 217
>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain
pdb|2GS6|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain In
Complex With An Atp Analog-Peptide Conjugate
pdb|2RF9|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RF9|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|3W2S|A Chain A, Egfr Kinase Domain With Compound4
Length = 330
Score = 37.7 bits (86), Expect = 0.020, Method: Compositional matrix adjust.
Identities = 43/195 (22%), Positives = 82/195 (42%), Gaps = 42/195 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNW--IVFQDGEREFKNEVFVISQTHHKNLVRL 432
+G G+FG VYKG+ I +V + + + +E +E +V++ + ++ RL
Sbjct: 26 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 433 LGFCDEGLNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYL------ 483
LG C +L+ + + G L ++ N+ + L N QIA+G+ YL
Sbjct: 86 LGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYLEDRRLV 142
Query: 484 HEDCSSQIILY----------------------SYKRTEGYVAPEWFRNSTITAKV---- 517
H D +++ +L Y G V +W +I ++
Sbjct: 143 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ 202
Query: 518 -DVYSFGFLLLEIIS 531
DV+S+G + E+++
Sbjct: 203 SDVWSYGVTVWELMT 217
>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In
Complex With Amppnp
Length = 334
Score = 37.4 bits (85), Expect = 0.020, Method: Compositional matrix adjust.
Identities = 43/195 (22%), Positives = 82/195 (42%), Gaps = 42/195 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNW--IVFQDGEREFKNEVFVISQTHHKNLVRL 432
+G G+FG VYKG+ I +V + + + +E +E +V++ + ++ RL
Sbjct: 30 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 433 LGFCDEGLNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYL------ 483
LG C +L+ + + G L ++ N+ + L N QIA+G+ YL
Sbjct: 90 LGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYLEDRRLV 146
Query: 484 HEDCSSQIILY----------------------SYKRTEGYVAPEWFRNSTITAKV---- 517
H D +++ +L Y G V +W +I ++
Sbjct: 147 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ 206
Query: 518 -DVYSFGFLLLEIIS 531
DV+S+G + E+++
Sbjct: 207 SDVWSYGVTVWELMT 221
>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Aee788
pdb|2ITU|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Afn941
pdb|2ITV|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Amp-pnp
pdb|2ITZ|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Iressa
Length = 327
Score = 37.4 bits (85), Expect = 0.020, Method: Compositional matrix adjust.
Identities = 43/195 (22%), Positives = 82/195 (42%), Gaps = 42/195 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNW--IVFQDGEREFKNEVFVISQTHHKNLVRL 432
+G G+FG VYKG+ I +V + + + +E +E +V++ + ++ RL
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 433 LGFCDEGLNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYL------ 483
LG C +L+ + + G L ++ N+ + L N QIA+G+ YL
Sbjct: 83 LGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYLEDRRLV 139
Query: 484 HEDCSSQIILY----------------------SYKRTEGYVAPEWFRNSTITAKV---- 517
H D +++ +L Y G V +W +I ++
Sbjct: 140 HRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ 199
Query: 518 -DVYSFGFLLLEIIS 531
DV+S+G + E+++
Sbjct: 200 SDVWSYGVTVWELMT 214
>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An
Irreversible Inhibitor 34-Jab
pdb|2ITW|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Afn941
pdb|2ITX|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Amp- Pnp
pdb|2ITY|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Iressa
pdb|2J6M|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Aee788
pdb|3POZ|A Chain A, Egfr Kinase Domain Complexed With Tak-285
Length = 327
Score = 37.4 bits (85), Expect = 0.020, Method: Compositional matrix adjust.
Identities = 43/195 (22%), Positives = 82/195 (42%), Gaps = 42/195 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNW--IVFQDGEREFKNEVFVISQTHHKNLVRL 432
+G G+FG VYKG+ I +V + + + +E +E +V++ + ++ RL
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 433 LGFCDEGLNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYL------ 483
LG C +L+ + + G L ++ N+ + L N QIA+G+ YL
Sbjct: 83 LGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYLEDRRLV 139
Query: 484 HEDCSSQIILY----------------------SYKRTEGYVAPEWFRNSTITAKV---- 517
H D +++ +L Y G V +W +I ++
Sbjct: 140 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ 199
Query: 518 -DVYSFGFLLLEIIS 531
DV+S+G + E+++
Sbjct: 200 SDVWSYGVTVWELMT 214
>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6
Length = 321
Score = 37.4 bits (85), Expect = 0.020, Method: Compositional matrix adjust.
Identities = 43/193 (22%), Positives = 75/193 (38%), Gaps = 46/193 (23%)
Query: 375 EVGRGSFGIV------YKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKN 428
++G GS GIV + G + + L+ Q R ++F NEV ++ H N
Sbjct: 52 KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLF--------NEVVIMRDYQHFN 103
Query: 429 LVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH---- 484
+V + G ++ EFL G L + ++ + + + + L YLH
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQGV 162
Query: 485 --EDCSSQIILYSY--------------------KR-----TEGYVAPEWFRNSTITAKV 517
D S IL + KR T ++APE S +V
Sbjct: 163 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISRSLYATEV 222
Query: 518 DVYSFGFLLLEII 530
D++S G +++E++
Sbjct: 223 DIWSLGIMVIEMV 235
>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An
Irreversible Inhibitor 13-Jab
Length = 327
Score = 37.4 bits (85), Expect = 0.020, Method: Compositional matrix adjust.
Identities = 43/195 (22%), Positives = 82/195 (42%), Gaps = 42/195 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNW--IVFQDGEREFKNEVFVISQTHHKNLVRL 432
+G G+FG VYKG+ I +V + + + +E +E +V++ + ++ RL
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 433 LGFCDEGLNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYL------ 483
LG C +L+ + + G L ++ N+ + L N QIA+G+ YL
Sbjct: 83 LGICLTSTVQLIT-QLMPFGXLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYLEDRRLV 139
Query: 484 HEDCSSQIILY----------------------SYKRTEGYVAPEWFRNSTITAKV---- 517
H D +++ +L Y G V +W +I ++
Sbjct: 140 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ 199
Query: 518 -DVYSFGFLLLEIIS 531
DV+S+G + E+++
Sbjct: 200 SDVWSYGVTVWELMT 214
>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In
Complex With Dacomitinib (soaked)
Length = 329
Score = 37.4 bits (85), Expect = 0.021, Method: Compositional matrix adjust.
Identities = 43/195 (22%), Positives = 82/195 (42%), Gaps = 42/195 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNW--IVFQDGEREFKNEVFVISQTHHKNLVRL 432
+G G+FG VYKG+ I +V + + + +E +E +V++ + ++ RL
Sbjct: 25 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 433 LGFCDEGLNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYL------ 483
LG C +L+ + + G L ++ N+ + L N QIA+G+ YL
Sbjct: 85 LGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYLEDRRLV 141
Query: 484 HEDCSSQIILY----------------------SYKRTEGYVAPEWFRNSTITAKV---- 517
H D +++ +L Y G V +W +I ++
Sbjct: 142 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ 201
Query: 518 -DVYSFGFLLLEIIS 531
DV+S+G + E+++
Sbjct: 202 SDVWSYGVTVWELMT 216
>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine
Length = 353
Score = 37.4 bits (85), Expect = 0.021, Method: Compositional matrix adjust.
Identities = 48/219 (21%), Positives = 84/219 (38%), Gaps = 37/219 (16%)
Query: 368 ATDNFK--EEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGERE-FKNEVFVISQT 424
DNF+ +G+GSFG V ++ T + + ++ QD + E E ++S
Sbjct: 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLA 80
Query: 425 HHKNLVRLLGFCDEGLNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYL 483
+ + L C + +RL V EF+N G L + + + A +I L++L
Sbjct: 81 RNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFL 140
Query: 484 H-------------------------------EDCSSQIILYSYKRTEGYVAPEWFRNST 512
H E + + ++ T Y+APE +
Sbjct: 141 HDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEML 200
Query: 513 ITAKVDVYSFGFLLLEIISCRKSFDIEMGEEY--AILTD 549
VD ++ G LL E++ F+ E ++ AIL D
Sbjct: 201 YGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND 239
>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|B Chain B, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|C Chain C, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|D Chain D, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
Length = 341
Score = 37.4 bits (85), Expect = 0.021, Method: Compositional matrix adjust.
Identities = 47/204 (23%), Positives = 77/204 (37%), Gaps = 54/204 (26%)
Query: 374 EEVGRGSFGIVYKGVIQT----TRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNL 429
E++G GSFG+V +G T V ++ + + + +F EV + H+NL
Sbjct: 18 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 430 VRLLGFCDEGLNRLLVYEFLNNGTL--------ASFLFGNLKPSWNLRTNIAFQIARGLL 481
+RL G + +V E G+L FL G L + A Q+A G+
Sbjct: 78 IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTL-------SRYAVQVAEGMG 129
Query: 482 YL------HEDCSSQIILYS----------------------YKRTE------GYVAPEW 507
YL H D +++ +L + Y E + APE
Sbjct: 130 YLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 189
Query: 508 FRNSTITAKVDVYSFGFLLLEIIS 531
+ T + D + FG L E+ +
Sbjct: 190 LKTRTFSHASDTWMFGVTLWEMFT 213
>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium
Complex Lambda-Fl172
pdb|3FY0|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium
Complex Dw1
pdb|4DAW|A Chain A, Crystal Structure Of Pak1 Kinase Domain With The Ruthenium
Phthalimide Complex
Length = 297
Score = 37.4 bits (85), Expect = 0.021, Method: Compositional matrix adjust.
Identities = 43/194 (22%), Positives = 73/194 (37%), Gaps = 46/194 (23%)
Query: 374 EEVGRGSFGIVYKGVIQTT------RQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHK 427
E++G+G+ G VY + T RQ+ LQ Q + ++ NE+ V+ + +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII--------NEILVMRENKNP 77
Query: 428 NLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYL---- 483
N+V L G +V E+L G+L + + + + + L +L
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALEFLHSNQ 136
Query: 484 --HEDCSS--------------------QIILYSYKRTEGYVAPEWFRNSTIT-----AK 516
H D S QI KR+ P W +T K
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPK 196
Query: 517 VDVYSFGFLLLEII 530
VD++S G + +E+I
Sbjct: 197 VDIWSLGIMAIEMI 210
>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071
pdb|3IW4|B Chain B, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071
pdb|3IW4|C Chain C, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071
Length = 360
Score = 37.4 bits (85), Expect = 0.022, Method: Compositional matrix adjust.
Identities = 48/206 (23%), Positives = 80/206 (38%), Gaps = 33/206 (16%)
Query: 371 NFKEEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKN-EVFVISQTHHKNL 429
NF +G+GSFG V + T ++ + +V QD + E E V++
Sbjct: 22 NFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPF 81
Query: 430 VRLLGFCDEGLNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHE--- 485
+ L C + ++RL V E++N G L + K A +I+ GL +LH+
Sbjct: 82 LTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHKRGI 141
Query: 486 ------------DCSSQIILYSYKR----------------TEGYVAPEWFRNSTITAKV 517
D I + + T Y+APE V
Sbjct: 142 IYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIAYQPYGKSV 201
Query: 518 DVYSFGFLLLEIISCRKSFDIEMGEE 543
D +++G LL E+++ + FD E +E
Sbjct: 202 DWWAYGVLLYEMLAGQPPFDGEDEDE 227
>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95
pdb|3EQP|A Chain A, Crystal Structure Of Ack1 With Compound T95
pdb|3EQR|A Chain A, Crystal Structure Of Ack1 With Compound T74
pdb|3EQR|B Chain B, Crystal Structure Of Ack1 With Compound T74
Length = 276
Score = 37.4 bits (85), Expect = 0.022, Method: Compositional matrix adjust.
Identities = 47/204 (23%), Positives = 77/204 (37%), Gaps = 54/204 (26%)
Query: 374 EEVGRGSFGIVYKGVIQT----TRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNL 429
E++G GSFG+V +G T V ++ + + + +F EV + H+NL
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 430 VRLLGFCDEGLNRLLVYEFLNNGTL--------ASFLFGNLKPSWNLRTNIAFQIARGLL 481
+RL G + +V E G+L FL G L + A Q+A G+
Sbjct: 74 IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTL-------SRYAVQVAEGMG 125
Query: 482 YL------HEDCSSQIILYS----------------------YKRTE------GYVAPEW 507
YL H D +++ +L + Y E + APE
Sbjct: 126 YLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 185
Query: 508 FRNSTITAKVDVYSFGFLLLEIIS 531
+ T + D + FG L E+ +
Sbjct: 186 LKTRTFSHASDTWMFGVTLWEMFT 209
>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain
pdb|3Q53|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain In Complex
With Atp
Length = 306
Score = 37.4 bits (85), Expect = 0.023, Method: Compositional matrix adjust.
Identities = 43/194 (22%), Positives = 73/194 (37%), Gaps = 46/194 (23%)
Query: 374 EEVGRGSFGIVYKGVIQTT------RQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHK 427
E++G+G+ G VY + T RQ+ LQ Q + ++ NE+ V+ + +
Sbjct: 27 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII--------NEILVMRENKNP 78
Query: 428 NLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYL---- 483
N+V L G +V E+L G+L + + + + + L +L
Sbjct: 79 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALEFLHSNQ 137
Query: 484 --HEDCSS--------------------QIILYSYKRTEGYVAPEWFRNSTIT-----AK 516
H D S QI KR+ P W +T K
Sbjct: 138 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPK 197
Query: 517 VDVYSFGFLLLEII 530
VD++S G + +E+I
Sbjct: 198 VDIWSLGIMAIEMI 211
>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase
Domain With Erlotinib
Length = 337
Score = 37.4 bits (85), Expect = 0.024, Method: Compositional matrix adjust.
Identities = 43/195 (22%), Positives = 82/195 (42%), Gaps = 42/195 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNW--IVFQDGEREFKNEVFVISQTHHKNLVRL 432
+G G+FG VYKG+ I +V + + + +E +E +V++ + ++ RL
Sbjct: 33 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 92
Query: 433 LGFCDEGLNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYL------ 483
LG C +L+ + + G L ++ N+ + L N QIA+G+ YL
Sbjct: 93 LGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYLEDRRLV 149
Query: 484 HEDCSSQIILY----------------------SYKRTEGYVAPEWFRNSTITAKV---- 517
H D +++ +L Y G V +W +I ++
Sbjct: 150 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ 209
Query: 518 -DVYSFGFLLLEIIS 531
DV+S+G + E+++
Sbjct: 210 SDVWSYGVTVWELMT 224
>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor
pdb|2RGP|A Chain A, Structure Of Egfr In Complex With Hydrazone, A Potent Dual
Inhibitor
Length = 315
Score = 37.4 bits (85), Expect = 0.024, Method: Compositional matrix adjust.
Identities = 43/195 (22%), Positives = 82/195 (42%), Gaps = 42/195 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNW--IVFQDGEREFKNEVFVISQTHHKNLVRL 432
+G G+FG VYKG+ I +V + + + +E +E +V++ + ++ RL
Sbjct: 17 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 76
Query: 433 LGFCDEGLNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYL------ 483
LG C +L+ + + G L ++ N+ + L N QIA+G+ YL
Sbjct: 77 LGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYLEDRRLV 133
Query: 484 HEDCSSQIILY----------------------SYKRTEGYVAPEWFRNSTITAKV---- 517
H D +++ +L Y G V +W +I ++
Sbjct: 134 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ 193
Query: 518 -DVYSFGFLLLEIIS 531
DV+S+G + E+++
Sbjct: 194 SDVWSYGVTVWELMT 208
>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From
The Structures Cdk6-P19ink4d Inhibitor Complex
pdb|1BI8|C Chain C, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From
The Structures Cdk6-P19ink4d Inhibitor Complex
pdb|1BI7|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From
The Structure Of The Cdk6-P16ink4a Tumor Suppressor
Complex
pdb|1BLX|A Chain A, P19ink4dCDK6 COMPLEX
pdb|1G3N|A Chain A, Structure Of A P18(Ink4c)-Cdk6-K-Cyclin Ternary Complex
pdb|1G3N|E Chain E, Structure Of A P18(Ink4c)-Cdk6-K-Cyclin Ternary Complex
Length = 326
Score = 37.4 bits (85), Expect = 0.024, Method: Compositional matrix adjust.
Identities = 52/206 (25%), Positives = 79/206 (38%), Gaps = 48/206 (23%)
Query: 375 EVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFK----NEVFVISQTH---HK 427
E+G G++G V+K + L+ + Q GE EV V+ H
Sbjct: 18 EIGEGAYGKVFKARDLKNGGRFVALKR---VRVQTGEEGMPLSTIREVAVLRHLETFEHP 74
Query: 428 NLVRLLGFC-----DEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGL 480
N+VRL C D LV+E ++ L ++L +P T ++ FQ+ RGL
Sbjct: 75 NVVRLFDVCTVSRTDRETKLTLVFEHVDQD-LTTYLDKVPEPGVPTETIKDMMFQLLRGL 133
Query: 481 LYLH------EDCSSQIIL-----------------YSYKR-------TEGYVAPEWFRN 510
+LH D Q IL YS++ T Y APE
Sbjct: 134 DFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ 193
Query: 511 STITAKVDVYSFGFLLLEIISCRKSF 536
S+ VD++S G + E+ + F
Sbjct: 194 SSYATPVDLWSVGCIFAEMFRRKPLF 219
>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain
pdb|4HZR|B Chain B, Crystal Structure Of Ack1 Kinase Domain
Length = 277
Score = 37.4 bits (85), Expect = 0.025, Method: Compositional matrix adjust.
Identities = 47/204 (23%), Positives = 77/204 (37%), Gaps = 54/204 (26%)
Query: 374 EEVGRGSFGIVYKGVIQT----TRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNL 429
E++G GSFG+V +G T V ++ + + + +F EV + H+NL
Sbjct: 18 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 430 VRLLGFCDEGLNRLLVYEFLNNGTL--------ASFLFGNLKPSWNLRTNIAFQIARGLL 481
+RL G + +V E G+L FL G L + A Q+A G+
Sbjct: 78 IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTL-------SRYAVQVAEGMG 129
Query: 482 YL------HEDCSSQIILYS----------------------YKRTE------GYVAPEW 507
YL H D +++ +L + Y E + APE
Sbjct: 130 YLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 189
Query: 508 FRNSTITAKVDVYSFGFLLLEIIS 531
+ T + D + FG L E+ +
Sbjct: 190 LKTRTFSHASDTWMFGVTLWEMFT 213
>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein
Kina
pdb|2P0C|B Chain B, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein
Kina
pdb|3BRB|A Chain A, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Tyrosine- Protein Kinase Mer In Complex
With Adp
pdb|3BRB|B Chain B, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Tyrosine- Protein Kinase Mer In Complex
With Adp
pdb|3BPR|A Chain A, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|B Chain B, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|C Chain C, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|D Chain D, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3TCP|A Chain A, Crystal Structure Of The Catalytic Domain Of The
Proto-Oncogene Tyrosine-Protein Kinase Mer In Complex
With Inhibitor Unc569
pdb|3TCP|B Chain B, Crystal Structure Of The Catalytic Domain Of The
Proto-Oncogene Tyrosine-Protein Kinase Mer In Complex
With Inhibitor Unc569
Length = 313
Score = 37.0 bits (84), Expect = 0.027, Method: Compositional matrix adjust.
Identities = 48/203 (23%), Positives = 86/203 (42%), Gaps = 47/203 (23%)
Query: 376 VGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGERE---FKNEVFVISQTHHKNLVRL 432
+G G FG V +G ++ L++ + + +RE F +E + H N++RL
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 433 LGFCDE----GLNR-LLVYEFLNNGTLASF-LFGNLKPSWN---LRTNIAFQ--IARGLL 481
LG C E G+ + +++ F+ G L ++ L+ L+ L+T + F IA G+
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 482 Y------LHEDCSSQIIL------------------YS---------YKRTEGYVAPEWF 508
Y LH D +++ + YS K ++A E
Sbjct: 162 YLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESL 221
Query: 509 RNSTITAKVDVYSFGFLLLEIIS 531
+ T+K DV++FG + EI +
Sbjct: 222 ADRVYTSKSDVWAFGVTMWEIAT 244
>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|B Chain B, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|C Chain C, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|D Chain D, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|E Chain E, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|F Chain F, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|G Chain G, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|H Chain H, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
Length = 327
Score = 37.0 bits (84), Expect = 0.028, Method: Compositional matrix adjust.
Identities = 43/195 (22%), Positives = 82/195 (42%), Gaps = 42/195 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNW--IVFQDGEREFKNEVFVISQTHHKNLVRL 432
+G G+FG VYKG+ I +V + + + +E +E +V++ + ++ RL
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 433 LGFCDEGLNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYL------ 483
LG C +L+ + + G L ++ N+ + L N QIA+G+ YL
Sbjct: 83 LGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYLEDRRLV 139
Query: 484 HEDCSSQIILY----------------------SYKRTEGYVAPEWFRNSTITAKV---- 517
H D +++ +L Y G V +W +I ++
Sbjct: 140 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ 199
Query: 518 -DVYSFGFLLLEIIS 531
DV+S+G + E+++
Sbjct: 200 SDVWSYGVTVWELMT 214
>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor
Cis-3-[8-amino-1-(4-
Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol
Length = 273
Score = 37.0 bits (84), Expect = 0.029, Method: Compositional matrix adjust.
Identities = 47/204 (23%), Positives = 77/204 (37%), Gaps = 54/204 (26%)
Query: 374 EEVGRGSFGIVYKGVIQT----TRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNL 429
E++G GSFG+V +G T V ++ + + + +F EV + H+NL
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 430 VRLLGFCDEGLNRLLVYEFLNNGTL--------ASFLFGNLKPSWNLRTNIAFQIARGLL 481
+RL G + +V E G+L FL G L + A Q+A G+
Sbjct: 74 IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTL-------SRYAVQVAEGMG 125
Query: 482 YL------HEDCSSQIILYS----------------------YKRTE------GYVAPEW 507
YL H D +++ +L + Y E + APE
Sbjct: 126 YLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 185
Query: 508 FRNSTITAKVDVYSFGFLLLEIIS 531
+ T + D + FG L E+ +
Sbjct: 186 LKTRTFSHASDTWMFGVTLWEMFT 209
>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor
pdb|4EWH|A Chain A, Co-Crystal Structure Of Ack1 With Inhibitor
Length = 275
Score = 37.0 bits (84), Expect = 0.029, Method: Compositional matrix adjust.
Identities = 46/204 (22%), Positives = 76/204 (37%), Gaps = 54/204 (26%)
Query: 374 EEVGRGSFGIVYKGVIQT----TRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNL 429
E++G GSFG+V +G T V ++ + + + +F EV + H+NL
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 430 VRLLGFCDEGLNRLLVYEFLNNGTL--------ASFLFGNLKPSWNLRTNIAFQIARGLL 481
+RL G + +V E G+L FL G L + A Q+A G+
Sbjct: 74 IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTL-------SRYAVQVAEGMG 125
Query: 482 YL------HEDCSSQIILYS----------------------------YKRTEGYVAPEW 507
YL H D +++ +L + K + APE
Sbjct: 126 YLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPES 185
Query: 508 FRNSTITAKVDVYSFGFLLLEIIS 531
+ T + D + FG L E+ +
Sbjct: 186 LKTRTFSHASDTWMFGVTLWEMFT 209
>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A
Dihydroquinazolinone Inhibitor
pdb|3GC9|B Chain B, The Structure Of P38beta C119s, C162s In Complex With A
Dihydroquinazolinone Inhibitor
Length = 370
Score = 37.0 bits (84), Expect = 0.029, Method: Compositional matrix adjust.
Identities = 45/195 (23%), Positives = 75/195 (38%), Gaps = 35/195 (17%)
Query: 376 VGRGSFGIVYKGVIQTTRQ-VLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
VG G++G V RQ V ++ SR + R ++ E+ ++ H+N++ LL
Sbjct: 36 VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYR-ELRLLKHLKHENVIGLLD 94
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN----IAFQIARGLLYLH------ 484
+ E TL N+ S L + +Q+ RGL Y+H
Sbjct: 95 VFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYIHSAGIIH 154
Query: 485 -----------EDCSSQIILYSYKRTE-----GYVAPEWFRNSTIT-------AKVDVYS 521
ED +I+ + R GYVA W+R I VD++S
Sbjct: 155 RDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATRWYRAPEIMLNWMHYNQTVDIWS 214
Query: 522 FGFLLLEIISCRKSF 536
G ++ E++ + F
Sbjct: 215 VGCIMAELLQGKALF 229
>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral
Cyclin
pdb|1XO2|B Chain B, Crystal Structure Of A Human Cyclin-Dependent Kinase 6
Complex With A Flavonol Inhibitor, Fisetin
pdb|2EUF|B Chain B, X-Ray Structure Of Human Cdk6-Vcyclin In Complex With The
Inhibitor Pd0332991
pdb|2F2C|B Chain B, X-Ray Structure Of Human Cdk6-Vcyclinwith The Inhibitor
Aminopurvalanol
Length = 308
Score = 37.0 bits (84), Expect = 0.034, Method: Compositional matrix adjust.
Identities = 52/206 (25%), Positives = 79/206 (38%), Gaps = 48/206 (23%)
Query: 375 EVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFK----NEVFVISQTH---HK 427
E+G G++G V+K + L+ + Q GE EV V+ H
Sbjct: 18 EIGEGAYGKVFKARDLKNGGRFVALKR---VRVQTGEEGMPLSTIREVAVLRHLETFEHP 74
Query: 428 NLVRLLGFC-----DEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGL 480
N+VRL C D LV+E ++ L ++L +P T ++ FQ+ RGL
Sbjct: 75 NVVRLFDVCTVSRTDRETKLTLVFEHVDQD-LTTYLDKVPEPGVPTETIKDMMFQLLRGL 133
Query: 481 LYLH------EDCSSQIIL-----------------YSYKR-------TEGYVAPEWFRN 510
+LH D Q IL YS++ T Y APE
Sbjct: 134 DFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ 193
Query: 511 STITAKVDVYSFGFLLLEIISCRKSF 536
S+ VD++S G + E+ + F
Sbjct: 194 SSYATPVDLWSVGCIFAEMFRRKPLF 219
>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase 1d
pdb|2JC6|C Chain C, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase 1d
Length = 334
Score = 36.6 bits (83), Expect = 0.035, Method: Compositional matrix adjust.
Identities = 43/187 (22%), Positives = 74/187 (39%), Gaps = 34/187 (18%)
Query: 372 FKEEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVR 431
FKE +G G+F V + T + L ++ + E +NE+ V+ + H+N+V
Sbjct: 26 FKETLGTGAFSEVVLAEEKATGK-LFAVKCIPKKALKGKESSIENEIAVLRKIKHENIVA 84
Query: 432 LLGFCDEGLNRLLVYEFLNNGTL--------------ASFLFGNLKPS--WNLRTNIAFQ 475
L + + LV + ++ G L AS L + + + R I +
Sbjct: 85 LEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRMGIVHR 144
Query: 476 IAR--GLLYLHEDCSSQIILYSYKR---------------TEGYVAPEWFRNSTITAKVD 518
+ LLY +D S+I++ + T GYVAPE + VD
Sbjct: 145 DLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPEVLAQKPYSKAVD 204
Query: 519 VYSFGFL 525
+S G +
Sbjct: 205 CWSIGVI 211
>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3
pdb|3G33|C Chain C, Crystal Structure Of Cdk4CYCLIN D3
Length = 308
Score = 36.6 bits (83), Expect = 0.036, Method: Compositional matrix adjust.
Identities = 37/148 (25%), Positives = 55/148 (37%), Gaps = 38/148 (25%)
Query: 426 HKNLVRLLGFC-----DEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIAR 478
H N+VRL+ C D + LV+E ++ L ++L P T ++ Q R
Sbjct: 73 HPNVVRLMDVCATSRTDREIKVTLVFEHVDQD-LRTYLDKAPPPGLPAETIKDLMRQFLR 131
Query: 479 GLLYLHEDC------------------------------SSQIILYSYKRTEGYVAPEWF 508
GL +LH +C S Q+ L T Y APE
Sbjct: 132 GLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVL 191
Query: 509 RNSTITAKVDVYSFGFLLLEIISCRKSF 536
ST VD++S G + E+ + F
Sbjct: 192 LQSTYATPVDMWSVGCIFAEMFRRKPLF 219
>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor
pdb|3NUX|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor
pdb|4AUA|A Chain A, Liganded X-ray Crystal Structure Of Cyclin Dependent
Kinase 6 (cdk6)
pdb|4EZ5|A Chain A, Cdk6 (monomeric) In Complex With Inhibitor
Length = 307
Score = 36.6 bits (83), Expect = 0.037, Method: Compositional matrix adjust.
Identities = 52/206 (25%), Positives = 79/206 (38%), Gaps = 48/206 (23%)
Query: 375 EVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFK----NEVFVISQTH---HK 427
E+G G++G V+K + L+ + Q GE EV V+ H
Sbjct: 18 EIGEGAYGKVFKARDLKNGGRFVALKR---VRVQTGEEGMPLSTIREVAVLRHLETFEHP 74
Query: 428 NLVRLLGFC-----DEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGL 480
N+VRL C D LV+E ++ L ++L +P T ++ FQ+ RGL
Sbjct: 75 NVVRLFDVCTVSRTDRETKLTLVFEHVDQD-LTTYLDKVPEPGVPTETIKDMMFQLLRGL 133
Query: 481 LYLH------EDCSSQIIL-----------------YSYKR-------TEGYVAPEWFRN 510
+LH D Q IL YS++ T Y APE
Sbjct: 134 DFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ 193
Query: 511 STITAKVDVYSFGFLLLEIISCRKSF 536
S+ VD++S G + E+ + F
Sbjct: 194 SSYATPVDLWSVGCIFAEMFRRKPLF 219
>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFD|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|C Chain C, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|D Chain D, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
Length = 324
Score = 36.2 bits (82), Expect = 0.045, Method: Compositional matrix adjust.
Identities = 43/195 (22%), Positives = 81/195 (41%), Gaps = 42/195 (21%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNW--IVFQDGEREFKNEVFVISQTHHKNLVRL 432
+G G+FG VYKG+ I +V + + + +E +E +V++ + ++ RL
Sbjct: 20 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 79
Query: 433 LGFCDEGLNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYL------ 483
LG C +L+ + + G L ++ N+ + L N QIA G+ YL
Sbjct: 80 LGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAEGMNYLEDRRLV 136
Query: 484 HEDCSSQIILY----------------------SYKRTEGYVAPEWFRNSTITAKV---- 517
H D +++ +L Y G V +W +I ++
Sbjct: 137 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ 196
Query: 518 -DVYSFGFLLLEIIS 531
DV+S+G + E+++
Sbjct: 197 SDVWSYGVTVWELMT 211
>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396
pdb|3BIZ|A Chain A, Wee1 Kinase Complex With Inhibitor Pd331618
pdb|3CQE|A Chain A, Wee1 Kinase Complex With Inhibitor Pd074291
pdb|3CR0|A Chain A, Wee1 Kinase Complex With Inhibitor Pd259_809
Length = 287
Score = 35.8 bits (81), Expect = 0.062, Method: Compositional matrix adjust.
Identities = 31/118 (26%), Positives = 55/118 (46%), Gaps = 9/118 (7%)
Query: 374 EEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVF---VISQTHHKNLV 430
E++G G FG V+K V + + +S+ + E+ EV+ V+ Q H ++V
Sbjct: 15 EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ--HSHVV 72
Query: 431 RLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLR----TNIAFQIARGLLYLH 484
R E + L+ E+ N G+LA + N + + ++ Q+ RGL Y+H
Sbjct: 73 RYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 130
>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed
With Inhibitor Pd0407824
Length = 289
Score = 35.8 bits (81), Expect = 0.063, Method: Compositional matrix adjust.
Identities = 31/118 (26%), Positives = 55/118 (46%), Gaps = 9/118 (7%)
Query: 374 EEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVF---VISQTHHKNLV 430
E++G G FG V+K V + + +S+ + E+ EV+ V+ Q H ++V
Sbjct: 17 EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ--HSHVV 74
Query: 431 RLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLR----TNIAFQIARGLLYLH 484
R E + L+ E+ N G+LA + N + + ++ Q+ RGL Y+H
Sbjct: 75 RYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 132
>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent
Protein Kinase Ii Gamma
Length = 336
Score = 35.8 bits (81), Expect = 0.065, Method: Compositional matrix adjust.
Identities = 39/195 (20%), Positives = 80/195 (41%), Gaps = 38/195 (19%)
Query: 369 TDNFK--EEVGRGSFGIVYKGVIQT-TRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTH 425
TD+++ EE+G+G+F +V + V +T T++ ++ + + +D ++ + E +
Sbjct: 30 TDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQK-LEREARICRLLK 88
Query: 426 HKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHE 485
H N+VRL E LV++ + G L + S ++ QI + ++H+
Sbjct: 89 HPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIHQ 148
Query: 486 ------DCSSQIIL----------------------------YSYKRTEGYVAPEWFRNS 511
D + +L + + T GY++PE R
Sbjct: 149 HDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLRKD 208
Query: 512 TITAKVDVYSFGFLL 526
VD+++ G +L
Sbjct: 209 PYGKPVDIWACGVIL 223
>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839
pdb|2IO6|A Chain A, Wee1 Kinase Complexed With Inhibitor Pd330961
Length = 287
Score = 35.8 bits (81), Expect = 0.066, Method: Compositional matrix adjust.
Identities = 31/118 (26%), Positives = 55/118 (46%), Gaps = 9/118 (7%)
Query: 374 EEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVF---VISQTHHKNLV 430
E++G G FG V+K V + + +S+ + E+ EV+ V+ Q H ++V
Sbjct: 15 EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ--HSHVV 72
Query: 431 RLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLR----TNIAFQIARGLLYLH 484
R E + L+ E+ N G+LA + N + + ++ Q+ RGL Y+H
Sbjct: 73 RYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 130
>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN The Apo Form
pdb|3UG2|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN Complex With Gefitinib
pdb|3VJN|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN Complex With Amppnp
Length = 334
Score = 35.8 bits (81), Expect = 0.070, Method: Compositional matrix adjust.
Identities = 42/192 (21%), Positives = 81/192 (42%), Gaps = 42/192 (21%)
Query: 379 GSFGIVYKGV-IQTTRQVLLQLQSRNW--IVFQDGEREFKNEVFVISQTHHKNLVRLLGF 435
G+FG VYKG+ I +V + + + +E +E +V++ + ++ RLLG
Sbjct: 33 GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 92
Query: 436 CDEGLNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYL------HED 486
C +L++ + + G L ++ N+ + L N QIA+G+ YL H D
Sbjct: 93 CLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYLEDRRLVHRD 149
Query: 487 CSSQIILY----------------------SYKRTEGYVAPEWFRNSTITAKV-----DV 519
+++ +L Y G V +W +I ++ DV
Sbjct: 150 LAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDV 209
Query: 520 YSFGFLLLEIIS 531
+S+G + E+++
Sbjct: 210 WSYGVTVWELMT 221
>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And
Kinase Domains
Length = 361
Score = 35.8 bits (81), Expect = 0.072, Method: Compositional matrix adjust.
Identities = 44/198 (22%), Positives = 84/198 (42%), Gaps = 48/198 (24%)
Query: 376 VGRGSFGIVYKGV-IQTTRQV-----LLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNL 429
+G G+FG VYKG+ I +V +++L+ +E +E +V++ + ++
Sbjct: 57 LGSGAFGTVYKGLWIPEGEKVKIPVAIMELREAT---SPKANKEILDEAYVMASVDNPHV 113
Query: 430 VRLLGFCDEGLNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYL--- 483
RLLG C + L+ + + G L ++ N+ + L N QIA+G+ YL
Sbjct: 114 CRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYLEDR 170
Query: 484 ---HEDCSSQIILY----------------------SYKRTEGYVAPEWFRNSTITAKV- 517
H D +++ +L Y G V +W +I ++
Sbjct: 171 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 230
Query: 518 ----DVYSFGFLLLEIIS 531
DV+S+G + E+++
Sbjct: 231 THQSDVWSYGVTVWELMT 248
>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With
Staurosporine At 2a Resolution
Length = 345
Score = 35.8 bits (81), Expect = 0.075, Method: Compositional matrix adjust.
Identities = 49/201 (24%), Positives = 71/201 (35%), Gaps = 33/201 (16%)
Query: 376 VGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKN-EVFVISQT-HHKNLVRLL 433
+G+GSFG V+ + T Q + +V D + E E V+S H L +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84
Query: 434 GFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHE-------- 485
N V E+LN G L + K + T A +I GL +LH
Sbjct: 85 CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDL 144
Query: 486 -------DCSSQIILYSYKR----------------TEGYVAPEWFRNSTITAKVDVYSF 522
D I + + T Y+APE VD +SF
Sbjct: 145 KLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLGQKYNHSVDWWSF 204
Query: 523 GFLLLEIISCRKSFDIEMGEE 543
G LL E++ + F + EE
Sbjct: 205 GVLLYEMLIGQSPFHGQDEEE 225
>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein
Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a
Resolution.
pdb|2JED|B Chain B, The Crystal Structure Of The Kinase Domain Of The Protein
Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a
Resolution
Length = 352
Score = 35.8 bits (81), Expect = 0.075, Method: Compositional matrix adjust.
Identities = 49/201 (24%), Positives = 71/201 (35%), Gaps = 33/201 (16%)
Query: 376 VGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKN-EVFVISQT-HHKNLVRLL 433
+G+GSFG V+ + T Q + +V D + E E V+S H L +
Sbjct: 26 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 85
Query: 434 GFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHE-------- 485
N V E+LN G L + K + T A +I GL +LH
Sbjct: 86 CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDL 145
Query: 486 -------DCSSQIILYSYKR----------------TEGYVAPEWFRNSTITAKVDVYSF 522
D I + + T Y+APE VD +SF
Sbjct: 146 KLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLGQKYNHSVDWWSF 205
Query: 523 GFLLLEIISCRKSFDIEMGEE 543
G LL E++ + F + EE
Sbjct: 206 GVLLYEMLIGQSPFHGQDEEE 226
>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770
Length = 285
Score = 35.4 bits (80), Expect = 0.087, Method: Compositional matrix adjust.
Identities = 31/118 (26%), Positives = 55/118 (46%), Gaps = 9/118 (7%)
Query: 374 EEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVF---VISQTHHKNLV 430
E++G G FG V+K V + + +S+ + E+ EV+ V+ Q H ++V
Sbjct: 13 EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ--HSHVV 70
Query: 431 RLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLR----TNIAFQIARGLLYLH 484
R E + L+ E+ N G+LA + N + + ++ Q+ RGL Y+H
Sbjct: 71 RYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 128
>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase I G
pdb|2JAM|B Chain B, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase I G
Length = 304
Score = 35.4 bits (80), Expect = 0.089, Method: Compositional matrix adjust.
Identities = 40/186 (21%), Positives = 69/186 (37%), Gaps = 34/186 (18%)
Query: 372 FKEEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVR 431
F E +G G+F V+ + T ++ + F+D E NE+ V+ + H+N+V
Sbjct: 13 FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE--NEIAVLKKIKHENIVT 70
Query: 432 LLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHE------ 485
L + + LV + ++ G L + + + + Q+ + YLHE
Sbjct: 71 LEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHR 130
Query: 486 DCSSQIILYSYKR--------------------------TEGYVAPEWFRNSTITAKVDV 519
D + +LY T GYVAPE + VD
Sbjct: 131 DLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVLAQKPYSKAVDC 190
Query: 520 YSFGFL 525
+S G +
Sbjct: 191 WSIGVI 196
>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s)
Length = 334
Score = 35.4 bits (80), Expect = 0.096, Method: Compositional matrix adjust.
Identities = 42/192 (21%), Positives = 80/192 (41%), Gaps = 42/192 (21%)
Query: 379 GSFGIVYKGV-IQTTRQVLLQLQSRNW--IVFQDGEREFKNEVFVISQTHHKNLVRLLGF 435
G+FG VYKG+ I +V + + + +E +E +V++ + ++ RLLG
Sbjct: 33 GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 92
Query: 436 CDEGLNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYL------HED 486
C +L+ + + G L ++ N+ + L N QIA+G+ YL H D
Sbjct: 93 CLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYLEDRRLVHRD 149
Query: 487 CSSQIILY----------------------SYKRTEGYVAPEWFRNSTITAKV-----DV 519
+++ +L Y G V +W +I ++ DV
Sbjct: 150 LAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDV 209
Query: 520 YSFGFLLLEIIS 531
+S+G + E+++
Sbjct: 210 WSYGVTVWELMT 221
>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb
Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP
Length = 311
Score = 35.0 bits (79), Expect = 0.10, Method: Compositional matrix adjust.
Identities = 14/38 (36%), Positives = 23/38 (60%)
Query: 499 TEGYVAPEWFRNSTITAKVDVYSFGFLLLEIISCRKSF 536
T Y++PE R ++ A+ DVYS G +L E+++ F
Sbjct: 182 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF 219
>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase
pdb|3COM|B Chain B, Crystal Structure Of Mst1 Kinase
Length = 314
Score = 35.0 bits (79), Expect = 0.10, Method: Compositional matrix adjust.
Identities = 30/123 (24%), Positives = 57/123 (46%), Gaps = 6/123 (4%)
Query: 363 KALEEATDNFKEEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVIS 422
K EE D E++G GS+G VYK + + T Q++ Q + + +E E+ ++
Sbjct: 25 KQPEEVFDVL-EKLGEGSYGSVYKAIHKETGQIVAIKQ----VPVESDLQEIIKEISIMQ 79
Query: 423 QTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFL-FGNLKPSWNLRTNIAFQIARGLL 481
Q ++V+ G + + +V E+ G+++ + N + + I +GL
Sbjct: 80 QCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLE 139
Query: 482 YLH 484
YLH
Sbjct: 140 YLH 142
>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Amp-Pnp
pdb|2ITO|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Iressa
pdb|2ITP|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Aee788
pdb|2ITQ|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Afn941
Length = 327
Score = 35.0 bits (79), Expect = 0.10, Method: Compositional matrix adjust.
Identities = 42/192 (21%), Positives = 80/192 (41%), Gaps = 42/192 (21%)
Query: 379 GSFGIVYKGV-IQTTRQVLLQLQSRNW--IVFQDGEREFKNEVFVISQTHHKNLVRLLGF 435
G+FG VYKG+ I +V + + + +E +E +V++ + ++ RLLG
Sbjct: 26 GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 85
Query: 436 CDEGLNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYL------HED 486
C +L+ + + G L ++ N+ + L N QIA+G+ YL H D
Sbjct: 86 CLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYLEDRRLVHRD 142
Query: 487 CSSQIILY----------------------SYKRTEGYVAPEWFRNSTITAKV-----DV 519
+++ +L Y G V +W +I ++ DV
Sbjct: 143 LAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDV 202
Query: 520 YSFGFLLLEIIS 531
+S+G + E+++
Sbjct: 203 WSYGVTVWELMT 214
>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORI|B Chain B, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORI|C Chain C, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORI|D Chain D, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORK|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 2)
pdb|3ORL|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 3)
pdb|3ORO|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 4)
pdb|3ORP|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 5)
pdb|3ORT|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 6)
Length = 311
Score = 35.0 bits (79), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 14/38 (36%), Positives = 23/38 (60%)
Query: 499 TEGYVAPEWFRNSTITAKVDVYSFGFLLLEIISCRKSF 536
T Y++PE R ++ A+ DVYS G +L E+++ F
Sbjct: 182 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF 219
>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb
Mutant Kinase Domain In Complex With Kt5720
pdb|3F69|B Chain B, Crystal Structure Of The Mycobacterium Tuberculosis Pknb
Mutant Kinase Domain In Complex With Kt5720
Length = 311
Score = 35.0 bits (79), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 14/38 (36%), Positives = 23/38 (60%)
Query: 499 TEGYVAPEWFRNSTITAKVDVYSFGFLLLEIISCRKSF 536
T Y++PE R ++ A+ DVYS G +L E+++ F
Sbjct: 182 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF 219
>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle
Protein Titin
pdb|1TKI|B Chain B, Autoinhibited Serine Kinase Domain Of The Giant Muscle
Protein Titin
Length = 321
Score = 35.0 bits (79), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 38/195 (19%), Positives = 84/195 (43%), Gaps = 44/195 (22%)
Query: 374 EEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLL 433
E++GRG FGIV++ V ++++ + ++ V + K E+ +++ H+N++ L
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYM---AKFVKVKGTDQVLVKKEISILNIARHRNILHLH 67
Query: 434 GFCDEGLNRLLVYEFLNNGTLASFLFGNLKPS---WNLRTNIAF--QIARGLLYLHE--- 485
+ ++++EF++ +F + S N R +++ Q+ L +LH
Sbjct: 68 ESFESMEELVMIFEFISGLD----IFERINTSAFELNEREIVSYVHQVCEALQFLHSHNI 123
Query: 486 ---DCSSQIILYSYKRTEG--------------------------YVAPEWFRNSTITAK 516
D + I+Y +R+ Y APE ++ ++
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTA 183
Query: 517 VDVYSFGFLLLEIIS 531
D++S G L+ ++S
Sbjct: 184 TDMWSLGTLVYVLLS 198
>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2
(Erbb2).
pdb|3PP0|B Chain B, Crystal Structure Of The Kinase Domain Of Human Her2
(Erbb2).
pdb|3RCD|A Chain A, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|B Chain B, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|C Chain C, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|D Chain D, Her2 Kinase Domain Complexed With Tak-285
Length = 338
Score = 35.0 bits (79), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 50/213 (23%), Positives = 84/213 (39%), Gaps = 52/213 (24%)
Query: 363 KALEEATDNFKEEVGRGSFGIVYKGV---------IQTTRQVLLQLQSRNWIVFQDGERE 413
+ L+E + +G G+FG VYKG+ I +VL + S +E
Sbjct: 12 RILKETELRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPK------ANKE 65
Query: 414 FKNEVFVISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKP--SWNLRTN 471
+E +V++ + RLLG C + LV + + G L + N S +L N
Sbjct: 66 ILDEAYVMAGVGSPYVSRLLGICLTSTVQ-LVTQLMPYGCLLDHVRENRGRLGSQDL-LN 123
Query: 472 IAFQIARGLLYL------HEDCSSQIILY----------------------SYKRTEGYV 503
QIA+G+ YL H D +++ +L Y G V
Sbjct: 124 WCMQIAKGMSYLEDVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKV 183
Query: 504 APEWFRNSTI-----TAKVDVYSFGFLLLEIIS 531
+W +I T + DV+S+G + E+++
Sbjct: 184 PIKWMALESILRRRFTHQSDVWSYGVTVWELMT 216
>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a
Double Mutant
pdb|3FE3|B Chain B, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a
Double Mutant
Length = 328
Score = 35.0 bits (79), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 42/194 (21%), Positives = 81/194 (41%), Gaps = 33/194 (17%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
+G+G+F V I T R+V +++ + + ++ F+ EV ++ +H N+V+L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKLFE 81
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLY------LHEDCS 488
+ L+ E+ + G + +L + + + QI + Y +H D
Sbjct: 82 VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLK 141
Query: 489 SQIIL-------------YSYKRTEG-----------YVAPEWFRNSTITA-KVDVYSFG 523
++ +L +S + T G Y APE F+ +VDV+S G
Sbjct: 142 AENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLG 201
Query: 524 FLLLEIISCRKSFD 537
+L ++S FD
Sbjct: 202 VILYTLVSGSLPFD 215
>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF
Mycobacterium Tuberculosis Pknb.
pdb|1MRU|B Chain B, Intracellular SerTHR PROTEIN KINASE DOMAIN OF
Mycobacterium Tuberculosis Pknb
Length = 311
Score = 35.0 bits (79), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 14/38 (36%), Positives = 23/38 (60%)
Query: 499 TEGYVAPEWFRNSTITAKVDVYSFGFLLLEIISCRKSF 536
T Y++PE R ++ A+ DVYS G +L E+++ F
Sbjct: 182 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF 219
>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1
pdb|2QNJ|B Chain B, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1
Length = 328
Score = 35.0 bits (79), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 42/194 (21%), Positives = 81/194 (41%), Gaps = 33/194 (17%)
Query: 376 VGRGSFGIVYKGV-IQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
+G+G+F V I T R+V +++ + + ++ F+ EV ++ +H N+V+L
Sbjct: 20 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKLFE 78
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLY------LHEDCS 488
+ L+ E+ + G + +L + + + QI + Y +H D
Sbjct: 79 VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLK 138
Query: 489 SQIIL-------------YSYKRTEG-----------YVAPEWFRNSTITA-KVDVYSFG 523
++ +L +S + T G Y APE F+ +VDV+S G
Sbjct: 139 AENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLG 198
Query: 524 FLLLEIISCRKSFD 537
+L ++S FD
Sbjct: 199 VILYTLVSGSLPFD 212
>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant
Length = 311
Score = 35.0 bits (79), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 14/38 (36%), Positives = 23/38 (60%)
Query: 499 TEGYVAPEWFRNSTITAKVDVYSFGFLLLEIISCRKSF 536
T Y++PE R ++ A+ DVYS G +L E+++ F
Sbjct: 182 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF 219
>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A
Dihydroquinazolinone
pdb|3GC8|B Chain B, The Structure Of P38beta C162s In Complex With A
Dihydroquinazolinone
Length = 370
Score = 35.0 bits (79), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 44/195 (22%), Positives = 74/195 (37%), Gaps = 35/195 (17%)
Query: 376 VGRGSFGIVYKGVIQTTRQ-VLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLG 434
VG G++G V RQ V ++ SR + R ++ E+ ++ H+N++ LL
Sbjct: 36 VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYR-ELRLLKHLKHENVIGLLD 94
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN----IAFQIARGLLYLH------ 484
+ E TL N+ L + +Q+ RGL Y+H
Sbjct: 95 VFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAGIIH 154
Query: 485 -----------EDCSSQIILYSYKRTE-----GYVAPEWFRNSTIT-------AKVDVYS 521
ED +I+ + R GYVA W+R I VD++S
Sbjct: 155 RDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATRWYRAPEIMLNWMHYNQTVDIWS 214
Query: 522 FGFLLLEIISCRKSF 536
G ++ E++ + F
Sbjct: 215 VGCIMAELLQGKALF 229
>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium
Tuberculosis
pdb|2FUM|A Chain A, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
pdb|2FUM|B Chain B, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
pdb|2FUM|C Chain C, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
pdb|2FUM|D Chain D, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
Length = 299
Score = 35.0 bits (79), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 14/38 (36%), Positives = 23/38 (60%)
Query: 499 TEGYVAPEWFRNSTITAKVDVYSFGFLLLEIISCRKSF 536
T Y++PE R ++ A+ DVYS G +L E+++ F
Sbjct: 199 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF 236
>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp
pdb|1S9I|B Chain B, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp
Length = 354
Score = 34.7 bits (78), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 47/212 (22%), Positives = 84/212 (39%), Gaps = 51/212 (24%)
Query: 363 KALEEATDNFKE--EVGRGSFGIVYK------GVIQTTRQVLLQLQS--RNWIVFQDGER 412
K E D+F+ E+G G+ G+V K G+I + + L+++ RN I+
Sbjct: 9 KVGELKDDDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQII------ 62
Query: 413 EFKNEVFVISQTHHKNLVRLLG-FCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN 471
E+ V+ + + +V G F +G + E ++ G+L L + +
Sbjct: 63 ---RELQVLHECNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVLKEAKRIPEEILGK 118
Query: 472 IAFQIARGLLYL-------HEDCSSQIILY-----------------------SYKRTEG 501
++ + RGL YL H D IL S+ T
Sbjct: 119 VSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS 178
Query: 502 YVAPEWFRNSTITAKVDVYSFGFLLLEIISCR 533
Y+APE + + + + D++S G L+E+ R
Sbjct: 179 YMAPERLQGTHYSVQSDIWSMGLSLVELAVGR 210
>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer
Length = 395
Score = 34.7 bits (78), Expect = 0.16, Method: Compositional matrix adjust.
Identities = 48/237 (20%), Positives = 93/237 (39%), Gaps = 55/237 (23%)
Query: 363 KALEEATDNFKE--EVGRGSFGIVYK------GVIQTTRQVLLQLQS--RNWIVFQDGER 412
K E D+F++ E+G G+ G+V+K G++ + + L+++ RN I+
Sbjct: 61 KVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII------ 114
Query: 413 EFKNEVFVISQTHHKNLVRLLG-FCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN 471
E+ V+ + + +V G F +G + E ++ G+L L + +
Sbjct: 115 ---RELQVLHECNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVLKKAGRIPEQILGK 170
Query: 472 IAFQIARGLLYL-------HEDCSSQIILY-----------------------SYKRTEG 501
++ + +GL YL H D IL S+ T
Sbjct: 171 VSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS 230
Query: 502 YVAPEWFRNSTITAKVDVYSFGFLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 558
Y++PE + + + + D++S G L+E+ R +E ++ F C G
Sbjct: 231 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM----FGCQVEG 283
>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And
Mgatp
pdb|3EQB|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And
Mgatp
Length = 333
Score = 34.7 bits (78), Expect = 0.17, Method: Compositional matrix adjust.
Identities = 43/210 (20%), Positives = 86/210 (40%), Gaps = 51/210 (24%)
Query: 365 LEEATDNFKE--EVGRGSFGIVYK------GVIQTTRQVLLQLQS--RNWIVFQDGEREF 414
+E D+F++ E+G G+ G+V+K G++ + + L+++ RN I+
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII-------- 52
Query: 415 KNEVFVISQTHHKNLVRLLG-FCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA 473
E+ V+ + + +V G F +G + E ++ G+L L + + ++
Sbjct: 53 -RELQVLHECNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVLKKAGRIPEQILGKVS 110
Query: 474 FQIARGLLYL-------HEDCSSQIILY-----------------------SYKRTEGYV 503
+ +GL YL H D IL S+ T Y+
Sbjct: 111 IAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYM 170
Query: 504 APEWFRNSTITAKVDVYSFGFLLLEIISCR 533
+PE + + + + D++S G L+E+ R
Sbjct: 171 SPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200
>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In
Complex With Ch4987655 And Mgamp-Pnp
pdb|3OS3|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In
Complex With Ch4858061 And Mgatp
Length = 307
Score = 34.7 bits (78), Expect = 0.17, Method: Compositional matrix adjust.
Identities = 43/210 (20%), Positives = 86/210 (40%), Gaps = 51/210 (24%)
Query: 365 LEEATDNFKE--EVGRGSFGIVYK------GVIQTTRQVLLQLQS--RNWIVFQDGEREF 414
+E D+F++ E+G G+ G+V+K G++ + + L+++ RN I+
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII-------- 52
Query: 415 KNEVFVISQTHHKNLVRLLG-FCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA 473
E+ V+ + + +V G F +G + E ++ G+L L + + ++
Sbjct: 53 -RELQVLHECNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVLKKAGRIPEQILGKVS 110
Query: 474 FQIARGLLYL-------HEDCSSQIILY-----------------------SYKRTEGYV 503
+ +GL YL H D IL S+ T Y+
Sbjct: 111 IAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYM 170
Query: 504 APEWFRNSTITAKVDVYSFGFLLLEIISCR 533
+PE + + + + D++S G L+E+ R
Sbjct: 171 SPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200
>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And
Mgatp
pdb|3DY7|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And
Mgatp
pdb|3E8N|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) Complexed With A Potent Inhibitor
Rdea119 And Mgatp
pdb|3V01|A Chain A, Discovery Of Novel Allosteric Mek Inhibitors Possessing
Classical And Non-Classical Bidentate Ser212
Interactions.
pdb|3V04|A Chain A, Discovery Of Novel Allosteric Mek Inhibitors Possessing
Classical And Non-Classical Bidentate Ser212
Interactions
Length = 341
Score = 34.3 bits (77), Expect = 0.18, Method: Compositional matrix adjust.
Identities = 43/210 (20%), Positives = 86/210 (40%), Gaps = 51/210 (24%)
Query: 365 LEEATDNFKE--EVGRGSFGIVYK------GVIQTTRQVLLQLQS--RNWIVFQDGEREF 414
+E D+F++ E+G G+ G+V+K G++ + + L+++ RN I+
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII-------- 52
Query: 415 KNEVFVISQTHHKNLVRLLG-FCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA 473
E+ V+ + + +V G F +G + E ++ G+L L + + ++
Sbjct: 53 -RELQVLHECNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVLKKAGRIPEQILGKVS 110
Query: 474 FQIARGLLYL-------HEDCSSQIILY-----------------------SYKRTEGYV 503
+ +GL YL H D IL S+ T Y+
Sbjct: 111 IAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYM 170
Query: 504 APEWFRNSTITAKVDVYSFGFLLLEIISCR 533
+PE + + + + D++S G L+E+ R
Sbjct: 171 SPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200
>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp
pdb|3PP1|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgatp
Length = 328
Score = 34.3 bits (77), Expect = 0.19, Method: Compositional matrix adjust.
Identities = 43/210 (20%), Positives = 86/210 (40%), Gaps = 51/210 (24%)
Query: 365 LEEATDNFKE--EVGRGSFGIVYK------GVIQTTRQVLLQLQS--RNWIVFQDGEREF 414
+E D+F++ E+G G+ G+V+K G++ + + L+++ RN I+
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII-------- 52
Query: 415 KNEVFVISQTHHKNLVRLLG-FCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA 473
E+ V+ + + +V G F +G + E ++ G+L L + + ++
Sbjct: 53 -RELQVLHECNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVLKKAGRIPEQILGKVS 110
Query: 474 FQIARGLLYL-------HEDCSSQIILY-----------------------SYKRTEGYV 503
+ +GL YL H D IL S+ T Y+
Sbjct: 111 IAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYM 170
Query: 504 APEWFRNSTITAKVDVYSFGFLLLEIISCR 533
+PE + + + + D++S G L+E+ R
Sbjct: 171 SPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200
>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound
Length = 322
Score = 34.3 bits (77), Expect = 0.19, Method: Compositional matrix adjust.
Identities = 43/210 (20%), Positives = 86/210 (40%), Gaps = 51/210 (24%)
Query: 365 LEEATDNFKE--EVGRGSFGIVYK------GVIQTTRQVLLQLQS--RNWIVFQDGEREF 414
+E D+F++ E+G G+ G+V+K G++ + + L+++ RN I+
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII-------- 52
Query: 415 KNEVFVISQTHHKNLVRLLG-FCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA 473
E+ V+ + + +V G F +G + E ++ G+L L + + ++
Sbjct: 53 -RELQVLHECNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVLKKAGRIPEQILGKVS 110
Query: 474 FQIARGLLYL-------HEDCSSQIILY-----------------------SYKRTEGYV 503
+ +GL YL H D IL S+ T Y+
Sbjct: 111 IAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYM 170
Query: 504 APEWFRNSTITAKVDVYSFGFLLLEIISCR 533
+PE + + + + D++S G L+E+ R
Sbjct: 171 SPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200
>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
pdb|3BHH|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
pdb|3BHH|C Chain C, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
pdb|3BHH|D Chain D, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
Length = 295
Score = 34.3 bits (77), Expect = 0.19, Method: Compositional matrix adjust.
Identities = 38/195 (19%), Positives = 77/195 (39%), Gaps = 38/195 (19%)
Query: 369 TDNFK--EEVGRGSFGIVYKGV-IQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTH 425
TD ++ E++G+G+F +V + V + T + ++ + + +D ++ + E +
Sbjct: 3 TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQK-LEREARICRLLK 61
Query: 426 HKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLY--- 482
H N+VRL E LV++ + G L + S ++ QI +L+
Sbjct: 62 HSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQ 121
Query: 483 ---LHEDCSSQIIL----------------------------YSYKRTEGYVAPEWFRNS 511
+H D + +L + + T GY++PE R
Sbjct: 122 MGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKE 181
Query: 512 TITAKVDVYSFGFLL 526
VD+++ G +L
Sbjct: 182 AYGKPVDIWACGVIL 196
>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium
Dependent Protein Kinase Cgd7_1840 In Presence Of
Indirubin E804
Length = 277
Score = 34.3 bits (77), Expect = 0.21, Method: Compositional matrix adjust.
Identities = 24/79 (30%), Positives = 39/79 (49%), Gaps = 2/79 (2%)
Query: 376 VGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLGF 435
+GRGS+G V V + TR + + V +D +R FK E+ ++ H N++RL
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV-EDVDR-FKQEIEIMKSLDHPNIIRLYET 74
Query: 436 CDEGLNRLLVYEFLNNGTL 454
++ + LV E G L
Sbjct: 75 FEDNTDIYLVMELCTGGEL 93
>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia
pdb|3GC0|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia In
Complex With Amp
Length = 329
Score = 34.3 bits (77), Expect = 0.22, Method: Compositional matrix adjust.
Identities = 37/162 (22%), Positives = 69/162 (42%), Gaps = 22/162 (13%)
Query: 351 GTVETNLR---CFSYKALEEAT--DNFKE--EVGRGSFGIVYKGVIQTTRQVL----LQL 399
GT+E + S A AT D ++ ++G G++G VYK + T + + ++L
Sbjct: 10 GTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRL 69
Query: 400 QSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLF 459
+ V RE V ++ + H+N++ L L++E+ N L ++
Sbjct: 70 EHEEEGVPGTAIRE----VSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEND-LKKYMD 124
Query: 460 GNLKPSWNLRTNIAFQIARGLLY------LHEDCSSQIILYS 495
N S + + +Q+ G+ + LH D Q +L S
Sbjct: 125 KNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLS 166
>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
pdb|2QG5|B Chain B, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
pdb|2QG5|D Chain D, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
Length = 294
Score = 33.9 bits (76), Expect = 0.23, Method: Compositional matrix adjust.
Identities = 24/79 (30%), Positives = 39/79 (49%), Gaps = 2/79 (2%)
Query: 376 VGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLLGF 435
+GRGS+G V V + TR + + V +D +R FK E+ ++ H N++RL
Sbjct: 34 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV-EDVDR-FKQEIEIMKSLDHPNIIRLYET 91
Query: 436 CDEGLNRLLVYEFLNNGTL 454
++ + LV E G L
Sbjct: 92 FEDNTDIYLVMELCTGGEL 110
>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
pdb|3LXP|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
Length = 318
Score = 33.9 bits (76), Expect = 0.24, Method: Compositional matrix adjust.
Identities = 53/227 (23%), Positives = 89/227 (39%), Gaps = 55/227 (24%)
Query: 346 NSPGDGTVETNLRCFSYKALEEATDNFKEEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWI 405
PGD TV F + L++ D +G G FG V T ++ + +
Sbjct: 20 QGPGDPTV------FHKRYLKKIRD-----LGEGHFGKVSLYCYDPTNDGTGEMVAVKAL 68
Query: 406 VFQDGERE---FKNEVFVISQTHHKNLVRLLGFC-DEGLNRL-LVYEFLNNGTLASFLFG 460
G + +K E+ ++ +H+++++ G C D G L LV E++ G+L +L
Sbjct: 69 KADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-- 126
Query: 461 NLKPSWNLRTNIAF--QIARGLLYL------HEDCSSQIILYSYKR-------------T 499
+ S L + F QI G+ YL H D +++ +L R
Sbjct: 127 -PRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185
Query: 500 EGY---------------VAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
EG+ APE + DV+SFG L E+++
Sbjct: 186 EGHEXYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232
>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With
Ind E804
Length = 324
Score = 33.9 bits (76), Expect = 0.25, Method: Compositional matrix adjust.
Identities = 35/129 (27%), Positives = 61/129 (47%), Gaps = 13/129 (10%)
Query: 374 EEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGER-EFKNEVFVISQTHHKNLVRL 432
+++G G++ VYKG + T ++ + R + ++G EV ++ H N+V L
Sbjct: 8 DKLGEGTYATVYKGKSKLTDNLVALKEIR--LEHEEGAPCTAIREVSLLKDLKHANIVTL 65
Query: 433 LGFCDEGLNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLY------LH 484
+ LV+E+L+ L +L GN+ N++ + FQ+ RGL Y LH
Sbjct: 66 HDIIHTEKSLTLVFEYLDKD-LKQYLDDCGNIINMHNVKLFL-FQLLRGLAYCHRQKVLH 123
Query: 485 EDCSSQIIL 493
D Q +L
Sbjct: 124 RDLKPQNLL 132
>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Back Pocket Binder
Length = 368
Score = 33.5 bits (75), Expect = 0.33, Method: Compositional matrix adjust.
Identities = 25/89 (28%), Positives = 44/89 (49%), Gaps = 6/89 (6%)
Query: 376 VGRGSFGIVYK----GVIQTTRQVLLQLQSRNWIVFQDGEREFKNEV-FVISQTHHKNLV 430
+GRG+FG V + G+ +T + ++ R +E+ +I HH N+V
Sbjct: 37 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 431 RLLGFCDE-GLNRLLVYEFLNNGTLASFL 458
LLG C + G +++ EF G L+++L
Sbjct: 97 NLLGACTKPGGPLMVIVEFCKFGNLSTYL 125
>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Ternary Complex With
Compound 1, Atp-Gs And Mg2p
pdb|3EQD|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Binary Complex With Atp-Gs
And Mg2p
pdb|3EQF|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Binary Complex With K252a
And Mg2p
pdb|3EQG|A Chain A, X-ray Structure Of The Human Mitogen-activated Protein
Kinase Kinase 1 (mek1) In A Ternary Complex With Pd, Adp
And Mg2p
pdb|3EQH|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Ternary Complex With U0126,
Adp And Mg2p
pdb|3EQI|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Binary Complex With Adp And
Mg2p
Length = 360
Score = 33.5 bits (75), Expect = 0.34, Method: Compositional matrix adjust.
Identities = 44/212 (20%), Positives = 86/212 (40%), Gaps = 51/212 (24%)
Query: 363 KALEEATDNFKE--EVGRGSFGIVYK------GVIQTTRQVLLQLQS--RNWIVFQDGER 412
K E D+F++ E+G G+ G+V+K G++ + + L+++ RN I+
Sbjct: 26 KVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII------ 79
Query: 413 EFKNEVFVISQTHHKNLVRLLG-FCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN 471
E+ V+ + + +V G F +G + E ++ G+L L + +
Sbjct: 80 ---RELQVLHECNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVLKKAGRIPEQILGK 135
Query: 472 IAFQIARGLLYL-------HEDCSSQIILY-----------------------SYKRTEG 501
++ + +GL YL H D IL S+ T
Sbjct: 136 VSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS 195
Query: 502 YVAPEWFRNSTITAKVDVYSFGFLLLEIISCR 533
Y++PE + + + + D++S G L+E+ R
Sbjct: 196 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk
Inhibitor For The Prevention Of Ischemia-Reperfusion
Injury
pdb|3TTI|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-930, An Orally
Active Anti-Fibrotic Jnk Inhibitor
Length = 464
Score = 33.5 bits (75), Expect = 0.36, Method: Compositional matrix adjust.
Identities = 43/200 (21%), Positives = 82/200 (41%), Gaps = 45/200 (22%)
Query: 376 VGRGSFGIV---YKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRL 432
+G G+ GIV Y V+ R V ++ SR + +R ++ E+ ++ +HKN++ L
Sbjct: 70 IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 126
Query: 433 LGF------CDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHE- 485
L +E + LV E ++ L + ++ + + +Q+ G+ +LH
Sbjct: 127 LNVFTPQKTLEEFQDVYLVMELMD-ANLCQVI--QMELDHERMSYLLYQMLCGIKHLHSA 183
Query: 486 ----------------DCSSQIILYSYKRTEG-------------YVAPEWFRNSTITAK 516
DC+ +I+ + RT G Y APE
Sbjct: 184 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 243
Query: 517 VDVYSFGFLLLEIISCRKSF 536
VD++S G ++ E++ + F
Sbjct: 244 VDIWSVGCIMGEMVRHKILF 263
>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
2-Anilino-5-Aryl-Oxazole Inhibitor
pdb|1Y6B|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
2-Anilino-5-Aryl-Oxazole Inhibitor
Length = 366
Score = 33.5 bits (75), Expect = 0.37, Method: Compositional matrix adjust.
Identities = 25/89 (28%), Positives = 44/89 (49%), Gaps = 6/89 (6%)
Query: 376 VGRGSFGIVYK----GVIQTTRQVLLQLQSRNWIVFQDGEREFKNEV-FVISQTHHKNLV 430
+GRG+FG V + G+ +T + ++ R +E+ +I HH N+V
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 431 RLLGFCDE-GLNRLLVYEFLNNGTLASFL 458
LLG C + G +++ EF G L+++L
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYL 123
>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With
Compound A
Length = 356
Score = 33.1 bits (74), Expect = 0.38, Method: Compositional matrix adjust.
Identities = 25/89 (28%), Positives = 44/89 (49%), Gaps = 6/89 (6%)
Query: 376 VGRGSFGIVYK----GVIQTTRQVLLQLQSRNWIVFQDGEREFKNEV-FVISQTHHKNLV 430
+GRG+FG V + G+ +T + ++ R +E+ +I HH N+V
Sbjct: 28 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 87
Query: 431 RLLGFCDE-GLNRLLVYEFLNNGTLASFL 458
LLG C + G +++ EF G L+++L
Sbjct: 88 NLLGACTKPGGPLMVIVEFCKFGNLSTYL 116
>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain
Length = 332
Score = 33.1 bits (74), Expect = 0.38, Method: Compositional matrix adjust.
Identities = 18/51 (35%), Positives = 30/51 (58%), Gaps = 4/51 (7%)
Query: 499 TEGYVAPEWFRNSTITAKVDVYSFGFLLLEIISCRKSFDIEMGEEYAILTD 549
T+ Y++PE + + KVD++S G +L E++ SF +M E I+TD
Sbjct: 239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY---SFSTQM-ERVRIITD 285
>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein
Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin
E804
pdb|2VZ6|B Chain B, Structure Of Human Calcium Calmodulin Dependent Protein
Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin
E804
Length = 313
Score = 33.1 bits (74), Expect = 0.40, Method: Compositional matrix adjust.
Identities = 36/188 (19%), Positives = 74/188 (39%), Gaps = 36/188 (19%)
Query: 374 EEVGRGSFGIVYKGV-IQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRL 432
EE+G+G+F +V + V + ++ ++ + + +D ++ + E + H N+VRL
Sbjct: 28 EELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQK-LEREARICRLLKHPNIVRL 86
Query: 433 LGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLY------LHED 486
E + L+++ + G L + S ++ QI +L+ +H D
Sbjct: 87 HDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRD 146
Query: 487 CSSQIILYSYKR----------------------------TEGYVAPEWFRNSTITAKVD 518
+ +L + K T GY++PE R VD
Sbjct: 147 LKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVD 206
Query: 519 VYSFGFLL 526
+++ G +L
Sbjct: 207 LWACGVIL 214
>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A
Novel Pyrrolopyrimidine Inhibitor
Length = 359
Score = 33.1 bits (74), Expect = 0.41, Method: Compositional matrix adjust.
Identities = 25/89 (28%), Positives = 44/89 (49%), Gaps = 6/89 (6%)
Query: 376 VGRGSFGIVYK----GVIQTTRQVLLQLQSRNWIVFQDGEREFKNEV-FVISQTHHKNLV 430
+GRG+FG V + G+ +T + ++ R +E+ +I HH N+V
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 431 RLLGFCDE-GLNRLLVYEFLNNGTLASFL 458
LLG C + G +++ EF G L+++L
Sbjct: 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYL 118
>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With
Quinoline-Thiadiazole- Thiophene Inhibitor
Length = 302
Score = 33.1 bits (74), Expect = 0.41, Method: Compositional matrix adjust.
Identities = 37/156 (23%), Positives = 65/156 (41%), Gaps = 41/156 (26%)
Query: 414 FKNEVFVISQTHHKNLVRLLGFC-DEGLNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTN 471
+K E+ ++ +H+++++ G C D+G L LV E++ G+L +L + S L
Sbjct: 63 WKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL---PRHSIGLAQL 119
Query: 472 IAF--QIARGLLYLHED-------CSSQIIL----------------------YSYKRTE 500
+ F QI G+ YLH + ++L Y R +
Sbjct: 120 LLFAQQICEGMAYLHSQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRED 179
Query: 501 G-----YVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
G + APE + DV+SFG L E+++
Sbjct: 180 GDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215
>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1
In With Amp-Pnp
pdb|3KN5|B Chain B, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1
In With Amp-Pnp
pdb|3KN6|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1
pdb|3KN6|B Chain B, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1
Length = 325
Score = 33.1 bits (74), Expect = 0.45, Method: Compositional matrix adjust.
Identities = 45/200 (22%), Positives = 71/200 (35%), Gaps = 48/200 (24%)
Query: 376 VGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTH-HKNLVRLLG 434
+G GSF I K V + + Q I+ + E + E+ + H N+V+L
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAV-----KIISKRMEANTQKEITALKLCEGHPNIVKLHE 73
Query: 435 FCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLL----------YLH 484
+ L+ LV E LN G LF +K + A I R L+ +H
Sbjct: 74 VFHDQLHTFLVMELLNGGE----LFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVH 129
Query: 485 EDCSSQ--------------IILYSYKR--------------TEGYVAPEWFRNSTITAK 516
D + II + + R T Y APE +
Sbjct: 130 RDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDES 189
Query: 517 VDVYSFGFLLLEIISCRKSF 536
D++S G +L ++S + F
Sbjct: 190 CDLWSLGVILYTMLSGQVPF 209
>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain
pdb|4AGU|B Chain B, Crystal Structure Of The Human Cdkl1 Kinase Domain
pdb|4AGU|C Chain C, Crystal Structure Of The Human Cdkl1 Kinase Domain
Length = 311
Score = 33.1 bits (74), Expect = 0.48, Method: Compositional matrix adjust.
Identities = 41/192 (21%), Positives = 79/192 (41%), Gaps = 38/192 (19%)
Query: 375 EVGRGSFGIVYKGVIQTTRQVLLQ---LQSRNWIVFQDGEREFKNEVFVISQTHHKNLVR 431
++G GS+G+V+K + T Q++ L+S + V + + E+ ++ Q H NLV
Sbjct: 10 KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIK---KIALREIRMLKQLKHPNLVN 66
Query: 432 LLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLY------LHE 485
LL LV+E+ ++ L +L +I +Q + + + +H
Sbjct: 67 LLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHR 126
Query: 486 DCSSQIIL-----------YSYKRT--------EGYVAPEWFRNSTITA-------KVDV 519
D + IL + + R + VA W+R+ + VDV
Sbjct: 127 DVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDV 186
Query: 520 YSFGFLLLEIIS 531
++ G + E++S
Sbjct: 187 WAIGCVFAELLS 198
>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6
Length = 302
Score = 33.1 bits (74), Expect = 0.48, Method: Compositional matrix adjust.
Identities = 37/156 (23%), Positives = 65/156 (41%), Gaps = 41/156 (26%)
Query: 414 FKNEVFVISQTHHKNLVRLLGFC-DEGLNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTN 471
+K E+ ++ +H+++++ G C D+G L LV E++ G+L +L + S L
Sbjct: 63 WKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL---PRHSIGLAQL 119
Query: 472 IAF--QIARGLLYLHED-------CSSQIIL----------------------YSYKRTE 500
+ F QI G+ YLH + ++L Y R +
Sbjct: 120 LLFAQQICEGMAYLHAQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRED 179
Query: 501 G-----YVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
G + APE + DV+SFG L E+++
Sbjct: 180 GDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215
>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420
Length = 504
Score = 32.7 bits (73), Expect = 0.57, Method: Compositional matrix adjust.
Identities = 21/74 (28%), Positives = 32/74 (43%)
Query: 412 REFKNEVFVISQTHHKNLVRLLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN 471
E NE+ ++ H N+++L ++ LV EF G L + K N
Sbjct: 91 EEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAAN 150
Query: 472 IAFQIARGLLYLHE 485
I QI G+ YLH+
Sbjct: 151 IMKQILSGICYLHK 164
>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN-
Dependent Protein Kinase Ii Delta In Complex With
Calmodulin
Length = 327
Score = 32.7 bits (73), Expect = 0.63, Method: Compositional matrix adjust.
Identities = 42/196 (21%), Positives = 82/196 (41%), Gaps = 40/196 (20%)
Query: 369 TDNFK--EEVGRGSFGIVYKGV-IQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTH 425
TD ++ EE+G+G+F +V + + I T ++ ++ + + +D ++ + E +
Sbjct: 3 TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQK-LEREARICRLLK 61
Query: 426 HKNLVRLL-GFCDEGLNRLL------------------------------VYEFLNNGTL 454
H N+VRL +EG + L+ + E +N+ L
Sbjct: 62 HPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHL 121
Query: 455 ASFLFGNLKPSWNLRTN----IAFQIARGLLYLHEDCSSQIILYSYKRTEGYVAPEWFRN 510
+ +LKP L + A ++A L + E Q + + T GY++PE R
Sbjct: 122 NGIVHRDLKPENLLLASKSKGAAVKLADFGLAI-EVQGDQQAWFGFAGTPGYLSPEVLRK 180
Query: 511 STITAKVDVYSFGFLL 526
VD+++ G +L
Sbjct: 181 DPYGKPVDMWACGVIL 196
>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With
Mgamp-Pnp
Length = 423
Score = 32.7 bits (73), Expect = 0.63, Method: Compositional matrix adjust.
Identities = 43/200 (21%), Positives = 82/200 (41%), Gaps = 45/200 (22%)
Query: 376 VGRGSFGIV---YKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRL 432
+G G+ GIV Y V+ R V ++ SR + +R ++ E+ ++ +HKN++ L
Sbjct: 70 IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 126
Query: 433 LGF------CDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHE- 485
L +E + LV E ++ L + ++ + + +Q+ G+ +LH
Sbjct: 127 LNVFTPQKTLEEFQDVYLVMELMD-ANLCQVI--QMELDHERMSYLLYQMLCGIKHLHSA 183
Query: 486 ----------------DCSSQIILYSYKRTEG-------------YVAPEWFRNSTITAK 516
DC+ +I+ + RT G Y APE
Sbjct: 184 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 243
Query: 517 VDVYSFGFLLLEIISCRKSF 536
VD++S G ++ E++ + F
Sbjct: 244 VDIWSVGCIMGEMVRHKILF 263
>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With
Ucb1353770 And Amppnp
pdb|3SLS|B Chain B, Crystal Structure Of Human Mek-1 Kinase In Complex With
Ucb1353770 And Amppnp
Length = 304
Score = 32.3 bits (72), Expect = 0.75, Method: Compositional matrix adjust.
Identities = 44/212 (20%), Positives = 86/212 (40%), Gaps = 51/212 (24%)
Query: 363 KALEEATDNFKE--EVGRGSFGIVYK------GVIQTTRQVLLQLQS--RNWIVFQDGER 412
K E D+F++ E+G G+ G+V+K G++ + + L+++ RN I+
Sbjct: 18 KVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII------ 71
Query: 413 EFKNEVFVISQTHHKNLVRLLG-FCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN 471
E+ V+ + + +V G F +G + E ++ G+L L + +
Sbjct: 72 ---RELQVLHECNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVLKKAGRIPEQILGK 127
Query: 472 IAFQIARGLLYL-------HEDCSSQIILY-----------------------SYKRTEG 501
++ + +GL YL H D IL S+ T
Sbjct: 128 VSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS 187
Query: 502 YVAPEWFRNSTITAKVDVYSFGFLLLEIISCR 533
Y++PE + + + + D++S G L+E+ R
Sbjct: 188 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 219
>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent
Protein Kinase Ii Delta Isoform 1, Camkd
pdb|2VN9|B Chain B, Crystal Structure Of Human Calcium Calmodulin Dependent
Protein Kinase Ii Delta Isoform 1, Camkd
Length = 301
Score = 32.0 bits (71), Expect = 0.84, Method: Compositional matrix adjust.
Identities = 42/196 (21%), Positives = 82/196 (41%), Gaps = 40/196 (20%)
Query: 369 TDNFK--EEVGRGSFGIVYKGV-IQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTH 425
TD ++ EE+G+G+F +V + + I T ++ ++ + + +D ++ + E +
Sbjct: 3 TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQK-LEREARICRLLK 61
Query: 426 HKNLVRLL-GFCDEGLNRLL------------------------------VYEFLNNGTL 454
H N+VRL +EG + L+ + E +N+ L
Sbjct: 62 HPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHL 121
Query: 455 ASFLFGNLKPSWNLRTN----IAFQIARGLLYLHEDCSSQIILYSYKRTEGYVAPEWFRN 510
+ +LKP L + A ++A L + E Q + + T GY++PE R
Sbjct: 122 NGIVHRDLKPENLLLASKSKGAAVKLADFGLAI-EVQGDQQAWFGFAGTPGYLSPEVLRK 180
Query: 511 STITAKVDVYSFGFLL 526
VD+++ G +L
Sbjct: 181 DPYGKPVDMWACGVIL 196
>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5-
Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6-
Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide
Length = 325
Score = 32.0 bits (71), Expect = 0.84, Method: Compositional matrix adjust.
Identities = 42/195 (21%), Positives = 76/195 (38%), Gaps = 45/195 (23%)
Query: 375 EVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKN---EVFVISQTHHKNLVR 431
E+G G+FG VYK + T VL + ++ E E ++ E+ +++ H N+V+
Sbjct: 44 ELGDGAFGKVYKAQNKET-SVLAAAK----VIDTKSEEELEDYMVEIDILASCDHPNIVK 98
Query: 432 LLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF-QIARGLLYLHE----- 485
LL N ++ EF G + + + +P + + Q L YLH+
Sbjct: 99 LLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIH 158
Query: 486 -DCSSQIILYSY-------------------KRTEGYV-APEWFRNSTITA--------- 515
D + IL++ +R + ++ P W +
Sbjct: 159 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYD 218
Query: 516 -KVDVYSFGFLLLEI 529
K DV+S G L+E+
Sbjct: 219 YKADVWSLGITLIEM 233
>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded
Form)
Length = 325
Score = 32.0 bits (71), Expect = 0.88, Method: Compositional matrix adjust.
Identities = 42/195 (21%), Positives = 76/195 (38%), Gaps = 45/195 (23%)
Query: 375 EVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKN---EVFVISQTHHKNLVR 431
E+G G+FG VYK + T VL + ++ E E ++ E+ +++ H N+V+
Sbjct: 44 ELGDGAFGKVYKAQNKET-SVLAAAK----VIDTKSEEELEDYMVEIDILASCDHPNIVK 98
Query: 432 LLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF-QIARGLLYLHE----- 485
LL N ++ EF G + + + +P + + Q L YLH+
Sbjct: 99 LLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIH 158
Query: 486 -DCSSQIILYSY-------------------KRTEGYV-APEWFRNSTITA--------- 515
D + IL++ +R + ++ P W +
Sbjct: 159 RDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCETSKDRPYD 218
Query: 516 -KVDVYSFGFLLLEI 529
K DV+S G L+E+
Sbjct: 219 YKADVWSLGITLIEM 233
>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map
Kinase Jnk1
Length = 370
Score = 32.0 bits (71), Expect = 0.89, Method: Compositional matrix adjust.
Identities = 41/194 (21%), Positives = 79/194 (40%), Gaps = 45/194 (23%)
Query: 376 VGRGSFGIV---YKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRL 432
+G G+ GIV Y +++ R V ++ SR + +R ++ E+ ++ +HKN++ L
Sbjct: 32 IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 433 LGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN------IAFQIARGLLYLHE- 485
L + + EF + + + NL + + + +Q+ G+ +LH
Sbjct: 89 LNVFTPQKS---LEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLHSA 145
Query: 486 ----------------DCSSQIILYSYKRTEG-------------YVAPEWFRNSTITAK 516
DC+ +I+ + RT G Y APE
Sbjct: 146 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 517 VDVYSFGFLLLEII 530
VD++S G ++ E+I
Sbjct: 206 VDIWSVGCIMGEMI 219
>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With
N-(4-chlorophenyl)-2-
((pyridin-4-ylmethyl)amino)benzamide
Length = 360
Score = 32.0 bits (71), Expect = 0.91, Method: Compositional matrix adjust.
Identities = 34/157 (21%), Positives = 65/157 (41%), Gaps = 26/157 (16%)
Query: 376 VGRGSFGIVYKGVI------QTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQT-HHKN 428
+GRG+FG V + T R V +++ + + E+ +++ HH N
Sbjct: 35 LGRGAFGKVVQASAFGIKKSPTCRTVAVKMLKEGATASE--YKALMTELKILTHIGHHLN 92
Query: 429 LVRLLGFC-DEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDC 487
+V LLG C +G +++ E+ G L+++L + R L +L++D
Sbjct: 93 VVNLLGACTKQGGPLMVIVEYCKYGNLSNYL----------------KSKRDLFFLNKDA 136
Query: 488 SSQIILYSYKRTEGYVAPEWFRNSTITAKVDVYSFGF 524
+ + K G + R ++T+ S GF
Sbjct: 137 ALHMEPKKEKMEPGLEQGKKPRLDSVTSSESFASSGF 173
Score = 30.8 bits (68), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 26/92 (28%), Positives = 40/92 (43%), Gaps = 33/92 (35%)
Query: 473 AFQIARGLLYL------HEDCSSQIILYS----------------YKRTE---------- 500
+FQ+ARG+ +L H D +++ IL S YK +
Sbjct: 205 SFQVARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLP 264
Query: 501 -GYVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
++APE + + K DV+S+G LL EI S
Sbjct: 265 LKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296
>pdb|3SOA|A Chain A, Full-Length Human Camkii
Length = 444
Score = 32.0 bits (71), Expect = 0.94, Method: Compositional matrix adjust.
Identities = 35/187 (18%), Positives = 65/187 (34%), Gaps = 34/187 (18%)
Query: 374 EEVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRLL 433
EE+G+G+F +V + V Q + + ++ + E + H N+VRL
Sbjct: 17 EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 76
Query: 434 GFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH--------- 484
E + L+++ + G L + S ++ QI +L+ H
Sbjct: 77 DSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNL 136
Query: 485 -------------------------EDCSSQIILYSYKRTEGYVAPEWFRNSTITAKVDV 519
E Q + + T GY++PE R VD+
Sbjct: 137 KPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDL 196
Query: 520 YSFGFLL 526
++ G +L
Sbjct: 197 WACGVIL 203
>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (
Diphosphorylated Form) Bound To 5- Amino-3-((4-(
Aminosulfonyl)phenyl)amino)-N-(2,6-
Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide
Length = 325
Score = 32.0 bits (71), Expect = 0.98, Method: Compositional matrix adjust.
Identities = 29/116 (25%), Positives = 53/116 (45%), Gaps = 9/116 (7%)
Query: 375 EVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKN---EVFVISQTHHKNLVR 431
E+G G+FG VYK + T VL + ++ E E ++ E+ +++ H N+V+
Sbjct: 44 ELGDGAFGKVYKAQNKET-SVLAAAK----VIDTKSEEELEDYMVEIDILASCDHPNIVK 98
Query: 432 LLGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF-QIARGLLYLHED 486
LL N ++ EF G + + + +P + + Q L YLH++
Sbjct: 99 LLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN 154
>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3-
Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide
pdb|2P33|A Chain A, Synthesis And Sar Of Aminopyrimidines As Novel C-Jun N-
Terminal Kinase (Jnk) Inhibitors
pdb|3CGF|A Chain A, Irak-4 Inhibitors (Part Ii)- A Structure Based Assessment
Of Imidazo[1,2 A]pyridine Binding
pdb|3CGO|A Chain A, Irak-4 Inhibitors (Part Ii)- A Structure Based Assessment
Of Imidazo[1,2 A]pyridine Binding
pdb|3G90|X Chain X, Jnk-3 Bound To
(Z)-5-Fluoro-1-((6-Fluoro-4h-Benzo[d][1,3]dioxin-8-Yl)
Methyl)-3-(Hydroxyimino)indolin-2-One
pdb|3G9N|A Chain A, Jnk3 Bound To
(Z)-1-((6-Fluoro-4h-Benzo[d][1,3]dioxin-8-Yl)methyl)-3-
(Hydroxyimino)-4-Phenylindolin-2-One
pdb|3G9L|X Chain X, Jnk3 Bound To
(Z)-1-((6-Fluoro-4h-Benzo[d][1,3]dioxin-8-Yl)methyl)-3-
(Hydroxyimino)-4-Styrylindolin-2-One
Length = 365
Score = 32.0 bits (71), Expect = 0.98, Method: Compositional matrix adjust.
Identities = 43/200 (21%), Positives = 82/200 (41%), Gaps = 45/200 (22%)
Query: 376 VGRGSFGIV---YKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRL 432
+G G+ GIV Y V+ R V ++ SR + +R ++ E+ ++ +HKN++ L
Sbjct: 33 IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 89
Query: 433 LGF------CDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHE- 485
L +E + LV E ++ L + ++ + + +Q+ G+ +LH
Sbjct: 90 LNVFTPQKTLEEFQDVYLVMELMD-ANLCQVI--QMELDHERMSYLLYQMLCGIKHLHSA 146
Query: 486 ----------------DCSSQIILYSYKRTEG-------------YVAPEWFRNSTITAK 516
DC+ +I+ + RT G Y APE
Sbjct: 147 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 206
Query: 517 VDVYSFGFLLLEIISCRKSF 536
VD++S G ++ E++ + F
Sbjct: 207 VDIWSVGCIMGEMVRHKILF 226
>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole-
Pyrimidine Inhibitor
pdb|1PMQ|A Chain A, The Structure Of Jnk3 In Complex With An Imidazole-
Pyrimidine Inhibitor
pdb|1PMU|A Chain A, The Crystal Structure Of Jnk3 In Complex With A
Phenantroline Inhibitor
pdb|1PMV|A Chain A, The Structure Of Jnk3 In Complex With A
Dihydroanthrapyrazole Inhibitor
Length = 364
Score = 32.0 bits (71), Expect = 1.0, Method: Compositional matrix adjust.
Identities = 44/200 (22%), Positives = 81/200 (40%), Gaps = 45/200 (22%)
Query: 376 VGRGSFGIV---YKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRL 432
+G G+ GIV Y V+ R V ++ SR + +R ++ E+ ++ +HKN++ L
Sbjct: 33 IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 89
Query: 433 LGF------CDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHE- 485
L +E + LV E ++ L + L + + +Q+ G+ +LH
Sbjct: 90 LNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMEL--DHERMSYLLYQMLCGIKHLHSA 146
Query: 486 ----------------DCSSQIILYSYKRTEG-------------YVAPEWFRNSTITAK 516
DC+ +I+ + RT G Y APE
Sbjct: 147 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 206
Query: 517 VDVYSFGFLLLEIISCRKSF 536
VD++S G ++ E++ + F
Sbjct: 207 VDIWSVGCIMGEMVRHKILF 226
>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With
N-{3-Cyano-6-[3-(1-
Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2,
3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide
pdb|2O2U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With
N-(3-Cyano-4,5,6,7-
Tetrahydro-1-Benzothien-2-Yl)-2-Fluorobenzamide
pdb|2ZDT|A Chain A, Crystal Structure Of Human Jnk3 Complexed With An
Isoquinolone Inhibitor
pdb|2ZDU|A Chain A, Crystal Structure Of Human Jnk3 Complexed With An
Isoquinolone Inhibitor
pdb|3DA6|A Chain A, Crystal Structure Of Human Jnk3 Complexed With
N-(3-Methyl-
4-(3-(2-(Methylamino)pyrimidin-4-Yl)pyridin-2-Yloxy)
Naphthalen-1-Yl)-1h-Benzo[d]imidazol-2-Amine
pdb|2WAJ|A Chain A, Crystal Structure Of Human Jnk3 Complexed With A
1-Aryl-3,4- Dihydroisoquinoline Inhibitor
pdb|3V6R|A Chain A, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
pdb|3V6R|B Chain B, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
pdb|3V6S|A Chain A, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
pdb|3V6S|B Chain B, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
Length = 364
Score = 32.0 bits (71), Expect = 1.0, Method: Compositional matrix adjust.
Identities = 43/200 (21%), Positives = 82/200 (41%), Gaps = 45/200 (22%)
Query: 376 VGRGSFGIV---YKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRL 432
+G G+ GIV Y V+ R V ++ SR + +R ++ E+ ++ +HKN++ L
Sbjct: 32 IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 88
Query: 433 LGF------CDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHE- 485
L +E + LV E ++ L + ++ + + +Q+ G+ +LH
Sbjct: 89 LNVFTPQKTLEEFQDVYLVMELMD-ANLCQVI--QMELDHERMSYLLYQMLCGIKHLHSA 145
Query: 486 ----------------DCSSQIILYSYKRTEG-------------YVAPEWFRNSTITAK 516
DC+ +I+ + RT G Y APE
Sbjct: 146 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 517 VDVYSFGFLLLEIISCRKSF 536
VD++S G ++ E++ + F
Sbjct: 206 VDIWSVGCIMGEMVRHKILF 225
>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious
Tri-Substituted Thiophene Based Jnk Inhibitor
Length = 363
Score = 32.0 bits (71), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 44/200 (22%), Positives = 81/200 (40%), Gaps = 45/200 (22%)
Query: 376 VGRGSFGIV---YKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRL 432
+G G+ GIV Y V+ R V ++ SR + +R ++ E+ ++ +HKN++ L
Sbjct: 32 IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 88
Query: 433 LGF------CDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHE- 485
L +E + LV E ++ L + L + + +Q+ G+ +LH
Sbjct: 89 LNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMEL--DHERMSYLLYQMLCGIKHLHSA 145
Query: 486 ----------------DCSSQIILYSYKRTEG-------------YVAPEWFRNSTITAK 516
DC+ +I+ + RT G Y APE
Sbjct: 146 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 517 VDVYSFGFLLLEIISCRKSF 536
VD++S G ++ E++ + F
Sbjct: 206 VDIWSVGCIMGEMVRHKILF 225
>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And
Thiazole Based Inhibitors Of Jnk For The Treatment Of
Neurodegenerative Diseases
pdb|3OY1|A Chain A, Highly Selective C-Jun N-Terminal Kinase (Jnk) 2 And 3
Inhibitors With In Vitro Cns-Like Pharmacokinetic
Properties
Length = 362
Score = 32.0 bits (71), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 44/200 (22%), Positives = 81/200 (40%), Gaps = 45/200 (22%)
Query: 376 VGRGSFGIV---YKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRL 432
+G G+ GIV Y V+ R V ++ SR + +R ++ E+ ++ +HKN++ L
Sbjct: 31 IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 87
Query: 433 LGF------CDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHE- 485
L +E + LV E ++ L + L + + +Q+ G+ +LH
Sbjct: 88 LNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMEL--DHERMSYLLYQMLCGIKHLHSA 144
Query: 486 ----------------DCSSQIILYSYKRTEG-------------YVAPEWFRNSTITAK 516
DC+ +I+ + RT G Y APE
Sbjct: 145 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 204
Query: 517 VDVYSFGFLLLEIISCRKSF 536
VD++S G ++ E++ + F
Sbjct: 205 VDIWSVGCIMGEMVRHKILF 224
>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3
Length = 356
Score = 31.6 bits (70), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 43/200 (21%), Positives = 82/200 (41%), Gaps = 45/200 (22%)
Query: 376 VGRGSFGIV---YKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRL 432
+G G+ GIV Y V+ R V ++ SR + +R ++ E+ ++ +HKN++ L
Sbjct: 26 IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 82
Query: 433 LGF------CDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHE- 485
L +E + LV E ++ L + ++ + + +Q+ G+ +LH
Sbjct: 83 LNVFTPQKTLEEFQDVYLVMELMD-ANLCQVI--QMELDHERMSYLLYQMLCGIKHLHSA 139
Query: 486 ----------------DCSSQIILYSYKRTEG-------------YVAPEWFRNSTITAK 516
DC+ +I+ + RT G Y APE
Sbjct: 140 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 199
Query: 517 VDVYSFGFLLLEIISCRKSF 536
VD++S G ++ E++ + F
Sbjct: 200 VDIWSVGCIMGEMVRHKILF 219
>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3
Length = 355
Score = 31.6 bits (70), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 43/200 (21%), Positives = 82/200 (41%), Gaps = 45/200 (22%)
Query: 376 VGRGSFGIV---YKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRL 432
+G G+ GIV Y V+ R V ++ SR + +R ++ E+ ++ +HKN++ L
Sbjct: 25 IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 81
Query: 433 LGF------CDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHE- 485
L +E + LV E ++ L + ++ + + +Q+ G+ +LH
Sbjct: 82 LNVFTPQKTLEEFQDVYLVMELMD-ANLCQVI--QMELDHERMSYLLYQMLCGIKHLHSA 138
Query: 486 ----------------DCSSQIILYSYKRTEG-------------YVAPEWFRNSTITAK 516
DC+ +I+ + RT G Y APE
Sbjct: 139 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 198
Query: 517 VDVYSFGFLLLEIISCRKSF 536
VD++S G ++ E++ + F
Sbjct: 199 VDIWSVGCIMGEMVRHKILF 218
>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092,
Delete A660- T867) At 2.28 A Resolution
pdb|4G34|A Chain A, Crystal Structure Of Gsk6924 Bound To Perk (R587-R1092,
Delete A660- T867) At 2.70 A Resolution
Length = 299
Score = 31.6 bits (70), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 17/51 (33%), Positives = 29/51 (56%), Gaps = 4/51 (7%)
Query: 499 TEGYVAPEWFRNSTITAKVDVYSFGFLLLEIISCRKSFDIEMGEEYAILTD 549
T+ Y++PE ++ + KVD++S G +L E++ F +M E LTD
Sbjct: 193 TKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM-ERVRTLTD 239
>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide
pdb|4H39|A Chain A, Crystal Structure Of Jnk3 In Complex With Jip1 Peptide
pdb|4H3B|A Chain A, Crystal Structure Of Jnk3 In Complex With Sab Peptide
pdb|4H3B|C Chain C, Crystal Structure Of Jnk3 In Complex With Sab Peptide
Length = 356
Score = 31.6 bits (70), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 43/200 (21%), Positives = 82/200 (41%), Gaps = 45/200 (22%)
Query: 376 VGRGSFGIV---YKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRL 432
+G G+ GIV Y V+ R V ++ SR + +R ++ E+ ++ +HKN++ L
Sbjct: 26 IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 82
Query: 433 LGF------CDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHE- 485
L +E + LV E ++ L + ++ + + +Q+ G+ +LH
Sbjct: 83 LNVFTPQKTLEEFQDVYLVMELMD-ANLCQVI--QMELDHERMSYLLYQMLCGIKHLHSA 139
Query: 486 ----------------DCSSQIILYSYKRTEG-------------YVAPEWFRNSTITAK 516
DC+ +I+ + RT G Y APE
Sbjct: 140 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 199
Query: 517 VDVYSFGFLLLEIISCRKSF 536
VD++S G ++ E++ + F
Sbjct: 200 VDIWSVGCIMGEMVRHKILF 219
>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs.
pdb|4AN3|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs.
pdb|4AN9|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs.
pdb|4ANB|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs
Length = 301
Score = 31.6 bits (70), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 42/209 (20%), Positives = 85/209 (40%), Gaps = 51/209 (24%)
Query: 366 EEATDNFKE--EVGRGSFGIVYK------GVIQTTRQVLLQLQS--RNWIVFQDGEREFK 415
E D+F++ E+G G+ G+V+K G++ + + L+++ RN I+
Sbjct: 5 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII--------- 55
Query: 416 NEVFVISQTHHKNLVRLLG-FCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF 474
E+ V+ + + +V G F +G + E ++ G+L L + + ++
Sbjct: 56 RELQVLHECNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSI 114
Query: 475 QIARGLLYL-------HEDCSSQIILYS-----------------------YKRTEGYVA 504
+ +GL YL H D IL + + T Y++
Sbjct: 115 AVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEFVGTRSYMS 174
Query: 505 PEWFRNSTITAKVDVYSFGFLLLEIISCR 533
PE + + + + D++S G L+E+ R
Sbjct: 175 PERLQGTHYSVQSDIWSMGLSLVEMAVGR 203
>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis
Length = 394
Score = 31.2 bits (69), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 49/208 (23%), Positives = 81/208 (38%), Gaps = 50/208 (24%)
Query: 376 VGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKN-EVFVISQTHHKNLVRLLG 434
+G GSFG+V++ + + +V ++ V QD + FKN E+ ++ H N+V L
Sbjct: 48 IGNGSFGVVFQAKLVESDEVAIKK------VLQD--KRFKNRELQIMRIVKHPNVVDLKA 99
Query: 435 FC-------DEGLNRLLVYEFLNNGTLASFLFGNLKPSWN--LRTNIAFQIARGLLYL-- 483
F DE L++ AS + LK + L +Q+ R L Y+
Sbjct: 100 FFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS 159
Query: 484 ----HEDCSSQIILY-------------------------SYKRTEGYVAPEW-FRNSTI 513
H D Q +L S + Y APE F +
Sbjct: 160 IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRYYRAPELIFGATNY 219
Query: 514 TAKVDVYSFGFLLLEIISCRKSFDIEMG 541
T +D++S G ++ E++ + F E G
Sbjct: 220 TTNIDIWSTGCVMAELMQGQPLFPGESG 247
>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform
pdb|3O17|B Chain B, Crystal Structure Of Jnk1-Alpha1 Isoform
pdb|3O2M|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Complex With A
Biaryl Tetrazol (A-82118)
pdb|3O2M|B Chain B, Crystal Structure Of Jnk1-Alpha1 Isoform Complex With A
Biaryl Tetrazol (A-82118)
Length = 370
Score = 31.2 bits (69), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 42/198 (21%), Positives = 81/198 (40%), Gaps = 46/198 (23%)
Query: 376 VGRGSFGIV---YKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRL 432
+G G+ GIV Y +++ R V ++ SR + +R ++ E+ ++ +HKN++ L
Sbjct: 32 IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 433 LGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN------IAFQIARGLLYLHE- 485
L + + EF + + + NL + + + +Q+ G+ +LH
Sbjct: 89 LNVFTPQKS---LEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 145
Query: 486 ----------------DCSSQIILYSYKRTEG-------------YVAPEWFRNSTITAK 516
DC+ +I+ + RT G Y APE
Sbjct: 146 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGMGYKEN 205
Query: 517 VDVYSFGFLLLEIISCRK 534
VD++S G ++ E++ C K
Sbjct: 206 VDIWSVGCIMGEMV-CHK 222
>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A
Natural Jnk1 Inhibitor
Length = 379
Score = 31.2 bits (69), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 41/194 (21%), Positives = 79/194 (40%), Gaps = 45/194 (23%)
Query: 376 VGRGSFGIV---YKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRL 432
+G G+ GIV Y +++ R V ++ SR + +R ++ E+ ++ +HKN++ L
Sbjct: 32 IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 433 LGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN------IAFQIARGLLYLHE- 485
L + + EF + + + NL + + + +Q+ G+ +LH
Sbjct: 89 LNVFTPQKS---LEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 145
Query: 486 ----------------DCSSQIILYSYKRTEG-------------YVAPEWFRNSTITAK 516
DC+ +I+ + RT G Y APE
Sbjct: 146 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPEVVTRYYRAPEVILGMGYKEN 205
Query: 517 VDVYSFGFLLLEII 530
VD++S G ++ E+I
Sbjct: 206 VDIWSVGCIMGEMI 219
>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin
Antagonistically Control The Nuclear Shuttling Of Nfat4
Length = 371
Score = 31.2 bits (69), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 41/194 (21%), Positives = 81/194 (41%), Gaps = 45/194 (23%)
Query: 376 VGRGSFGIV---YKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRL 432
+G G+ GIV Y +++ R V ++ SR + +R ++ E+ ++ +HKN++ L
Sbjct: 33 IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 89
Query: 433 LGF------CDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHE- 485
L +E + +V E ++ L + ++ + + +Q+ G+ +LH
Sbjct: 90 LNVFTPQKSLEEFQDVYIVMELMD-ANLCQVI--QMELDHERMSYLLYQMLCGIKHLHSA 146
Query: 486 ----------------DCSSQIILYSYKRTEG-------------YVAPEWFRNSTITAK 516
DC+ +I+ + RT G Y APE
Sbjct: 147 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 206
Query: 517 VDVYSFGFLLLEII 530
VD++S G ++ E+I
Sbjct: 207 VDIWSVGCIMGEMI 220
>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By
The Scaffolding Protein Jip1 And Sp600125
pdb|1UKI|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By
The Scaffolding Protein Jip1 And Sp600125
Length = 369
Score = 31.2 bits (69), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 41/194 (21%), Positives = 81/194 (41%), Gaps = 45/194 (23%)
Query: 376 VGRGSFGIV---YKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRL 432
+G G+ GIV Y +++ R V ++ SR + +R ++ E+ ++ +HKN++ L
Sbjct: 32 IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 433 LGF------CDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHE- 485
L +E + +V E ++ L + ++ + + +Q+ G+ +LH
Sbjct: 89 LNVFTPQKSLEEFQDVYIVMELMD-ANLCQVI--QMELDHERMSYLLYQMLCGIKHLHSA 145
Query: 486 ----------------DCSSQIILYSYKRTEG-------------YVAPEWFRNSTITAK 516
DC+ +I+ + RT G Y APE
Sbjct: 146 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 517 VDVYSFGFLLLEII 530
VD++S G ++ E+I
Sbjct: 206 VDIWSVGCIMGEMI 219
>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin
Antagonistically Control The Nuclear Shuttling Of Nfat4
Length = 386
Score = 31.2 bits (69), Expect = 1.8, Method: Compositional matrix adjust.
Identities = 41/194 (21%), Positives = 79/194 (40%), Gaps = 45/194 (23%)
Query: 376 VGRGSFGIV---YKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRL 432
+G G+ GIV Y +++ R V ++ SR + +R ++ E+ ++ +HKN++ L
Sbjct: 34 IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 90
Query: 433 LGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN------IAFQIARGLLYLHE- 485
L + + EF + + + NL + + + +Q+ G+ +LH
Sbjct: 91 LNVFTPQKS---LEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 147
Query: 486 ----------------DCSSQIILYSYKRTEG-------------YVAPEWFRNSTITAK 516
DC+ +I+ + RT G Y APE
Sbjct: 148 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVVTRYYRAPEVILGMGYKEN 207
Query: 517 VDVYSFGFLLLEII 530
VD++S G ++ E+I
Sbjct: 208 VDIWSVGCIMGEMI 221
>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole
Inhibitor
Length = 290
Score = 30.8 bits (68), Expect = 1.9, Method: Compositional matrix adjust.
Identities = 35/154 (22%), Positives = 63/154 (40%), Gaps = 37/154 (24%)
Query: 414 FKNEVFVISQTHHKNLVRLLGFC-DEGLNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTN 471
++ E+ ++ +H+++V+ G C D+G + LV E++ G+L +L + L
Sbjct: 57 WQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLL- 115
Query: 472 IAFQIARGLLYLHED-------CSSQIIL----------------------YSYKRTEG- 501
A QI G+ YLH + ++L Y R +G
Sbjct: 116 FAQQICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 175
Query: 502 ----YVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
+ APE + DV+SFG L E+++
Sbjct: 176 SPVFWYAPECLKECKFYYASDVWSFGVTLYELLT 209
>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map
Kinase Jnk1
Length = 370
Score = 30.8 bits (68), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 41/194 (21%), Positives = 81/194 (41%), Gaps = 45/194 (23%)
Query: 376 VGRGSFGIV---YKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRL 432
+G G+ GIV Y +++ R V ++ SR + +R ++ E+ ++ +HKN++ L
Sbjct: 32 IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 433 LGF------CDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHE- 485
L +E + +V E ++ L + ++ + + +Q+ G+ +LH
Sbjct: 89 LNVFTPQKSLEEFQDVYIVMELMD-ANLCQVI--QMELDHERMSYLLYQMLCGIKHLHSA 145
Query: 486 ----------------DCSSQIILYSYKRTEG-------------YVAPEWFRNSTITAK 516
DC+ +I+ + RT G Y APE
Sbjct: 146 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 517 VDVYSFGFLLLEII 530
VD++S G ++ E+I
Sbjct: 206 VDIWSVGCIMGEMI 219
>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole
Inhibitor
Length = 291
Score = 30.8 bits (68), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 35/154 (22%), Positives = 63/154 (40%), Gaps = 37/154 (24%)
Query: 414 FKNEVFVISQTHHKNLVRLLGFC-DEGLNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTN 471
++ E+ ++ +H+++V+ G C D+G + LV E++ G+L +L + L
Sbjct: 58 WQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLL- 116
Query: 472 IAFQIARGLLYLHED-------CSSQIIL----------------------YSYKRTEG- 501
A QI G+ YLH + ++L Y R +G
Sbjct: 117 FAQQICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 176
Query: 502 ----YVAPEWFRNSTITAKVDVYSFGFLLLEIIS 531
+ APE + DV+SFG L E+++
Sbjct: 177 SPVFWYAPECLKECKFYYASDVWSFGVTLYELLT 210
>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Sangivamycin
pdb|3NYN|B Chain B, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Sangivamycin
pdb|3NYO|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Amp
pdb|3NYO|B Chain B, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Amp
Length = 576
Score = 30.8 bits (68), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 15/39 (38%), Positives = 22/39 (56%)
Query: 499 TEGYVAPEWFRNSTITAKVDVYSFGFLLLEIISCRKSFD 537
T GY+APE +N T D ++ G LL E+I+ + F
Sbjct: 348 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQ 386
>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6
Bound To Amppnp
pdb|2ACX|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 6
Bound To Amppnp
Length = 576
Score = 30.8 bits (68), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 15/38 (39%), Positives = 22/38 (57%)
Query: 499 TEGYVAPEWFRNSTITAKVDVYSFGFLLLEIISCRKSF 536
T GY+APE +N T D ++ G LL E+I+ + F
Sbjct: 348 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF 385
>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine
Inhibitor
Length = 369
Score = 30.4 bits (67), Expect = 2.5, Method: Compositional matrix adjust.
Identities = 42/198 (21%), Positives = 81/198 (40%), Gaps = 46/198 (23%)
Query: 376 VGRGSFGIV---YKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRL 432
+G G+ GIV Y +++ R V ++ SR + +R ++ E+ ++ +HKN++ L
Sbjct: 37 IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 93
Query: 433 LGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN------IAFQIARGLLYLHE- 485
L + + EF + + + NL + + + +Q+ G+ +LH
Sbjct: 94 LNVFTPQKS---LEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 150
Query: 486 ----------------DCSSQIILYSYKRTEG-------------YVAPEWFRNSTITAK 516
DC+ +I+ + RT G Y APE
Sbjct: 151 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 210
Query: 517 VDVYSFGFLLLEIISCRK 534
VD++S G ++ E++ C K
Sbjct: 211 VDLWSVGCIMGEMV-CHK 227
>pdb|1W8B|L Chain L, Factor7 - 413 Complex
Length = 57
Score = 30.4 bits (67), Expect = 2.5, Method: Composition-based stats.
Identities = 19/56 (33%), Positives = 24/56 (42%), Gaps = 10/56 (17%)
Query: 167 ICVNIGGGLGSGACGYNSICTLDSDRRPRCACPKGYSLLDENDRYGSCKPDFELSC 222
ICVN GG C+ + + C C +GYSLL + SC P E C
Sbjct: 3 ICVNENGGC-------EQYCSDHTGTKRSCRCHEGYSLLADG---VSCTPTVEYPC 48
>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor
Length = 358
Score = 30.4 bits (67), Expect = 2.6, Method: Compositional matrix adjust.
Identities = 42/198 (21%), Positives = 81/198 (40%), Gaps = 46/198 (23%)
Query: 376 VGRGSFGIV---YKGVIQTTRQVLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNLVRL 432
+G G+ GIV Y +++ R V ++ SR + +R ++ E+ ++ +HKN++ L
Sbjct: 26 IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 82
Query: 433 LGFCDEGLNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN------IAFQIARGLLYLHE- 485
L + + EF + + + NL + + + +Q+ G+ +LH
Sbjct: 83 LNVFTPQKS---LEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 139
Query: 486 ----------------DCSSQIILYSYKRTEG-------------YVAPEWFRNSTITAK 516
DC+ +I+ + RT G Y APE
Sbjct: 140 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 199
Query: 517 VDVYSFGFLLLEIISCRK 534
VD++S G ++ E++ C K
Sbjct: 200 VDLWSVGCIMGEMV-CHK 216
>pdb|1KLI|L Chain L, Cofactor-And Substrate-Assisted Activation Of Factor Viia
pdb|1KLJ|L Chain L, Crystal Structure Of Uninhibited Factor Viia
Length = 69
Score = 30.4 bits (67), Expect = 2.8, Method: Composition-based stats.
Identities = 19/56 (33%), Positives = 24/56 (42%), Gaps = 10/56 (17%)
Query: 167 ICVNIGGGLGSGACGYNSICTLDSDRRPRCACPKGYSLLDENDRYGSCKPDFELSC 222
ICVN GG C+ + + C C +GYSLL + SC P E C
Sbjct: 7 ICVNENGGC-------EQYCSDHTGTKRSCRCHEGYSLLADG---VSCTPTVEYPC 52
>pdb|1CVW|L Chain L, Crystal Structure Of Active Site-inhibited Human
Coagulation Factor Viia (des-gla)
pdb|1W7X|L Chain L, Factor7- 413 Complex
pdb|4ISI|L Chain L, Structure Of Factor Viia In Complex With The Inhibitor
(6s)-n-(4-
Carbamimidoylbenzyl)-1-chloro-3-(cyclobutylamino)-8,
8-diethyl-4-oxo-
4,6,7,8-tetrahydropyrrolo[1,2-a]pyrazine-6-carboxamide
Length = 55
Score = 30.4 bits (67), Expect = 2.8, Method: Composition-based stats.
Identities = 19/56 (33%), Positives = 24/56 (42%), Gaps = 10/56 (17%)
Query: 167 ICVNIGGGLGSGACGYNSICTLDSDRRPRCACPKGYSLLDENDRYGSCKPDFELSC 222
ICVN GG C+ + + C C +GYSLL + SC P E C
Sbjct: 1 ICVNENGGC-------EQYCSDHTGTKRSCRCHEGYSLLADG---VSCTPTVEYPC 46
>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B
(STK17B)
pdb|3LM5|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B
(STK17B) IN Complex With Quercetin
Length = 327
Score = 30.4 bits (67), Expect = 2.8, Method: Compositional matrix adjust.
Identities = 46/205 (22%), Positives = 77/205 (37%), Gaps = 48/205 (23%)
Query: 374 EEVGRGSFGIVYKGVIQTTRQ----VLLQLQSRNWIVFQDGEREFKNEVFVISQTHHKNL 429
+E+GRG F +V + + ++T Q L+ + R QD E +E+ V+ K+
Sbjct: 35 KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRG----QDCRAEILHEIAVLELA--KSC 88
Query: 430 VRLLGFCDEGLNR---LLVYEFLNNGTLASFLFGNLKP--SWNLRTNIAFQIARGLLYLH 484
R++ + N +L+ E+ G + S L S N + QI G+ YLH
Sbjct: 89 PRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH 148
Query: 485 E------DCSSQIILYS---------------------------YKRTEGYVAPEWFRNS 511
+ D Q IL S T Y+APE
Sbjct: 149 QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYD 208
Query: 512 TITAKVDVYSFGFLLLEIISCRKSF 536
IT D+++ G + +++ F
Sbjct: 209 PITTATDMWNIGIIAYMLLTHTSPF 233
>pdb|1JBU|L Chain L, Coagulation Factor Vii Zymogen (Egf2PROTEASE) IN COMPLEX
WITH Inhibitory Exosite Peptide A-183
pdb|1YGC|L Chain L, Short Factor Viia With A Small Molecule Inhibitor
Length = 63
Score = 30.4 bits (67), Expect = 2.9, Method: Composition-based stats.
Identities = 19/56 (33%), Positives = 24/56 (42%), Gaps = 10/56 (17%)
Query: 167 ICVNIGGGLGSGACGYNSICTLDSDRRPRCACPKGYSLLDENDRYGSCKPDFELSC 222
ICVN GG C+ + + C C +GYSLL + SC P E C
Sbjct: 1 ICVNENGGC-------EQYCSDHTGTKRSCRCHEGYSLLADG---VSCTPTVEYPC 46
>pdb|2BZ6|L Chain L, Orally Available Factor7a Inhibitor
Length = 53
Score = 30.4 bits (67), Expect = 2.9, Method: Composition-based stats.
Identities = 19/56 (33%), Positives = 24/56 (42%), Gaps = 10/56 (17%)
Query: 167 ICVNIGGGLGSGACGYNSICTLDSDRRPRCACPKGYSLLDENDRYGSCKPDFELSC 222
ICVN GG C+ + + C C +GYSLL + SC P E C
Sbjct: 1 ICVNENGGC-------EQYCSDHTGTKRSCRCHEGYSLLADG---VSCTPTVEYPC 46
>pdb|1QFK|L Chain L, Structure Of Human Factor Viia And Its Implications For
The Triggering Of Blood Coagulation
Length = 104
Score = 30.0 bits (66), Expect = 3.9, Method: Composition-based stats.
Identities = 19/56 (33%), Positives = 24/56 (42%), Gaps = 10/56 (17%)
Query: 167 ICVNIGGGLGSGACGYNSICTLDSDRRPRCACPKGYSLLDENDRYGSCKPDFELSC 222
ICVN GG C+ + + C C +GYSLL + SC P E C
Sbjct: 42 ICVNENGGC-------EQYCSDHTGTKRSCRCHEGYSLLADG---VSCTPTVEYPC 87
>pdb|2PUQ|L Chain L, Crystal Structure Of Active Site Inhibited Coagulation
Factor Viia In Complex With Soluble Tissue Factor
Length = 94
Score = 30.0 bits (66), Expect = 3.9, Method: Composition-based stats.
Identities = 19/56 (33%), Positives = 24/56 (42%), Gaps = 10/56 (17%)
Query: 167 ICVNIGGGLGSGACGYNSICTLDSDRRPRCACPKGYSLLDENDRYGSCKPDFELSC 222
ICVN GG C+ + + C C +GYSLL + SC P E C
Sbjct: 42 ICVNENGGC-------EQYCSDHTGTKRSCRCHEGYSLLADG---VSCTPTVEYPC 87
>pdb|1J9C|L Chain L, Crystal Structure Of Tissue Factor-Factor Viia Complex
Length = 95
Score = 30.0 bits (66), Expect = 4.0, Method: Composition-based stats.
Identities = 19/56 (33%), Positives = 24/56 (42%), Gaps = 10/56 (17%)
Query: 167 ICVNIGGGLGSGACGYNSICTLDSDRRPRCACPKGYSLLDENDRYGSCKPDFELSC 222
ICVN GG C+ + + C C +GYSLL + SC P E C
Sbjct: 43 ICVNENGGC-------EQYCSDHTGTKRSCRCHEGYSLLADG---VSCTPTVEYPC 88
>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine
pdb|1Q3D|B Chain B, Gsk-3 Beta Complexed With Staurosporine
pdb|1Q3W|A Chain A, Gsk-3 Beta Complexed With Alsterpaullone
pdb|1Q3W|B Chain B, Gsk-3 Beta Complexed With Alsterpaullone
pdb|1Q41|A Chain A, Gsk-3 Beta Complexed With Indirubin-3'-Monoxime
pdb|1Q41|B Chain B, Gsk-3 Beta Complexed With Indirubin-3'-Monoxime
pdb|1Q4L|A Chain A, Gsk-3 Beta Complexed With Inhibitor I-5
pdb|1Q4L|B Chain B, Gsk-3 Beta Complexed With Inhibitor I-5
pdb|3Q3B|A Chain A, 6-Amino-4-(Pyrimidin-4-Yl)pyridones: Novel Glycogen
Synthase Kinase-3 Inhibitors
pdb|3Q3B|B Chain B, 6-Amino-4-(Pyrimidin-4-Yl)pyridones: Novel Glycogen
Synthase Kinase-3 Inhibitors
Length = 424
Score = 30.0 bits (66), Expect = 4.1, Method: Compositional matrix adjust.
Identities = 20/61 (32%), Positives = 35/61 (57%), Gaps = 8/61 (13%)
Query: 376 VGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKN-EVFVISQTHHKNLVRLLG 434
+G GSFG+VY+ + + +++ + V QD + FKN E+ ++ + H N+VRL
Sbjct: 66 IGNGSFGVVYQAKLCDSGELVAIKK-----VLQD--KRFKNRELQIMRKLDHCNIVRLRY 118
Query: 435 F 435
F
Sbjct: 119 F 119
>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In
Complexed With Inhibitor
pdb|1Q5K|B Chain B, Crystal Structure Of Glycogen Synthase Kinase 3 In
Complexed With Inhibitor
pdb|3I4B|A Chain A, Crystal Structure Of Gsk3b In Complex With A
Pyrimidylpyrrole Inhibitor
pdb|3I4B|B Chain B, Crystal Structure Of Gsk3b In Complex With A
Pyrimidylpyrrole Inhibitor
pdb|3L1S|A Chain A, 3-Aryl-4-(Arylhydrazono)-1h-Pyrazol-5-Ones: Highly Ligand
Efficient And Potent Inhibitors Of Gsk3
pdb|3L1S|B Chain B, 3-Aryl-4-(Arylhydrazono)-1h-Pyrazol-5-Ones: Highly Ligand
Efficient And Potent Inhibitors Of Gsk3
Length = 414
Score = 30.0 bits (66), Expect = 4.1, Method: Compositional matrix adjust.
Identities = 20/61 (32%), Positives = 35/61 (57%), Gaps = 8/61 (13%)
Query: 376 VGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKN-EVFVISQTHHKNLVRLLG 434
+G GSFG+VY+ + + +++ + V QD + FKN E+ ++ + H N+VRL
Sbjct: 56 IGNGSFGVVYQAKLCDSGELVAIKK-----VLQD--KRFKNRELQIMRKLDHCNIVRLRY 108
Query: 435 F 435
F
Sbjct: 109 F 109
>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp
pdb|1PYX|B Chain B, Gsk-3 Beta Complexed With Amp-Pnp
pdb|3DU8|A Chain A, Crystal Structure Of Gsk-3 Beta In Complex With
Nms-869553a
pdb|3DU8|B Chain B, Crystal Structure Of Gsk-3 Beta In Complex With
Nms-869553a
Length = 422
Score = 30.0 bits (66), Expect = 4.1, Method: Compositional matrix adjust.
Identities = 20/61 (32%), Positives = 35/61 (57%), Gaps = 8/61 (13%)
Query: 376 VGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKN-EVFVISQTHHKNLVRLLG 434
+G GSFG+VY+ + + +++ + V QD + FKN E+ ++ + H N+VRL
Sbjct: 64 IGNGSFGVVYQAKLCDSGELVAIKK-----VLQD--KRFKNRELQIMRKLDHCNIVRLRY 116
Query: 435 F 435
F
Sbjct: 117 F 117
>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b)
pdb|1I09|B Chain B, Structure Of Glycogen Synthase Kinase-3 (Gsk3b)
pdb|1J1B|A Chain A, Binary Complex Structure Of Human Tau Protein Kinase I
With Amppnp
pdb|1J1B|B Chain B, Binary Complex Structure Of Human Tau Protein Kinase I
With Amppnp
pdb|1J1C|A Chain A, Binary Complex Structure Of Human Tau Protein Kinase I
With Adp
pdb|1J1C|B Chain B, Binary Complex Structure Of Human Tau Protein Kinase I
With Adp
pdb|2JLD|A Chain A, Extremely Tight Binding Of Ruthenium Complex To Glycogen
Synthase Kinase 3
pdb|2JLD|B Chain B, Extremely Tight Binding Of Ruthenium Complex To Glycogen
Synthase Kinase 3
pdb|3M1S|A Chain A, Structure Of Ruthenium Half-Sandwich Complex Bound To
Glycogen Synthase Kinase 3
pdb|3M1S|B Chain B, Structure Of Ruthenium Half-Sandwich Complex Bound To
Glycogen Synthase Kinase 3
pdb|3PUP|A Chain A, Structure Of Glycogen Synthase Kinase 3 Beta (Gsk3b) In
Complex With A Ruthenium Octasporine Ligand (Os1)
pdb|3PUP|B Chain B, Structure Of Glycogen Synthase Kinase 3 Beta (Gsk3b) In
Complex With A Ruthenium Octasporine Ligand (Os1)
Length = 420
Score = 29.6 bits (65), Expect = 4.2, Method: Compositional matrix adjust.
Identities = 20/61 (32%), Positives = 35/61 (57%), Gaps = 8/61 (13%)
Query: 376 VGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKN-EVFVISQTHHKNLVRLLG 434
+G GSFG+VY+ + + +++ + V QD + FKN E+ ++ + H N+VRL
Sbjct: 62 IGNGSFGVVYQAKLCDSGELVAIKK-----VLQD--KRFKNRELQIMRKLDHCNIVRLRY 114
Query: 435 F 435
F
Sbjct: 115 F 115
>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta
(Gsk3b) In Complex With Inhibitor 142
pdb|3SAY|B Chain B, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta
(Gsk3b) In Complex With Inhibitor 142
Length = 430
Score = 29.6 bits (65), Expect = 4.4, Method: Compositional matrix adjust.
Identities = 20/61 (32%), Positives = 35/61 (57%), Gaps = 8/61 (13%)
Query: 376 VGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKN-EVFVISQTHHKNLVRLLG 434
+G GSFG+VY+ + + +++ + V QD + FKN E+ ++ + H N+VRL
Sbjct: 62 IGNGSFGVVYQAKLCDSGELVAIKK-----VLQD--KRFKNRELQIMRKLDHCNIVRLRY 114
Query: 435 F 435
F
Sbjct: 115 F 115
>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACC|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACD|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACD|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACG|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACG|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACH|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACH|B Chain B, Gsk3b In Complex With Inhibitor
Length = 465
Score = 29.6 bits (65), Expect = 4.6, Method: Compositional matrix adjust.
Identities = 20/61 (32%), Positives = 35/61 (57%), Gaps = 8/61 (13%)
Query: 376 VGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKN-EVFVISQTHHKNLVRLLG 434
+G GSFG+VY+ + + +++ + V QD + FKN E+ ++ + H N+VRL
Sbjct: 107 IGNGSFGVVYQAKLCDSGELVAIKK-----VLQD--KRFKNRELQIMRKLDHCNIVRLRY 159
Query: 435 F 435
F
Sbjct: 160 F 160
>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With
3-Indolyl-4- Arylmaleimide Inhibitor
pdb|1R0E|B Chain B, Glycogen Synthase Kinase-3 Beta In Complex With
3-Indolyl-4- Arylmaleimide Inhibitor
Length = 391
Score = 29.6 bits (65), Expect = 4.7, Method: Compositional matrix adjust.
Identities = 20/61 (32%), Positives = 35/61 (57%), Gaps = 8/61 (13%)
Query: 376 VGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKN-EVFVISQTHHKNLVRLLG 434
+G GSFG+VY+ + + +++ + V QD + FKN E+ ++ + H N+VRL
Sbjct: 33 IGNGSFGVVYQAKLCDSGELVAIKK-----VLQD--KRFKNRELQIMRKLDHCNIVRLRY 85
Query: 435 F 435
F
Sbjct: 86 F 86
>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5
pdb|1OB3|B Chain B, Structure Of P. Falciparum Pfpk5
pdb|1V0P|A Chain A, Structure Of P. Falciparum Pfpk5-Purvalanol B Ligand
Complex
pdb|1V0P|B Chain B, Structure Of P. Falciparum Pfpk5-Purvalanol B Ligand
Complex
Length = 288
Score = 29.6 bits (65), Expect = 4.7, Method: Compositional matrix adjust.
Identities = 50/202 (24%), Positives = 80/202 (39%), Gaps = 47/202 (23%)
Query: 374 EEVGRGSFGIVYK---------------------GVIQTTRQ---VLLQLQSRNWIVFQD 409
E++G G++G+VYK G+ TT + +L +L+ N + D
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 410 GEREFKNEVFVISQTHHKNLVRLLGFCDEGLNRLLVYEF---LNNGTL----ASFLFGNL 462
K V V ++L +LL C+ GL + F L NG L +L
Sbjct: 68 VIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDL 126
Query: 463 KPSWNLRTN------IA-FQIARGLLYLHEDCSSQIILYSYKRTEGYVAPEWFRNS-TIT 514
KP NL N IA F +AR + +I+ T Y AP+ S +
Sbjct: 127 KPQ-NLLINREGELKIADFGLARAFGIPVRKYTHEIV------TLWYRAPDVLMGSKKYS 179
Query: 515 AKVDVYSFGFLLLEIISCRKSF 536
+D++S G + E+++ F
Sbjct: 180 TTIDIWSVGCIFAEMVNGTPLF 201
>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7
pdb|1UA2|B Chain B, Crystal Structure Of Human Cdk7
pdb|1UA2|C Chain C, Crystal Structure Of Human Cdk7
pdb|1UA2|D Chain D, Crystal Structure Of Human Cdk7
Length = 346
Score = 29.6 bits (65), Expect = 5.2, Method: Compositional matrix adjust.
Identities = 32/118 (27%), Positives = 57/118 (48%), Gaps = 13/118 (11%)
Query: 376 VGRGSFGIVYKGVIQTTRQVL----LQLQSRNWIVFQDG-EREFKNEVFVISQTHHKNLV 430
+G G F VYK + T Q++ ++L R+ +DG R E+ ++ + H N++
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEA--KDGINRTALREIKLLQELSHPNII 75
Query: 431 RLLGFCDEGLNRLLVYEFLNNGTLASFLFGN---LKPSWNLRTNIAFQIARGLLYLHE 485
LL N LV++F+ L + N L PS +++ + + +GL YLH+
Sbjct: 76 GLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPS-HIKAYMLMTL-QGLEYLHQ 130
>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A
Imidazopyridine Inhibitor
Length = 382
Score = 29.6 bits (65), Expect = 5.2, Method: Compositional matrix adjust.
Identities = 20/61 (32%), Positives = 35/61 (57%), Gaps = 8/61 (13%)
Query: 376 VGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKN-EVFVISQTHHKNLVRLLG 434
+G GSFG+VY+ + + +++ + V QD + FKN E+ ++ + H N+VRL
Sbjct: 40 IGNGSFGVVYQAKLCDSGELVAIKK-----VLQD--KRFKNRELQIMRKLDHCNIVRLRY 92
Query: 435 F 435
F
Sbjct: 93 F 93
>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A
Benzoimidazol Inhibitor
Length = 372
Score = 29.6 bits (65), Expect = 5.2, Method: Compositional matrix adjust.
Identities = 20/61 (32%), Positives = 35/61 (57%), Gaps = 8/61 (13%)
Query: 376 VGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKN-EVFVISQTHHKNLVRLLG 434
+G GSFG+VY+ + + +++ + V QD + FKN E+ ++ + H N+VRL
Sbjct: 41 IGNGSFGVVYQAKLCDSGELVAIKK-----VLQD--KRFKNRELQIMRKLDHCNIVRLRY 93
Query: 435 F 435
F
Sbjct: 94 F 94
>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective
Gsk-3 Inhibitors
pdb|4AFJ|B Chain B, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective
Gsk-3 Inhibitors
Length = 367
Score = 29.6 bits (65), Expect = 5.2, Method: Compositional matrix adjust.
Identities = 20/61 (32%), Positives = 35/61 (57%), Gaps = 8/61 (13%)
Query: 376 VGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKN-EVFVISQTHHKNLVRLLG 434
+G GSFG+VY+ + + +++ + V QD + FKN E+ ++ + H N+VRL
Sbjct: 36 IGNGSFGVVYQAKLCDSGELVAIKK-----VLQD--KRFKNRELQIMRKLDHCNIVRLRY 88
Query: 435 F 435
F
Sbjct: 89 F 89
>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With
Frattide Peptide
pdb|1GNG|B Chain B, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With
Frattide Peptide
Length = 378
Score = 29.6 bits (65), Expect = 5.4, Method: Compositional matrix adjust.
Identities = 20/61 (32%), Positives = 35/61 (57%), Gaps = 8/61 (13%)
Query: 376 VGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKN-EVFVISQTHHKNLVRLLG 434
+G GSFG+VY+ + + +++ + V QD + FKN E+ ++ + H N+VRL
Sbjct: 47 IGNGSFGVVYQAKLCDSGELVAIKK-----VLQD--KRFKNRELQIMRKLDHCNIVRLRY 99
Query: 435 F 435
F
Sbjct: 100 F 100
>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRK|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRL|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRL|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRM|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-
3beta Inhibitors
pdb|3ZRM|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-
3beta Inhibitors
Length = 371
Score = 29.6 bits (65), Expect = 5.4, Method: Compositional matrix adjust.
Identities = 20/61 (32%), Positives = 35/61 (57%), Gaps = 8/61 (13%)
Query: 376 VGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKN-EVFVISQTHHKNLVRLLG 434
+G GSFG+VY+ + + +++ + V QD + FKN E+ ++ + H N+VRL
Sbjct: 40 IGNGSFGVVYQAKLCDSGELVAIKK-----VLQD--KRFKNRELQIMRKLDHCNIVRLRY 92
Query: 435 F 435
F
Sbjct: 93 F 93
>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex
Length = 353
Score = 29.3 bits (64), Expect = 5.8, Method: Compositional matrix adjust.
Identities = 21/61 (34%), Positives = 36/61 (59%), Gaps = 8/61 (13%)
Query: 376 VGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKN-EVFVISQTHHKNLVRLLG 434
+G GSFG+VY+ + + + L+ ++ V QD + FKN E+ ++ + H N+VRL
Sbjct: 32 IGNGSFGVVYQAKLCDSGE-LVAIKK----VLQD--KRFKNRELQIMRKLDHCNIVRLRY 84
Query: 435 F 435
F
Sbjct: 85 F 85
>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor
That Attenuates Hyperactivity In Clock Mutant Mice
pdb|3SD0|B Chain B, Identification Of A Glycogen Synthase Kinase-3b Inhibitor
That Attenuates Hyperactivity In Clock Mutant Mice
pdb|4B7T|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide And Leucettine L4
Length = 350
Score = 29.3 bits (64), Expect = 5.9, Method: Compositional matrix adjust.
Identities = 21/61 (34%), Positives = 36/61 (59%), Gaps = 8/61 (13%)
Query: 376 VGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKN-EVFVISQTHHKNLVRLLG 434
+G GSFG+VY+ + + + L+ ++ V QD + FKN E+ ++ + H N+VRL
Sbjct: 28 IGNGSFGVVYQAKLCDSGE-LVAIKK----VLQD--KRFKNRELQIMRKLDHCNIVRLRY 80
Query: 435 F 435
F
Sbjct: 81 F 81
>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide And Inhibitor 7d
Length = 350
Score = 29.3 bits (64), Expect = 6.1, Method: Compositional matrix adjust.
Identities = 21/61 (34%), Positives = 36/61 (59%), Gaps = 8/61 (13%)
Query: 376 VGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKN-EVFVISQTHHKNLVRLLG 434
+G GSFG+VY+ + + + L+ ++ V QD + FKN E+ ++ + H N+VRL
Sbjct: 28 IGNGSFGVVYQAKLCDSGE-LVAIKK----VLQD--KRFKNRELQIMRKLDHCNIVRLRY 80
Query: 435 F 435
F
Sbjct: 81 F 81
>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase
3beta In Complex With An Inhibitor
pdb|3F7Z|B Chain B, X-ray Co-crystal Structure Of Glycogen Synthase Kinase
3beta In Complex With An Inhibitor
Length = 350
Score = 29.3 bits (64), Expect = 6.1, Method: Compositional matrix adjust.
Identities = 21/61 (34%), Positives = 36/61 (59%), Gaps = 8/61 (13%)
Query: 376 VGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKN-EVFVISQTHHKNLVRLLG 434
+G GSFG+VY+ + + + L+ ++ V QD + FKN E+ ++ + H N+VRL
Sbjct: 29 IGNGSFGVVYQAKLCDSGE-LVAIKK----VLQD--KRFKNRELQIMRKLDHCNIVRLRY 81
Query: 435 F 435
F
Sbjct: 82 F 82
>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis-
(Indole)maleimide Pyridinophane Inhibitor
pdb|2OW3|B Chain B, Glycogen Synthase Kinase-3 Beta In Complex With Bis-
(Indole)maleimide Pyridinophane Inhibitor
Length = 352
Score = 29.3 bits (64), Expect = 6.2, Method: Compositional matrix adjust.
Identities = 21/61 (34%), Positives = 36/61 (59%), Gaps = 8/61 (13%)
Query: 376 VGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKN-EVFVISQTHHKNLVRLLG 434
+G GSFG+VY+ + + + L+ ++ V QD + FKN E+ ++ + H N+VRL
Sbjct: 28 IGNGSFGVVYQAKLCDSGE-LVAIKK----VLQD--KRFKNRELQIMRKLDHCNIVRLRY 80
Query: 435 F 435
F
Sbjct: 81 F 81
>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex
pdb|3F88|B Chain B, Glycogen Synthase Kinase 3beta Inhibitor Complex
Length = 349
Score = 29.3 bits (64), Expect = 6.3, Method: Compositional matrix adjust.
Identities = 21/61 (34%), Positives = 36/61 (59%), Gaps = 8/61 (13%)
Query: 376 VGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGEREFKN-EVFVISQTHHKNLVRLLG 434
+G GSFG+VY+ + + + L+ ++ V QD + FKN E+ ++ + H N+VRL
Sbjct: 28 IGNGSFGVVYQAKLCDSGE-LVAIKK----VLQD--KRFKNRELQIMRKLDHCNIVRLRY 80
Query: 435 F 435
F
Sbjct: 81 F 81
>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5
pdb|1V0B|B Chain B, Crystal Structure Of The T198a Mutant Of Pfpk5
Length = 288
Score = 29.3 bits (64), Expect = 6.8, Method: Compositional matrix adjust.
Identities = 45/191 (23%), Positives = 77/191 (40%), Gaps = 35/191 (18%)
Query: 374 EEVGRGSFGIVYK---------------------GVIQTTRQ---VLLQLQSRNWIVFQD 409
E++G G++G+VYK G+ TT + +L +L+ N + D
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 410 GEREFKNEVFVISQTHHKNLVRLLGFCDEGLNRLLVYEF---LNNGTL----ASFLFGNL 462
K V V ++L +LL C+ GL + F L NG L +L
Sbjct: 68 VIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDL 126
Query: 463 KPSWNLRTNIAFQIARGLLYLHEDCSSQIILYSYK-RTEGYVAPEWFRNS-TITAKVDVY 520
KP NL N ++ L + Y+++ T Y AP+ S + +D++
Sbjct: 127 KPQ-NLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTIDIW 185
Query: 521 SFGFLLLEIIS 531
S G + E+++
Sbjct: 186 SVGCIFAEMVN 196
>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate
Ligand Complex
pdb|1V0O|B Chain B, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate
Ligand Complex
Length = 288
Score = 29.3 bits (64), Expect = 6.9, Method: Compositional matrix adjust.
Identities = 45/191 (23%), Positives = 77/191 (40%), Gaps = 35/191 (18%)
Query: 374 EEVGRGSFGIVYK---------------------GVIQTTRQ---VLLQLQSRNWIVFQD 409
E++G G++G+VYK G+ TT + +L +L+ N + D
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 410 GEREFKNEVFVISQTHHKNLVRLLGFCDEGLNRLLVYEF---LNNGTL----ASFLFGNL 462
K V V ++L +LL C+ GL + F L NG L +L
Sbjct: 68 VIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDL 126
Query: 463 KPSWNLRTNIAFQIARGLLYLHEDCSSQIILYSYK-RTEGYVAPEWFRNS-TITAKVDVY 520
KP NL N ++ L + Y+++ T Y AP+ S + +D++
Sbjct: 127 KPQ-NLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTIDIW 185
Query: 521 SFGFLLLEIIS 531
S G + E+++
Sbjct: 186 SVGCIFAEMVN 196
>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb
pdb|3MIA|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Atp-Bound
Human P-Tefb
Length = 351
Score = 28.9 bits (63), Expect = 7.7, Method: Compositional matrix adjust.
Identities = 33/141 (23%), Positives = 59/141 (41%), Gaps = 26/141 (18%)
Query: 375 EVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGERE-----FKNEVFVISQTHHKNL 429
++G+G+FG V+K + T Q + + V + E+E E+ ++ H+N+
Sbjct: 24 KIGQGTFGEVFKARHRKTGQKVALKK-----VLMENEKEGFPITALREIKILQLLKHENV 78
Query: 430 VRLLGFCD---EGLNR-----LLVYEF-------LNNGTLASFLFGNLKPSWNLRTNIAF 474
V L+ C NR LV++F L + L F +K + N +
Sbjct: 79 VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLY 138
Query: 475 QIARGLLYLHEDCSSQIILYS 495
I R + LH D + +L +
Sbjct: 139 YIHRNKI-LHRDMKAANVLIT 158
>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 331
Score = 28.9 bits (63), Expect = 7.8, Method: Compositional matrix adjust.
Identities = 33/141 (23%), Positives = 59/141 (41%), Gaps = 26/141 (18%)
Query: 375 EVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGERE-----FKNEVFVISQTHHKNL 429
++G+G+FG V+K + T Q + + V + E+E E+ ++ H+N+
Sbjct: 25 KIGQGTFGEVFKARHRKTGQKVALKK-----VLMENEKEGFPITALREIKILQLLKHENV 79
Query: 430 VRLLGFCD---EGLNR-----LLVYEF-------LNNGTLASFLFGNLKPSWNLRTNIAF 474
V L+ C NR LV++F L + L F +K + N +
Sbjct: 80 VNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLY 139
Query: 475 QIARGLLYLHEDCSSQIILYS 495
I R + LH D + +L +
Sbjct: 140 YIHRNKI-LHRDMKAANVLIT 159
>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And
Drb
pdb|4EC9|A Chain A, Crystal Structure Of Full-Length Cdk9 In Complex With
Cyclin T
Length = 373
Score = 28.9 bits (63), Expect = 7.9, Method: Compositional matrix adjust.
Identities = 33/141 (23%), Positives = 59/141 (41%), Gaps = 26/141 (18%)
Query: 375 EVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGERE-----FKNEVFVISQTHHKNL 429
++G+G+FG V+K + T Q + + V + E+E E+ ++ H+N+
Sbjct: 25 KIGQGTFGEVFKARHRKTGQKVALKK-----VLMENEKEGFPITALREIKILQLLKHENV 79
Query: 430 VRLLGFCD---EGLNR-----LLVYEF-------LNNGTLASFLFGNLKPSWNLRTNIAF 474
V L+ C NR LV++F L + L F +K + N +
Sbjct: 80 VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLY 139
Query: 475 QIARGLLYLHEDCSSQIILYS 495
I R + LH D + +L +
Sbjct: 140 YIHRNKI-LHRDMKAANVLIT 159
>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1
pdb|3BLQ|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 IN COMPLEX WITH
ATP
pdb|3BLR|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 IN COMPLEX WITH
Flavopiridol
pdb|3MY1|A Chain A, Structure Of Cdk9CYCLINT1 IN COMPLEX WITH DRB
pdb|3LQ5|A Chain A, Structure Of Cdk9CYCLINT IN COMPLEX WITH S-Cr8
pdb|3TN8|A Chain A, Cdk9CYCLIN T IN COMPLEX WITH CAN508
pdb|3TNH|A Chain A, Cdk9CYCLIN T IN COMPLEX WITH CAN508
pdb|3TNI|A Chain A, Structure Of Cdk9CYCLIN T F241L
pdb|4BCH|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCI|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCJ|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 331
Score = 28.9 bits (63), Expect = 8.2, Method: Compositional matrix adjust.
Identities = 33/141 (23%), Positives = 59/141 (41%), Gaps = 26/141 (18%)
Query: 375 EVGRGSFGIVYKGVIQTTRQVLLQLQSRNWIVFQDGERE-----FKNEVFVISQTHHKNL 429
++G+G+FG V+K + T Q + + V + E+E E+ ++ H+N+
Sbjct: 25 KIGQGTFGEVFKARHRKTGQKVALKK-----VLMENEKEGFPITALREIKILQLLKHENV 79
Query: 430 VRLLGFCD---EGLNR-----LLVYEF-------LNNGTLASFLFGNLKPSWNLRTNIAF 474
V L+ C NR LV++F L + L F +K + N +
Sbjct: 80 VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLY 139
Query: 475 QIARGLLYLHEDCSSQIILYS 495
I R + LH D + +L +
Sbjct: 140 YIHRNKI-LHRDMKAANVLIT 159
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.320 0.138 0.431
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 18,570,450
Number of Sequences: 62578
Number of extensions: 848413
Number of successful extensions: 3685
Number of sequences better than 100.0: 661
Number of HSP's better than 100.0 without gapping: 248
Number of HSP's successfully gapped in prelim test: 413
Number of HSP's that attempted gapping in prelim test: 2818
Number of HSP's gapped (non-prelim): 950
length of query: 573
length of database: 14,973,337
effective HSP length: 104
effective length of query: 469
effective length of database: 8,465,225
effective search space: 3970190525
effective search space used: 3970190525
T: 11
A: 40
X1: 16 ( 7.4 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.8 bits)
S2: 54 (25.4 bits)